<?xml version="1.0" encoding="UTF-8"?>
<Pathway xmlns="http://pathvisio.org/GPML/2013a" Name="Serotonin HTR1 group and FOS pathway" Organism="Homo sapiens">
  <Comment Source="WikiPathways-description">This pathway is courtesy of Ariadne Genomics Pathway Studio.</Comment>
  <Comment Source="WikiPathways-category">Cellular Process</Comment>
  <Graphics BoardWidth="938.0" BoardHeight="1602.0"/>
  <DataNode TextLabel="RPS6K" GraphId="a6431" Type="GeneProduct">
    <Comment>Functional Class RPS6K (ribosomal protein S6 kinase)</Comment>
    <Graphics Color="ff6600"/>
    </DataNode>
  <DataNode TextLabel="PKC" GraphId="ae0ca" Type="GeneProduct">
    <Comment>protein kinase C</Comment>
    <Graphics Color="ff6600"/>
    </DataNode>
  <DataNode TextLabel="GNAI1" GraphId="ae915" Type="Protein">
        </DataNode>
  <DataNode TextLabel="ELK1" GraphId="b1b8a" Type="GeneProduct">
    <Comment>ELK1, member of ETS oncogene family</Comment>
        </DataNode>
  <DataNode TextLabel="RASGRF1" GraphId="b456e" Type="GeneProduct">
    <Comment>RAS protein-specific guanine nucleotide-releasing factor 1</Comment>
        </DataNode>
  <DataNode TextLabel="MAP2K6" GraphId="b8237" Type="GeneProduct">
    <Comment>mitogen activated protein kinase kinase 6</Comment>
        </DataNode>
  <DataNode TextLabel="1,2-Diacetin" GraphId="b91eb" Type="Metabolite">
    <Comment>diacylglycerol</Comment>
    <Graphics Color="009900"/>
    </DataNode>
  <DataNode TextLabel="GNAI2" GraphId="b9df7" Type="Protein">
        </DataNode>
  <DataNode TextLabel="MAPK3" GraphId="bda33" Type="GeneProduct">
    <Comment>mitogen activated protein kinase 3</Comment>
        </DataNode>
  <DataNode TextLabel="Ras" GraphId="beaf5" Type="GeneProduct">
    <Comment>RAS oncogene homolog</Comment>
    <Graphics Color="ff6600"/>
    </DataNode>
  <DataNode TextLabel="HTR1D" GraphId="bf366" Type="Protein">
    <Graphics Color="cc0000"/>
    </DataNode>
  <DataNode TextLabel="HTR1A" GraphId="c3282" Type="Protein">
    <Graphics Color="cc0000"/>
    </DataNode>
  <DataNode TextLabel="PDPK1" GraphId="c3d64" Type="GeneProduct">
    <Comment>3-phosphoinositide dependent protein kinase-1</Comment>
        </DataNode>
  <DataNode TextLabel="PtdIns3P" GraphId="c56f6" Type="GeneProduct">
    <Comment>phosphatidylinositol 3,4,5-triphosphate</Comment>
    <Graphics Color="009900"/>
    </DataNode>
  <DataNode TextLabel="RASGRP1" GraphId="c6568" Type="GeneProduct">
    <Comment>RAS guanyl releasing protein 1</Comment>
        </DataNode>
  <DataNode TextLabel="Gb/g" GraphId="c67ec" Type="Complex">
    <Comment/>
    <Graphics Color="ff6600"/>
    </DataNode>
  <DataNode TextLabel="HTR1B" GraphId="c8d79" Type="Protein">
    <Graphics Color="cc0000"/>
    </DataNode>
  <DataNode TextLabel="RHOA" GraphId="cbd30" Type="GeneProduct">
    <Comment>ras homolog gene family, member A</Comment>
        </DataNode>
  <DataNode TextLabel="RAP1A" GraphId="cc60d" Type="GeneProduct">
    <Comment>RAS-related protein-1a</Comment>
        </DataNode>
  <DataNode TextLabel="GNAO1" GraphId="cedc2" Type="Protein">
        </DataNode>
  <DataNode TextLabel="PI3K" GraphId="d1342" Type="GeneProduct">
    <Comment>phosphatidylinositol 3-kinase</Comment>
    <Graphics Color="ff6600"/>
    </DataNode>
  <DataNode TextLabel="RPS6KA5" GraphId="d4bbc" Type="GeneProduct">
    <Comment>ribosomal protein S6 kinase, polypeptide 5</Comment>
        </DataNode>
  <DataNode TextLabel="GNAI3" GraphId="d4c53" Type="Protein">
        </DataNode>
  <DataNode TextLabel="HTR1E" GraphId="d7022" Type="Protein">
    <Graphics Color="cc0000"/>
    </DataNode>
  <DataNode TextLabel="MAP2K1" GraphId="d7383" Type="GeneProduct">
    <Comment>mitogen activated protein kinase kinase 1</Comment>
        </DataNode>
  <DataNode TextLabel="SRF" GraphId="d8696" Type="GeneProduct">
    <Comment>serum response factor</Comment>
        </DataNode>
  <DataNode TextLabel="ELK4" GraphId="d87ce" Type="GeneProduct">
    <Comment>ETS domain-containing protein Elk-4 (SRF accessory protein 1)</Comment>
        </DataNode>
  <DataNode TextLabel="PLC" GraphId="da47e" Type="GeneProduct">
    <Comment>phospholipase C</Comment>
    <Graphics Color="ff6600"/>
    </DataNode>
  <DataNode TextLabel="1,4,5-Insp3" GraphId="dbd89" Type="Metabolite">
    <Graphics Color="009900"/>
    </DataNode>
  <DataNode TextLabel="HTR1F" GraphId="de412" Type="Protein">
    <Graphics Color="cc0000"/>
    </DataNode>
  <DataNode TextLabel="MAPKAPK3" GraphId="de99a" Type="GeneProduct">
    <Comment>mitogen-activated protein kinase-activated protein kinase 3</Comment>
        </DataNode>
  <DataNode TextLabel="CREB1" GraphId="df2fc" Type="GeneProduct">
    <Comment>cAMP response element-binding protein 1</Comment>
        </DataNode>
  <DataNode TextLabel="BRAF" GraphId="e7898" Type="GeneProduct">
    <Comment>v-raf murine sarcoma viral oncogene homolog B1</Comment>
        </DataNode>
  <DataNode TextLabel="MAPKAPK2" GraphId="edbcf" Type="GeneProduct">
    <Comment>mitogen activated protein kinase 3</Comment>
        </DataNode>
  <DataNode TextLabel="MAP2K2" GraphId="edc2e" Type="GeneProduct">
    <Comment>mitogen activated protein kinase kinase 2</Comment>
        </DataNode>
  <DataNode TextLabel="MAPK14" GraphId="eea31" Type="GeneProduct">
    <Comment>mitogen activated protein kinase 14</Comment>
        </DataNode>
  <DataNode TextLabel="CALCIUM" GraphId="f039e" Type="Metabolite">
    <Graphics Color="009900"/>
    </DataNode>
  <DataNode TextLabel="MAP3K1" GraphId="f091e" Type="GeneProduct">
    <Comment>mitogen activated protein kinase kinase kinase 1</Comment>
        </DataNode>
  <DataNode TextLabel="FOS" GraphId="f4dd2" Type="GeneProduct">
    <Comment>proto-oncogene protein c-fos</Comment>
        </DataNode>
  <DataNode TextLabel="ITPR1" GraphId="f7c77" Type="GeneProduct">
    <Comment>inositol 1,4,5-triphosphate receptor 1</Comment>
        </DataNode>
  <DataNode TextLabel="MAP2K3" GraphId="f88a3" Type="GeneProduct">
    <Comment>mitogen activated protein kinase kinase 3</Comment>
        </DataNode>
  <DataNode TextLabel="Serotonin" GraphId="fb161" Type="Metabolite">
    <Graphics Color="009900"/>
    </DataNode>
  <DataNode TextLabel="MAPK1" GraphId="fe3cb" Type="GeneProduct">
    <Comment>mitogen activated protein kinase 1</Comment>
        </DataNode>
  <Interaction GraphId="a137a">
    <Comment>Binding HTR1A ---- serotonin</Comment>
    <Comment>These observations suggested that serotonergic nerves or other cell types in the saphenous vein are activated by field stimulation to release serotonin, which in turn activates presynaptic 5-HT 1A receptors on adrenergic neurons to effect norepinephrine release</Comment>
    <BiopaxRef>c58</BiopaxRef>
    <Graphics Color="990099">
      <Point GraphRef="fb161"/>
      <Point GraphRef="c3282"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="a21c0">
    <Comment>Binding GNAI1 ---- HTR1D</Comment>
    <Comment>Coexpression of the human 5-HT(1D) receptor with Galpha(i1), alpha(i2), alpha(i3), or Galpha(o)-proteins and Gbeta(1)gamma(2)-subunits reconstituted a Gpp(NH)p-sensitive, high affinity binding of [(3)H]5-HT to this receptor 
</Comment>
    <BiopaxRef>ff3</BiopaxRef>
    <Graphics Color="990099">
      <Point GraphRef="bf366"/>
      <Point GraphRef="ae915"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="a2beb">
    <Graphics Color="999900">
      <Point GraphRef="fe3cb"/>
      <Point GraphRef="a6431" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="a61f0">
    <Comment>Binding GNAO1 ---- HTR1F</Comment>
    <Comment>11916537 

Among the seven classes of serotonin (5-hydroxytryptamine, 5-HT) receptors which have been identified to date, the 5-HT(1) class is comprised of five receptor types, with the 5-HT(1A), 5-HT(1B) and 5-HT(1D) characterized by a high affinity for 5-carboxamido-tryptamine, the 5-HT(1E) and 5-HT(1F) characterized by a low affinity for this synthetic agonist, and all five having a nanomolar affinity for the endogenous indolamine ligand. 

</Comment>
    <Comment>14965240 Among the seven classes of serotonin (5-hydroxytryptamine, 5-HT) receptors which have been identified to date, the 5-HT(1) class is comprised of five receptor types, with the 5-HT(1A), 5-HT(1B) and 5-HT(1D) characterized by a high affinity for 5-carboxamido-tryptamine, the 5-HT(1E) and 5-HT(1F) characterized by a low affinity for this synthetic agonist, and all five having a nanomolar affinity for the endogenous indolamine ligand. 
</Comment>
    <BiopaxRef>f8d</BiopaxRef>
    <BiopaxRef>f3f</BiopaxRef>
    <Graphics Color="990099">
      <Point GraphRef="de412"/>
      <Point GraphRef="cedc2"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="a693b">
    <Comment>DirectRegulation Ras --+&gt; BRAF</Comment>
    <Comment>14984580 BRAF, a serine/threonine kinase, is a component of the retrovirus-associated sequence (RAS)-RAF-extracellular-regulated protein kinase (ERK)-MAP kinase signal transduction pathway mediating signals from RAS to ERK. 

8887643 Unexpectedly, yeast two-hybrid binding analyses showed that although both Ras and TC21 could interact with the isolated Ras-binding domain of Raf-1, only Ras interacted with full-length Raf-1, A-Raf, or B-Raf. 

11032810 In this report, we examined the potential phosphorylation sites in B-Raf responsible for Ras-induced activation. 

11856330 However, clear inhibition of the interaction between Ras and B-Raf was not observed (Fig. 3C ). 

11283246 In UT7-Mpl cells, Raf-1 but not B-Raf mediates the Ras-induced activation of Elk1. 

8687465 (Organ: brain) These results suggest that there is a subtle structural difference in requirements for the interaction of Ras with Raf-1 and B-Raf. 

8617731 (Organ: brain) In rat brain the association of MEK1 with Ras is dependent on B-Raf, not on Raf-1( 14 ) . 

7744815 (Organ: brain) GTP-Ras directly interacts with B-Raf (13, 14) and c-Raf-1 ( 19 , 20 , 21 , 22 , 23 , 24 ) . 

11696358 (Organ: kidney, CellLineName: 293) On the other hand, Ras-dependent extracellular signal-regulated kinase/mitogen-activated protein kinase kinase stimulator (a complex of B-Raf and 14-3-3) failed to activate Raf-1 in our cell-free system. 

8622647 (CellLineName: NIH 3T3) B-Raf was not detectably tyrosine phosphorylated, membrane localized, or further activated upon Ras transformation, even though B-Raf has been shown to bind to Ras in vitro. 

</Comment>
    <BiopaxRef>a26</BiopaxRef>
    <BiopaxRef>ba7</BiopaxRef>
    <BiopaxRef>d4f</BiopaxRef>
    <BiopaxRef>bd0</BiopaxRef>
    <BiopaxRef>bad</BiopaxRef>
    <BiopaxRef>e7d</BiopaxRef>
    <BiopaxRef>cde</BiopaxRef>
    <BiopaxRef>a3b</BiopaxRef>
    <BiopaxRef>f96</BiopaxRef>
    <BiopaxRef>a79</BiopaxRef>
    <Graphics>
      <Point GraphRef="beaf5"/>
      <Point GraphRef="e7898" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="a698b">
    <Comment>Binding GNAI2 ---- HTR1D</Comment>
    <Comment>Coexpression of the human 5-HT(1D) receptor with Galpha(i1), alpha(i2), alpha(i3), or Galpha(o)-proteins and Gbeta(1)gamma(2)-subunits reconstituted a Gpp(NH)p-sensitive, high affinity binding of [(3)H]5-HT to this receptor 
</Comment>
    <BiopaxRef>f8c</BiopaxRef>
    <Graphics Color="990099">
      <Point GraphRef="c8d79"/>
      <Point GraphRef="d4c53"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="a8402">
    <Comment>Regulation PKC --+&gt; RAP1A</Comment>
    <Comment>10629034 (CellType: platelet) Here we show that thrombin induces a second phase of Rap1 activation, which is mediated by protein kinase C (PKC). 

15078882 (CellType: platelet) Intracellular Ca2+ and protein kinase C have been proposed to mediate agonist-induced Rap1B activation in platelets ( 10 , 11 ). 
</Comment>
    <BiopaxRef>ef4</BiopaxRef>
    <BiopaxRef>eaa</BiopaxRef>
    <Graphics>
      <Point GraphRef="ae0ca"/>
      <Point GraphRef="cc60d" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="a8f2f">
    <Comment>ChemicalReaction 1,2-Diacetin; PLC; 1,4,5-Insp3</Comment>
    <Comment>The PLC that hydrolyzes PC-PLC generates the products phosphocholine and DAG. 
</Comment>
    <BiopaxRef>a0b</BiopaxRef>
    <Graphics>
      <Point GraphRef="da47e"/>
      <Point GraphRef="dbd89" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="a93b7">
    <Comment>ProtModification MAPK3 --+&gt; ELK4</Comment>
    <Comment>MedLine Reference  9130707  
Sentence  Sap-1a is phosphorylated by ERK-1.  
Source  Ariadne Pathways  
</Comment>
    <BiopaxRef>ff5</BiopaxRef>
    <Graphics Color="999900">
      <Point GraphRef="bda33"/>
      <Point GraphRef="d87ce" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="a962a">
    <Comment>ProtModification BRAF --+&gt; MAP2K2,</Comment>
    <Comment>12801936 (Organ: pituitar, Tissue: epithelia) ERKs are activated by the mitogen-activated protein kinase kinases, MEK1 and MEK2, which are activated by the MEK kinases, Raf-1, A-Raf, and B-Raf. 

10783132 (Organ: lung, Tissue: epithelia) Raf-1 and B-Raf are serine/threonine-protein kinases that selectively phosphorylate and activate MEK1 and MEK2 ( 22 ). 

8621389 Raf-1 and B-Raf are serine/threonine-protein kinases that selectively phosphorylate and activate MEK 1 and MEK 2( 14 , 15 , 16 , 17 ) . 

12351703 Next, actions of the D2 receptor on c-Raf and B-Raf, which phosphorylate MEK1/2, were examined (Fig. 10 ). 

8668348 We show that, consequently, B-Raf interacts with MEK-1 and MEK-2 with a better affinity than does c-Raf-1, thus strengthening the notion that B-Raf is a stronger MEK activator than c-Raf-l. 

15153095 (CellType: neural) In addition, MEK1/2 can be activated by B-Raf, a neuron-enriched isoform of Raf, which is in turn activated by a cAMP-responsive Ras homologue called Rap-1 [ 41 ]. 

9733801 (CellLineName: COS I) A , quantitative analysis of the interaction of Raf-1 and B-Raf with MEK-1 and MEK-2 in the yeast two-hybrid system. 

12738761 Next, actions of the D2 receptor on c-Raf and B-Raf, which phosphorylate MEK1/2, were examined (Fig. 10 ). 
</Comment>
    <BiopaxRef>c57</BiopaxRef>
    <BiopaxRef>fc5</BiopaxRef>
    <BiopaxRef>c5d</BiopaxRef>
    <BiopaxRef>dec</BiopaxRef>
    <BiopaxRef>a75</BiopaxRef>
    <BiopaxRef>c1c</BiopaxRef>
    <BiopaxRef>c80</BiopaxRef>
    <BiopaxRef>b29</BiopaxRef>
    <Graphics Color="999900">
      <Point GraphRef="e7898"/>
      <Point GraphRef="edc2e" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="aa3a9">
    <Comment>Binding GNAI2 ---- HTR1F</Comment>
    <Comment>Among the seven classes of serotonin (5-hydroxytryptamine, 5-HT) receptors which have been identified to date, the 5-HT(1) class is comprised of five receptor types, with the 5-HT(1A), 5-HT(1B) and 5-HT(1D) characterized by a high affinity for 5-carboxamido-tryptamine, the 5-HT(1E) and 5-HT(1F) characterized by a low affinity for this synthetic agonist, and all five having a nanomolar affinity for the endogenous indolamine ligand. </Comment>
    <BiopaxRef>f3f</BiopaxRef>
    <Graphics Color="990099">
      <Point GraphRef="de412"/>
      <Point GraphRef="b9df7"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="aaeb6">
    <Comment>Binding GNAI2 ---- HTR1D</Comment>
    <Comment>Coexpression of the human 5-HT(1D) receptor with Galpha(i1), alpha(i2), alpha(i3), or Galpha(o)-proteins and Gbeta(1)gamma(2)-subunits reconstituted a Gpp(NH)p-sensitive, high affinity binding of [(3)H]5-HT to this receptor 
</Comment>
    <BiopaxRef>f8c</BiopaxRef>
    <Graphics Color="990099">
      <Point GraphRef="bf366"/>
      <Point GraphRef="b9df7"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="aaeff">
    <Comment>Binding GNAI1 ---- HTR1F</Comment>
    <Comment>Among the seven classes of serotonin (5-hydroxytryptamine, 5-HT) receptors which have been identified to date, the 5-HT(1) class is comprised of five receptor types, with the 5-HT(1A), 5-HT(1B) and 5-HT(1D) characterized by a high affinity for 5-carboxamido-tryptamine, the 5-HT(1E) and 5-HT(1F) characterized by a low affinity for this synthetic agonist, and all five having a nanomolar affinity for the endogenous indolamine ligand. 
</Comment>
    <BiopaxRef>f3f</BiopaxRef>
    <Graphics Color="990099">
      <Point GraphRef="de412"/>
      <Point GraphRef="ae915"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="ac0a6">
    <Comment>MolSynthesis PI3K --+&gt; PtdIns3P</Comment>
    <Comment>15826941 PI3K activity depends on the production of phosphatidylinositol 3,4,5-triphosphate, a messenger molecule produced in response to a variety of growth factors. 

12970364 Activation of PI 3-kinase generates phosphatidylinositol 3,4,5-triphosphate (PIP3) and thereby stimulates anti-apoptotic proteins ( 26 ). 

12595573 Alternatively, phosphatidylinositol 3,4,5-triphosphate generated by PI3K may activate downstream components that serve to enhance AC activity. 
</Comment>
    <BiopaxRef>eeb</BiopaxRef>
    <BiopaxRef>b53</BiopaxRef>
    <BiopaxRef>b07</BiopaxRef>
    <Graphics Color="009999">
      <Point GraphRef="d1342"/>
      <Point GraphRef="c56f6" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="aca12">
    <Graphics Color="999900">
      <Point GraphRef="edbcf"/>
      <Point GraphRef="d8696" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="acdb2">
    <Comment>Binding GNAO1 ---- HTR1E</Comment>
    <Comment>All the 5-HT(1) receptor types actually interact with G alpha i/G alpha o proteins to inhibit adenylyl cyclase and modulate ionic effectors, i.e. potassium and/or calcium channels. 
</Comment>
    <BiopaxRef>f3f</BiopaxRef>
    <Graphics Color="990099">
      <Point GraphRef="d7022"/>
      <Point GraphRef="cedc2"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="acf2c">
    <Comment>Regulation RASGRP1 --+&gt; Ras</Comment>
    <Comment>10777559 Both Ras-GRF and Ras-GRP/CalDAG-GEFII activate Ras and R-Ras; therefore, these GEFs appear to have two pathways for activation of JNK . 

12782630 Sos and RasGRP proteins are involved in linking the activation of membrane or cytoplasmic tyrosine kinases with the stimulation of Ras GTPases ( 8 ). 

10807788 (CellType: t cell) Here we show that RasGRP, a Ras activator that contains calcium-binding EF hands and a DAG-binding domain, is expressed in T cells. 

15604236 (CellType: keratinocyte) TPA may activate PLCe through Ras activation, which is mediated by RasGRP1, a TPA-regulated Ras-specific guanine nucleotide exchange factor (GEF) expressed in keratinocytes (13) . 

12070163 (CellType: t cell) Activated RasGRP ( 34 , 35 ) and PKCeta ( 36 , 37 ) in turn stimulate the Ras-ERK-AP-1 and NFkappaB pathways, respectively. 

14532295 (CellType: keratinocyte) This result suggests that, although RasGRP1 can directly activate Ras in response to phorbol esters, PKC is still required for the downstream stimulation of the Raf/MEK/ERK pathway. 

17190838 (CellType: MAST) These data indicated that N-Ras is the Ras member that is activated by RasGRP1 in mast cells. 

11395491 (CellLineName: JURKAT) Recent studies have demonstrated that overexpression of another exchange factor for Ras, RasGRP, can enhance TCR-Ras-Erk signaling and increase interleukin-2 production in Jurkat cells ( 18 ). 

14970203 (CellLineName: WEHI 231) This could be due to synergy between RasGRP1-mediated Ras activation and parallel BCR-initiated signaling pathways not involving Ras activation. 

11120810 (CellType: t cell, CellLineName: JURKAT) RasGRP can mediate Ras activation in response to TCR cross-linking in Jurkat T cells and RasGRP overexpression enhances TCR-mediated activation of ERK ( 23 ). 

</Comment>
    <BiopaxRef>e8e</BiopaxRef>
    <BiopaxRef>bf1</BiopaxRef>
    <BiopaxRef>e89</BiopaxRef>
    <BiopaxRef>c9f</BiopaxRef>
    <BiopaxRef>bcd</BiopaxRef>
    <BiopaxRef>c36</BiopaxRef>
    <BiopaxRef>d08</BiopaxRef>
    <BiopaxRef>eab</BiopaxRef>
    <BiopaxRef>d4d</BiopaxRef>
    <BiopaxRef>d27</BiopaxRef>
    <Graphics LineStyle="Broken">
      <Point GraphRef="c6568"/>
      <Point GraphRef="beaf5" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="ad624">
    <Comment>MolTransport GNAI3 --+&gt; Gb/g</Comment>
    <Graphics Color="666666">
      <Point GraphRef="d4c53"/>
      <Point GraphRef="c67ec" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="ae40b">
    <Comment>Binding GNAO1 ---- HTR1D</Comment>
    <Comment>Coexpression of the human 5-HT(1D) receptor with Galpha(i1), alpha(i2), alpha(i3), or Galpha(o)-proteins and Gbeta(1)gamma(2)-subunits reconstituted a Gpp(NH)p-sensitive, high affinity binding of [(3)H]5-HT to this receptor 
</Comment>
    <BiopaxRef>f8c</BiopaxRef>
    <Graphics Color="990099">
      <Point GraphRef="bf366"/>
      <Point GraphRef="cedc2"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="b30dc">
    <Comment>ProtModification MAP3K1 --+&gt; MAP2K3</Comment>
    <Comment>9006914 Activation of the JNK/p38 protein kinases involves a kinase cascade in which the upstream activator MAP kinase kinase kinase (MEKK) phosphorylates and activates MAP kinase kinase 3, 4, and 6 (MKK 3, 4 and 6), which in turn phosphorylate and activate JNK and p38 MAP kinases ( 34-37 ). 

9065412 Although Mekk1 could phosphorylate Mek1, Mek2, Sek1, and MKK3, when it was expressed at physiological levels, only SAP kinase was markedly activated without Hog ( 13 ) or Erk ( 34 ) stimulation. 

10358048 Each cascade consists of a three kinase module: a MAP kinase, a MAP kinase/ERK kinase (MEK ) that activates the MAP kinase, and a MEK kinase (MEKK ) that activates the MEK ( 3 ). 

10644746 (CellLineName: 293T) Cotransfection of the cells with ASK-1 , a MEK kinase known to activate MEK3, resulted in increases in luciferase activity of up to 10-fold (data not shown). 

11304531 (CellLineName: HEK 293) For example, MEKK1 preferentially activates MKK3, MKK4, and MKK6 rather than MKK7 ( 39 ), whereas MEKK4 activates MKK3 and MKK6 rather than MKK4 ( 40 ). 

11306453 In response to extracellular stimuli, MEKK1 is a strong activator of MKK4 and MKK7, and a weaker activator of MKK3 and MKK6 (Fig. 1 A ; Ref. 19 ). 

7797459 MEKK1 can activate MKK4, MKK3, MEK1, and MEK2( 27 , 46 , 47 ) , suggesting that MEKKs have a broader substrate specificity than MEKs. 

11956220 MEKK1 can also activate MEK3, which subsequently activates p38 MAPKs ( 30 , 31 ). 

11698415 (CellType: keratinocyte) MEKK1, in turn, activates MEK1, MEK3, and MEK7 ( 17 , 34 ). 

9639556 (CellType: keratinocyte) MEKK1, however, was found to activate additional MAPKKs, including Jun amino (N)-terminal kinase kinase 1(MKK4) [JNKK1(MKK4)] (DA?A&#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189;rijard et al. 1995 ; Lin et al. 1995 ), JNKK2(MKK7) (Wu et al. 1997 ), MKK3, and MKK6 (Stein et al. 1996 ). 

</Comment>
    <BiopaxRef>e4c</BiopaxRef>
    <BiopaxRef>d9a</BiopaxRef>
    <BiopaxRef>a8f</BiopaxRef>
    <BiopaxRef>e13</BiopaxRef>
    <BiopaxRef>cb9</BiopaxRef>
    <BiopaxRef>bf3</BiopaxRef>
    <BiopaxRef>fe4</BiopaxRef>
    <BiopaxRef>e01</BiopaxRef>
    <BiopaxRef>ee6</BiopaxRef>
    <BiopaxRef>b1e</BiopaxRef>
    <Graphics Color="999900">
      <Point GraphRef="f091e"/>
      <Point GraphRef="f88a3" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="b42e7">
    <Comment>Binding GNAI3 ---- HTR1A</Comment>
    <Comment>Taken together, these data show that low but not high concentrations of high-efficacy 5-HT(1A) agonists direct receptor signaling to Galpha(i3). In contrast, partial agonists favor h5-HT(1A) receptor signaling to Galpha(i3) over a wide concentration range, whereas inverse agonists inhibit constitutive Galpha(i3) activation. 
</Comment>
    <BiopaxRef>b38</BiopaxRef>
    <Graphics Color="990099">
      <Point GraphRef="c3282"/>
      <Point GraphRef="d4c53"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="b4a20">
    <Comment>ProtModification BRAF --+&gt; MAP2K1,</Comment>
    <Comment>12167697 Reactions were immunoblotted as indicated. (B) The reactions were identical to those for panel A, except that recombinant WT-MEK1 activated by recombinant B-Raf in vitro was used to phosphorylate the immunoprecipitated ERKs. 

12351703 V., Calleja V., Scimeca J.-C., Filloux C., Calothy G. and Van Obberghen E. (1995) Regulation of the MAP kinases cascade in PC12 cells: B-Raf activates MEK-1 (MAP kinase or ERK kinase) and is inhibited by cAMP. 

15153095 In addition, MEK1/2 can be activated by B-Raf, a neuron-enriched isoform of Raf, which is in turn activated by a cAMP-responsive Ras homologue called Rap-1 [ 41 ]. 

14570902 The activated Ras and Rap1 stimulate sequential activation of Raf serine/threonine kinases C-Raf and B-Raf, respectively, which in turn activate MEK1/ERKs. 

7559496 We also showed that B-Raf interacts in vivo with Mek-1 and phosphorylates this protein on both serine 218 and 222( 25 ) . 

15572664 Activated B-Raf activates MEK1, which in turn phosphorylates and activates ERK1/2 for a sustained period. 

8668348 We show that, consequently, B-Raf interacts with MEK-1 and MEK-2 with a better affinity than does c-Raf-1, thus strengthening the notion that B-Raf is a stronger MEK activator than c-Raf-l. 

7731720 However, there has been no evidence for a direct interaction between B-Raf and Mek-1. 

12218141 (CellType: neutrophil) This is consistent with other findings that C5a causes the activation of Raf-1 and B-Raf, which are upstream stimulators of MEK-1 in human neutrophils, with a peak of activation at 5 min, followed by suppressed activation thereafter ( 38 ). 

</Comment>
    <BiopaxRef>ea0</BiopaxRef>
    <BiopaxRef>c27</BiopaxRef>
    <BiopaxRef>c94</BiopaxRef>
    <BiopaxRef>c14</BiopaxRef>
    <BiopaxRef>bb9</BiopaxRef>
    <BiopaxRef>fa5</BiopaxRef>
    <BiopaxRef>a28</BiopaxRef>
    <BiopaxRef>e2b</BiopaxRef>
    <BiopaxRef>cc1</BiopaxRef>
    <BiopaxRef>a9d</BiopaxRef>
    <Graphics Color="999900">
      <Point GraphRef="e7898"/>
      <Point GraphRef="d7383" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="b6462">
    <Comment>Binding HTR1F ---- serotonin,</Comment>
    <Comment>Among the seven classes of serotonin (5-hydroxytryptamine, 5-HT) receptors which have been identified to date, the 5-HT(1) class is comprised of five receptor types, with the 5-HT(1A), 5-HT(1B) and 5-HT(1D) characterized by a high affinity for 5-carboxamido-tryptamine, the 5-HT(1E) and 5-HT(1F) characterized by a low affinity for this synthetic agonist, and all five having a nanomolar affinity for the endogenous indolamine ligand. </Comment>
    <BiopaxRef>f3f</BiopaxRef>
    <Graphics Color="990099">
      <Point GraphRef="fb161"/>
      <Point GraphRef="de412"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="b6c11">
    <Comment>PromoterBinding CREB1 --+&gt; FOS</Comment>
    <Comment>Source  Ariadne Pathways  
MedLine Reference  9528766:10034  
Sentence  In addition to the TCF-SRF complex, the cyclic AMP response element binding protein (CREB), which binds to three separate sequences within the c- fos promoter distinct from the SRE, appears to be required for NGF induction of c- fos transcription ( 5 , 24 ).  

--------------------------------------------------------------------------------
Source  Ariadne Pathways  
MedLine Reference  9473689:5  
Sentence  We propose a model in which inflammation-induced phosphorylation of CREB relieves CREB repression at the DYNCRE3 site, P-CREB binds to the c-Fos promoter, and Fos/Fra, P-CREB, and P-c-Jun interact at the DYNCRE3 site to activate prodynorphin gene transcription.  

--------------------------------------------------------------------------------
Journal Link  http://www.jimmunol.org/cgi/content/full/173/5/3557  
Source  Ariadne Pathways  
MedLine Reference  15322221:10104  
Sentence  The site that CREB binds to the c -fos promoter is a CRE centered on the ?57 nt.  
Journal  J. Immunol  
Journal Reference  v173 i5 p3557  
</Comment>
    <BiopaxRef>b9e</BiopaxRef>
    <BiopaxRef>dbd</BiopaxRef>
    <Graphics Color="009900">
      <Point GraphRef="df2fc"/>
      <Point GraphRef="f4dd2" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="b835d">
    <Comment>Binding HTR1D ---- serotonin</Comment>
    <Comment>[3H]5-HT binding, in the presence of pindolol (to block 5-HT1A and 5-HT1B receptors) and mesulergine (to block 5-HT1C receptors), was specific, saturable, reversible, and of high affinity. </Comment>
    <BiopaxRef>bd4</BiopaxRef>
    <Graphics Color="990099">
      <Point GraphRef="fb161"/>
      <Point GraphRef="bf366"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="b8c07">
    <Comment>Binding HTR1E ---- serotonin</Comment>
    <Comment>Among the seven classes of serotonin (5-hydroxytryptamine, 5-HT) receptors which have been identified to date, the 5-HT(1) class is comprised of five receptor types, with the 5-HT(1A), 5-HT(1B) and 5-HT(1D) characterized by a high affinity for 5-carboxamido-tryptamine, the 5-HT(1E) and 5-HT(1F) characterized by a low affinity for this synthetic agonist, and all five having a nanomolar affinity for the endogenous indolamine ligand. </Comment>
    <BiopaxRef>d9c</BiopaxRef>
    <Graphics Color="990099">
      <Point GraphRef="fb161"/>
      <Point GraphRef="d7022"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="b8d8e">
    <Comment>Binding GNAI3 ---- HTR1F</Comment>
    <Comment>Among the seven classes of serotonin (5-hydroxytryptamine, 5-HT) receptors which have been identified to date, the 5-HT(1) class is comprised of five receptor types, with the 5-HT(1A), 5-HT(1B) and 5-HT(1D) characterized by a high affinity for 5-carboxamido-tryptamine, the 5-HT(1E) and 5-HT(1F) characterized by a low affinity for this synthetic agonist, and all five having a nanomolar affinity for the endogenous indolamine ligand. 
</Comment>
    <BiopaxRef>f3f</BiopaxRef>
    <Graphics Color="990099">
      <Point GraphRef="de412"/>
      <Point GraphRef="d4c53"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="b956a">
    <Comment>DirectRegulation RASGRF1 --+&gt; RAP1A</Comment>
    <Comment>10196191 In contrast, mutation of residue 70 does not affect the interaction of Cdc25 Mm with Rap1A and even increases the activity toward Ras(Q70L) almost 2-fold, indicating that residue 70 has an important role in the interaction with C3G but not as much with Cdc25 Mm . 

15572660 (Tissue: endothelial) However, RasGRP2 is a Rap1 activator and not a Ras activator, whereas RasGRP3 is an activator of Ras and Rap1. 

15213298 RasGRP3 activates both Ras and Rap1 (Yamashita et al., 2000 ), and RasGRP4 activates Ras (Reuther et al., 2002 ; Yang et al., 2002 ). 
</Comment>
    <BiopaxRef>deb</BiopaxRef>
    <BiopaxRef>dfa</BiopaxRef>
    <BiopaxRef>c19</BiopaxRef>
    <Graphics>
      <Point GraphRef="b456e"/>
      <Point GraphRef="cc60d" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="bb7f0">
    <Comment>DirectRegulation RAP1A --+&gt; BRAF</Comment>
    <Comment>15064721 Our study further showed that the E1/4 cell-specific B-Raf activity was stimulated by PLC gamma and subsequent Rap1 activation. 

10854065 (CellType: spermatid) Moreover, in mouse spermatids, i.e., the haploid cytodifferentiating cells, a so far unidentified protein complex formed by endogenous Rap1/B-Raf/14-3-3 theta can be coimmunoprecipitated. 

11950876 Rap1, a Ras-related G protein, has been reported to activate B-Raf but to inhibit Raf-1 (Vossler et al., 1997 ). 

12855697 (Tissue: lymph, CellType: t cell) Recent studies indicate that Rap1 activates B-Raf by recruiting B-Raf to the membrane. 

15572664 By recruiting a different set of adapter proteins, TrkA causes an activation of Rap-1 that stimulates B-Raf. 

12446733 In contrast to Raf-1, B-Raf is activated by Rap1. 

12351703 Activation of G o releases Rap1-GTPase activating protein to inhibit Rap1- induced B-Raf activation ( 65 ), providing an appealing mechanism for G o-mediated D2S action. 

14963045 (Organ: gastric, Tissue: epithelia) Rap1 activates B-Raf and subsequently induces sustained Erk activation by a growth factor. 

9094716 (CellType: neural, CellLineName: PC 12) Rap1, activated by mutation or by the cAMP-dependent protein kinase PKA, is a selective activator of B-Raf and an inhibitor of Raf-1. 

10976102 (CellType: fibroblast, CellLineName: Swiss 3T3) Rap1 then activates B-Raf and thereby MEK and ERK ( 38 , 53-55 ). 

</Comment>
    <BiopaxRef>a0a</BiopaxRef>
    <BiopaxRef>e64</BiopaxRef>
    <BiopaxRef>beb</BiopaxRef>
    <BiopaxRef>bc4</BiopaxRef>
    <BiopaxRef>d92</BiopaxRef>
    <BiopaxRef>cd5</BiopaxRef>
    <BiopaxRef>fc3</BiopaxRef>
    <BiopaxRef>f4a</BiopaxRef>
    <BiopaxRef>e98</BiopaxRef>
    <BiopaxRef>a28</BiopaxRef>
    <Graphics>
      <Point GraphRef="cc60d"/>
      <Point GraphRef="e7898" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="bc755">
    <Comment>ProtModification MAPK3 --+&gt; MAPKAPK2</Comment>
    <Comment>MedLine Reference  10625698:1036  
Sentence  Activated MAPK interacts with a number of downstream targets, including the p90 ribosomal S6 kinase (p90 Rsk ) ( 19 ) and MAPK-activated protein kinase-2 (MAPKAP-K2 ) ( 20 , 21 ), which are activated by ERK1/2 and p38 MAPK , respectively.  
Journal  J. Biol. Chem  
Journal Reference  v275 i2 p1457 (2000)  
Journal Link  http://www.jbc.org/cgi/content/full/275/2/1457  
Organ  ventricle  
CellType  myocyte  
Source  Ariadne Pathways  
--------------------------------------------------------------------------------
MedLine Reference  7923353:0  
Sentence  MAPK-activated protein kinase-2 (MAPKAP kinase-2) is activated in vitro by the p42 and p44 isoforms of MAPK (p42/p44MAPK).  
Source  Ariadne Pathways  
--------------------------------------------------------------------------------
MedLine Reference  8900202:1138  
Sentence  MBP is an efficient substrate for ERK1 and ERK2, whereas GST-cJun (1-169) includes the activating phosphorylation sites Ser-63 and Ser-73, which have been shown to be phosphorylated by SAPK/JNK but not by ERK1, ERK2, or p38 HOG1 ( 3 ). 2 Similarly, hsp27 is an efficient substrate for MAPKAPK2, which in turn is predominantly activated by p38 HOG1, although MAPKAPK2 can also be phosphorylated in vitro by ERK1 and ERK2 ( 29 , 30 ). -- Fig. 2.  
Journal  J. Biol. Chem  
Journal Reference  v271 i43 p27107 (1996)  
Journal Link  http://www.jbc.org/cgi/content/full/271/43/27107  
CellLineName  Pam 212  
Source  Ariadne Pathways  

--------------------------------------------------------------------------------
MedLine Reference  7592979:1021  
Sentence  In this article we use a recombinant glutathione S -transferase (GST)-MAPKAP kinase 2-fusion protein and various mutants to study the mechanism of activation of MAPKAP kinase 2 by p44 (ERK1) and p38/40 (RK) in vitro .  
Journal  J. Biol. Chem  
Journal Reference  v270 i45 p27213 (1995)  
Journal Link  http://www.jbc.org/cgi/content/full/270/45/27213  
Source  Ariadne Pathways  

--------------------------------------------------------------------------------
MedLine Reference  10753939:1120  
Sentence  The ERK1 and ERK2 activator, MEK1 , has also been observed to activate MAPKAPK2 ( 58 ).  
Journal  J. Biol. Chem  
Journal Reference  v275 i15 p11284 (2000)  
Journal Link  http://www.jbc.org/cgi/content/full/275/15/11284  
Source  Ariadne Pathways  
</Comment>
    <BiopaxRef>a49</BiopaxRef>
    <BiopaxRef>b42</BiopaxRef>
    <BiopaxRef>c40</BiopaxRef>
    <BiopaxRef>a59</BiopaxRef>
    <BiopaxRef>f80</BiopaxRef>
    <Graphics Color="999900">
      <Point GraphRef="bda33"/>
      <Point GraphRef="edbcf" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="bcb29">
    <Comment>G protein beta/gamma</Comment>
    <Comment>Binding Gb/g ---- GNAO1</Comment>
    <Comment>11124982 If the Getagamma subunits served as linkers, dialyzing Galpha o should have bound the Getagamma subunits, prevented their activation, and thus depolarized the cell. 

(Tissue: plasma) Of interest, when mutations that disrupt interactions of Ga o with G&#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189;&#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189;&#195;&#142;&#194;&#169;&#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189;&#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189;&#195;&#142;&#194;&#169;&#195;&#142;&#194;&#169;&#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189;&#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189;&#195;&#142;&#194;&#169;&#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189;&#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189;&#195;&#142;&#194;&#169;&#195;&#142;&#194;&#169;&#195;&#142;&#194;&#169;&#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189;&#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189;&#195;&#142;&#194;&#169;&#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189;&#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189;&#195;&#142;&#194;&#169;&#195;&#142;&#194;&#169;&#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189;&#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189;&#195;&#142;&#194;&#169;&#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189;&#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189;&#195;&#142;&#194;&#169;&#195;&#142;&#194;&#169;&#195;&#142;&#194;&#169;&#195;&#142;&#194;&#169;&#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189;&#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189;&#195;&#142;&#194;&#169;&#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189;&#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189;&#195;&#142;&#194;&#169;&#195;&#142;&#194;&#169;&#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189;&#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189;&#195;&#142;&#194;&#169;&#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189;&#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189;&#195;&#142;&#194;&#169;&#195;&#142;&#194;&#169;&#195;&#142;&#194;&#169;&#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189;&#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189;&#195;&#142;&#194;&#169;&#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189;&#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189;&#195;&#142;&#194;&#169;&#195;&#142;&#194;&#169;&#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189;&#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189;&#195;&#142;&#194;&#169;&#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189;&#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189;&#195;&#142;&#194;&#169;&#195;&#142;&#194;&#169;&#195;&#142;&#194;&#169;&#195;&#142;&#194;&#169;&#195;&#142;&#194;&#169;? are combined with a G2A mutation to inhibit N -myristoylation, palmitoylation is no longer evident - even when plasma membrane targeting is apparently maintained ( Wang et al. , 1999b ). 


9065414 To analyze the interaction of Getagamma complex with Galpha o , 10 &#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189;&#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189;&#195;&#142;&#194;&#169;&#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189;&#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189;&#195;&#142;&#194;&#169;&#195;&#142;&#194;&#169;&#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189;&#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189;&#195;&#142;&#194;&#169;&#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189;&#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189;&#195;&#142;&#194;&#169;&#195;&#142;&#194;&#169;&#195;&#142;&#194;&#169;&#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189;&#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189;&#195;&#142;&#194;&#169;&#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189;&#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189;&#195;&#142;&#194;&#169;&#195;&#142;&#194;&#169;&#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189;&#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189;&#195;&#142;&#194;&#169;&#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189;&#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189;&#195;&#142;&#194;&#169;&#195;&#142;&#194;&#169;&#195;&#142;&#194;&#169;&#195;&#142;&#194;&#169;&#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189;&#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189;&#195;&#142;&#194;&#169;&#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189;&#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189;&#195;&#142;&#194;&#169;&#195;&#142;&#194;&#169;&#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189;&#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189;&#195;&#142;&#194;&#169;&#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189;&#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189;&#195;&#142;&#194;&#169;&#195;&#142;&#194;&#169;&#195;&#142;&#194;&#169;&#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189;&#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189;&#195;&#142;&#194;&#169;&#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189;&#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189;&#195;&#142;&#194;&#169;&#195;&#142;&#194;&#169;&#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189;&#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189;&#195;&#142;&#194;&#169;&#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189;&#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189;&#195;&#142;&#194;&#169;&#195;&#142;&#194;&#169;&#195;&#142;&#194;&#169;&#195;&#142;&#194;&#169;&#195;&#142;&#194;&#169;g of Geta, 10 &#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189;&#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189;&#195;&#142;&#194;&#169;&#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189;&#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189;&#195;&#142;&#194;&#169;&#195;&#142;&#194;&#169;&#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189;&#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189;&#195;&#142;&#194;&#169;&#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189;&#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189;&#195;&#142;&#194;&#169;&#195;&#142;&#194;&#169;&#195;&#142;&#194;&#169;&#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189;&#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189;&#195;&#142;&#194;&#169;&#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189;&#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189;&#195;&#142;&#194;&#169;&#195;&#142;&#194;&#169;&#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189;&#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189;&#195;&#142;&#194;&#169;&#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189;&#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189;&#195;&#142;&#194;&#169;&#195;&#142;&#194;&#169;&#195;&#142;&#194;&#169;&#195;&#142;&#194;&#169;&#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189;&#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189;&#195;&#142;&#194;&#169;&#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189;&#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189;&#195;&#142;&#194;&#169;&#195;&#142;&#194;&#169;&#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189;&#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189;&#195;&#142;&#194;&#169;&#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189;&#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189;&#195;&#142;&#194;&#169;&#195;&#142;&#194;&#169;&#195;&#142;&#194;&#169;&#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189;&#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189;&#195;&#142;&#194;&#169;&#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189;&#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189;&#195;&#142;&#194;&#169;&#195;&#142;&#194;&#169;&#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189;&#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189;&#195;&#142;&#194;&#169;&#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189;&#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189;&#195;&#142;&#194;&#169;&#195;&#142;&#194;&#169;&#195;&#142;&#194;&#169;&#195;&#142;&#194;&#169;&#195;&#142;&#194;&#169;g of Ggamma, and 10 &#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189;&#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189;&#195;&#142;&#194;&#169;&#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189;&#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189;&#195;&#142;&#194;&#169;&#195;&#142;&#194;&#169;&#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189;&#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189;&#195;&#142;&#194;&#169;&#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189;&#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189;&#195;&#142;&#194;&#169;&#195;&#142;&#194;&#169;&#195;&#142;&#194;&#169;&#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189;&#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189;&#195;&#142;&#194;&#169;&#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189;&#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189;&#195;&#142;&#194;&#169;&#195;&#142;&#194;&#169;&#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189;&#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189;&#195;&#142;&#194;&#169;&#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189;&#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189;&#195;&#142;</Comment>
    <BiopaxRef>ed0</BiopaxRef>
    <BiopaxRef>bae</BiopaxRef>
    <BiopaxRef>fe8</BiopaxRef>
    <BiopaxRef>e14</BiopaxRef>
    <Graphics Color="990099">
      <Point GraphRef="cedc2"/>
      <Point GraphRef="c67ec"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="bd0df">
    <Comment>Type your comment here</Comment>
    <Comment>MedLine Reference  12842874:1221  
Sentence  Several other kinases such as CKII, MAPK, PKC, and CaMK are known to phosphorylate CREB and thereby activate CREB-dependent transcription ( 25 , 26 , 29 , 30 , 49 , 56 - 59 ).  
Journal  J. Biol. Chem  
Journal Reference  v278 i40 p38860 (2003)  
Journal Link  http://www.jbc.org/cgi/content/full/278/40/38860  
CellType  b cell  
Source  Ariadne Pathways  

--------------------------------------------------------------------------------
MedLine Reference  10931853:1209  
Sentence  However, others have suggested that calcium/calmodulin-dependent kinases, Ras/mitogen-activated protein kinase, and protein kinase C can phosphorylate CREB at Ser 133 ( 47-49 ).  
Journal  J. Biol. Chem  
Journal Reference  v275 i43 p33365 (2000)  
Journal Link  http://www.jbc.org/cgi/content/full/275/43/33365  
Source  Ariadne Pathways  

--------------------------------------------------------------------------------
MedLine Reference  11416000:1287  
Sentence  CRE- binding protein (CREB) has been reported to be phosphorylated by MAP kinase-activated protein kinase, possibly through p70S6K, as well as cAMP kinase ( 35 , 36 ).  
Journal  Endocrinology  
Journal Reference  v142 i7 p2811 (2001)  
Journal Link  http://endo.endojournals.org/cgi/content/full/142/7/2811  
Source  Ariadne Pathways  

--------------------------------------------------------------------------------
MedLine Reference  10098484:1177  
Sentence  However, the MEK inhibitor PD98059 was not able to modulate phosphorylation of CREB at a dose that fully inhibited the phosphorylation of MAP kinase (Fig. 6b ).  
Journal  Endocrinology  
Journal Reference  v140 i4 p1525 (1999)  
Journal Link  http://endo.endojournals.org/cgi/content/full/140/4/1525  
Source  Ariadne Pathways  

--------------------------------------------------------------------------------
MedLine Reference  10951185:1095  
Sentence  This could occur via RSK2, a protein kinase activated by MAP kinases/ERKs, that phosphorylates CREB on its activator site serine 133 [ 43 ].  
Journal  Eur. J. Biochem  
Journal Reference  v267 i17 p5280.html) (2000)  
Journal Link  http://www.ejbiochem.org/cgi/content/full/267/17/5280.h  
CellType  dendritic  
Source  Ariadne Pathways  
</Comment>
    <BiopaxRef>d22</BiopaxRef>
    <BiopaxRef>e2c</BiopaxRef>
    <BiopaxRef>a90</BiopaxRef>
    <BiopaxRef>b24</BiopaxRef>
    <Graphics Color="999900">
      <Point GraphRef="a6431"/>
      <Point GraphRef="df2fc" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="bde86">
    <Comment>Binding GNAI2 ---- HTR1E</Comment>
    <Comment>All the 5-HT(1) receptor types actually interact with G alpha i/G alpha o proteins to inhibit adenylyl cyclase and modulate ionic effectors, i.e. potassium and/or calcium channels. 
</Comment>
    <BiopaxRef>f3f</BiopaxRef>
    <Graphics Color="990099">
      <Point GraphRef="d7022"/>
      <Point GraphRef="b9df7"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="bea01">
    <Comment>PromoterBinding ELK1 --+&gt; FOS</Comment>
    <Comment>--------------------------------------------------------------------------------
Journal Link  http://www.jimmunol.org/cgi/content/full/167/2/827  
CellType  t cell  
Source  Ariadne Pathways  
MedLine Reference  11441089:1223  
Sentence  Elk-1 is known to constitutively associate with serum response factor (SRF) homodimers at the serum response element (SRE) of the 5&amp;apos; c- fos gene DNA promoter/enhancer (reviewed by Cahill et al. in Ref. 28 ).  
Journal  J. Immunol  
Journal Reference  v167 i2 p827 (2001)  

--------------------------------------------------------------------------------
Journal Link  http://www.jbc.org/cgi/content/full/271/44/27366  
CellType  t cell  
Source  Ariadne Pathways  
MedLine Reference  8910314:1030  
Sentence  In addition, JNKs up-regulate c-Fos expression by phosphorylation of the ternary complex factor, p62 TCF (Elk-1), which binds the c- fos promoter ( 23 , 25 ).  
Journal  J. Biol. Chem  
Journal Reference  v271 i44 p27366 (1996)  
--------------------------------------------------------------------------------
Journal Link  http://www.jbc.org/cgi/content/full/275/21/16064  
CellLineName  ags  
Source  Ariadne Pathways  
MedLine Reference  10747974:1309  
Sentence  Elk-1 binds the c- fos promoter together with the serum response factor ( SRF ) at the serum response element.  
Journal  J. Biol. Chem  
Journal Reference  v275 i21 p16064 (2000)  
--------------------------------------------------------------------------------
Journal Link  http://www.jbc.org/cgi/content/full/277/43/40911  
Source  Ariadne Pathways  
MedLine Reference  12145292:1036  
Sentence  Subsequently, phosphorylated/activated Elk-1 binds the c- fos promoter and allows transcriptional activation of c- fos , an immediate early response gene ( 10 , 11 ).  
Journal  J. Biol. Chem  
Journal Reference  v277 i43 p40911 (2002)  

--------------------------------------------------------------------------------
Journal Link  http://www.jbc.org/cgi/content/full/273/27/16905  
Source  Ariadne Pathways  
MedLine Reference  9642252:1220  
Sentence  Elk-1 binds to a serum response element within the c- fos promoter region together with a serum response factor, inducing c-Fos expression ( 42 , 52 , 53 ).  
Journal  J. Biol. Chem  
Journal Reference  v273 i27 p16905 (1998) 
</Comment>
    <BiopaxRef>e94</BiopaxRef>
    <BiopaxRef>f81</BiopaxRef>
    <BiopaxRef>b92</BiopaxRef>
    <BiopaxRef>dcb</BiopaxRef>
    <BiopaxRef>d1d</BiopaxRef>
    <Graphics Color="009900">
      <Point GraphRef="b1b8a"/>
      <Point GraphRef="f4dd2" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="bf237">
    <Comment>DirectRegulation RHOA --+&gt; MAP3K1,</Comment>
    <Comment>15492006 (Tissue: endoderm) The recent observation that p115RhoGEF and RhoA can bind to MEKK, especially MEKK1 directly, might suggest an alternative pathway from Galpha13 to MEKK activation ( 55 , 59 ). 

(CellLineName: AP) 

11315998 (CellLineName: AP) Moreover, SB203580, a specific inhibitor of p38 mitogen-activated protein kinase (MAPK), and PD-98059, a specific inhibitor of MAPK kinase (MEKK), also reduced IL-1alpha and RhoA expression in Ap cells. 
</Comment>
    <BiopaxRef>ea3</BiopaxRef>
    <BiopaxRef>b90</BiopaxRef>
    <Graphics>
      <Point GraphRef="cbd30"/>
      <Point GraphRef="f091e" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="bf9ef">
    <Comment>DirectRegulation CALCIUM --+&gt; RASGRF1</Comment>
    <Comment>We have recently shown that the neuronal exchange factor p140 Ras-GRF becomes activated in vivo in response to elevated calcium levels. 
</Comment>
    <BiopaxRef>a17</BiopaxRef>
    <Graphics>
      <Point GraphRef="f039e"/>
      <Point GraphRef="b456e" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="c16ef">
    <Comment>DirectRegulation CALCIUM --+&gt; RASGRP1,</Comment>
    <Comment>CalDAG-GEFI and CalDAG-GEFII (identical to RasGRP) are novel, brain-enriched guanine nucleotide exchange factors (GEFs) that can be stimulated by calcium and diacylglycerol and that can activate small GTPases, including Ras and Rap1, molecules increasingly recognized as having signaling functions in neurons. 
</Comment>
    <BiopaxRef>c96</BiopaxRef>
    <Graphics>
      <Point GraphRef="f039e"/>
      <Point GraphRef="c6568" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="c2702">
    <Comment>ProtModification MAP2K1 --+&gt; MAPK3</Comment>
    <Comment>--------------------------------------------------------------------------------
MedLine Reference  9927426:1014  
Sentence  Both p42 and p44MAPK are activated by dual phosphorylation on a threonine and a tyrosine residue, achieved by the dual-specificity kinase MKK1/2.  
Journal  EMBO  
Journal Reference  v18 i3 p664 (1999)  
Journal Link  http://embojournal.npgjournals.com/cgi/content/full/18/3/664  
CellType  fibroblast  
CellLineName  PC 12  
Source  Ariadne Pathways  
--------------------------------------------------------------------------------
MedLine Reference  12393899:1257  
Sentence  Furthermore, expression of a constitutively active MKK1, which directly activated ERK1/2, suppressed cortical neuron apoptosis induced by expression of recombinant wild-type GSK3eta or the GSK3eta(S9A) mutant.  
Journal  J. Biol. Chem  
Journal Reference  v277 i51 p49577 (2002)  
Journal Link  http://www.jbc.org/cgi/content/full/277/51/49577  
Tissue  cortex  
Source  Ariadne Pathways  
--------------------------------------------------------------------------------
MedLine Reference  10958792:5  
Sentence  In the ovarian carcinoma cell line A2780, inhibition of ERK1/2 activation with the mitogen-activated protein kinase/ERK kinase 1 (MEK1) inhibitor PD98059 resulted in decreased p53 protein half-life and diminished accumulation of p53 protein during exposure to cisplatin.  
CellLineName  A2780  
Source  Ariadne Pathways  

--------------------------------------------------------------------------------
MedLine Reference  9159118:3  
Sentence  Inhibiting activation of ERK1 and ERK2 with the MEK1/2 inhibitor PD98059 has no effect on insulin secretion, indicating that ERK activity is not necessary for secretion under these conditions.  
Source  Ariadne Pathways  

--------------------------------------------------------------------------------
MedLine Reference  11673351:5  
CellType  cardiomyocyte  
Source  Ariadne Pathways  

--------------------------------------------------------------------------------
MedLine Reference  10711350:4  
Sentence  PD98059, a specific inhibitor of MEK-1 which phosphorylates p44/p42 MAP kinase, strongly suppressed both the thapsigargin (30 nM)- and TPA (30 nM)-induced histamine production, whereas SB203580, a specific inhibitor of p38 MAP kinase, inhibited them only partially. 6.  
CellType  macrophage  
CellLineName  RAW264.7  
Source  Ariadne Pathways  

--------------------------------------------------------------------------------
MedLine Reference  11496823:2  
Sentence  PD98059, a specific inhibitor of MEK-1 which phosphorylates p44/p42 MAP kinase, strongly suppressed the thapsigargin-induced histamine production, the increase in HDC mRNA level and 74-kDa HDC protein expression.  
CellType  macrophage  
CellLineName  RAW264.7  
Source  Ariadne Pathways  
--------------------------------------------------------------------------------
MedLine Reference  9235901:1031  
Sentence  In the mammalian Erk1/2 pathway, the proximal kinases Raf-1 and B-Raf phosphorylate and activate the dual function threonine/tyrosine kinases MAP/Erk kinases 1 and 2, which in turn phosphorylate Erk1/2.  
Journal  J. Biol. Chem  
Journal Reference  v272 i31 p19125 (1997)  
Journal Link  http://www.jbc.org/cgi/content/full/272/31/19125  
Organ  heart  
CellType  myocyte  
CellLineName  AR  
Source  Ariadne Pathways  
</Comment>
    <BiopaxRef>da1</BiopaxRef>
    <BiopaxRef>a89</BiopaxRef>
    <BiopaxRef>cef</BiopaxRef>
    <BiopaxRef>fdc</BiopaxRef>
    <BiopaxRef>a48</BiopaxRef>
    <BiopaxRef>fd9</BiopaxRef>
    <BiopaxRef>de6</BiopaxRef>
    <Graphics Color="999900">
      <Point GraphRef="d7383"/>
      <Point GraphRef="bda33" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="c32e2">
    <Comment>ProtModification MAP3K1 --+&gt; MAP2K1</Comment>
    <Comment>10969079 (Organ: brain, Tissue: spore, CellType: cardiomyocyte, CellLineName: JURKAT) Initially, MEKK1 was proposed to be an activator of MEK1/MEK2 (Lange-Carter et al. 1993 ). 

10226075 (Organ: trachea, CellType: myocyte) Therefore, it is unlikely that MEKK1 is a major activator of MEK1 in bovine tracheal myocytes. 

11278353 MEKK1 also activates ERK and JNK MAPK cascades, and Stat3 Ser-727 can be phosphorylated by multiple kinases in the MAPK cascades including MEKK1 , MEK1, and ERK/JNK. 

12588875 Since MEKK1 is also able to activate MEK1, the MEK1-MAPK pathway may play a role in the stimulatory effect of MEKK1. 

9162092 Additionally, the catalytic domain of MEKK1 activated MEK1 and MEK2 in vitro and interacted with MEK in the yeast two-hybrid system. 

11454875 MEKK1, in turn, targets several MEKs, including MEK1, MEK3, and MEK7 but not MEK4 ( 3 , 22 ). 

15491994 MEK1, activated by MEKK1, also has strong inhibitory effects on SMRT function ( solid arrows ). 

11698415 MEKK1, in turn, activates MEK1, MEK3, and MEK7 ( 17 , 34 ). 

12048245 MEKK1 activates MEK1, which in turn seems to activate the ERKs. 

7499206 Here we report that PD 098059 does not inhibit Raf-activated MAPKK1 but that it prevents the activation of MAPKK1 by Raf or MEK kinase in vitro at concentrations (IC50 = 2-7 microM) similar to those concentrations that inhibit dephosphorylated MAPKK1 or MAPKK1(S217E,S221E). 

</Comment>
    <BiopaxRef>ab9</BiopaxRef>
    <BiopaxRef>cfc</BiopaxRef>
    <BiopaxRef>fd6</BiopaxRef>
    <BiopaxRef>c11</BiopaxRef>
    <BiopaxRef>da5</BiopaxRef>
    <BiopaxRef>f82</BiopaxRef>
    <BiopaxRef>f5d</BiopaxRef>
    <BiopaxRef>a24</BiopaxRef>
    <BiopaxRef>bda</BiopaxRef>
    <BiopaxRef>af4</BiopaxRef>
    <Graphics Color="999900">
      <Point GraphRef="f091e"/>
      <Point GraphRef="d7383" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="c50a3">
    <Comment>DirectRegulation 1,2-Diacetin --+&gt; PKC</Comment>
    <Comment>The "conventional" PKC isoforms ( , ?1, ?II, and ) are regulated by DAG, which binds the C1 domain, and by Ca2+, which binds the C2 domain. 
</Comment>
    <BiopaxRef>a92</BiopaxRef>
    <Graphics>
      <Point GraphRef="b91eb"/>
      <Point GraphRef="ae0ca" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="c518c">
    <Comment>ProtModification MAP2K6 --+&gt; MAPK14,</Comment>
    <Comment>12746452 Several upstream kinases have been implicated in the activation of the p38 MAPK and JNK 1/2 including apoptosis signaling kinase-1 which appears to activate both p38 MAPK and JNK 1/2, MKK 3/6 which activates p38 MAPK, and MKK 4/7 which activates JNK 1/2 ( 23 ). 

12649265 Infecting cardiomyocytes with adenoviruses that encode mutant, phosphorylation-resistant MKK6 or p38??2 MAPK inhibited interleukin-1????induced p38 MAPK activation, COX-2 gene expression, and PGE2 release. 

10942386 In contrast, neither dominant negative MKK6 nor SB203580, which specifically inhibit p38 MAP kinase activation, abrogated the MNNG-induced effect. 

12600999 ERK is activated by MEK1 and MEK2, whereas p38 kinase is activated by MKK3 and MKK6, and JNK is activated by MKK4 ( 24-28 ). 

12670941 Among them, MKK6 and MKK3 activate p38 MAPK. 

11245462 This pathway is stimulated by environmental and chemical stress as well as by exposure to cytokines, and it appears to play a role in the induction of apoptosis (10 , 11) . p38 MAPK is activated by hyperosmolarity and environmental stress and regulates pro- or anti-apoptotic effects in a stimulus and cell-type specific manner (12 , 13) . p38 MAPK is phosphorylated by either MKK3 (14) or MKK6 (15 , 16) . 

11732999 (CellType: chondrocyte) On the other hand, p38 MAPK is known to be a stress signal transducer, and phosphorylation of p38 MAPK in chondrocytes by EGF [ 25 ], PTH [ 41 ], and GDF-5 [ 42 ] regulates differentiation of chondrocytes. p38 MAPK is phosphorylated by MKK3, and MKK6 [ 45 ], and Atf-2 is one of the transcription factors downstream of p38 MAPK [ 31 ]. 

10716930 Thus, MKK3 requires a docking domain for efficient dual phosphorylation of p38alpha, but MKK6 is able to phosphorylate p38alpha on both threonine and tyrosine in the absence of a docking domain. 

11500363 (CellLineName: HeLa) MKK4 and MKK6 are both known to phosphorylate stress-activated protein kinase 2a (SAPK2a, also called p38). 

</Comment>
    <BiopaxRef>ac9</BiopaxRef>
    <BiopaxRef>e49</BiopaxRef>
    <BiopaxRef>a88</BiopaxRef>
    <BiopaxRef>b87</BiopaxRef>
    <BiopaxRef>db5</BiopaxRef>
    <BiopaxRef>d60</BiopaxRef>
    <BiopaxRef>d2c</BiopaxRef>
    <BiopaxRef>c69</BiopaxRef>
    <BiopaxRef>abf</BiopaxRef>
    <Graphics Color="999900">
      <Point GraphRef="b8237"/>
      <Point GraphRef="eea31" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="c6da2">
    <Comment>MolTransport ITPR1 --+&gt; CALCIUM,</Comment>
    <Comment>8571671 The molecular basis of the complex Ca2+ signals is the regenerative character of the inositol trisphosphate receptor (InsP3R) responsible for the release of Ca2+ from intracellular stores. 

8765993 A Ca2+-mediated conformational change of the InsP3R is most likely the key feature of the mechanism for quantal Ca2+ release, but the exact mode of operation remains unclear. 

9675184 The InsP3R channels release Ca2+ from intracellular compartments to generate localized Ca2+ transients that govern a myriad of cellular signaling phenomena (Berridge, 1993. Nature. 361:315-325; Joseph, 1996. Cell Signal. 8:1-7; Kume et al., 1997. Science. 278:1940-1943; Berridge, 1997. Nature. 368:759-760). express multiple InsP3R isoforms, but only the function of the single type 1 InsP3R channel is known. 

15201137 (Tissue: skeletal) Agonist-induced increase in gene expression and calcium release were blocked by the InsP(3)R inhibitors 2-aminoethoxydiphenyl borate and xestospongin C. 

15677321 Addition of native GAPDH and NAD(+) to WT IP(3)R stimulates calcium release, whereas no stimulation occurs with C992S/995S IP(3)R that cannot bind GAPDH. 

9607940 The inositol (1,4,5)-trisphosphate receptor (InsP3R) mediates Ca2+ release from intracellular stores in response to generation of second messenger InsP3. 

7533300 (Tissue: skeletal muscle) Disrupting the IP3R-FKBP12 interaction increases Ca2+ flux through IP3R, an effect that is reversed by added FKBP12. 

9831561 The inositol 1,4,5-trisphosphate (IP3) receptor (IP3R) acts as a Ca2+ release channel on internal Ca2+ stores. 

10096607 Inositol 1,4,5-trisphosphate receptors (IP3R) are mediators of second messenger-induced intracellular calcium release. 

12491767 IP3receptor (IP3R) works as an IP3 induced Ca2+ release channel and requires IP3 and Ca2+ as coagoinist. 

</Comment>
    <BiopaxRef>f66</BiopaxRef>
    <BiopaxRef>e7b</BiopaxRef>
    <BiopaxRef>e62</BiopaxRef>
    <BiopaxRef>abd</BiopaxRef>
    <BiopaxRef>a8e</BiopaxRef>
    <BiopaxRef>c8a</BiopaxRef>
    <BiopaxRef>eb9</BiopaxRef>
    <BiopaxRef>fa7</BiopaxRef>
    <BiopaxRef>c29</BiopaxRef>
    <BiopaxRef>b33</BiopaxRef>
    <Graphics>
      <Point GraphRef="f7c77"/>
      <Point GraphRef="f039e" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="cadcd">
    <Comment>Binding GNAI3 ---- HTR1D</Comment>
    <Comment>Coexpression of the human 5-HT(1D) receptor with Galpha(i1), alpha(i2), alpha(i3), or Galpha(o)-proteins and Gbeta(1)gamma(2)-subunits reconstituted a Gpp(NH)p-sensitive, high affinity binding of [(3)H]5-HT to this receptor 
</Comment>
    <BiopaxRef>f8c</BiopaxRef>
    <Graphics Color="990099">
      <Point GraphRef="bf366"/>
      <Point GraphRef="d4c53"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="cb467">
    <Comment>ProtModification MAP3K1 --+&gt; MAP2K6</Comment>
    <Comment>9639556 MLK2 and MEKK1 also activated SKK2/MKK3 and SKK3/MKK6, the direct upstream activators of SAPK2a/p38. 

9808624 MEKK1, however, was found to activate additional MAPKKs, including Jun amino (N)-terminal kinase kinase 1(MKK4) [JNKK1(MKK4)] (D?rijard et al. 1995 ; Lin et al. 1995 ), JNKK2(MKK7) (Wu et al. 1997 ), MKK3, and MKK6 (Stein et al. 1996 ). 

11306453 In response to extracellular stimuli, MEKK1 is a strong activator of MKK4 and MKK7, and a weaker activator of MKK3 and MKK6 (Fig. 1 A ; Ref. 19 ). 

12960165 (CellLineName: RAW264.7) In addition, MEKK1 can stimulate the p38 MAPK through phosphorylation of MKK3 and MKK6 ( 37 ). 

11574474 (CellLineName: 293) D-MEKK1 was found to phosphorylate MKK6 efficiently in vitro . 
</Comment>
    <BiopaxRef>cda</BiopaxRef>
    <BiopaxRef>a30</BiopaxRef>
    <BiopaxRef>b2f</BiopaxRef>
    <BiopaxRef>baa</BiopaxRef>
    <BiopaxRef>dee</BiopaxRef>
    <Graphics Color="999900">
      <Point GraphRef="f091e"/>
      <Point GraphRef="b8237" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="cb469">
    <Comment>Binding ELK4 ---- SRF</Comment>
    <BiopaxRef>e95</BiopaxRef>
    <BiopaxRef>fb7</BiopaxRef>
    <BiopaxRef>a0e</BiopaxRef>
    <Graphics Color="990099">
      <Point GraphRef="d8696"/>
      <Point GraphRef="d87ce"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="ccf0e">
    <Comment>ProtModification PKC --+&gt; CREB1</Comment>
    <Comment>15814901 Later, Xie and Rothstein showed that PKC phosphorylates CREB on Ser133 in B cells [ 41 ]. 

15262987 In favor of this possibility, CREB has been shown to be phosphorylated by PKC in vitro ( 16 ). 

11591753 Several pieces of evidence suggest that PKC can phosphorylate CREB directly. 

11574420 Phosphorylation of CREB by PKC was reported to increase the binding of CREB to CRE in vitro and to stimulate CREB homodimerization or heterodimer complex formation with ATF-1, a transcription factor that shares many structural properties with CREB ( 37 , 38 , 39 , 40 ). 

</Comment>
    <BiopaxRef>b84</BiopaxRef>
    <BiopaxRef>e2e</BiopaxRef>
    <BiopaxRef>c82</BiopaxRef>
    <BiopaxRef>a16</BiopaxRef>
    <Graphics ConnectorType="Curved" Color="999900">
      <Point GraphRef="cc60d"/>
      <Point/>
      <Point GraphRef="df2fc" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="ce324">
    <Comment>Regulation PtdIns3P --+&gt; PDPK1</Comment>
    <Comment>Phosphorylation of Akt at threonine 308 is catalyzed by the ubiquitously expressed and constitutively activated phosphatidylinositol 3,4,5-triphosphate-dependent protein kinase-1 (PDK-1) ( 34 , 35 ). 
</Comment>
    <BiopaxRef>e84</BiopaxRef>
    <Graphics LineStyle="Broken">
      <Point GraphRef="c56f6"/>
      <Point GraphRef="c3d64" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="ceac4">
    <Comment>ProtModification RPS6KA5 --+&gt; CREB1</Comment>
    <Comment>MedLine Reference  12414794:1133  
Sentence  MSK1 has been shown to phosphorylate CREB and to be activated by EGF , as well as ERK1/2 and p38 MAPKs ( 27 ).  
Journal  J. Biol. Chem  
Journal Reference  v277 i52 p50550 (2002)  
Journal Link  http://www.jbc.org/cgi/content/full/277/52/50550  
CellLineName  HeLa  
Source  Ariadne Pathways  

--------------------------------------------------------------------------------
MedLine Reference  12896977:1312  
Sentence  It is interesting to note that H89 is also a potent inhibitor of protein kinase A (PKA) and that both MSK1 and PKA can phosphorylate CREB.  
Journal  J. Biol. Chem  
Journal Reference  v278 i42 p41034 (2003)  
Journal Link  http://www.jbc.org/cgi/content/full/278/42/41034  
CellType  lymphocyte  
Source  Ariadne Pathways  

--------------------------------------------------------------------------------
MedLine Reference  9687510:1176  
Sentence  MSK1 phosphorylates CREB at Ser133. ( A ) Comparison of the substrate specificities of MSK1, MAPKAP-K1a and MAPKAP-K1b towards the indicated peptides and CREB.  
Journal  EMBO  
Journal Reference  v17 i15 p4426 (1998)  
Journal Link  http://embojournal.npgjournals.com/cgi/content/full/17/15/4426  
Source  Ariadne Pathways  

--------------------------------------------------------------------------------
MedLine Reference  11907026:1243  
Sentence  MSK-1 phosphorylates CREB in response to FGF or NGF in PC12 cells.  
Journal  J. Biol. Chem  
Journal Reference  v277 i21 p18710 (2002)  
Journal Link  http://www.jbc.org/cgi/content/full/277/21/18710  
CellLineName  PC 12  
Source  Ariadne Pathways  

--------------------------------------------------------------------------------
MedLine Reference  11701463:1152  
Sentence  Activated MSK1 phosphorylates CREB at Ser133.  
Journal  ATVB  
Journal Reference  v21 i11 p1764 (2001)  
Journal Link  http://atvb.ahajournals.org/cgi/content/full/21/11/1764  
Source  Ariadne Pathways  
</Comment>
    <BiopaxRef>ed7</BiopaxRef>
    <BiopaxRef>b55</BiopaxRef>
    <BiopaxRef>c90</BiopaxRef>
    <BiopaxRef>c12</BiopaxRef>
    <BiopaxRef>c6a</BiopaxRef>
    <Graphics Color="999900">
      <Point GraphRef="d4bbc"/>
      <Point GraphRef="df2fc" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="cfd29">
    <Comment>ProtModification MAP2K2 --+&gt; MAPK1</Comment>
    <Comment>MedLine Reference  11238126:1108  
Sentence  MEK-1/2 activation correlated with ERK-1/2 activation in 7 of 14 AML cell lines and 2 of 5 CML cell lines.  
Journal  Blood  
Journal Reference  v97 i6 p1823 (2001)  
Journal Link  http://www.bloodjournal.org/cgi/content/full/97/6/1823  
CellLineName  AML  
Source  Ariadne Pathways  

--------------------------------------------------------------------------------
MedLine Reference  10650934:1110  
Sentence  Cells were pretreated for 30 min with 10 &#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189; M PD98059, an inhibitor of MEK1 and -2, the MAPK kinases that are responsible for activation of ERK1 and -2.  
Journal  Endocrinology  
Journal Reference  v141 i2 p544 (2000)  
Journal Link  http://endo.endojournals.org/cgi/content/full/141/2/544  
Source  Ariadne Pathways  

--------------------------------------------------------------------------------
MedLine Reference  11108712:1201  
Sentence  Finally, because MEK1 and MEK2 activate ERK , we assayed for ERK activity in the presence of the MEK inhibitor PD 98059 (Fig. 6 D ).  
Journal  J. Biol. Chem  
Journal Reference  v276 i10 p7586 (2001)  
Journal Link  http://www.jbc.org/cgi/content/full/276/10/7586  
CellType  osteoblast  
Source  Ariadne Pathways  

--------------------------------------------------------------------------------
MedLine Reference  10747974:1181  
Sentence  PD 98059 and U0126 specifically inhibit MEK1 and MEK2, the kinases that phosphorylate ERK, but have no effect on other kinases including SAPK/JNK ( 56 , 57 ).  
Journal  J. Biol. Chem  
Journal Reference  v275 i21 p16064 (2000)  
Journal Link  http://www.jbc.org/cgi/content/full/275/21/16064  
Tissue  epithelia  
Organ  gastric  
Source  Ariadne Pathways  

--------------------------------------------------------------------------------
MedLine Reference  12225966:1161  
Sentence  We have recently reported that inhibition of muscle MAPKK1/2 (MEK1/2) abolishes isoproterenol-stimulated NKCC activity and ERK1/2 phosphorylation ( 31 ).  
Journal  Cell Phys  
Journal Reference  v283 i4 pC1025 (2002)  
Journal Link  http://ajpcell.physiology.org/cgi/content/full/283/4/C1025  
Tissue  muscle  
Source  Ariadne Pathways  

--------------------------------------------------------------------------------
MedLine Reference  12393899:1082  
Sentence  To inhibit the ERK1/2 pathway, we applied PD98059, an inhibitor of MKK1 and MKK2 ( 30 ), which are upstream kinases that phosphorylate and activate ERK1/2.  
Journal  J. Biol. Chem  
Journal Reference  v277 i51 p49577 (2002)  
Journal Link  http://www.jbc.org/cgi/content/full/277/51/49577  
Tissue  cortex  
CellType  neural  
Source  Ariadne Pathways  

MedLine Reference  12839832:1143  
Sentence  U-0126 is a selective inhibitor of the MAPK kinase MEK1/2, which directly activates ERK1/2 ( 13 , 50 ).  
Journal  Cell Phys  
Journal Reference  v285 i5 pC1122 (2003)  
Journal Link  http://ajpcell.physiology.org/cgi/content/full/285/5/C1122  
Source  Ariadne Pathways  

--------------------------------------------------------------------------------
MedLine Reference  10891480:1248  
Sentence  In contrast to its effect on HA-MEK1, the kinase-inactive mutant PKCetaKR did not block MEK2E-induced HA-ERK2 activation (Fig. 5 C).  
Journal  Mol. Cell. Biol  
Journal Reference  v20 i15 p5392 (2000)  
Journal Link  http://mcb.asm.org/cgi/content/full/20/15/5392  
Source  Ariadne Pathways  
--------------------------------------------------------------------------------
MedLine Reference  12623839:1052  
Sentence  Mkk1 and Mkk2 phosphorylate Erk kinases in the Thr-Glu-Tyr motif; Mkk3, Mkk4, and Mkk6 phosphorylate p38 kinases in the Thr-Gly-Tyr motif, while Mkk4 and Mkk7 regulate dual phosphorylation of JNK kinases in the Thr-Pro-Tyr motif ( Table 2 ).  
Journal  Blood  
Journal Reference  v101 i12 p4667 (2003)  
Journal Link  http://www.bloodjournal.org/cgi/content/full/101/12/4667  
Source  Ariadne Pathways  

--------------------------------------------------------------------------------
MedLine Reference  11038347:1040  
Sentence  The specificity of MEK1/2 inhibition was achieved by using two different MEK inhibitors, and by the additional use of transdominant-negative mutants, which inhibit MEK/ERK activation.  
Journal  J. Biol. Chem  
Journal Reference  v275 i50 p38953 (2000)  
Journal Link  http://www.jbc.org/cgi/content/full/275/50/38953  
Source  Ariadne Pathways  
</Comment>
    <BiopaxRef>c59</BiopaxRef>
    <BiopaxRef>f52</BiopaxRef>
    <BiopaxRef>a66</BiopaxRef>
    <BiopaxRef>ce6</BiopaxRef>
    <BiopaxRef>b91</BiopaxRef>
    <BiopaxRef>b4d</BiopaxRef>
    <BiopaxRef>f3e</BiopaxRef>
    <BiopaxRef>aed</BiopaxRef>
    <BiopaxRef>e1f</BiopaxRef>
    <BiopaxRef>cf8</BiopaxRef>
    <Graphics Color="999900">
      <Point GraphRef="edc2e"/>
      <Point GraphRef="fe3cb" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="cffaf">
    <Comment>Binding GNAI1 ---- HTR1E</Comment>
    <Comment>All the 5-HT(1) receptor types actually interact with G alpha i/G alpha o proteins to inhibit adenylyl cyclase and modulate ionic effectors, i.e. potassium and/or calcium channels. 
</Comment>
    <BiopaxRef>f3f</BiopaxRef>
    <Graphics Color="990099">
      <Point GraphRef="d7022"/>
      <Point GraphRef="ae915"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="d0584">
    <Comment>ProtModification MAP2K2 --+&gt; MAPK3</Comment>
    <Comment>MedLine Reference  11983682:1198  
Sentence  Hippocampal neurons were treated with UO126, an inhibitor of MEK1 and MEK2, which can activate ERK1 and ERK2.  
Journal  J. Biol. Chem  
Journal Reference  v277 i27 p24676 (2002)  
Journal Link  http://www.jbc.org/cgi/content/full/277/27/24676  
Organ  hippocampal  
CellType  neural  
Source  Ariadne Pathways  

--------------------------------------------------------------------------------
MedLine Reference  9927426:1014  
Sentence  Both p42 and p44MAPK are activated by dual phosphorylation on a threonine and a tyrosine residue, achieved by the dual-specificity kinase MKK1/2.  
Journal  EMBO  
Journal Reference  v18 i3 p664 (1999)  
Journal Link  http://embojournal.npgjournals.com/cgi/content/full/18/3/664  
CellType  fibroblast  
CellLineName  PC 12  
Source  Ariadne Pathways  

--------------------------------------------------------------------------------
MedLine Reference  11238126:1108  
Sentence  MEK-1/2 activation correlated with ERK-1/2 activation in 7 of 14 AML cell lines and 2 of 5 CML cell lines.  
Journal  Blood  
Journal Reference  v97 i6 p1823 (2001)  
Journal Link  http://www.bloodjournal.org/cgi/content/full/97/6/1823  
CellLineName  AML  
Source  Ariadne Pathways  

--------------------------------------------------------------------------------
MedLine Reference  10650934:1110  
Sentence  Cells were pretreated for 30 min with 10 &#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189; M PD98059, an inhibitor of MEK1 and -2, the MAPK kinases that are responsible for activation of ERK1 and -2.  
Journal  Endocrinology  
Journal Reference  v141 i2 p544 (2000)  
Journal Link  http://endo.endojournals.org/cgi/content/full/141/2/544  
Source  Ariadne Pathways  

--------------------------------------------------------------------------------
MedLine Reference  12584202:1152  
Sentence  Because MEK1/2 phosphorylates and activates p42/p44MAPK, the inhibitor would be expected to inhibit the phosphorylation of p42/p44MAPK and their downstream targets.  
Journal  J. Biol. Chem  
Journal Reference  v278 i17 p14753 (2003)  
Journal Link  http://www.jbc.org/cgi/content/full/278/17/14753  
Source  Ariadne Pathways  

--------------------------------------------------------------------------------
MedLine Reference  12832465:1147  
Sentence  All together, these results indicated that MEK2 is not essential for cell proliferation and ERK1/ERK2 activation in response to mitogens.  
Journal  Mol. Cell. Biol  
Journal Reference  v23 i14 p4778 (2003)  
Journal Link  http://mcb.asm.org/cgi/content/full/23/14/4778  
Source  Ariadne Pathways  

--------------------------------------------------------------------------------
MedLine Reference  11080204:1217  
Sentence  Activated Raf phosphorylates the MAP kinase kinases MEK1 and MEK2, which subsequently activate ERK1 and ERK2.  
Journal  J. Neurochem  
Journal Reference  v75 i6 p2511 (2000)  
Journal Link  http://www.blackwell-synergy.com/servlet/useragent?func=showIssues&amp;code=jnc  
CellType  fibroblast  
CellLineName  PC12-E2  
Source  Ariadne Pathways  

--------------------------------------------------------------------------------
MedLine Reference  12242299:1278  
Sentence  Neither LY-294002 nor wortmannin significantly affected the phosphorylation of ERK1/2 or MKK1/2 (Fig. 9A ), indicating that ERK activation is not controlled by PI3K signaling.  
Journal  Mol. Cell. Biol  
Journal Reference  v22 i20 p7226 (2002)  
Journal Link  http://mcb.asm.org/cgi/content/full/22/20/7226  
CellLineName  HeLa  
Source  Ariadne Pathways  

--------------------------------------------------------------------------------
MedLine Reference  12730329:1047  
Sentence  Two upstream dual specificity enzyme kinases MEK1/MEK2 (MAPKKs) phosphorylate threonine and tyrosine residues of ERK1/2 and initiate an ultrasensitive downstream phosphorylation cascade ( 25 ).  
Journal  Mol. Endocrin  
Journal Reference  v17 i8 p1593 (2003)  
Journal Link  http://mend.endojournals.org/cgi/content/full/17/8/1593  
Source  Ariadne Pathways  
--------------------------------------------------------------------------------
MedLine Reference  12496361:1025  
Sentence  Activated Ras associates with Raf that phosphorylates and activates the mitogen-activated protein (MAP) kinase kinases MEK1 and MEK2, which in turn phosphorylate the MAP kinases ERK1 and ERK2.  
Journal  Mol. Cancer Res  
Journal Reference  v1 i2 p147 (2002)  
Journal Link  http://mcr.aacrjournals.org/cgi/content/full/1/2/147  
Tissue  nerve  
CellType  neural  
Source  Ariadne Pathways  
</Comment>
    <BiopaxRef>ea6</BiopaxRef>
    <BiopaxRef>da1</BiopaxRef>
    <BiopaxRef>c59</BiopaxRef>
    <BiopaxRef>f52</BiopaxRef>
    <BiopaxRef>a42</BiopaxRef>
    <BiopaxRef>db6</BiopaxRef>
    <BiopaxRef>bd7</BiopaxRef>
    <BiopaxRef>b0e</BiopaxRef>
    <BiopaxRef>f91</BiopaxRef>
    <BiopaxRef>e6c</BiopaxRef>
    <Graphics Color="999900">
      <Point GraphRef="edc2e"/>
      <Point GraphRef="bda33" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="d0a0d">
    <Comment>DirectRegulation 1,2-Diacetin --+&gt; RASGRF1</Comment>
    <Comment>RasGRP3 localization and activity is regulated by DAG, and this interaction is mimicked by the phorbol ester PMA. 
</Comment>
    <BiopaxRef>dfa</BiopaxRef>
    <Graphics>
      <Point GraphRef="b91eb"/>
      <Point GraphRef="b456e" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="d60c1">
    <Comment>DirectRegulation CALCIUM --+&gt; PKC,</Comment>
    <Comment>10713965 PDBu-induced activation of PKC promotes the priming of secretory granules, thereby enhancing the efficacy for Ca2+ to trigger fusion/exocytosis. 

8429046 It appears, therefore, that the binding of Ca2+ to PKC requires a complex tertiary structure in the regulatory domain. 

1313322 (Tissue: articular cartilage, CellType: chondrocyte) The activity of various subspecies of protein kinase C (PKC) in chondrocytes derived from rodent costal cartilage and bovine articular cartilage has been determined and the role of PKC in GAG synthesis as well as the possible interactions of PKC with calcium- or cyclic AMP (cAMP)-dependent systems in the synthesis of GAG. 

10325235 (CellType: cardiomyocyte) Phorbol ester-sensitive PKC isoforms were detected at very low levels in caveolae fractions prepared from unstimulated cardiomyocytes; phorbol 12-myristate 13-acetate (PMA) (but not 4alpha-PMA, which does not activate PKC) recruited calcium-sensitive PKCalpha and novel PKCdelta and PKCepsilon to this compartment. 

9725212 (CellType: t cell) Since cyclosporin does not have any effect on cytosolic Ca 2+ levels and thus does not interfere with the interaction between PKC and Ca 2+ , we tested the effect of an inhibitor of intracellular Ca 2+ redistribution, TMB-8 ( 36 ), on TCR cross-linking-induced AICD. 

10751227 (Tissue: mesangia) DAG can directly activate classical types of PKC by interacting with its lipid-binding domain, and IP3 can indirectly activate PKC by increasing intracellular Ca2+, which interacts with the PKC Ca2+-binding domain. 

11342594 Synaptotagmins are transmembrane proteins with a short NH2-terminal ectodomain, a single transmembrane region, and two highly conserved, independently folding Ca2+-binding C2 domains (C2A and C2B) homologous to the C2 regulatory region of protein kinase C. 

7836388 At odds with the concept of calcium modulation of lipid binding, these authors considered phospholipids as modulators for the binding of calcium to PKC( 31 , 34 ) . 

9852158 The four inhibitors of PKC all accelerated the breakdown of the F-actin network observed after 5 min (Fig. 6 D ) and 30 min (Fig. 6 E ) in 0 Ca 2+ . 

9218480 These data reveal that the negative charge on the carboxyl terminus of protein kinase C contributes to the interaction of protein kinase C with Ca 2+ . 

</Comment>
    <BiopaxRef>c3a</BiopaxRef>
    <BiopaxRef>fef</BiopaxRef>
    <BiopaxRef>f0a</BiopaxRef>
    <BiopaxRef>d95</BiopaxRef>
    <BiopaxRef>f25</BiopaxRef>
    <BiopaxRef>d21</BiopaxRef>
    <BiopaxRef>bfb</BiopaxRef>
    <BiopaxRef>e57</BiopaxRef>
    <BiopaxRef>d26</BiopaxRef>
    <BiopaxRef>cd7</BiopaxRef>
    <Graphics>
      <Point GraphRef="f039e"/>
      <Point GraphRef="ae0ca" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="d64ba">
    <Comment>ProtModification MAP2K3 --+&gt; MAPK14,</Comment>
    <Comment>11245462 This pathway is stimulated by environmental and chemical stress as well as by exposure to cytokines, and it appears to play a role in the induction of apoptosis (10 , 11) . p38 MAPK is activated by hyperosmolarity and environmental stress and regulates pro- or anti-apoptotic effects in a stimulus and cell-type specific manner (12 , 13) . p38 MAPK is phosphorylated by either MKK3 (14) or MKK6 (15 , 16) . 

8939929 B , graphical representation of p38 hog and SAPK activation in each cell line and in vector transfected G418-resistant control cells. [View Larger Version of this Image (39K GIF file)] MKK3-AL and MKK6-AL Expression Impair the Activation of p38 hog But Not SAPK MKK3 and MKK6 can phosphorylate p38 hog in vitro and have been proposed as potential physiologic p38 hog activators ( 18 , 19 , 20 ). 

11732999 (CellType: chondrocyte) On the other hand, p38 MAPK is known to be a stress signal transducer, and phosphorylation of p38 MAPK in chondrocytes by EGF [ 25 ], PTH [ 41 ], and GDF-5 [ 42 ] regulates differentiation of chondrocytes. p38 MAPK is phosphorylated by MKK3, and MKK6 [ 45 ], and Atf-2 is one of the transcription factors downstream of p38 MAPK [ 31 ]. 

10716930 Since MKK3 does not bind to p38alpha or p38eta2, the selectivity of MKK3 in activating p38alpha MAPK is not caused by a difference in docking interactions of MKK3 with p38alpha and p38eta2. 

11560921 SEK-1 and MKK-3/6 are known to phosphorylate p38 MAPK and SAPK/JNK, respectively ( 41-45 ); thus, we theorize that alpha-synuclein affects the phosphorylation of MAPKs by MAPKKs. 

12589052 (CellLineName: COS I) Expression of Smad7 facilitates the interaction between MKK3 and p38 MAP kinase. 

10593906 Both MKK3 and MKK6 are upstream kinases that can activate and phosphorylate p38 MAPK ( 25 , 26 ). 

9430721 These data demonstrate that MKK3 and MKK6 differentially phosphorylate p38 MAP kinase isoforms. 

9379049 (Tissue: marrow, CellType: macrophage) 

MKK3 phosphorylates an unspecified isoform of p38. This interaction was modeled on a demonstrated interaction between human MKK3 and p38 from an unspecified species 

8622669 (Organ: heart, Tissue: smooth muscle, CellType: cardiomyocyte, CellLineName: MB-231) In contrast, MKK3, MKK4, and MKK6 contribute to p38 MAPK activation caused by UV radiation. 

</Comment>
    <BiopaxRef>ee1</BiopaxRef>
    <BiopaxRef>d84</BiopaxRef>
    <BiopaxRef>d6b</BiopaxRef>
    <BiopaxRef>dca</BiopaxRef>
    <BiopaxRef>ac4</BiopaxRef>
    <BiopaxRef>a52</BiopaxRef>
    <BiopaxRef>e6e</BiopaxRef>
    <BiopaxRef>eca</BiopaxRef>
    <BiopaxRef>d06</BiopaxRef>
    <BiopaxRef>bd2</BiopaxRef>
    <Graphics Color="999900">
      <Point GraphRef="f88a3"/>
      <Point GraphRef="eea31" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="d75b7">
    <Comment>ProtModification MAPK14 --+&gt; MAPKAPK2</Comment>
    <Comment>MedLine Reference  10666409:1192  
Sentence  These data indicate that activation of MAPKAPK2, which is immediately downstream of p38 MAPK, is highly correlated with PC&#195;&#162;&#194;&#128;&#194;&#153;s protection.  
Journal  Circulation Res  
Journal Reference  v272 i6 p3296 (1997)  
Journal Link  http://circres.ahajournals.org/cgi/content/full/86/2/144  
Organ  immunologic  
CellType  myocyte  
Source  Ariadne Pathways  

--------------------------------------------------------------------------------
MedLine Reference  9679149:1317  
Sentence  Therefore, the data are consistent with phosphorylation of MAPKAPK2 by p38-MAPK being essential for activation.  
Journal  J. Cell Biol  
Journal Reference  v142 i2 p523 (1998)  
Journal Link  http://www.jcb.org/cgi/content/full/142/2/523  
Organ  heart  
CellType  myocyte  
Source  Ariadne Pathways  

--------------------------------------------------------------------------------
MedLine Reference  10993748:1166  
Sentence  Thus, unlike other MAP kinases, p38 MAP kinase activates the MAPKAP kinase 2 ( 21 ).  
Journal  Heart Circul  
Journal Reference  v279 i3 pH901 (2000)  
Journal Link  http://ajpheart.physiology.org/cgi/content/full/279/3/H901  
Organ  heart  
Source  Ariadne Pathways  

--------------------------------------------------------------------------------
MedLine Reference  9727040:11  
Sentence  These findings demonstrate that the activation of p38 MAP kinase is involved not only in response to stress, but also in physiological signaling by gastrointestinal hormones such as CCK, where activation of Gq-coupled receptors stimulates a cascade in which p38 MAP kinase activates MAP kinase-activated protein kinase-2, resulting in Hsp 27 phosphorylation.  
Journal  J. Cell Biol  
Journal Reference  v142 i2 p523 (1998)  
Journal Link  http://www.jcb.org/cgi/content/full/142/2/523  
Organ  gastric  
CellType  myocyte  
Source  Ariadne Pathways  
--------------------------------------------------------------------------------
MedLine Reference  14499342:1  
Sentence  MAPK-activated protein kinase-2 (MK2) is activated by p38 MAPK in human neutrophils.  
CellType  neutrophil  
Source  Ariadne Pathways  

--------------------------------------------------------------------------------
MedLine Reference  10704466:1014  
Sentence  Therefore, these studies demonstrate that p38alpha is a major upstream activator of MAPKAP kinase 2 and a key component of the IL-1 signaling pathway.  
Journal  J. Exp. Med  
Journal Reference  v274 i25 p17491 (1999)  
Journal Link  http://www.jem.org/cgi/content/full/191/5/859  
CellType  macrophage  
CellLineName  ES  
Source  Ariadne Pathways  

--------------------------------------------------------------------------------
MedLine Reference  9759836:1135  
Sentence  Both MAPKAPK-2 and its recently identified homologue, MAPKAPK-3, are phosphorylated and activated by p38 MAPK in vivo ( 43 , 59 ).  
Journal  J. Immunol  
Journal Reference  v161 i7 p3225 (1998)  
Journal Link  http://www.jimmunol.org/cgi/content/full/161/7/3225  
CellType  b cell  
Source  Ariadne Pathways  

--------------------------------------------------------------------------------
MedLine Reference  10066767:1186  
Sentence  Although p38-alpha phosphorylated MAPKAP kinase-2 significantly but not GST-c-Jun (Fig. 6 A ), p38-delta phosphorylated GST-c-Jun but not MAPKAP kinase-2 (Fig. 6 B ).  
Journal  J. Biol. Chem  
Journal Reference  v274 i11 p7095 (1999)  
Journal Link  http://www.jbc.org/cgi/content/full/274/11/7095  
CellLineName  293T  
Source  Ariadne Pathways  

--------------------------------------------------------------------------------
MedLine Reference  11490018:1219  
Sentence  MAPKAPK2, which was originally designated HSP25/27 kinase, is phosphorylated and activated by p38 MAPK ( 8 , 9 , 10 ).  
Journal  J. Immunol  
Journal Reference  v167 i4 p2298 (2001)  
Journal Link  http://www.jimmunol.org/cgi/content/full/167/4/2298  
CellType  MAST  
Source  Ariadne Pathways  

--------------------------------------------------------------------------------
MedLine Reference  11859076:1323  
Sentence  SRF can be phosphorylated by pp90 rsk , a known effector of ERKs, CaM kinases II and IV, and the MAPKAP-2 (MK2), which is regulated by p38 MAPK ( 10 ).  
Journal  J. Biol. Chem  
Journal Reference  v277 i18 p15376 (2002)  
Journal Link  http://www.jbc.org/cgi/content/full/277/18/15376  
CellType  t cell  
Source  Ariadne Pathways  
</Comment>
    <BiopaxRef>e67</BiopaxRef>
    <BiopaxRef>c05</BiopaxRef>
    <BiopaxRef>cc3</BiopaxRef>
    <BiopaxRef>c74</BiopaxRef>
    <BiopaxRef>bbd</BiopaxRef>
    <BiopaxRef>c7d</BiopaxRef>
    <BiopaxRef>b11</BiopaxRef>
    <BiopaxRef>c0d</BiopaxRef>
    <BiopaxRef>fe3</BiopaxRef>
    <BiopaxRef>ddd</BiopaxRef>
    <Graphics Color="999900">
      <Point GraphRef="eea31"/>
      <Point GraphRef="edbcf" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="da2f2">
    <Comment>ProtModification MAPK14 --+&gt; ELK4</Comment>
    <Comment>MedLine Reference  9130707  
Sentence  In contrast, the TCF Sap-1a is efficiently phosphorylated by p38 MAP kinase in vitro and in vivo on the homologous residues Ser381 and Ser387.  
Source  Ariadne Pathways  
</Comment>
    <BiopaxRef>ff5</BiopaxRef>
    <Graphics ConnectorType="Curved" Color="999900">
      <Point GraphRef="eea31"/>
      <Point GraphRef="d87ce" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="dab31">
    <Comment>DirectRegulation Ras --+&gt; MAP3K1,</Comment>
    <Comment>7744823 The interaction between Ras and MEKK was GTP-stimulated as measured by the increased phosphorylation of KMMEK1 using GST-Ras (GTP S) beads incubated with recombinant MEKK . 

7622446 So far, no direct interaction between Ras and MEKK1 has been observed, and it is not clear how it is activated by Ras. 

11082445 Direct interaction between Ras and MEKK1 may result in the latter being stimulated (Russell et al., 1995 ). 

8621725 (CellType: t cell, CellLineName: JURKAT) We recently demonstrated that MEKK activity can be stimulated by Ras and that MEKK1 physically binds to Ras in a GTP-dependent manner( 61 , 62 ) . 
</Comment>
    <BiopaxRef>f08</BiopaxRef>
    <BiopaxRef>a32</BiopaxRef>
    <BiopaxRef>de0</BiopaxRef>
    <BiopaxRef>a6d</BiopaxRef>
    <Graphics>
      <Point GraphRef="beaf5"/>
      <Point GraphRef="f091e" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="df73c">
    <Comment>ProtModification MAPK14 --+&gt; RPS6KA5</Comment>
    <Comment>--------------------------------------------------------------------------------
MedLine Reference  12690113:1232  
Sentence  MSK1 is known to be regulated by MAPK/ERK and SAPK2a/p38 and is currently the best candidate for the mediation of cytokine-induced CREB phosphorylation at Ser133 ( 37 ? 39 , 47 ).  
Journal  J. Biol. Chem  
Journal Reference  v278 i26 p23243 (2003)  
Journal Link  http://www.jbc.org/cgi/content/full/278/26/23243  
Tissue  epithelia  
Organ  lung  
Source  Ariadne Pathways  
--------------------------------------------------------------------------------
MedLine Reference  9873047:7  
Sentence  Although purified recombinant RLPK can be phosphorylated by ERK2 and p38alpha in vitro, its activity is not affected by this phosphorylation.  
CellLineName  HeLa  
Source  Ariadne Pathways  
--------------------------------------------------------------------------------
MedLine Reference  12896977:1308  
Sentence  Although the p38 MAPK can activate mitogen and stress-activated protein kinase-1 (MSK1), a major histone H3 kinase ( 67 ), SB203580 shows no effect on histone H3 acetylation at the IL-2 promoter ( Fig. 9 D ).  
Journal  J. Biol. Chem  
Journal Reference  v278 i42 p41034 (2003)  
Journal Link  http://www.jbc.org/cgi/content/full/278/42/41034  
Source  Ariadne Pathways  

--------------------------------------------------------------------------------
MedLine Reference  11701463:1153  
Sentence  Suppression of ERK and p38 MAPK is required to suppress the activation of MSK1.  
Journal  ATVB  
Journal Reference  v21 i11 p1764 (2001)  
Journal Link  http://atvb.ahajournals.org/cgi/content/full/21/11/1764  
Source  Ariadne Pathways  

--------------------------------------------------------------------------------
MedLine Reference  12628924:1039  
Sentence  The nuclear kinase MSK1 is activated by both ERK and p38 MAPK.  
Journal  EMBO  
Journal Reference  v22 i6 p1313 (2003)  
Journal Link  http://embojournal.npgjournals.com/cgi/content/full/22/6/1313  
Source  Ariadne Pathways  
</Comment>
    <BiopaxRef>ffa</BiopaxRef>
    <BiopaxRef>ec4</BiopaxRef>
    <BiopaxRef>dd0</BiopaxRef>
    <BiopaxRef>e74</BiopaxRef>
    <BiopaxRef>fbe</BiopaxRef>
    <Graphics Color="999900">
      <Point GraphRef="eea31"/>
      <Point GraphRef="d4bbc" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="df7e4">
    <Comment>DirectRegulation 1,4,5-Insp3 --+&gt; ITPR1</Comment>
    <Comment>11274965 We compared the effects of oxidizing reagents, in particular thimerosal, and of cyclic ADP-ribose (cADPR) on IP3 binding to the various IP3R isoforms. 

8633244 IP3 activates the IP3 receptor (IP3R), an intracellular calcium release channel on the endoplasmic reticulum. 

9688849 Thus, besides affecting the binding of IP3 to IP3R ( 49 , 50 ), the effects of Mg2+ on the single-channel properties of the IP3R may therefore contribute to the control of temporal and spatial patterns of Ca2+ release from intracellular stores. 

11017917 (CellType: myocyte) IP3 releases Ca2+ from intracellular stores by opening specific Ca2+ channels (IP3R). 

12621039 (Organ: cerebellar, CellType: Brain Stem, CellLineName: ng108-15) It has been reported that IP3 binding to the IP3R is not cooperative ( 31 , 33 ), and the same property holds true for the wild-type receptor and all of the mutant receptors except D1-223 expressed in R23-11 cells (Table I ). 
</Comment>
    <BiopaxRef>b48</BiopaxRef>
    <BiopaxRef>fbb</BiopaxRef>
    <BiopaxRef>d82</BiopaxRef>
    <BiopaxRef>fee</BiopaxRef>
    <BiopaxRef>ebb</BiopaxRef>
    <Graphics>
      <Point GraphRef="dbd89"/>
      <Point GraphRef="f7c77" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="df921">
    <Comment>DirectRegulation Gb/g --+&gt; PLC</Comment>
    <Comment>Activation of Gi/o-coupled receptors induces dissociation of Galpha from Getagamma, which activates phospholipase C and a resultant generation of the second messengers D - myo -inositol 1,4,5-trisphosphate and diacylglycerol, leading to activation of protein kinase C (PKC). 
</Comment>
    <BiopaxRef>fb3</BiopaxRef>
    <Graphics>
      <Point GraphRef="c67ec"/>
      <Point GraphRef="da47e" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="e044e">
    <Comment>DirectRegulation RASGRP1 --+&gt; RAP1A</Comment>
    <Comment>11292831 (Organ: brain, CellLineName: PC12D) We next showed in coimmunoprecipitation experiments that CalDAG-GEFI forms a complex with Rap1 and B-Raf following exposure to carbachol or calcium ionophore and the DAG analogue OAG (Fig. 8 ). 

9789079 (CellLineName: 293T) Expression of CalDAG-GEFI activates Rap1A and inhibits Ras-dependent activation of the Erk/MAP kinase cascade in 293T cells. 

14702343 (CellLineName: JURKAT) Our results have demonstrated that forced expression of CalDAG-GEFI activated endogenous Rap1 and augmented adhesion to ICAM-1 in response to TCR stimulation. 

10835426 (CellLineName: 293T) As reported previously ( 15 , 16 ), CalDAG-GEFI activated Rap1 and, to a lesser extent, R-Ras, and CalDAG-GEFII activated both Ha-Ras and R-Ras
</Comment>
    <BiopaxRef>bbe</BiopaxRef>
    <BiopaxRef>cd8</BiopaxRef>
    <BiopaxRef>cdc</BiopaxRef>
    <BiopaxRef>c2d</BiopaxRef>
    <Graphics>
      <Point GraphRef="c6568"/>
      <Point GraphRef="cc60d" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="e2de4">
    <Graphics Color="999900">
      <Point GraphRef="bda33"/>
      <Point GraphRef="a6431" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="e305e">
    <Comment>ProtModification MAPK1 --+&gt; MAPKAPK2</Comment>
    <Comment>MedLine Reference  10625698:1034  
Sentence  Activated MAPK interacts with a number of downstream targets, including the p90 ribosomal S6 kinase (p90 Rsk ) ( 19 ) and MAPK-activated protein kinase-2 (MAPKAP-K2 ) ( 20 , 21 ), which are activated by ERK1/2 and p38 MAPK , respectively.  
Journal  J. Biol. Chem  
Journal Reference  v275 i2 p1457 (2000)  
Journal Link  http://www.jbc.org/cgi/content/full/275/2/1457  
Organ  ventricle  
CellType  myocyte  
Source  Ariadne Pathways  

--------------------------------------------------------------------------------
MedLine Reference  8846784:6  
Sentence  In contrast, full-length GST-MAPKAP kinase-2 was phosphorylated at Thr25 (and not activated) by p42 MAPK, suggesting a role for the N-terminal domain in specifying activation by RK in vivo.  
CellLineName  KB  
Source  Ariadne Pathways  

--------------------------------------------------------------------------------
MedLine Reference  14499342:7  
Sentence  ERK phosphorylated MK2 in vitro and activated MK2 in f-methionyl-leucyl-phenylalanine (FMLP)-stimulated neutrophils.  
CellType  neutrophil  
Source  Ariadne Pathways  

--------------------------------------------------------------------------------
MedLine Reference  8900202:1138  
Sentence  MBP is an efficient substrate for ERK1 and ERK2, whereas GST-cJun (1-169) includes the activating phosphorylation sites Ser-63 and Ser-73, which have been shown to be phosphorylated by SAPK/JNK but not by ERK1, ERK2, or p38 HOG1 ( 3 ). 2 Similarly, hsp27 is an efficient substrate for MAPKAPK2, which in turn is predominantly activated by p38 HOG1, although MAPKAPK2 can also be phosphorylated in vitro by ERK1 and ERK2 ( 29 , 30 ). -- Fig. 2.  
Journal  J. Biol. Chem  
Journal Reference  v271 i43 p27107 (1996)  
Journal Link  http://www.jbc.org/cgi/content/full/271/43/27107  
CellLineName  Pam 212  
Source  Ariadne Pathways  

--------------------------------------------------------------------------------
MedLine Reference  8798679:1021  
Sentence  Although p42 MAPK can also phosphorylate and activate MAPKAP kinase-2 in vitro , the MAPK pathway is not activated by these stresses; conversely, activation of the MAPK pathway is not associated with activation of MAPKAP kinase-2 ( 9 , 11 ).  
Journal  J. Biol. Chem  
Journal Reference  v271 i40 p24313 (1996)  
Journal Link  http://www.jbc.org/cgi/content/full/271/40/24313  
Source  Ariadne Pathways  

--------------------------------------------------------------------------------
MedLine Reference  10022874:1302  
Sentence  The MAP kinase-activated protein kinases, Rsk and MAPKAPK-2, are similarly phosphorylated in their T loops by ERK and p38, respectively ( 2 , 8 ).  
Journal  Mol. Cell. Biol  
Journal Reference  v19 i3 p1871 (1999)  
Journal Link  http://mcb.asm.org/cgi/content/full/19/3/1871  
Source  Ariadne Pathways  

--------------------------------------------------------------------------------
MedLine Reference  12649327:1050  
Sentence  Both ERK and p38 can phosphorylate CREB via several downstream kinases including MSK1 for ERK and p38, p90RSK for ERK, and MAPKAPK2 for p38 ( 12 , 14 , 26 ).  
Journal  Mol. Endocrin  
Journal Reference  v17 i6 p1131 (2003)  
Journal Link  http://mend.endojournals.org/cgi/content/full/17/6/1131  
Source  Ariadne Pathways  

--------------------------------------------------------------------------------
MedLine Reference  14688255:1134  
Sentence  This co-expression system was used previously in our laboratory to activate GST-RSK CTD ( 21 ), and ERK2 has been reported to activate MK2 ( 26 ).  
Journal  J. Biol. Chem  
Journal Reference  v279 i11 p10176 (2004)  
Journal Link  http://www.jbc.org/cgi/content/full/279/11/10176  
Source  Ariadne Pathways  

--------------------------------------------------------------------------------
MedLine Reference  8995385:1254  
Sentence  First, LY294002, which inhibited Erk-1 and 2 but not p38, failed to inhibit MAPKAPK-2.  
Journal  J. Biol. Chem  
Journal Reference  v272 i2 p937 (1997)  
Journal Link  http://www.jbc.org/cgi/content/full/272/2/937  
CellType  leukocyte  
Source  Ariadne Pathways  
--------------------------------------------------------------------------------
MedLine Reference  11463795:1195  
Sentence  With respect to alternative non-PLD/PA mechanisms whereby ERK could conceivably activate PKC-eta/ , it has been reported that ERK-activated MAPK-activated kinase-2 ( 34 , 35 ) and MSK-1 ( 36 ) can act like PDK-1 and/or PDK-2 and phosphorylate PKB on serine 308 and threonine 473 residues.  
Journal  J. Biol. Chem  
Journal Reference  v276 i38 p35537 (2001)  
Journal Link  http://www.jbc.org/cgi/content/full/276/38/35537  
Tissue  skeletal muscle  
CellType  adipocyte  
Source  Ariadne Pathways  
</Comment>
    <BiopaxRef>a63</BiopaxRef>
    <BiopaxRef>c5a</BiopaxRef>
    <BiopaxRef>c5e</BiopaxRef>
    <BiopaxRef>f54</BiopaxRef>
    <BiopaxRef>c40</BiopaxRef>
    <BiopaxRef>fdd</BiopaxRef>
    <BiopaxRef>e6d</BiopaxRef>
    <BiopaxRef>e0c</BiopaxRef>
    <BiopaxRef>a69</BiopaxRef>
    <BiopaxRef>ab4</BiopaxRef>
    <Graphics Color="999900">
      <Point GraphRef="fe3cb"/>
      <Point GraphRef="edbcf" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="e36b2">
    <Comment>ProtModification MAPK3 --+&gt; ELK1</Comment>
    <Comment>MedLine Reference  10024371:1025  
Sentence  Induction of the SRE occurs upon formation of a ternary complex with serum response factor, p62 TCF , and the SRE. 118 ERK1/2 was shown to phosphorylate p62 TCF (also known as elk-1 or SAP-1), resulting in enhanced ternary complex formation. 119 Thus, the SRE present in the c- fos promoter may be regulated by angiotensin II??????stimulated ERK1/2 phosphorylation of p62 TCF , as shown for EGF. 119 Activation of ERK1/2 requires activation of Ras and Raf, events that are regulated by tyrosine phosphorylation.  
Journal  J. Neurosci  
Journal Reference  v19 i5 p1876 (1999)  
Journal Link  http://www.blackwell-synergy.com/links/doi/10.1046/j.1471-4159.2002.01075.x/full/  
Tissue  fat  
Organ  liver  
CellType  eosinophil  
CellLineName  CWSV1  
Source  Ariadne Pathways  

--------------------------------------------------------------------------------
MedLine Reference  11751459:1010  
Sentence  On bryo 1 treatment, the activity of ERK2 (p42) rapidly increased, with ERK1 (p44) protein levels remaining constant. p44/42 immunoprecipitates from lysates of bryo 1-treated cells had increased their ability to phosphorylate the transcription factor Elk-1.  
Journal  Cell Growth and Diff  
Journal Reference  v12 i12 p641 (2001)  
Journal Link  http://cgd.aacrjournals.org/cgi/content/full/12/12/641  
Tissue  lymph  
CellLineName  reh  
Source  Ariadne Pathways  

--------------------------------------------------------------------------------
MedLine Reference  11782488:1286  
Sentence  It was also reported that BMK1 activation is required for neurotrophin stimulation of MEF2C in both cortical neurons and PC12 cells, distinct from ERK1/2-induced activation of Elk1 and CREB transcription factors ( 30 ).  
Journal  J. Biol. Chem  
Journal Reference  v277 i11 p9614 (2002)  
Journal Link  http://www.jbc.org/cgi/content/full/277/11/9614  
Tissue  cortex  
CellType  neural  
CellLineName  PC 12  
Source  Ariadne Pathways  

--------------------------------------------------------------------------------
MedLine Reference  11297525:1051  
Sentence  In addition, the activation of ERK1/2 correlated with increased activation of the downstream transcription factor Elk-1.  
Journal  J. Biol. Chem  
Journal Reference  v276 i18 p15537 (2001)  
Journal Link  http://www.jbc.org/cgi/content/full/276/18/15537  
Tissue  marrow  
Source  Ariadne Pathways  

--------------------------------------------------------------------------------
MedLine Reference  12032150:1015  
Sentence  In the nucleus, activated ERK1/2 continuously phosphorylate Elk-1, leading to the prolonged expression of c- fos , which results in the expression of several genes such as matrix metalloproteinase (mmp)-9 ; MMP-9 activity is required for the induction of the cell motility response.  
Journal  J. Biol. Chem  
Journal Reference  v277 i31 p28256 (2002)  
Journal Link  http://www.jbc.org/cgi/content/full/277/31/28256  
Organ  kidney  
CellLineName  Madin Darby  
Source  Ariadne Pathways  
--------------------------------------------------------------------------------
MedLine Reference  9020136:1065  
Sentence  Likewise GST-Sap, the GST fusion protein containing the C-terminal activation domain of Elk-1 was more readily phosphorylated by ERK-1 than by JNK-1 in vitro (Fig. 1 A , lower right panel ), although this difference was not as pronounced as with GST-Sap. -- Fig. 1.  
Journal  J. Biol. Chem  
Journal Reference  v272 i7 p4219 (1997)  
Journal Link  http://www.jbc.org/cgi/content/full/272/7/4219  
Source  Ariadne Pathways  

--------------------------------------------------------------------------------
MedLine Reference  11408617:1037  
Sentence  Once activated, ERK1/2 can phosphorylate a ternary complex factor, Elk-1, that further interacts with serum response factor and induces the transcription of c-fos through serum-responsive element (Karin, 1995 ).  
Journal  Mol. Pharm  
Journal Reference  v60 i1 p217 (2001)  
Journal Link  http://molpharm.aspetjournals.org/cgi/content/full/60/1/217  
Source  Ariadne Pathways  

--------------------------------------------------------------------------------
MedLine Reference  12239223:1248  
Sentence  ERK1/2 then activates transcription factor ELK-1, whereas JNK and p38 MAPK activate ATF2 .  
Journal  J. Biol. Chem  
Journal Reference  v277 i50 p48755 (2002)  
Journal Link  http://www.jbc.org/cgi/content/full/277/50/48755  
Source  Ariadne Pathways  

--------------------------------------------------------------------------------
MedLine Reference  11463794:1190  
Sentence  A, phosphorylation of Elk1 by HA-ERK1 and HA-ERK1b.  
Journal  J. Biol. Chem  
Journal Reference  v276 i38 p35280 (2001)  
Journal Link  http://www.jbc.org/cgi/content/full/276/38/35280  
CellLineName  COS-7  
Source  Ariadne Pathways  
--------------------------------------------------------------------------------
MedLine Reference  12498787:4  
Sentence  Since Erk1 and Erk2 regulate transcription from the Fos serum response element (SRE) by phosphorylating the ternary complex factors Elk-1 and SAP-1 ( Treisman, 1995 ), we examined the effect of integrin ligation on the Fos SRE.  
Journal  Renal Phys  
Journal Reference  v276 i29 p26814 (2001)  
Journal Link  http://www.jbc.org/cgi/content/full/276/29/26814  
Source  Ariadne Pathways 
</Comment>
    <BiopaxRef>ccb</BiopaxRef>
    <BiopaxRef>e28</BiopaxRef>
    <BiopaxRef>c2f</BiopaxRef>
    <BiopaxRef>c6f</BiopaxRef>
    <BiopaxRef>b2e</BiopaxRef>
    <BiopaxRef>d6d</BiopaxRef>
    <BiopaxRef>aca</BiopaxRef>
    <BiopaxRef>b80</BiopaxRef>
    <BiopaxRef>e0d</BiopaxRef>
    <Graphics Color="999900">
      <Point GraphRef="bda33"/>
      <Point GraphRef="b1b8a" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="e643f">
    <Comment>ProtModification MAPKAPK3 --+&gt; CREB1</Comment>
    <Comment>MedLine Reference  12896977:1200  
Sentence  Multiple p38 MAPK-dependent kinases such as MAPKAP kinase 2/3 have been shown to increase CREB phosphorylation in various cell types, including T-lymphocytes ( 36 , 49 A?A?A? 51 ).  
Journal  Mol. Endocrin  
Journal Reference  v278 i42 p41034 (2003)  
Journal Link  http://www.jbc.org/cgi/content/full/278/42/41034  
Tissue  egg  
Organ  heart  
CellType  t cell  
CellLineName  PC 12  
Source  Ariadne Pathways  

--------------------------------------------------------------------------------
MedLine Reference  10488088:1234  
Sentence  We now demonstrate that IGF-I induces promoter activity of the bcl-2 gene through activation of CREB via a novel signaling pathway mediated by MAPK kinase 6/p38eta MAPK/MAPKAP-K3 (Fig. 8 ).  
Journal  J. Biol. Chem  
Journal Reference  v274 i39 p27529 (1999)  
Journal Link  http://www.jbc.org/cgi/content/full/274/39/27529  
Tissue  cortex  
CellType  neural  
Source  Ariadne Pathways  

--------------------------------------------------------------------------------
MedLine Reference  11328854:1137  
Sentence  Additionally, these immune complex kinase assays confirmed previous reports indicating that MAPKAPK-3 can directly phosphorylate CREB in vitro ( 12 , 26 ).  
Journal  Mol. Endocrin  
Journal Reference  v15 i5 p716 (2001)  
Journal Link  http://mend.endojournals.org/cgi/content/full/15/5/716  
Tissue  egg  
Source  Ariadne Pathways  
--------------------------------------------------------------------------------
MedLine Reference  10781029:1082  
Sentence  Indeed, MK2 was shown to phosphorylate the nuclear transcription factors CREB as well as SRF ( 5 , 6 ) and to modulate their transcriptional activity. 3pK is also able to phosphorylate CREB in vitro and to interact with several nuclear proteins in vivo . 2 We used a human heart cDNA library and a kinase inactive version of 3pK as a bait, because wild-type 3pK autonomously led to the transactivation of the reporter genes.  
Journal  J. Biol. Chem  
Journal Reference  v275 i27 p20239 (2000)  
Journal Link  http://www.jbc.org/cgi/content/full/275/27/20239  
Organ  heart  
Source  Ariadne Pathways  

--------------------------------------------------------------------------------
MedLine Reference  0:10240051  
Source  Ariadne Pathways  

--------------------------------------------------------------------------------
MedLine Reference  10706690:1224  
Sentence  MAPKAP-K2, MAPKAP-K3, and PKA also phosphorylate CREB and ATF1 at Ser 133 and Ser 63 , respectively ( 2 ).  
Journal  J. Immunol  
Journal Reference  v164 i6 p3018 (2000)  
Journal Link  http://www.jimmunol.org/cgi/content/full/164/6/3018  
CellType  macrophage  
Source  Ariadne Pathways  
</Comment>
    <BiopaxRef>d39</BiopaxRef>
    <BiopaxRef>be5</BiopaxRef>
    <BiopaxRef>dcd</BiopaxRef>
    <BiopaxRef>eac</BiopaxRef>
    <BiopaxRef>b26</BiopaxRef>
    <Graphics Color="999900">
      <Point GraphRef="de99a"/>
      <Point GraphRef="df2fc" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="e6cb2">
    <Comment>ChemicalReaction 1,2-Diacetin; PLC; 1,4,5-Insp3,</Comment>
    <Comment>The PLC that hydrolyzes PC-PLC generates the products phosphocholine and DAG. 
</Comment>
    <BiopaxRef>a0b</BiopaxRef>
    <Graphics>
      <Point GraphRef="da47e"/>
      <Point GraphRef="b91eb" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="ea3b6">
    <Comment>ProtModification MAP2K1 --+&gt; MAPK1</Comment>
    <Comment>--------------------------------------------------------------------------------
MedLine Reference  10428835:1222  
Sentence  PD98059 is a specific inhibitor for MKK1 and -2 ( 56 ), upstream kinases that phosphorylate and activate ERK ( 15 , 57 ).  
Journal  J. Biol. Chem  
Journal Reference  v274 i32 p22569 (1999)  
Journal Link  http://www.jbc.org/cgi/content/full/274/32/22569  
Tissue  cortex  
CellType  neural  
CellLineName  DIV  
Source  Ariadne Pathways  
--------------------------------------------------------------------------------
MedLine Reference  12529254:1190  
Sentence  The present study provides direct evidence that the P2X7-R can mediate ERK1/2 activation through a cellular pathway that is dependent on intracellular and extracellular Ca2+, Pyk2, c-Src, PI 3-K, and MEK1/2.  
Journal  Cell Phys  
Journal Reference  v284 i2 pC571 (2003)  
Journal Link  http://ajpcell.physiology.org/cgi/content/full/284/2/C571  
CellType  macrophage  
Source  Ariadne Pathways  
--------------------------------------------------------------------------------
MedLine Reference  10827000:1180  
Sentence  MEK1 activity was assayed in muscle protein by measuring the ability of MEK1 immune complexes to phosphorylate a recombinant kinase-inactive MAPK (p42MAPK).  
Journal  Endocrin. Metabol  
Journal Reference  v278 i6 pE992 (2000)  
Journal Link  http://ajpendo.physiology.org/cgi/content/full/278/6/E992  
Tissue  muscle  
Source  Ariadne Pathways  
--------------------------------------------------------------------------------
MedLine Reference  12746434:1159  
Sentence  These activation kinetic data are consistent with the fact that ERK1/2 is specifically activated by MEK1/2.  
Journal  J. Biol. Chem  
Journal Reference  v278 i31 p29000 (2003)  
Journal Link  http://www.jbc.org/cgi/content/full/278/31/29000  
Source  Ariadne Pathways  

--------------------------------------------------------------------------------
MedLine Reference  9207092:1125  
Sentence  Control experiments demonstrated that ERK2 and p38alpha were activated by their cognate MAP kinase kinases, MKK1 and MKK6 (data not shown).  
Journal  PNAS  
Journal Reference  v94 i14 p7337 (1997)  
Journal Link  http://www.pnas.org/cgi/content/full/94/14/7337  
Source  Ariadne Pathways  

--------------------------------------------------------------------------------
MedLine Reference  10636870:1150  
Sentence  MEK1/2 inhibition prevents H 2 O 2 -mediated activation of ERK1/2 to a greater extent than activation of p90RSK.  
Journal  J. Biol. Chem  
Journal Reference  v275 i3 p1739 (2000)  
Journal Link  http://www.jbc.org/cgi/content/full/275/3/1739  
CellLineName  JURKAT  
Source  Ariadne Pathways  

--------------------------------------------------------------------------------
MedLine Reference  11303030:1103  
Sentence  The closely related mammalian kinases, ERK1 and ERK2 (also called p44 and p42), are activated by the MEK1/2 kinases in response to mitogenic signals.  
Journal  J. Biol. Chem  
Journal Reference  v276 i24 p20805 (2001)  
Journal Link  http://www.jbc.org/cgi/content/full/276/24/20805  
Source  Ariadne Pathways  

--------------------------------------------------------------------------------
MedLine Reference  11571230:1117  
Sentence  Assessment of VES-induced differentiation after blockage of ERK1/2 activation by MEK1 using the chemical inhibitor PD 98059.  
Journal  Cell Growth and Diff  
Journal Reference  v12 i9 p471 (2001)  
Journal Link  http://cgd.aacrjournals.org/cgi/content/full/12/9/471  
Source  Ariadne Pathways  

--------------------------------------------------------------------------------
MedLine Reference  12226077:1214  
Sentence  Expression of dominant negative MEK1 significantly attenuates the bFGF-induced phosphorylation of ERK1/2 (Fig. 3 C , lane 4 on the bottom panel ).  
Journal  J. Biol. Chem  
Journal Reference  v277 i46 p44417 (2002)  
Journal Link  http://www.jbc.org/cgi/content/full/277/46/44417  
Source  Ariadne Pathways  
--------------------------------------------------------------------------------
MedLine Reference  12960148:1141  
Sentence  Furthermore, S100A1-mediated activation of ERK 1/2 could be prevented by preincubation with PD98095 (2-10 &#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189; M ) ( Fig. 6 B ), a specific inhibitor of MEK1 ( 26 , 27 ).  
Journal  J. Biol. Chem  
Journal Reference  v278 i48 p48404 (2003)  
Journal Link  http://www.jbc.org/cgi/content/full/278/48/48404  
Source  Ariadne Pathways  
</Comment>
    <BiopaxRef>db1</BiopaxRef>
    <BiopaxRef>a67</BiopaxRef>
    <BiopaxRef>cdd</BiopaxRef>
    <BiopaxRef>c18</BiopaxRef>
    <BiopaxRef>ded</BiopaxRef>
    <BiopaxRef>d9d</BiopaxRef>
    <BiopaxRef>dd6</BiopaxRef>
    <BiopaxRef>cbe</BiopaxRef>
    <BiopaxRef>b4f</BiopaxRef>
    <BiopaxRef>b36</BiopaxRef>
    <Graphics Color="999900">
      <Point GraphRef="d7383"/>
      <Point GraphRef="fe3cb" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="eb709">
    <Comment>DirectRegulation Gb/g --+&gt; PI3K</Comment>
    <Comment>11879201 Type IB phosphoinositide 3OH-kinase (PI3K) is activated by G-protein betagamma subunits (Gbetagammas). 

10642513 A novel p110gamma PI-3K was reported to be activated by G(i)-coupled receptors via Gbetagamma subunits. 

11400324 Recent studies have demonstrated that PI3-Kinase can be activated by G beta gamma, but not by G alpha subunit. 

11673483 Gbetagamma coimmunoprecipitated with PLCbeta and phosphatidylinositol 3-kinase. 

14575867 (CellType: melanophore) In Xenopus aggregation, we suggest that melatonin stimulation of the Mel1c receptor via G(beta gamma) activates PI3-K that, directly or indirectly via MAPK, activates PDE. 

7896797 (CellType: platelet) Recent reports indicate that cytosolic PI 3-Ks can also be activated by the beta gamma subunits of heterotrimeric G-proteins (G beta gamma). 

12181454 Moreover, it is generally accepted that Getagamma is involved in PI3K activation (Clapham and Neer, 1997 ; Vanhaesebroeck et al., 1997 ). 

12796499 It should be noted that it has been well established that PI3K can be activated by the Getagamma-coupled signaling pathway ( 23 &#195;&#162;&#194;&#128;&#194;&#147; 25 ). 

12529253 (Tissue: egg) Moreover, it is generally accepted that Getagamma is involved in PI3K activation ( 1 , 15 ). 

10788495 Identity and purity of recombinant PI3Ks, PLC isozymes, and Getagamma dimers. 

</Comment>
    <BiopaxRef>edf</BiopaxRef>
    <BiopaxRef>f1a</BiopaxRef>
    <BiopaxRef>d5d</BiopaxRef>
    <BiopaxRef>ed6</BiopaxRef>
    <BiopaxRef>bce</BiopaxRef>
    <BiopaxRef>ffb</BiopaxRef>
    <BiopaxRef>bf5</BiopaxRef>
    <BiopaxRef>b25</BiopaxRef>
    <BiopaxRef>aae</BiopaxRef>
    <BiopaxRef>b40</BiopaxRef>
    <Graphics>
      <Point GraphRef="c67ec"/>
      <Point GraphRef="d1342" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="eb846">
    <Comment>ProtModification PDPK1 --+&gt; PKC</Comment>
    <Comment>11035106 (Tissue: alveola, CellType: macrophage) We then evaluated whether or not PDK-1 might be involved in PKC activation by examining complex formation. 

12169624 Interestingly, however, PDK1 can only interact with full-length PKC when it is not phosphorylated at its hydrophobic motif and phosphorylation of this motif was shown to somehow mask this region, preventing it from interacting with PDK1 ( Gao et al ., 2001 ). 

11500364 Furthermore, the data appear to exclude a role for members of the PKC family that are also regulated by PDK1 in the regulation of 4E-BP1 phosphorylation: an earlier report indicated a role in this for PKCdelta ( Kumar et al ., 2000 ). 

10330161 (CellLineName: PC 12) Very recently, PKCdelta ( 27 ) and PKCeta ( 5 , 27 ) have been shown to be activated by a wortmannin-sensitive, PI-3-kinase-dependent pathway via phosphorylation of PKC by PDK1. 

11376011 To probe whether the interaction of protein kinase C with PDK-1 was direct or mediated by a scaffold protein, we examined the interaction of pure PDK-1 with pure protein kinase C. 

11971024 Complicating the picture, the PIP 3 -dependent PDK1, besides playing a critical role in activating PKB, has also been shown to phosphorylate/activate various PKC isoforms ( 27 , 28 , 29 ). 

10438924 Recent work has shown that PDK1 phosphorylates and activates the p70 S6K kinase ( 86 ), the Sgk protein kinase ( 87 ), and the isoform of protein kinase C (PKC) ( 88 ). 

10744767 In this communication, we addressed whether the phosphorylation of protein kinase C by PDK-1 is conformationally regulated. 

10861044 PDK-1 has been shown to phosphorylate/activate various PKC isoforms ( 24 , 25 , 26 , 27 , 28 ). 

</Comment>
    <BiopaxRef>f98</BiopaxRef>
    <BiopaxRef>da9</BiopaxRef>
    <BiopaxRef>a70</BiopaxRef>
    <BiopaxRef>f57</BiopaxRef>
    <BiopaxRef>bfc</BiopaxRef>
    <BiopaxRef>a47</BiopaxRef>
    <BiopaxRef>cb6</BiopaxRef>
    <BiopaxRef>a51</BiopaxRef>
    <BiopaxRef>ecd</BiopaxRef>
    <Graphics Color="999900">
      <Point GraphRef="c3d64"/>
      <Point GraphRef="ae0ca" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="ef1a7">
    <Comment>ProtModification MAPK14 --+&gt; ELK1</Comment>
    <Comment>MedLine Reference  10781582:1069  
Sentence  Protein Phosphorylation Assay in Vitro-- Phosphorylation of p53, Elk-1, ATF-2, or c-Jun by active recombinant ERK1, ERK2, p38 kinase or JNK2 was carried out at 30 ???&#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189;C for 60 min in the presence of the kinase buffer with 200 ???&#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189; M ATP and p53, Elk-1, ATF-2, or c-Jun as substrate.  
Journal  J. Biol. Chem  
Journal Reference  v275 i27 p20444 (2000)  
Journal Link  http://www.jbc.org/cgi/content/full/275/27/20444  
Source  Ariadne Pathways  

--------------------------------------------------------------------------------
MedLine Reference  12208764:1103  
Sentence  The transactivation domains of ATF2, Elk-1, and c-Jun are physiologically phosphorylated by p38HOG, ERK, and SAPK, respectively.  
Journal  Cancer Res  
Journal Reference  v62 i17 p5076 (2002)  
Journal Link  http://cancerres.aacrjournals.org/cgi/content/full/62/17/5076  
CellLineName  U2 OS  
Source  Ariadne Pathways  

--------------------------------------------------------------------------------
MedLine Reference  11732999:1035  
Sentence  It is reported that Elk-1 and Atf-2 are phosphorylated by ERK and p38 MAPK, respectively [ 30 , 33 , 34 ].  
Journal  Eur. J. Biochem  
Journal Reference  v268 i23 p6058.html) (2001)  
Journal Link  http://www.ejbiochem.org/cgi/content/full/268/23/6058.h  
Source  Ariadne Pathways  
--------------------------------------------------------------------------------
MedLine Reference  9054448:1196  
Sentence  For example, while JNK appears to preferentially phosphorylate c-Jun, ERK/MAPK preferentially phosphorylates c-Myc, p38 MAPK preferentially phosphorylates ATF-2 and ERK/MAPK and p38 MAPK phosphorylate Elk-1 to similar extents ( 68 ).  
Journal  J. Biol. Chem  
Journal Reference  v272 i11 p7464 (1997)  
Journal Link  http://www.jbc.org/cgi/content/full/272/11/7464  
Organ  heart  
CellType  myocyte  
Source  Ariadne Pathways  

--------------------------------------------------------------------------------
</Comment>
    <BiopaxRef>fa2</BiopaxRef>
    <BiopaxRef>c4f</BiopaxRef>
    <Graphics Color="999900">
      <Point GraphRef="eea31"/>
      <Point GraphRef="b1b8a" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="efe61">
    <Comment>Regulation 1,2-Diacetin --+&gt; RASGRP1,</Comment>
    <Comment>11880369 Diacylglycerol has been shown to regulate RasGRP subcellular location and catalytic activity ( 8 , 15-17 ). 

15879121 Y775 and Y783 are therefore identified as the primary regulatory tyrosines for both the IP 3 -mediated Ca 2+ flux and the DAG-mediated activation of the PKC/RasGRP pathway. 

17492052 (CellType: platelet) We have recently identified Ca 2+ and diacylglycerol-regulated guanine nucleotide exchange factor I (CalDAG-GEFI; also referred to as RasGRP2) as crucial for &#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189;&#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189;&#195;&#142;&#194;&#169;&#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189;&#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189;&#195;&#142;&#194;&#169;&#195;&#142;&#194;&#169;&#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189;&#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189;&#195;&#142;&#194;&#169;&#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189;&#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189;&#195;&#142;&#194;&#169;&#195;&#142;&#194;&#169;&#195;&#142;&#194;&#169; 3 integrin activation in platelets ( 15 ). 

11395491 (CellType: t cell) IP 3 binds receptors that regulate the release of stored Ca 2+ , whereas DAG is required to activate proteins such as protein kinase C and Ras guanyl nucleotide releasing protein (RasGRP) ( 17-19 ). 

15795236 (CellType: t cell) An increase in inositol ( 1 , 4 , 5 ) tris phosphate levels results in release of calcium from intracellular stores, whereas increased diacylglycerol results in stimulation of PKC and RasGRP (for review see reference 30 ). 

11292831 (CellLineName: PC12D) Together, these data define a novel signaling pathway for M 1 mAChR , where increases in Ca 2+ and diacylglycerol stimulate the sequential activation of CalDAG-GEFI , Rap1, and B-Raf, resulting in the activation of MEK and ERK1/2. 

14532295 (CellType: b cell, CellLineName: ramos) Conversely, diacylglycerol both activates RasGRP1 and causes the activation and translocation of diacylglycerol kinase, which abrogates the activation of the GRP protein ( 43 , 44 ). 

14557275 (CellLineName: MOCK) In this regard, it has been reported that DAG kinase zeta phosphorylates specifically localized DAG molecules, thereby controlling the activation of the DAG-activated signaling protein RasGRP and H-Ras ( 20 ). 

11257115 (CellLineName: Rat2) It is important then that cells regulate the DAG that activates RasGRP. 

11352924 (Organ: brain) DAG produced in response to these external stimuli activates PKC and the guanine nucleotide exchange factors vav and RasGRP ( 39 , 40 ). 

</Comment>
    <BiopaxRef>a3f</BiopaxRef>
    <BiopaxRef>ccf</BiopaxRef>
    <BiopaxRef>e1e</BiopaxRef>
    <BiopaxRef>eab</BiopaxRef>
    <BiopaxRef>f1e</BiopaxRef>
    <BiopaxRef>bbe</BiopaxRef>
    <BiopaxRef>c36</BiopaxRef>
    <BiopaxRef>ec3</BiopaxRef>
    <BiopaxRef>ecb</BiopaxRef>
    <BiopaxRef>bb3</BiopaxRef>
    <Graphics LineStyle="Broken">
      <Point GraphRef="b91eb"/>
      <Point GraphRef="c6568" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="f1e53">
    <Comment>MolTransport GNAI2 --+&gt; Gb/g,</Comment>
    <Comment>Alpha-thrombin-mediated phosphatidylinositol 3-kinase activation through release of Gbetagamma dimers from Galphaq and Galphai2. 
</Comment>
    <BiopaxRef>cbd</BiopaxRef>
    <Graphics Color="333333">
      <Point GraphRef="b9df7"/>
      <Point GraphRef="c67ec" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="f2ea8">
    <Comment>ProtModification MAPKAPK2 --+&gt; CREB1</Comment>
    <Comment>MedLine Reference  8887554:4  
Sentence  We show that MAPKAP kinase-2 phosphorylates CREB at Ser133 in vitro, that the FGF- or stress-induced activation of MAPKAP kinase-2 and phosphorylation of CREB and ATF-1 are prevented by similar concentrations of the specific p38 MAP kinase inhibitor SB 203580, and that MAPKAP kinase-2 is the only detectable SB 203580-sensitive CREB kinase in SK-N-MC cell extracts.  
CellLineName  sk-n-mc  
Source  Ariadne Pathways  

--------------------------------------------------------------------------------
MedLine Reference  10487749:1189  
Sentence  MK2 phosphorylates the nuclear transcription factors CREB (Tan et al. , 1996 ; Iordanov et al. , 1997 ), ATF-1 (Tan et al. , 1996 ) and SRF (Heidenreich et al. , 1999 ), indicating a role in transcriptional regulation.  
Journal  EMBO  
Journal Reference  v18 i18 p4969 (1999)  
Journal Link  http://embojournal.npgjournals.com/cgi/content/full/18/18/4969  
Source  Ariadne Pathways  

--------------------------------------------------------------------------------
MedLine Reference  9422727:1245  
Sentence  Although it has been shown that MAPKAPK-2 phosphorylates CREB at Ser-133 in vitro ( 73 ), we did not observe an increase in phosphorylation of CREB by MAPKAPK-2 activated by OA HS.  
Journal  J. Biol. Chem  
Journal Reference  v273 i2 p749 (1998)  
Journal Link  http://www.jbc.org/cgi/content/full/273/2/749  
CellLineName  9L  
Source  Ariadne Pathways  

--------------------------------------------------------------------------------
MedLine Reference  9139689:1033  
Sentence  One of the downstream targets of p38 is the MAPKAP kinase-2, which can activate the transcription factors CREB and ATF-1 ( 18 ) and phosphorylate heat-shock protein hsp27 ( 19 , 20 ).  
Journal  J. Biol. Chem  
Journal Reference  v272 i19 p12422 (1997)  
Journal Link  http://www.jbc.org/cgi/content/full/272/19/12422  
CellType  pre B  
Source  Ariadne Pathways  

--------------------------------------------------------------------------------
MedLine Reference  11123233:1259  
Sentence  Furthermore, activation of MAPKAP kinase 2 results in activation of the transcriptional factor CREB ( 44 ) as well as HSP27 in human cells and HSP25 in bovine and murine cells ( 4 , 17 ).  
Journal  Heart Circul  
Journal Reference  v280 i1 pH189 (2001)  
Journal Link  http://ajpheart.physiology.org/cgi/content/full/280/1/H189  
CellLineName  P0  
Source  Ariadne Pathways  

--------------------------------------------------------------------------------
MedLine Reference  11907026:1240  
Sentence  In contrast to EGF or NGF , fibroblast growth factor (FGF )-induced CREB phosphorylation is mediated by MAPKAP kinase-2 ( 14 ) that lies immediately downstream from p38MAPK.  
Journal  J. Biol. Chem  
Journal Reference  v277 i21 p18710 (2002)  
Journal Link  http://www.jbc.org/cgi/content/full/277/21/18710  
Source  Ariadne Pathways  

--------------------------------------------------------------------------------
MedLine Reference  12810757:1144  
Sentence  Therefore, p90rsk2 and MAPKAP kinase-2 might be responsible for phosphorylation of CREB downstream from ERK and p38 MAPK, respectively.  
Journal  Hypertension  
Journal Reference  v42 i2 p177 (2003)  
Journal Link  http://hyper.ahajournals.org/cgi/content/full/42/2/177  
CellType  macrophage  
Source  Ariadne Pathways  

--------------------------------------------------------------------------------
MedLine Reference  9759836:1029  
Sentence  In addition, MAPKAPK-2, a downstream target for p38 MAPK, phosphorylates CREB in response to FGF and arsenite ( 33 ).  
Journal  J. Immunol  
Journal Reference  v161 i7 p3225 (1998)  
Journal Link  http://www.jimmunol.org/cgi/content/full/161/7/3225  
CellType  myocyte  
Source  Ariadne Pathways  

--------------------------------------------------------------------------------
MedLine Reference  11278709:1233  
Sentence  PKA , PKC , CaM kinase, CK2 , MAPKAP kinase-2, p60 S6K , and p90 RSK have been reported to phosphorylate CREB .  
Journal  J. Biol. Chem  
Journal Reference  v276 i17 p13858 (2001)  
Journal Link  http://www.jbc.org/cgi/content/full/276/17/13858  
Source  Ariadne Pathways  

--------------------------------------------------------------------------------
MedLine Reference  11006268:1158  
Sentence  It has been reported that MAPKAP kinase-2 phosphorylates CREB in response to fibroblast growth factor in neuroblastoma cells ( 45 ).  
Journal  J. Biol. Chem  
Journal Reference  v275 i51 p40539 (2000)  
Journal Link  http://www.jbc.org/cgi/content/full/275/51/40539  
Source  Ariadne Pathways  
</Comment>
    <BiopaxRef>e07</BiopaxRef>
    <BiopaxRef>ebc</BiopaxRef>
    <BiopaxRef>b23</BiopaxRef>
    <BiopaxRef>f51</BiopaxRef>
    <BiopaxRef>b9d</BiopaxRef>
    <BiopaxRef>d34</BiopaxRef>
    <BiopaxRef>b37</BiopaxRef>
    <BiopaxRef>f9d</BiopaxRef>
    <BiopaxRef>d74</BiopaxRef>
    <BiopaxRef>f89</BiopaxRef>
    <Graphics Color="999900">
      <Point GraphRef="edbcf"/>
      <Point GraphRef="df2fc" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="f446e">
    <Comment>G protein beta/gamma</Comment>
    <Comment>Binding Gb/g ---- GNAI1</Comment>
    <Comment>12488455 However, the extent of Getagamma binding to GST-Galphai 3-GDP was always greater than to GST (Fig. 3 , A and B ). 

(Tissue: neuroendocrine, CellLineName: AtT20) 

</Comment>
    <Comment>15488193 (Tissue: neuroendocrine, CellLineName: AtT20) The particular sequences chosen have been demonstrated to bind selectively to the GDP-bound form of Galphai, but not Galphao, and preclude association of Gbetagamma and Galphai subunits. 
</Comment>
    <BiopaxRef>ec8</BiopaxRef>
    <BiopaxRef>fcc</BiopaxRef>
    <Graphics Color="990099">
      <Point GraphRef="ae915"/>
      <Point GraphRef="c67ec"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="f5603">
    <Comment>Binding GNAI3 ---- HTR1E</Comment>
    <Comment>All the 5-HT(1) receptor types actually interact with G alpha i/G alpha o proteins to inhibit adenylyl cyclase and modulate ionic effectors, i.e. potassium and/or calcium channels. 
</Comment>
    <BiopaxRef>f3f</BiopaxRef>
    <Graphics Color="990099">
      <Point GraphRef="d7022"/>
      <Point GraphRef="d4c53"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="f6183">
    <Comment>ProtModification MAPK1 --+&gt; ELK1</Comment>
    <Comment>--------------------------------------------------------------------------------
MedLine Reference  11454682:1161  
Sentence  Activated ERK1/2 phosphorylated Elk-1, which involves in the induction of the growth-related genes, suggesting that stimulative effects of low-dose irradiation were mediated by ERK1/2 activation.  
Journal  Cancer Res  
Journal Reference  v61 i14 p5396 (2001)  
Journal Link  http://cancerres.aacrjournals.org/cgi/content/full/61/14/5396  
Source  Ariadne Pathways  

--------------------------------------------------------------------------------
MedLine Reference  10444401:1223  
Sentence  Once in the nucleus, ERK can phosphorylate and activate transcription factors such as TCF/ELK-1, resulting in c-Fos production and AP-1 complex formation ( 13 , 15 ).  
Journal  Cell Phys  
Journal Reference  v277 i2 pC253 (1999)  
Journal Link  http://ajpcell.physiology.org/cgi/content/full/277/2/C253  
Source  Ariadne Pathways  

--------------------------------------------------------------------------------
MedLine Reference  11090049:1273  
Sentence  Therefore, it has been proposed that Elk1-dependent gene activation can occur independently of SRE/SRF if it can bind to the promoter efficiently. 50 This proposition is supported by the finding that the phosphorylation of Elk1 by ERK2 increases its ability to bind to DNA without interacting with SRF 54 , 55 and by the fact that Elk1 binding is facilitated in transfection experiments with a reporter gene containing multiple high-affinity Elk1 binding sites 40 , 56 or phosphorylation in its C-terminus. 55 , 57 Even though the 9E3/cCAF promoter does not contain an SRE, Elk1 binds to the Elk1 elements and activates transcription, suggesting that thrombin-induced Elk1 activation does not require cooperation with SRF.  
Journal  Blood  
Journal Reference  v96 i12 p3696 (2000)  
Journal Link  http://www.bloodjournal.org/cgi/content/full/96/12/3696  
Tissue  smooth muscle  
Organ  umbilical vein  
CellType  fibroblast  
Source  Ariadne Pathways  

--------------------------------------------------------------------------------
MedLine Reference  11812784:1038  
Sentence  Activated ERK1/2 phosphorylated Elk-1, which involves in the induction of the growth-related genes, suggesting that stimulative effects of low-dose irradiation were mediated by ERK1/2 activation.  
Journal  EBM  
Journal Reference  v277 i15 p12532 (2002)  
Journal Link  http://www.blackwell-synergy.com/links/doi/10.1046/j.1471-4159.2002.01075.x/full/  
Tissue  stroma  
Organ  renal  
CellType  b cell  
CellLineName  JEG3  
Source  Ariadne Pathways  

--------------------------------------------------------------------------------
MedLine Reference  10463587:1029  
Sentence  MAP kinase (MAPK/ERK) phosphorylates Elk-1, which is part of the ternary complex factor that binds to the serum response element in the fos promotor; JNK phosphorylates c-Jun, Elk-1, and ATF-2; and p38 kinase phosphorylates both ternary-complex-factor /Elk-1 and ATF-2.  
Journal  Cancer Res  
Journal Reference  v59 i16 p3935 (1999)  
Journal Link  http://cancerres.aacrjournals.org/cgi/content/full/59/16/3935  
Source  Ariadne Pathways  

--------------------------------------------------------------------------------
MedLine Reference  11520792:1024  
Sentence  TCFs, such as Elk-1, Sap-1, and Fli-1, are targets of the MAPK pathway. 36 , 37 Our data indicated that phosphorylation of Elk-1 by the MEK-ERK1/2 pathway induces Egr-1 expression in LPS-stimulated monocytes and subsequent TF gene expression.  
Journal  Blood  
Journal Reference  v98 i5 p1429 (2001)  
Journal Link  http://www.bloodjournal.org/cgi/content/full/98/5/1429  
CellType  monocyte  
Source  Ariadne Pathways  

--------------------------------------------------------------------------------
MedLine Reference  12495932:1207  
Sentence  In summary, this study has demonstrated, in a rat in vivo model, that both serpentine and amphibole asbestos fibers induced protracted phosphorylation of intrapulmonary ERK proteins and upregulated Elk-1 phosphorylation by ERK.  
Journal  AJRCMB  
Journal Reference  v28 i1 p51 (2003)  
Journal Link  http://ajrcmb.atsjournals.org/cgi/content/full/28/1/51  
Source  Ariadne Pathways  

--------------------------------------------------------------------------------
</Comment>
    <BiopaxRef>c2b</BiopaxRef>
    <BiopaxRef>eee</BiopaxRef>
    <BiopaxRef>cad</BiopaxRef>
    <BiopaxRef>e9e</BiopaxRef>
    <BiopaxRef>ea8</BiopaxRef>
    <BiopaxRef>f27</BiopaxRef>
    <BiopaxRef>e18</BiopaxRef>
    <Graphics Color="999900">
      <Point GraphRef="fe3cb"/>
      <Point GraphRef="b1b8a" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="f67c5">
    <Comment>Binding HTR1B ---- serotonin</Comment>
    <Comment>Serotonin treatment of these cells has been reported to inhibit forskolin-stimulated cAMP accumulation in the 5-HT 1B -expressing cells, but not the parental HeLa cells (Hamblin et al., 1992 ). </Comment>
    <BiopaxRef>a8a</BiopaxRef>
    <Graphics Color="990099">
      <Point GraphRef="fb161"/>
      <Point GraphRef="c8d79"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="f6964">
    <Comment>PromoterBinding SRF --+&gt; FOS</Comment>
    <Comment>--------------------------------------------------------------------------------
Source  Ariadne Pathways  
MedLine Reference  7854423:1  
Sentence  Here we show that the general transcription factor TFIIF is also a target for a transcriptional activator, namely serum response factor (SRF), which binds to the c-fos promoter.  

--------------------------------------------------------------------------------
Source  Ariadne Pathways  
MedLine Reference  12788062:0  
Sentence  Serum stimulation leads to activation of the serum response factor (SRF)-mediated transcription of immediate-early genes such as c-fos via various signal transduction pathways.  

--------------------------------------------------------------------------------
Source  Ariadne Pathways  
MedLine Reference  9813041:1  
Sentence  The transcription factors Elk-1 and Serum Response Factor are necessary for GH-stimulated transcription of c-fos through the Serum Response Element (SRE).  

--------------------------------------------------------------------------------
Source  Ariadne Pathways  
MedLine Reference  9467416:2  
Sentence  The binding of SRF to SRE plays an integral role in c-fos transcription and may occur independently of the association of the ternary complex factors.  

--------------------------------------------------------------------------------
Source  Ariadne Pathways  
MedLine Reference  9584171:8  
Sentence  Moreover, TFII-I can form in vivo protein-protein complexes with the c-fos upstream activators SRF, STAT1, and STAT3.  

--------------------------------------------------------------------------------
Source  Ariadne Pathways  
MedLine Reference  8864058:3  
Sentence  SRF is hyperphosphorylated in senescent HDFs and fails to bind to the serum-response element in the c-fos promoter. 
--------------------------------------------------------------------------------
CellType  fibroblast  
Source  Ariadne Pathways  
MedLine Reference  8413226:4  
Sentence  Phosphorylation of serine 103 significantly enhances the affinity and rate with which SRF associates with its binding site, the serum response element, within the c-fos promoter.  

--------------------------------------------------------------------------------
CellLineName  PML-/  
CellType  promyelocyte  
Source  Ariadne Pathways  
MedLine Reference  12622724:3  
Sentence  PML modulates SRF-mediated c-fos promoter activities upon addition of serum to cells or expression of constitutively active Rho family GTPases.  

--------------------------------------------------------------------------------
Tissue  muscle  
Source  Ariadne Pathways  
MedLine Reference  10642500:0  
Sentence  Serum response factor (SRF) is a key transcriptional activator of the c-fos gene and of muscle-specific gene expression.  

--------------------------------------------------------------------------------
CellLineName  LEC  
Source  Ariadne Pathways  
MedLine Reference  9570363:5  
Sentence  SRF may play an important role in the development of hepatocellular carcinoma in LEC rats by mediating the proto-oncogene c-fos induction. 
</Comment>
    <Graphics Color="009900">
      <Point GraphRef="d8696"/>
      <Point GraphRef="f4dd2" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="f956d">
    <Graphics Color="999900">
      <Point GraphRef="eea31"/>
      <Point GraphRef="de99a" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="f9acd">
    <Comment>DirectRegulation RASGRF1 --+&gt; RHOA</Comment>
    <Comment>11058585 (CellType: neural) We recently isolated a putative GEF , termed p190RhoGEF that binds to RhoA and, when overexpressed in neuronal cells, induces cell rounding and inhibits neurite outgrowth. 

12496377 (CellType: b cell, CellLineName: WEHI 231) CD40-induced cellular changes and the colocalization of p190RhoGEF with RhoA The enhanced p190RhoGEF expression after a 48-h CD40 stimulation was also shown by an indirect immunofluorescence for endogenous p190RhoGEF in WEHI 231 B cells (Fig. 2 A , 50&#195;&#162;&#194;&#128;&#194;&#147;60% induction). 
</Comment>
    <BiopaxRef>e81</BiopaxRef>
    <BiopaxRef>ee7</BiopaxRef>
    <Graphics>
      <Point GraphRef="b456e"/>
      <Point GraphRef="cbd30" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="fa17b">
    <Comment>DirectRegulation RASGRF1 --+&gt; Ras</Comment>
    <Comment>8626650 Here we report that mutations within the switch 2 domain of Ras (residues 62-69) inhibit activation of Ras by the mammalian GEFs, Sos1, and GRF/CDC25Mm. 

1447167 As a consequence, the CDC25Mm induces a rapid formation of the biologically active Ras.GTP complex. 

(Tissue: blood, CellType: b cell) Phosphorylation of RasGRP3 by PKC may be critical to modulate its association with Ras at the plasma membrane and the subsequent activation of the ERK MAPK cascade. 

14749369 Furthermore, we have recently demonstrated that the ability of RasGRF1 to activate Ras is regulated by the Rho family GTPase Cdc42, by a mechanism that entails the translocation of RasGRF1 to the cell particulate fraction ( 3 , 4 ). 

14676298 (CellType: b cell) This defective Ras activation is suppressed by the expression of RasGRP3 as a membrane-attached form, suggesting that phospholipase C-gamma2 regulates RasGRP3 localization and thereby Ras activation. 

11500497 Our results suggest that mUBPy may play a role in controlling degradation of CDC25 Mm , thus regulating the level of this Ras-guanine nucleotide exchange factor. 

15572660 (Tissue: endothelial) However, RasGRP2 is a Rap1 activator and not a Ras activator, whereas RasGRP3 is an activator of Ras and Rap1. 

15213298 RasGRP3 activates both Ras and Rap1 (Yamashita et al., 2000 ), and RasGRP4 activates Ras (Reuther et al., 2002 ; Yang et al., 2002 ). 

8717044 (CellLineName: COS-7) These results demonstrate a G-protein-coupled mechanism for Ras activation, mediated by p140 Ras-GRF. 

8700529 (CellLineName: CHO) Transient expression of CDC25Mm in CHO cells activates Ras. 

</Comment>
    <BiopaxRef>ab1</BiopaxRef>
    <BiopaxRef>c17</BiopaxRef>
    <BiopaxRef>b69</BiopaxRef>
    <BiopaxRef>a62</BiopaxRef>
    <BiopaxRef>f40</BiopaxRef>
    <BiopaxRef>ab8</BiopaxRef>
    <BiopaxRef>c02</BiopaxRef>
    <BiopaxRef>d97</BiopaxRef>
    <BiopaxRef>b63</BiopaxRef>
    <Graphics>
      <Point GraphRef="b456e"/>
      <Point GraphRef="beaf5" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="fb02d">
    <Comment>Binding ELK1 ---- SRF</Comment>
    <Comment>MedLine Reference  11245588:10383  
Sentence  The three MAP kinase pathways regulate AP-1 activity both by increasing the transcription of the jun and fos genes and by phosphorylation of newly synthesized AP-1 transcription complexes. c-Fos gene transcription is activated by the cooperative interaction of Elk-1 with the serum response factor (SRF).  
Journal  Cell Phys  
Journal Reference  v280 i4 pC719  
Journal Link  http://ajpcell.physiology.org/cgi/content/full/280/4/C719  

--------------------------------------------------------------------------------
MedLine Reference  12600988:10161  
Sentence  First, it has been concluded from many transfection (permanent and transient) experiments that the serum response factor-ELK1 complex, likely also including the nearby AP-1 proteins, is required for the optimal transcriptional response to growth factors and to phorbol esters (TPA ).  
Journal  J. Biol. Chem  
Journal Reference  v278 i18 p15794  
Journal Link  http://www.jbc.org/cgi/content/full/278/18/15794  

--------------------------------------------------------------------------------
MedLine Reference  10477597:10028  
Sentence  Also, they phosphorylate Elk1, which interacts with the serum response factor and participates in c- fos activation (reviewed in Refs. 18 and 19 ).  
Journal  J. Immunol  
Journal Reference  v163 i6 p3279  
Journal Link  http://www.jimmunol.org/cgi/content/full/163/6/3279  

--------------------------------------------------------------------------------
MedLine Reference  131101359:11268  
Sentence  D. (1994) The transcription factors Elk-1 and serum response factor interact by direct protein-protein contacts mediated by a short region of Elk-1.  
Journal  J. Neurochem  
Journal Reference  v77 i1 p25  
Journal Link  http://www.blackwell-synergy.com/doi/full/10.1046/j.1471-4159.2001.00232.x  

--------------------------------------------------------------------------------
MedLine Reference  131104515:11133  
Sentence  We have designed and expressed a dominant-negative mutant of Elk-1 that binds to DNA and serum response factor but lacks the phosphorylation-dependent transcriptional activation domain.  
Journal  J. Neurochem  
Journal Reference  v97 i1 p8  
Journal Link  http://www.blackwell-synergy.com/doi/full/10.1111/j.1471-4159.2006.03749.x  

--------------------------------------------------------------------------------
MedLine Reference  162101848:11031  
Sentence  One possibility is that the sequence-specificity of DNA recognition by Sd is augmented by the coactivator; this could be achieved, for example, if Vg itself contacts some bases or if it alters the stability of Sdthat confer added DNA-binding specificity on a complex by contacting the DNA, as in the interactions of SAP1 and ELK-1 with serum response factor [ 14 ].  
Journal  Current Biology  
Journal Reference  v9 i7 p7  
Journal Link  http://www.current-biology.com/content/article/fulltext?uid=PIIS0960982299801547  
Organ  wing  

--------------------------------------------------------------------------------
MedLine Reference  9755064:10025  
Sentence  Activated Elk-1 interacts with the serum response factor (SRF) to mediate transcription through serum response elements (SREs) and adjacent Ets motif sequences contained within the 5&amp;apos;-flanking region of several genes (reviewed in Ref. 24 ), including the immediate-early gene (IEG) Egr-1 ( 59 ).  
Journal  Cell Phys  
Journal Reference  v275 i4 pC1104  
Journal Link  http://ajpcell.physiology.org/cgi/content/full/275/4/C1104  
Tissue  serum  

--------------------------------------------------------------------------------
MedLine Reference  10196167:10161  
Sentence  Elk-1 forms a ternary complex with serum response factor and the serum response element (SRE ) that is present in many genes ( 35 ).  
Journal  J. Biol. Chem  
Journal Reference  v274 i16 p10897  
Journal Link  http://www.jbc.org/cgi/content/full/274/16/10897  
Tissue  serum  

--------------------------------------------------------------------------------
MedLine Reference  11053438:10182  
Sentence  Activation of Transcription Factor Elk1 during Thapsigargin-induced pip92 Expression-- Previous studies have shown that serum response element (SRE ) present in the pip92 promoter can interact with recombinant serum response factor (SRF ) and Elk1 proteins forming a tertiary complex ( 16 , 25 ).  
Journal  J. Biol. Chem  
Journal Reference  v276 i3 p2132  
Journal Link  http://www.jbc.org/cgi/content/full/276/3/2132  
Tissue  serum  

--------------------------------------------------------------------------------
MedLine Reference  11839761:10228  
Sentence  When phosphorylated by ERK2, Elk-1 forms a complex with the serum response factor and binds the serum response promoter element to enhance transcription from the c- fos promoter.  
Journal  J. Biol. Chem  
Journal Reference  v277 i16 p13889  
Journal Link  http://www.jbc.org/cgi/content/full/277/16/13889  
Tissue  serum  
</Comment>
    <BiopaxRef>fdf</BiopaxRef>
    <BiopaxRef>a98</BiopaxRef>
    <BiopaxRef>e47</BiopaxRef>
    <BiopaxRef>a84</BiopaxRef>
    <BiopaxRef>e32</BiopaxRef>
    <BiopaxRef>eb7</BiopaxRef>
    <BiopaxRef>b13</BiopaxRef>
    <BiopaxRef>c4a</BiopaxRef>
    <BiopaxRef>a37</BiopaxRef>
    <BiopaxRef>c3b</BiopaxRef>
    <Graphics Color="990099">
      <Point GraphRef="b1b8a"/>
      <Point GraphRef="d8696"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="fef9c">
    <Comment>ProtModification MAP3K1 --+&gt; MAP2K2</Comment>
    <Comment>9328344 (CellLineName: 293) MEK2 is Activated by MEKK1 and Ligands for Multiple Receptor Types in 293 Cells 293 cells transfected with HA-MEKK1 or empty vector were stimulated with EGF, carbachol, phorbol 12-myristate 13-acetate, and A1F 4 - as described. 

12242299 Conceivably, the two compounds may act through distinct mechanisms, in which U-0126 directly suppresses MKK1/2 activity, whereas PD-98059 suppresses MKK1/2 phosphorylation and activation by upstream kinases such as Raf-1 or MEK kinase-1 ( 5 , 17 ). 

8969228 (CellType: neutrophil) Our data suggest that in human neutrophils both MEK1 and MEK2 are activated by MEKK and that PI 3-kinase may modulate MEKK activation and that of its two downstream components (MEK and MAPK). 

11588191 (CellLineName: PC 12) In parallel experiments, we verified that c-MEKK1 led to phosphorylation of MAP kinase through a mechanism involving MEK-1/2 activation by examining effects of the MEK-1/2 inhibitor U0126. 

7797459 MEKK1 can activate MKK4, MKK3, MEK1, and MEK2( 27 , 46 , 47 ) , suggesting that MEKKs have a broader substrate specificity than MEKs. 

9162092 Additionally, the catalytic domain of MEKK1 activated MEK1 and MEK2 in vitro and interacted with MEK in the yeast two-hybrid system. 

8940180 Furthermore, expression of MEKK1 in mammalian cells led to the constitutive activation of Mek1 and Mek2 but not of Erk2 ( 34 ). 

10918063 (Tissue: squamous, CellType: keratinocyte, CellLineName: TBE) MEKK1 phosphorylates MKK1/2, which then activates two downstream kinases, ERK1 and ERK2, to stimulate the binding of transcription factors to regulate target gene expression ( 68 ). 

</Comment>
    <BiopaxRef>a8c</BiopaxRef>
    <BiopaxRef>f99</BiopaxRef>
    <BiopaxRef>cca</BiopaxRef>
    <BiopaxRef>f83</BiopaxRef>
    <BiopaxRef>e17</BiopaxRef>
    <BiopaxRef>fe4</BiopaxRef>
    <BiopaxRef>e06</BiopaxRef>
    <BiopaxRef>a33</BiopaxRef>
    <Graphics Color="999900">
      <Point GraphRef="f091e"/>
      <Point GraphRef="edc2e" ArrowHead="Arrow"/>
    </Graphics>
    </Interaction>
  <GraphicalLine GraphId="b86ed">
    <Graphics Color="009999">
      <Point/>
      <Point ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="c1516">
    <Graphics LineStyle="Broken">
      <Point/>
      <Point ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="e66d6">
    <Graphics>
      <Point/>
      <Point ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="e9cb5">
    <Graphics Color="cccc00">
      <Point/>
      <Point ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="eac7a">
    <Graphics Color="00cc00">
      <Point/>
      <Point ArrowHead="Arrow"/>
    </Graphics>
  </GraphicalLine>
  <GraphicalLine GraphId="ef964">
    <Graphics Color="cc00cc">
      <Point/>
      <Point/>
    </Graphics>
  </GraphicalLine>
  <Label TextLabel="Synthesis " GraphId="a4070">
    <Graphics FillColor="ffffff"/>
  </Label>
  <Label TextLabel="Functional Protein Class" GraphId="a8274">
    <Graphics FillColor="ffffff"/>
  </Label>
  <Label TextLabel="Small Molecule" GraphId="ae329">
    <Graphics FillColor="ffffff"/>
  </Label>
  <Label TextLabel="LEGEND" GraphId="b7d1f">
    <Graphics FillColor="ffffff"/>
  </Label>
  <Label TextLabel="Protein Modification" GraphId="bbc88">
    <Graphics FillColor="ffffff"/>
  </Label>
  <Label TextLabel="Receptor" GraphId="d7e90">
    <Graphics FillColor="ffffff"/>
  </Label>
  <Label TextLabel="Indirect Regulation" GraphId="e3880">
    <Graphics FillColor="ffffff"/>
  </Label>
  <Label TextLabel="Promoter Binding" GraphId="e3c0f">
    <Graphics FillColor="ffffff"/>
  </Label>
  <Label TextLabel="Binding" GraphId="eecbc">
    <Graphics FillColor="ffffff"/>
  </Label>
  <Label TextLabel="Protein" GraphId="f1553">
    <Graphics FillColor="ffffff"/>
  </Label>
  <Label TextLabel="Direct Regulation" GraphId="fb4a4">
    <Graphics FillColor="ffffff"/>
  </Label>
  <Shape GraphId="ac7e4">
    <Graphics ShapeType="Rectangle" Color="cc0000"/>
  </Shape>
  <Shape GraphId="cb71f">
    <Graphics ShapeType="Rectangle"/>
  </Shape>
  <Shape GraphId="e8ab5">
    <Graphics ShapeType="Rectangle" Color="ff6600"/>
  </Shape>
  <Shape GraphId="ffd87">
    <Graphics ShapeType="Rectangle" Color="00cc00"/>
  </Shape>
  <InfoBox/>
  <Biopax>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="bbe">
      <bp:ID >11292831</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >A CalDAG-GEFI/Rap1/B-Raf cassette couples M(1) muscarinic acetylcholine receptors to the activation of ERK1/2.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >2001</bp:YEAR>
      <bp:AUTHORS >Guo FF</bp:AUTHORS>
      <bp:AUTHORS >Kumahara E</bp:AUTHORS>
      <bp:AUTHORS >Saffen D</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="d74">
      <bp:ID >9422727</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Involvement of p38 mitogen-activated protein kinase signaling pathway in the rapid induction of the 78-kDa glucose-regulated protein in 9L rat brain tumor cells.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >1998</bp:YEAR>
      <bp:AUTHORS >Chen KD</bp:AUTHORS>
      <bp:AUTHORS >Chen LY</bp:AUTHORS>
      <bp:AUTHORS >Huang HL</bp:AUTHORS>
      <bp:AUTHORS >Lieu CH</bp:AUTHORS>
      <bp:AUTHORS >Chang YN</bp:AUTHORS>
      <bp:AUTHORS >Chang MD</bp:AUTHORS>
      <bp:AUTHORS >Lai YK</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="ac4">
      <bp:ID >10716930</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Molecular determinants that mediate selective activation of p38 MAP kinase isoforms.</bp:TITLE>
      <bp:SOURCE >EMBO J</bp:SOURCE>
      <bp:YEAR >2000</bp:YEAR>
      <bp:ID >10716930</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Molecular determinants that mediate selective activation of p38 MAP kinase isoforms.</bp:TITLE>
      <bp:SOURCE >EMBO J</bp:SOURCE>
      <bp:YEAR >2000</bp:YEAR>
      <bp:AUTHORS >Enslen H</bp:AUTHORS>
      <bp:AUTHORS >Brancho DM</bp:AUTHORS>
      <bp:AUTHORS >Davis RJ</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="d06">
      <bp:ID >9430721</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Selective activation of p38 mitogen-activated protein (MAP) kinase isoforms by the MAP kinase kinases MKK3 and MKK6.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >1998</bp:YEAR>
      <bp:AUTHORS >Enslen H</bp:AUTHORS>
      <bp:AUTHORS >Raingeaud J</bp:AUTHORS>
      <bp:AUTHORS >Davis RJ</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e32">
      <bp:ID >131104515</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Hormonal regulation of liver mitochondrial pyruvate carrier in relation to gluconeogenesis and lipogenesis.</bp:TITLE>
      <bp:SOURCE >FEBS Lett</bp:SOURCE>
      <bp:YEAR >1976</bp:YEAR>
      <bp:ID >11133</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Hormonal regulation of liver mitochondrial pyruvate carrier in relation to gluconeogenesis and lipogenesis.</bp:TITLE>
      <bp:SOURCE >FEBS Lett</bp:SOURCE>
      <bp:YEAR >1976</bp:YEAR>
      <bp:AUTHORS >Titheradge MA</bp:AUTHORS>
      <bp:AUTHORS >Coore HG</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="d5e">
      <bp:ID >15103690</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Ultrastructural interactions between terminals expressing the norepinephrine transporter and dopamine neurons in the rat and monkey ventral tegmental area.</bp:TITLE>
      <bp:SOURCE >Synapse</bp:SOURCE>
      <bp:YEAR >2004</bp:YEAR>
      <bp:ID >15103690</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Ultrastructural interactions between terminals expressing the norepinephrine transporter and dopamine neurons in the rat and monkey ventral tegmental area.</bp:TITLE>
      <bp:SOURCE >Synapse</bp:SOURCE>
      <bp:YEAR >2004</bp:YEAR>
      <bp:AUTHORS >Liprando LA</bp:AUTHORS>
      <bp:AUTHORS >Miner LH</bp:AUTHORS>
      <bp:AUTHORS >Blakely RD</bp:AUTHORS>
      <bp:AUTHORS >Lewis DA</bp:AUTHORS>
      <bp:AUTHORS >Sesack SR</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="b33">
      <bp:ID >12491767</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >[IP3 receptor, a Ca2+ oscilator--role of IP3 receptor in development and neural plasticity]</bp:TITLE>
      <bp:SOURCE >Nippon Yakurigaku Zasshi</bp:SOURCE>
      <bp:YEAR >2002</bp:YEAR>
      <bp:AUTHORS >Mikoshiba K</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="cb9">
      <bp:ID >11304531</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Parallel regulation of mitogen-activated protein kinase kinase 3 (MKK3) and MKK6 in Gq-signaling cascade.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >2001</bp:YEAR>
      <bp:ID >11304531</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Parallel regulation of mitogen-activated protein kinase kinase 3 (MKK3) and MKK6 in Gq-signaling cascade.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >2001</bp:YEAR>
      <bp:AUTHORS >Yamauchi J</bp:AUTHORS>
      <bp:AUTHORS >Tsujimoto G</bp:AUTHORS>
      <bp:AUTHORS >Kaziro Y</bp:AUTHORS>
      <bp:AUTHORS >Itoh H</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="f1e">
      <bp:ID >15795236</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Mutation of the phospholipase C-gamma1-binding site of LAT affects both positive and negative thymocyte selection.</bp:TITLE>
      <bp:SOURCE >J Exp Med</bp:SOURCE>
      <bp:YEAR >2005</bp:YEAR>
      <bp:AUTHORS >Sommers CL</bp:AUTHORS>
      <bp:AUTHORS >Lee J</bp:AUTHORS>
      <bp:AUTHORS >Steiner KL</bp:AUTHORS>
      <bp:AUTHORS >Gurson JM</bp:AUTHORS>
      <bp:AUTHORS >Depersis CL</bp:AUTHORS>
      <bp:AUTHORS >El-Khoury D</bp:AUTHORS>
      <bp:AUTHORS >Fuller CL</bp:AUTHORS>
      <bp:AUTHORS >Shores EW</bp:AUTHORS>
      <bp:AUTHORS >Love PE</bp:AUTHORS>
      <bp:AUTHORS >Samelson LE</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="a79">
      <bp:ID >11283246</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Thrombopoietin-mediated sustained activation of extracellular signal-regulated kinase in UT7-Mpl cells requires both Ras-Raf-1- and Rap1-B-Raf-dependent pathways.</bp:TITLE>
      <bp:SOURCE >Mol Cell Biol</bp:SOURCE>
      <bp:YEAR >2001</bp:YEAR>
      <bp:AUTHORS >Garcia J</bp:AUTHORS>
      <bp:AUTHORS >de Gunzburg J</bp:AUTHORS>
      <bp:AUTHORS >Eych&#232;ne A</bp:AUTHORS>
      <bp:AUTHORS >Gisselbrecht S</bp:AUTHORS>
      <bp:AUTHORS >Porteu F</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="f99">
      <bp:ID >9328344</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Differential regulation of mitogen-activated protein/ERK kinase (MEK)1 and MEK2 and activation by a Ras-independent mechanism.</bp:TITLE>
      <bp:SOURCE >Mol Endocrinol</bp:SOURCE>
      <bp:YEAR >1997</bp:YEAR>
      <bp:ID >9328344</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Differential regulation of mitogen-activated protein/ERK kinase (MEK)1 and MEK2 and activation by a Ras-independent mechanism.</bp:TITLE>
      <bp:SOURCE >Mol Endocrinol</bp:SOURCE>
      <bp:YEAR >1997</bp:YEAR>
      <bp:AUTHORS >Xu S</bp:AUTHORS>
      <bp:AUTHORS >Khoo S</bp:AUTHORS>
      <bp:AUTHORS >Dang A</bp:AUTHORS>
      <bp:AUTHORS >Witt S</bp:AUTHORS>
      <bp:AUTHORS >Do V</bp:AUTHORS>
      <bp:AUTHORS >Zhen E</bp:AUTHORS>
      <bp:AUTHORS >Schaefer EM</bp:AUTHORS>
      <bp:AUTHORS >Cobb MH</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="a16">
      <bp:ID >15262987</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Depolarization of skeletal muscle cells induces phosphorylation of cAMP response element binding protein via calcium and protein kinase Calpha.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >2004</bp:YEAR>
      <bp:AUTHORS >C&#225;rdenas C</bp:AUTHORS>
      <bp:AUTHORS >M&#252;ller M</bp:AUTHORS>
      <bp:AUTHORS >Jaimovich E</bp:AUTHORS>
      <bp:AUTHORS >P&#233;rez F</bp:AUTHORS>
      <bp:AUTHORS >Buchuk D</bp:AUTHORS>
      <bp:AUTHORS >Quest AF</bp:AUTHORS>
      <bp:AUTHORS >Carrasco MA</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="ecb">
      <bp:ID >11257115</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Diacylglycerol kinase zeta regulates Ras activation by a novel mechanism.</bp:TITLE>
      <bp:SOURCE >J Cell Biol</bp:SOURCE>
      <bp:YEAR >2001</bp:YEAR>
      <bp:AUTHORS >Topham MK</bp:AUTHORS>
      <bp:AUTHORS >Prescott SM</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c7d">
      <bp:ID >10066767</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >The effect of host adrenalectomy on the physiology of Trypanosoma rhodesiense.</bp:TITLE>
      <bp:SOURCE >Comp Biochem Physiol A Comp Physiol</bp:SOURCE>
      <bp:YEAR >1975</bp:YEAR>
      <bp:AUTHORS >Hu MC</bp:AUTHORS>
      <bp:AUTHORS >Wang YP</bp:AUTHORS>
      <bp:AUTHORS >Mikhail A</bp:AUTHORS>
      <bp:AUTHORS >Qiu WR</bp:AUTHORS>
      <bp:AUTHORS >Tan TH</bp:AUTHORS>
      <bp:AUTHORS >Sanchez G</bp:AUTHORS>
      <bp:AUTHORS >Alderete JF</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="a0a">
      <bp:ID >15064721</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Transformation potency of ErbB heterodimer signaling is determined by B-Raf kinase.</bp:TITLE>
      <bp:SOURCE >Oncogene</bp:SOURCE>
      <bp:YEAR >2004</bp:YEAR>
      <bp:AUTHORS >Hatakeyama M</bp:AUTHORS>
      <bp:AUTHORS >Yumoto N</bp:AUTHORS>
      <bp:AUTHORS >Yu X</bp:AUTHORS>
      <bp:AUTHORS >Shirouzu M</bp:AUTHORS>
      <bp:AUTHORS >Yokoyama S</bp:AUTHORS>
      <bp:AUTHORS >Konagaya A</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="fcc">
      <bp:ID >15488193</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >GoLoco motif peptides as probes of Galpha subunit specificity in coupling of G-protein-coupled receptors to ion channels.</bp:TITLE>
      <bp:SOURCE >Methods Enzymol</bp:SOURCE>
      <bp:YEAR >2004</bp:YEAR>
      <bp:AUTHORS >Oxford GS</bp:AUTHORS>
      <bp:AUTHORS >Webb CK</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="cb5">
      <bp:ID >15155839</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Adenosine receptor, protein kinase G, and p38 mitogen-activated protein kinase-dependent up-regulation of serotonin transporters involves both transporter trafficking and activation.</bp:TITLE>
      <bp:SOURCE >Mol Pharmacol</bp:SOURCE>
      <bp:YEAR >2004</bp:YEAR>
      <bp:AUTHORS >Zhu CB</bp:AUTHORS>
      <bp:AUTHORS >Hewlett WA</bp:AUTHORS>
      <bp:AUTHORS >Feoktistov I</bp:AUTHORS>
      <bp:AUTHORS >Biaggioni I</bp:AUTHORS>
      <bp:AUTHORS >Blakely RD</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e17">
      <bp:ID >11588191</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >5-hydroxytryptamine (5-HT)1A autoreceptor adaptive changes in substance P (neurokinin 1) receptor knock-out mice mimic antidepressant-induced desensitization.</bp:TITLE>
      <bp:SOURCE >J Neurosci</bp:SOURCE>
      <bp:YEAR >2001</bp:YEAR>
      <bp:ID >11588191</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >5-hydroxytryptamine (5-HT)1A autoreceptor adaptive changes in substance P (neurokinin 1) receptor knock-out mice mimic antidepressant-induced desensitization.</bp:TITLE>
      <bp:SOURCE >J Neurosci</bp:SOURCE>
      <bp:YEAR >2001</bp:YEAR>
      <bp:AUTHORS >Froger N</bp:AUTHORS>
      <bp:AUTHORS >Gardier AM</bp:AUTHORS>
      <bp:AUTHORS >Moratalla R</bp:AUTHORS>
      <bp:AUTHORS >Alberti I</bp:AUTHORS>
      <bp:AUTHORS >Lena I</bp:AUTHORS>
      <bp:AUTHORS >Boni C</bp:AUTHORS>
      <bp:AUTHORS >De Felipe C</bp:AUTHORS>
      <bp:AUTHORS >Rupniak NM</bp:AUTHORS>
      <bp:AUTHORS >Hunt SP</bp:AUTHORS>
      <bp:AUTHORS >Jacquot C</bp:AUTHORS>
      <bp:AUTHORS >Hamon M</bp:AUTHORS>
      <bp:AUTHORS >Lanfumey L</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e7d">
      <bp:ID >7744815</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Purification of a Ras-dependent mitogen-activated protein kinase kinase kinase from bovine brain cytosol and its identification as a complex of B-Raf and 14-3-3 proteins.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >1995</bp:YEAR>
      <bp:AUTHORS >Yamamori B</bp:AUTHORS>
      <bp:AUTHORS >Kuroda S</bp:AUTHORS>
      <bp:AUTHORS >Shimizu K</bp:AUTHORS>
      <bp:AUTHORS >Fukui K</bp:AUTHORS>
      <bp:AUTHORS >Ohtsuka T</bp:AUTHORS>
      <bp:AUTHORS >Takai Y</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="a8e">
      <bp:ID >15677321</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Inositol 1,4,5-trisphosphate receptor/GAPDH complex augments Ca2+ release via locally derived NADH.</bp:TITLE>
      <bp:SOURCE >Proc Natl Acad Sci U S A</bp:SOURCE>
      <bp:YEAR >2005</bp:YEAR>
      <bp:AUTHORS >Patterson RL</bp:AUTHORS>
      <bp:AUTHORS >van Rossum DB</bp:AUTHORS>
      <bp:AUTHORS >Kaplin AI</bp:AUTHORS>
      <bp:AUTHORS >Barrow RK</bp:AUTHORS>
      <bp:AUTHORS >Snyder SH</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="f40">
      <bp:ID >11500497</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Cloning and characterization of mouse UBPy, a deubiquitinating enzyme that interacts with the ras guanine nucleotide exchange factor CDC25(Mm)/Ras-GRF1.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >2001</bp:YEAR>
      <bp:AUTHORS >Gnesutta N</bp:AUTHORS>
      <bp:AUTHORS >Ceriani M</bp:AUTHORS>
      <bp:AUTHORS >Innocenti M</bp:AUTHORS>
      <bp:AUTHORS >Mauri I</bp:AUTHORS>
      <bp:AUTHORS >Zippel R</bp:AUTHORS>
      <bp:AUTHORS >Sturani E</bp:AUTHORS>
      <bp:AUTHORS >Borgonovo B</bp:AUTHORS>
      <bp:AUTHORS >Berruti G</bp:AUTHORS>
      <bp:AUTHORS >Martegani E</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="f82">
      <bp:ID >11454875</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >MEK6 regulates human involucrin gene expression via a p38alpha - and p38delta -dependent mechanism.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >2001</bp:YEAR>
      <bp:AUTHORS >Dashti SR</bp:AUTHORS>
      <bp:AUTHORS >Efimova T</bp:AUTHORS>
      <bp:AUTHORS >Eckert RL</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="da1">
      <bp:ID >9927426</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Evidence for histidine as another functional group of delta-aminolevulinic acid dehydratase from beef liver.</bp:TITLE>
      <bp:SOURCE >Biochem Biophys Res Commun</bp:SOURCE>
      <bp:YEAR >1975</bp:YEAR>
      <bp:AUTHORS >Brunet A</bp:AUTHORS>
      <bp:AUTHORS >Roux D</bp:AUTHORS>
      <bp:AUTHORS >Lenormand P</bp:AUTHORS>
      <bp:AUTHORS >Dowd S</bp:AUTHORS>
      <bp:AUTHORS >Keyse S</bp:AUTHORS>
      <bp:AUTHORS >Pouyssegur J</bp:AUTHORS>
      <bp:AUTHORS >Tsukamoto I</bp:AUTHORS>
      <bp:AUTHORS >Yoshinaga T</bp:AUTHORS>
      <bp:AUTHORS >Sano S</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="dec">
      <bp:ID >12351703</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Dopamine-D2S receptor inhibition of calcium influx, adenylyl cyclase, and mitogen-activated protein kinase in pituitary cells: distinct Galpha and Gbetagamma requirements.</bp:TITLE>
      <bp:SOURCE >Mol Endocrinol</bp:SOURCE>
      <bp:YEAR >2002</bp:YEAR>
      <bp:ID >12351703</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Dopamine-D2S receptor inhibition of calcium influx, adenylyl cyclase, and mitogen-activated protein kinase in pituitary cells: distinct Galpha and Gbetagamma requirements.</bp:TITLE>
      <bp:SOURCE >Mol Endocrinol</bp:SOURCE>
      <bp:YEAR >2002</bp:YEAR>
      <bp:AUTHORS >Banihashemi B</bp:AUTHORS>
      <bp:AUTHORS >Albert PR</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="b48">
      <bp:ID >11274965</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Modulation of inositol 1,4,5-trisphosphate binding to the various inositol 1,4,5-trisphosphate receptor isoforms by thimerosal and cyclic ADP-ribose.</bp:TITLE>
      <bp:SOURCE >Biochem Pharmacol</bp:SOURCE>
      <bp:YEAR >2001</bp:YEAR>
      <bp:AUTHORS >Vanlingen S</bp:AUTHORS>
      <bp:AUTHORS >Sipma H</bp:AUTHORS>
      <bp:AUTHORS >De Smet P</bp:AUTHORS>
      <bp:AUTHORS >Callewaert G</bp:AUTHORS>
      <bp:AUTHORS >Missiaen L</bp:AUTHORS>
      <bp:AUTHORS >De Smedt H</bp:AUTHORS>
      <bp:AUTHORS >Parys JB</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c94">
      <bp:ID >12351703</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Dopamine-D2S receptor inhibition of calcium influx, adenylyl cyclase, and mitogen-activated protein kinase in pituitary cells: distinct Galpha and Gbetagamma requirements.</bp:TITLE>
      <bp:SOURCE >Mol Endocrinol</bp:SOURCE>
      <bp:YEAR >2002</bp:YEAR>
      <bp:ID >12351703</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Dopamine-D2S receptor inhibition of calcium influx, adenylyl cyclase, and mitogen-activated protein kinase in pituitary cells: distinct Galpha and Gbetagamma requirements.</bp:TITLE>
      <bp:SOURCE >Mol Endocrinol</bp:SOURCE>
      <bp:YEAR >2002</bp:YEAR>
      <bp:AUTHORS >Banihashemi B</bp:AUTHORS>
      <bp:AUTHORS >Albert PR</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e0d">
      <bp:ID >12498787</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Effect of chloroquine on cultured fibroblasts: release of lysosomal hydrolases and inhibition of their uptake.</bp:TITLE>
      <bp:SOURCE >Biochem Biophys Res Commun</bp:SOURCE>
      <bp:YEAR >1975</bp:YEAR>
      <bp:ID >12498787</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Effect of chloroquine on cultured fibroblasts: release of lysosomal hydrolases and inhibition of their uptake.</bp:TITLE>
      <bp:SOURCE >Biochem Biophys Res Commun</bp:SOURCE>
      <bp:YEAR >1975</bp:YEAR>
      <bp:ID >4</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Effect of chloroquine on cultured fibroblasts: release of lysosomal hydrolases and inhibition of their uptake.</bp:TITLE>
      <bp:SOURCE >Biochem Biophys Res Commun</bp:SOURCE>
      <bp:YEAR >1975</bp:YEAR>
      <bp:ID >4</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Effect of chloroquine on cultured fibroblasts: release of lysosomal hydrolases and inhibition of their uptake.</bp:TITLE>
      <bp:SOURCE >Biochem Biophys Res Commun</bp:SOURCE>
      <bp:YEAR >1975</bp:YEAR>
      <bp:AUTHORS >Wiesmann UN</bp:AUTHORS>
      <bp:AUTHORS >DiDonato S</bp:AUTHORS>
      <bp:AUTHORS >Herschkowitz NN</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="fd6">
      <bp:ID >11278353</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Regulation of Stat3 activation by MEK kinase 1.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >2001</bp:YEAR>
      <bp:AUTHORS >Lim CP</bp:AUTHORS>
      <bp:AUTHORS >Cao X</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e98">
      <bp:ID >10976102</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Distinct roles of the adaptor protein Shc and focal adhesion kinase in integrin signaling to ERK.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >2000</bp:YEAR>
      <bp:AUTHORS >Barberis L</bp:AUTHORS>
      <bp:AUTHORS >Wary KK</bp:AUTHORS>
      <bp:AUTHORS >Fiucci G</bp:AUTHORS>
      <bp:AUTHORS >Liu F</bp:AUTHORS>
      <bp:AUTHORS >Hirsch E</bp:AUTHORS>
      <bp:AUTHORS >Brancaccio M</bp:AUTHORS>
      <bp:AUTHORS >Altruda F</bp:AUTHORS>
      <bp:AUTHORS >Tarone G</bp:AUTHORS>
      <bp:AUTHORS >Giancotti FG</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="a24">
      <bp:ID >11698415</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Green tea polyphenol stimulates a Ras, MEKK1, MEK3, and p38 cascade to increase activator protein 1 factor-dependent involucrin gene expression in normal human keratinocytes.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >2002</bp:YEAR>
      <bp:AUTHORS >Balasubramanian S</bp:AUTHORS>
      <bp:AUTHORS >Efimova T</bp:AUTHORS>
      <bp:AUTHORS >Eckert RL</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="beb">
      <bp:ID >11950876</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Extracellular signal regulated kinase (ERK)/mitogen activated protein kinase (MAPK)-independent functions of Raf kinases.</bp:TITLE>
      <bp:SOURCE >J Cell Sci</bp:SOURCE>
      <bp:YEAR >2002</bp:YEAR>
      <bp:ID >11950876</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Extracellular signal regulated kinase (ERK)/mitogen activated protein kinase (MAPK)-independent functions of Raf kinases.</bp:TITLE>
      <bp:SOURCE >J Cell Sci</bp:SOURCE>
      <bp:YEAR >2002</bp:YEAR>
      <bp:AUTHORS >Hindley A</bp:AUTHORS>
      <bp:AUTHORS >Kolch W</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="af4">
      <bp:ID >7499206</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >1995</bp:YEAR>
      <bp:AUTHORS >Alessi DR</bp:AUTHORS>
      <bp:AUTHORS >Cuenda A</bp:AUTHORS>
      <bp:AUTHORS >Cohen P</bp:AUTHORS>
      <bp:AUTHORS >Dudley DT</bp:AUTHORS>
      <bp:AUTHORS >Saltiel AR</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="b91">
      <bp:ID >12225966</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >The dependence of tryptamine excretion on urinary pH.</bp:TITLE>
      <bp:SOURCE >Clin Chim Acta</bp:SOURCE>
      <bp:YEAR >1975</bp:YEAR>
      <bp:AUTHORS >Gosmanov AR</bp:AUTHORS>
      <bp:AUTHORS >Wong JA</bp:AUTHORS>
      <bp:AUTHORS >Thomason DB</bp:AUTHORS>
      <bp:AUTHORS >Price J</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="f0a">
      <bp:ID >1313322</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Signal transduction in glycosaminoglycan (GAG) synthesis by cultured chondrocytes and its inhibition by inflammatory cell-derived hydrogen peroxide.</bp:TITLE>
      <bp:SOURCE >Br J Rheumatol</bp:SOURCE>
      <bp:YEAR >1992</bp:YEAR>
      <bp:ID >1313322</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Signal transduction in glycosaminoglycan (GAG) synthesis by cultured chondrocytes and its inhibition by inflammatory cell-derived hydrogen peroxide.</bp:TITLE>
      <bp:SOURCE >Br J Rheumatol</bp:SOURCE>
      <bp:YEAR >1992</bp:YEAR>
      <bp:AUTHORS >Matsubara T</bp:AUTHORS>
      <bp:AUTHORS >Kimura T</bp:AUTHORS>
      <bp:AUTHORS >Kuroda T</bp:AUTHORS>
      <bp:AUTHORS >Hirohata K</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="eb7">
      <bp:ID >162101848</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Blood sugar and beta-blockers.</bp:TITLE>
      <bp:SOURCE >Br Med J</bp:SOURCE>
      <bp:YEAR >1976</bp:YEAR>
      <bp:ID >11031</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Blood sugar and beta-blockers.</bp:TITLE>
      <bp:SOURCE >Br Med J</bp:SOURCE>
      <bp:YEAR >1976</bp:YEAR>
      <bp:AUTHORS >Linton SP</bp:AUTHORS>
      <bp:AUTHORS >Scott PH</bp:AUTHORS>
      <bp:AUTHORS >Kendall MJ</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="dd0">
      <bp:ID >12896977</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Order and disorder at hospital meetings.</bp:TITLE>
      <bp:SOURCE >Dimens Health Serv</bp:SOURCE>
      <bp:YEAR >1975</bp:YEAR>
      <bp:AUTHORS >Smith JL</bp:AUTHORS>
      <bp:AUTHORS >Collins I</bp:AUTHORS>
      <bp:AUTHORS >Chandramouli GV</bp:AUTHORS>
      <bp:AUTHORS >Butscher WG</bp:AUTHORS>
      <bp:AUTHORS >Zaitseva E</bp:AUTHORS>
      <bp:AUTHORS >Freebern WJ</bp:AUTHORS>
      <bp:AUTHORS >Haggerty CM</bp:AUTHORS>
      <bp:AUTHORS >Doseeva V</bp:AUTHORS>
      <bp:AUTHORS >Gardner K</bp:AUTHORS>
      <bp:AUTHORS >Rozovsky LE</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="bc4">
      <bp:ID >12855697</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Ectopic B-Raf expression enhances extracellular signal-regulated kinase (ERK) signaling in T cells and prevents antigen-presenting cell-induced anergy.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >2003</bp:YEAR>
      <bp:AUTHORS >Dillon TJ</bp:AUTHORS>
      <bp:AUTHORS >Karpitski V</bp:AUTHORS>
      <bp:AUTHORS >Wetzel SA</bp:AUTHORS>
      <bp:AUTHORS >Parker DC</bp:AUTHORS>
      <bp:AUTHORS >Shaw AS</bp:AUTHORS>
      <bp:AUTHORS >Stork PJ</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="a9d">
      <bp:ID >12218141</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE />
      <bp:SOURCE />
      <bp:YEAR />
      <bp:ID >12218141</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Complement-induced impairment of innate immunity during sepsis.</bp:TITLE>
      <bp:SOURCE >J Immunol</bp:SOURCE>
      <bp:YEAR >2002</bp:YEAR>
      <bp:AUTHORS >Huber-Lang MS</bp:AUTHORS>
      <bp:AUTHORS >Younkin EM</bp:AUTHORS>
      <bp:AUTHORS >Sarma JV</bp:AUTHORS>
      <bp:AUTHORS >McGuire SR</bp:AUTHORS>
      <bp:AUTHORS >Lu KT</bp:AUTHORS>
      <bp:AUTHORS >Guo RF</bp:AUTHORS>
      <bp:AUTHORS >Padgaonkar VA</bp:AUTHORS>
      <bp:AUTHORS >Curnutte JT</bp:AUTHORS>
      <bp:AUTHORS >Erickson R</bp:AUTHORS>
      <bp:AUTHORS >Ward PA</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c02">
      <bp:ID >15213298</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >PKCdelta associates with and is involved in the phosphorylation of RasGRP3 in response to phorbol esters.</bp:TITLE>
      <bp:SOURCE >Mol Pharmacol</bp:SOURCE>
      <bp:YEAR >2004</bp:YEAR>
      <bp:AUTHORS >Brodie C</bp:AUTHORS>
      <bp:AUTHORS >Steinhart R</bp:AUTHORS>
      <bp:AUTHORS >Kazimirsky G</bp:AUTHORS>
      <bp:AUTHORS >Rubinfeld H</bp:AUTHORS>
      <bp:AUTHORS >Hyman T</bp:AUTHORS>
      <bp:AUTHORS >Ayres JN</bp:AUTHORS>
      <bp:AUTHORS >Hur GM</bp:AUTHORS>
      <bp:AUTHORS >Toth A</bp:AUTHORS>
      <bp:AUTHORS >Yang D</bp:AUTHORS>
      <bp:AUTHORS >Garfield SH</bp:AUTHORS>
      <bp:AUTHORS >Stone JC</bp:AUTHORS>
      <bp:AUTHORS >Blumberg PM</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="db6">
      <bp:ID >12832465</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >L-[alphaS, 5S]-alpha-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid (NSC-163501): a new amino acid antibiotic with the properties of an antagonist of L-glutamine.</bp:TITLE>
      <bp:SOURCE >Cancer Chemother Rep</bp:SOURCE>
      <bp:YEAR >1975</bp:YEAR>
      <bp:AUTHORS >Belanger LF</bp:AUTHORS>
      <bp:AUTHORS >Roy S</bp:AUTHORS>
      <bp:AUTHORS >Tremblay M</bp:AUTHORS>
      <bp:AUTHORS >Brott B</bp:AUTHORS>
      <bp:AUTHORS >Steff AM</bp:AUTHORS>
      <bp:AUTHORS >Mourad W</bp:AUTHORS>
      <bp:AUTHORS >Hugo P</bp:AUTHORS>
      <bp:AUTHORS >Erikson R</bp:AUTHORS>
      <bp:AUTHORS >Charron J</bp:AUTHORS>
      <bp:AUTHORS >Jayaram HN</bp:AUTHORS>
      <bp:AUTHORS >Cooney DA</bp:AUTHORS>
      <bp:AUTHORS >Ryan JA</bp:AUTHORS>
      <bp:AUTHORS >Neil G</bp:AUTHORS>
      <bp:AUTHORS >Dion RL</bp:AUTHORS>
      <bp:AUTHORS >Bono VH</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="cda">
      <bp:ID >9639556</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Differential activation of stress-activated protein kinase kinases SKK4/MKK7 and SKK1/MKK4 by the mixed-lineage kinase-2 and mitogen-activated protein kinase kinase (MKK) kinase-1.</bp:TITLE>
      <bp:SOURCE >Biochem J</bp:SOURCE>
      <bp:YEAR >1998</bp:YEAR>
      <bp:ID >9639556</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Differential activation of stress-activated protein kinase kinases SKK4/MKK7 and SKK1/MKK4 by the mixed-lineage kinase-2 and mitogen-activated protein kinase kinase (MKK) kinase-1.</bp:TITLE>
      <bp:SOURCE >Biochem J</bp:SOURCE>
      <bp:YEAR >1998</bp:YEAR>
      <bp:ID >9639556</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Differential activation of stress-activated protein kinase kinases SKK4/MKK7 and SKK1/MKK4 by the mixed-lineage kinase-2 and mitogen-activated protein kinase kinase (MKK) kinase-1.</bp:TITLE>
      <bp:SOURCE >Biochem J</bp:SOURCE>
      <bp:YEAR >1998</bp:YEAR>
      <bp:AUTHORS >Cuenda A</bp:AUTHORS>
      <bp:AUTHORS >Dorow DS</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="bd7">
      <bp:ID >11080204</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Identification and urinary excretion of p-chlorophenoxyacetamide, a metabolite of iproclozide, in humans.</bp:TITLE>
      <bp:SOURCE >Drug Metab Dispos</bp:SOURCE>
      <bp:YEAR >1975</bp:YEAR>
      <bp:AUTHORS >Malaspina A</bp:AUTHORS>
      <bp:AUTHORS >Kaushik N</bp:AUTHORS>
      <bp:AUTHORS >de Belleroche J</bp:AUTHORS>
      <bp:AUTHORS >De Sagher RM</bp:AUTHORS>
      <bp:AUTHORS >De Leenheer AP</bp:AUTHORS>
      <bp:AUTHORS >Cruyl AA</bp:AUTHORS>
      <bp:AUTHORS >Claeys AE</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="f66">
      <bp:ID >8571671</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >[Molecular and functional diversity of inositol triphosphate-induced Ca(2+) release]</bp:TITLE>
      <bp:SOURCE >Verh K Acad Geneeskd Belg</bp:SOURCE>
      <bp:YEAR >1995</bp:YEAR>
      <bp:AUTHORS >De Smedt H</bp:AUTHORS>
      <bp:AUTHORS >Parys JB</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="ed6">
      <bp:ID >11673483</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Activation of betagamma subunits of G(i2) and G(i3) proteins by basic secretagogues induces exocytosis through phospholipase Cbeta and arachidonate release through phospholipase Cgamma in mast cells.</bp:TITLE>
      <bp:SOURCE >J Immunol</bp:SOURCE>
      <bp:YEAR >2001</bp:YEAR>
      <bp:AUTHORS >Ferry X</bp:AUTHORS>
      <bp:AUTHORS >Eichwald V</bp:AUTHORS>
      <bp:AUTHORS >Daeffler L</bp:AUTHORS>
      <bp:AUTHORS >Landry Y</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="ec3">
      <bp:ID >14557275</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Overexpression of diacylglycerol acyltransferase-1 reduces phospholipid synthesis, proliferation, and invasiveness in simian virus 40-transformed human lung fibroblasts.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >2003</bp:YEAR>
      <bp:AUTHORS >Bagnato C</bp:AUTHORS>
      <bp:AUTHORS >Igal RA</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c9f">
      <bp:ID >15604236</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Crucial role of phospholipase Cepsilon in chemical carcinogen-induced skin tumor development.</bp:TITLE>
      <bp:SOURCE >Cancer Res</bp:SOURCE>
      <bp:YEAR >2004</bp:YEAR>
      <bp:ID >15604236</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Crucial role of phospholipase Cepsilon in chemical carcinogen-induced skin tumor development.</bp:TITLE>
      <bp:SOURCE >Cancer Res</bp:SOURCE>
      <bp:YEAR >2004</bp:YEAR>
      <bp:AUTHORS >Bai Y</bp:AUTHORS>
      <bp:AUTHORS >Edamatsu H</bp:AUTHORS>
      <bp:AUTHORS >Maeda S</bp:AUTHORS>
      <bp:AUTHORS >Saito H</bp:AUTHORS>
      <bp:AUTHORS >Suzuki N</bp:AUTHORS>
      <bp:AUTHORS >Satoh T</bp:AUTHORS>
      <bp:AUTHORS >Kataoka T</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="b36">
      <bp:ID >12960148</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Trans-synaptic regulation of the development of end organ innervation by sympathetic neurons.</bp:TITLE>
      <bp:SOURCE >Brain Res</bp:SOURCE>
      <bp:YEAR >1976</bp:YEAR>
      <bp:AUTHORS >Most P</bp:AUTHORS>
      <bp:AUTHORS >Boerries M</bp:AUTHORS>
      <bp:AUTHORS >Eicher C</bp:AUTHORS>
      <bp:AUTHORS >Schweda C</bp:AUTHORS>
      <bp:AUTHORS >Ehlermann P</bp:AUTHORS>
      <bp:AUTHORS >Pleger ST</bp:AUTHORS>
      <bp:AUTHORS >Loeffler E</bp:AUTHORS>
      <bp:AUTHORS >Koch WJ</bp:AUTHORS>
      <bp:AUTHORS >Katus HA</bp:AUTHORS>
      <bp:AUTHORS >Schoenenberger CA</bp:AUTHORS>
      <bp:AUTHORS >Remppis A</bp:AUTHORS>
      <bp:AUTHORS >Black IB</bp:AUTHORS>
      <bp:AUTHORS >Mytilineou C</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c80">
      <bp:ID >9733801</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Modulation of kinase activity and oncogenic properties by alternative splicing reveals a novel regulatory mechanism for B-Raf.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >1998</bp:YEAR>
      <bp:ID >9733801</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Modulation of kinase activity and oncogenic properties by alternative splicing reveals a novel regulatory mechanism for B-Raf.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >1998</bp:YEAR>
      <bp:AUTHORS >Papin C</bp:AUTHORS>
      <bp:AUTHORS >Denouel-Galy A</bp:AUTHORS>
      <bp:AUTHORS >Laugier D</bp:AUTHORS>
      <bp:AUTHORS >Calothy G</bp:AUTHORS>
      <bp:AUTHORS >Eychene A</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e14">
      <bp:ID >7761832</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >A region of adenylyl cyclase 2 critical for regulation by G protein beta gamma subunits.</bp:TITLE>
      <bp:SOURCE >Science</bp:SOURCE>
      <bp:YEAR >1995</bp:YEAR>
      <bp:AUTHORS >Chen J</bp:AUTHORS>
      <bp:AUTHORS >DeVivo M</bp:AUTHORS>
      <bp:AUTHORS >Dingus J</bp:AUTHORS>
      <bp:AUTHORS >Harry A</bp:AUTHORS>
      <bp:AUTHORS >Li J</bp:AUTHORS>
      <bp:AUTHORS >Sui J</bp:AUTHORS>
      <bp:AUTHORS >Carty DJ</bp:AUTHORS>
      <bp:AUTHORS >Blank JL</bp:AUTHORS>
      <bp:AUTHORS >Exton JH</bp:AUTHORS>
      <bp:AUTHORS >Stoffel RH</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c27">
      <bp:ID >12167697</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Rac-PAK signaling stimulates extracellular signal-regulated kinase (ERK) activation by regulating formation of MEK1-ERK complexes.</bp:TITLE>
      <bp:SOURCE >Mol Cell Biol</bp:SOURCE>
      <bp:YEAR >2002</bp:YEAR>
      <bp:AUTHORS >Eblen ST</bp:AUTHORS>
      <bp:AUTHORS >Slack JK</bp:AUTHORS>
      <bp:AUTHORS >Weber MJ</bp:AUTHORS>
      <bp:AUTHORS >Catling AD</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="ead">
      <bp:ID >15728187</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >p38 MAPK activation elevates serotonin transport activity via a trafficking-independent, protein phosphatase 2A-dependent process.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >2005</bp:YEAR>
      <bp:AUTHORS >Zhu CB</bp:AUTHORS>
      <bp:AUTHORS >Carneiro AM</bp:AUTHORS>
      <bp:AUTHORS >Dostmann WR</bp:AUTHORS>
      <bp:AUTHORS >Hewlett WA</bp:AUTHORS>
      <bp:AUTHORS >Blakely RD</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e28">
      <bp:ID >11751459</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Formation of non-amidine products in the chemical modification of horse liver alcohol dehydrogenase with imido esters.</bp:TITLE>
      <bp:SOURCE >Biochem Biophys Res Commun</bp:SOURCE>
      <bp:YEAR >1975</bp:YEAR>
      <bp:ID >1010</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Formation of non-amidine products in the chemical modification of horse liver alcohol dehydrogenase with imido esters.</bp:TITLE>
      <bp:SOURCE >Biochem Biophys Res Commun</bp:SOURCE>
      <bp:YEAR >1975</bp:YEAR>
      <bp:AUTHORS >Browne DT</bp:AUTHORS>
      <bp:AUTHORS >Kent SB</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="ecd">
      <bp:ID >10861044</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Thapsigargin-induced degranulation of mast cells is dependent on transient activation of phosphatidylinositol-3 kinase.</bp:TITLE>
      <bp:SOURCE >J Immunol</bp:SOURCE>
      <bp:YEAR >2000</bp:YEAR>
      <bp:AUTHORS >Huber M</bp:AUTHORS>
      <bp:AUTHORS >Hughes MR</bp:AUTHORS>
      <bp:AUTHORS >Krystal G</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="dd6">
      <bp:ID >11303030</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >[The fragmentation and reconstruction of the oligomycin-sensitive ATPase system of liver mitochondria]</bp:TITLE>
      <bp:SOURCE >Biokhimiia</bp:SOURCE>
      <bp:YEAR >1975</bp:YEAR>
      <bp:AUTHORS >Cyert MS</bp:AUTHORS>
      <bp:AUTHORS >Chucklova IA</bp:AUTHORS>
      <bp:AUTHORS >Sotnikova VS</bp:AUTHORS>
      <bp:AUTHORS >Shchipakin VN</bp:AUTHORS>
      <bp:AUTHORS >Evtodienko YV</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="ab8">
      <bp:ID >15572660</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >A vascular gene trap screen defines RasGRP3 as an angiogenesis-regulated gene required for the endothelial response to phorbol esters.</bp:TITLE>
      <bp:SOURCE >Mol Cell Biol</bp:SOURCE>
      <bp:YEAR >2004</bp:YEAR>
      <bp:AUTHORS >Roberts DM</bp:AUTHORS>
      <bp:AUTHORS >Anderson AL</bp:AUTHORS>
      <bp:AUTHORS >Hidaka M</bp:AUTHORS>
      <bp:AUTHORS >Swetenburg RL</bp:AUTHORS>
      <bp:AUTHORS >Patterson C</bp:AUTHORS>
      <bp:AUTHORS >Stanford WL</bp:AUTHORS>
      <bp:AUTHORS >Bautch VL</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="a3f">
      <bp:ID >11880369</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >RasGRP4 is a novel Ras activator isolated from acute myeloid leukemia.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >2002</bp:YEAR>
      <bp:AUTHORS >Reuther GW</bp:AUTHORS>
      <bp:AUTHORS >Lambert QT</bp:AUTHORS>
      <bp:AUTHORS >Rebhun JF</bp:AUTHORS>
      <bp:AUTHORS >Caligiuri MA</bp:AUTHORS>
      <bp:AUTHORS >Quilliam LA</bp:AUTHORS>
      <bp:AUTHORS >Der CJ</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="d60">
      <bp:ID >11245462</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Inhibition of extracellular signal-regulated kinase (ERK) mediates cell cycle phase independent apoptosis in vinblastine-treated ML-1 cells.</bp:TITLE>
      <bp:SOURCE >Cancer Res</bp:SOURCE>
      <bp:YEAR >2001</bp:YEAR>
      <bp:AUTHORS >Stadheim TA</bp:AUTHORS>
      <bp:AUTHORS >Xiao H</bp:AUTHORS>
      <bp:AUTHORS >Eastman A</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e6e">
      <bp:ID >12589052</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Transforming growth factor-beta1 (TGF-beta)-induced apoptosis of prostate cancer cells involves Smad7-dependent activation of p38 by TGF-beta-activated kinase 1 and mitogen-activated protein kinase kinase 3.</bp:TITLE>
      <bp:SOURCE >Mol Biol Cell</bp:SOURCE>
      <bp:YEAR >2003</bp:YEAR>
      <bp:AUTHORS >Edlund S</bp:AUTHORS>
      <bp:AUTHORS >Bu S</bp:AUTHORS>
      <bp:AUTHORS >Schuster N</bp:AUTHORS>
      <bp:AUTHORS >Aspenstrom P</bp:AUTHORS>
      <bp:AUTHORS >Heuchel R</bp:AUTHORS>
      <bp:AUTHORS >Heldin NE</bp:AUTHORS>
      <bp:AUTHORS >ten Dijke P</bp:AUTHORS>
      <bp:AUTHORS >Heldin CH</bp:AUTHORS>
      <bp:AUTHORS >Landstrom M</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="a26">
      <bp:ID >8887643</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >TC21 causes transformation by Raf-independent signaling pathways.</bp:TITLE>
      <bp:SOURCE >Mol Cell Biol</bp:SOURCE>
      <bp:YEAR >1996</bp:YEAR>
      <bp:AUTHORS >Graham SM</bp:AUTHORS>
      <bp:AUTHORS >Vojtek AB</bp:AUTHORS>
      <bp:AUTHORS >Huff SY</bp:AUTHORS>
      <bp:AUTHORS >Cox AD</bp:AUTHORS>
      <bp:AUTHORS >Clark GJ</bp:AUTHORS>
      <bp:AUTHORS >Cooper JA</bp:AUTHORS>
      <bp:AUTHORS >Der CJ</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="b4f">
      <bp:ID >12226077</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >[Adenine and pyridine nucleotides in forms of Verticillium dahliae Kleb. differing in pathogenicity]</bp:TITLE>
      <bp:SOURCE >Dokl Akad Nauk SSSR</bp:SOURCE>
      <bp:YEAR >1975</bp:YEAR>
      <bp:ID >1214</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >[Adenine and pyridine nucleotides in forms of Verticillium dahliae Kleb. differing in pathogenicity].</bp:TITLE>
      <bp:SOURCE >Dokl Akad Nauk SSSR</bp:SOURCE>
      <bp:YEAR >1975</bp:YEAR>
      <bp:AUTHORS >Rubin BA</bp:AUTHORS>
      <bp:AUTHORS >Voronkov LA</bp:AUTHORS>
      <bp:AUTHORS >Zhivopistseva IV</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="aca">
      <bp:ID >12239223</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Investigations on the kinetic mechanism of octopine dehydrogenase. 1. Steady-state kinetics.</bp:TITLE>
      <bp:SOURCE >Eur J Biochem</bp:SOURCE>
      <bp:YEAR >1975</bp:YEAR>
      <bp:ID >1248</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Investigations on the kinetic mechanism of octopine dehydrogenase. 1. Steady-state kinetics.</bp:TITLE>
      <bp:SOURCE >Eur J Biochem</bp:SOURCE>
      <bp:YEAR >1975</bp:YEAR>
      <bp:ID >1248</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Investigations on the kinetic mechanism of octopine dehydrogenase. 1. Steady-state kinetics.</bp:TITLE>
      <bp:SOURCE >Eur J Biochem</bp:SOURCE>
      <bp:YEAR >1975</bp:YEAR>
      <bp:AUTHORS >Doublet MO</bp:AUTHORS>
      <bp:AUTHORS >Olomucki A</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="eb9">
      <bp:ID >7533300</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Immunophilin FK506 binding protein associated with inositol 1,4,5-trisphosphate receptor modulates calcium flux.</bp:TITLE>
      <bp:SOURCE >Proc Natl Acad Sci U S A</bp:SOURCE>
      <bp:YEAR >1995</bp:YEAR>
      <bp:AUTHORS >Cameron AM</bp:AUTHORS>
      <bp:AUTHORS >Steiner JP</bp:AUTHORS>
      <bp:AUTHORS >Sabatini DM</bp:AUTHORS>
      <bp:AUTHORS >Kaplin AI</bp:AUTHORS>
      <bp:AUTHORS >Walensky LD</bp:AUTHORS>
      <bp:AUTHORS >Snyder SH</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="bfb">
      <bp:ID >11342594</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >The Exocytosis-regulatory protein synaptotagmin VII mediates cell invasion by Trypanosoma cruzi.</bp:TITLE>
      <bp:SOURCE >J Exp Med</bp:SOURCE>
      <bp:YEAR >2001</bp:YEAR>
      <bp:ID >11342594</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >The Exocytosis-regulatory protein synaptotagmin VII mediates cell invasion by Trypanosoma cruzi.</bp:TITLE>
      <bp:SOURCE >J Exp Med</bp:SOURCE>
      <bp:YEAR >2001</bp:YEAR>
      <bp:AUTHORS >Caler EV</bp:AUTHORS>
      <bp:AUTHORS >Chakrabarti S</bp:AUTHORS>
      <bp:AUTHORS >Fowler KT</bp:AUTHORS>
      <bp:AUTHORS >Rao S</bp:AUTHORS>
      <bp:AUTHORS >Andrews NW</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e49">
      <bp:ID >12649265</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >MAP kinase kinase 6-p38 MAP kinase signaling cascade regulates cyclooxygenase-2 expression in cardiac myocytes in vitro and in vivo.</bp:TITLE>
      <bp:SOURCE >Circ Res</bp:SOURCE>
      <bp:YEAR >2003</bp:YEAR>
      <bp:AUTHORS >Degousee N</bp:AUTHORS>
      <bp:AUTHORS >Martindale J</bp:AUTHORS>
      <bp:AUTHORS >Stefanski E</bp:AUTHORS>
      <bp:AUTHORS >Cieslak M</bp:AUTHORS>
      <bp:AUTHORS >Lindsay TF</bp:AUTHORS>
      <bp:AUTHORS >Fish JE</bp:AUTHORS>
      <bp:AUTHORS >Marsden PA</bp:AUTHORS>
      <bp:AUTHORS >Thuerauf DJ</bp:AUTHORS>
      <bp:AUTHORS >Glembotski CC</bp:AUTHORS>
      <bp:AUTHORS >Rubin BB</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="db1">
      <bp:ID >10428835</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >N-hydroxyamobarbital: the second major metabolite of amobarbital in man.</bp:TITLE>
      <bp:SOURCE >Drug Metab Dispos</bp:SOURCE>
      <bp:YEAR >1975</bp:YEAR>
      <bp:AUTHORS >Hetman M</bp:AUTHORS>
      <bp:AUTHORS >Kanning K</bp:AUTHORS>
      <bp:AUTHORS >Cavanaugh JE</bp:AUTHORS>
      <bp:AUTHORS >Xia Z</bp:AUTHORS>
      <bp:AUTHORS >Tang BK</bp:AUTHORS>
      <bp:AUTHORS >Inaba T</bp:AUTHORS>
      <bp:AUTHORS >Kalow W</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c40">
      <bp:ID >8900202</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Editorial: Bronchiectasis today.</bp:TITLE>
      <bp:SOURCE >Br Med J</bp:SOURCE>
      <bp:YEAR >1975</bp:YEAR>
      <bp:AUTHORS >Tao J</bp:AUTHORS>
      <bp:AUTHORS >Sanghera JS</bp:AUTHORS>
      <bp:AUTHORS >Pelech SL</bp:AUTHORS>
      <bp:AUTHORS >Wong G</bp:AUTHORS>
      <bp:AUTHORS >Levy JG</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="fa0">
      <bp:ID >12629174</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >A regulated interaction of syntaxin 1A with the antidepressant-sensitive norepinephrine transporter establishes catecholamine clearance capacity.</bp:TITLE>
      <bp:SOURCE >J Neurosci</bp:SOURCE>
      <bp:YEAR >2003</bp:YEAR>
      <bp:AUTHORS >Sung U</bp:AUTHORS>
      <bp:AUTHORS >Apparsundaram S</bp:AUTHORS>
      <bp:AUTHORS >Galli A</bp:AUTHORS>
      <bp:AUTHORS >Kahlig KM</bp:AUTHORS>
      <bp:AUTHORS >Savchenko V</bp:AUTHORS>
      <bp:AUTHORS >Schroeter S</bp:AUTHORS>
      <bp:AUTHORS >Quick MW</bp:AUTHORS>
      <bp:AUTHORS >Blakely RD</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e89">
      <bp:ID >10807788</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >RasGRP links T-cell receptor signaling to Ras.</bp:TITLE>
      <bp:SOURCE >Blood</bp:SOURCE>
      <bp:YEAR >2000</bp:YEAR>
      <bp:ID >10807788</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >RasGRP links T-cell receptor signaling to Ras.</bp:TITLE>
      <bp:SOURCE >Blood</bp:SOURCE>
      <bp:YEAR >2000</bp:YEAR>
      <bp:ID >10807788</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >RasGRP links T-cell receptor signaling to Ras.</bp:TITLE>
      <bp:SOURCE >Blood</bp:SOURCE>
      <bp:YEAR >2000</bp:YEAR>
      <bp:AUTHORS >Ebinu JO</bp:AUTHORS>
      <bp:AUTHORS >Stang SL</bp:AUTHORS>
      <bp:AUTHORS >Teixeira C</bp:AUTHORS>
      <bp:AUTHORS >Bottorff DA</bp:AUTHORS>
      <bp:AUTHORS >Hooton J</bp:AUTHORS>
      <bp:AUTHORS >Blumberg PM</bp:AUTHORS>
      <bp:AUTHORS >Barry M</bp:AUTHORS>
      <bp:AUTHORS >Bleakley RC</bp:AUTHORS>
      <bp:AUTHORS >Ostergaard HL</bp:AUTHORS>
      <bp:AUTHORS >Stone JC</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="cc1">
      <bp:ID >7731720</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >B-Raf protein isoforms interact with and phosphorylate Mek-1 on serine residues 218 and 222.</bp:TITLE>
      <bp:SOURCE >Oncogene</bp:SOURCE>
      <bp:YEAR >1995</bp:YEAR>
      <bp:AUTHORS >Papin C</bp:AUTHORS>
      <bp:AUTHORS >Eychene A</bp:AUTHORS>
      <bp:AUTHORS >Brunet A</bp:AUTHORS>
      <bp:AUTHORS >Pages G</bp:AUTHORS>
      <bp:AUTHORS >Pouyssegur J</bp:AUTHORS>
      <bp:AUTHORS >Calothy G</bp:AUTHORS>
      <bp:AUTHORS >Barnier JV</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c1c">
      <bp:ID >15153095</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Oxidative neuronal injury. The dark side of ERK1/2.</bp:TITLE>
      <bp:SOURCE >Eur J Biochem</bp:SOURCE>
      <bp:YEAR >2004</bp:YEAR>
      <bp:ID >15153095</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Oxidative neuronal injury. The dark side of ERK1/2.</bp:TITLE>
      <bp:SOURCE >Eur J Biochem</bp:SOURCE>
      <bp:YEAR >2004</bp:YEAR>
      <bp:AUTHORS >Chu CT</bp:AUTHORS>
      <bp:AUTHORS >Levinthal DJ</bp:AUTHORS>
      <bp:AUTHORS >Kulich SM</bp:AUTHORS>
      <bp:AUTHORS >Chalovich EM</bp:AUTHORS>
      <bp:AUTHORS >DeFranco DB</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c2f">
      <bp:ID >11782488</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Differences between the heavy chains of fast and slow muscle myosin.</bp:TITLE>
      <bp:SOURCE >Exp Neurol</bp:SOURCE>
      <bp:YEAR >1975</bp:YEAR>
      <bp:ID >1286</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Differences between the heavy chains of fast and slow muscle myosin.</bp:TITLE>
      <bp:SOURCE >Exp Neurol</bp:SOURCE>
      <bp:YEAR >1975</bp:YEAR>
      <bp:ID >1286</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Differences between the heavy chains of fast and slow muscle myosin.</bp:TITLE>
      <bp:SOURCE >Exp Neurol</bp:SOURCE>
      <bp:YEAR >1975</bp:YEAR>
      <bp:ID >1286</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Differences between the heavy chains of fast and slow muscle myosin.</bp:TITLE>
      <bp:SOURCE >Exp Neurol</bp:SOURCE>
      <bp:YEAR >1975</bp:YEAR>
      <bp:AUTHORS >Jean DH</bp:AUTHORS>
      <bp:AUTHORS >Albers RW</bp:AUTHORS>
      <bp:AUTHORS >Guth L</bp:AUTHORS>
      <bp:AUTHORS >Aron HJ</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="b87">
      <bp:ID >12600999</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Hypertonicity-induced aquaporin-1 (AQP1) expression is mediated by the activation of MAPK pathways and hypertonicity-responsive element in the AQP1 gene.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >2003</bp:YEAR>
      <bp:AUTHORS >Umenishi F</bp:AUTHORS>
      <bp:AUTHORS >Schrier RW</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="fdc">
      <bp:ID >9159118</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Metal substitutions incarbonic anhydrase: a halide ion probe study.</bp:TITLE>
      <bp:SOURCE >Biochem Biophys Res Commun</bp:SOURCE>
      <bp:YEAR >1975</bp:YEAR>
      <bp:AUTHORS >Khoo S</bp:AUTHORS>
      <bp:AUTHORS >Cobb MH</bp:AUTHORS>
      <bp:AUTHORS >Smith RJ</bp:AUTHORS>
      <bp:AUTHORS >Bryant RG</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="b40">
      <bp:ID >10788495</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Gbeta 5gamma 2 is a highly selective activator of phospholipid-dependent enzymes.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >2000</bp:YEAR>
      <bp:ID >10788495</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Gbeta 5gamma 2 is a highly selective activator of phospholipid-dependent enzymes.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >2000</bp:YEAR>
      <bp:AUTHORS >Maier U</bp:AUTHORS>
      <bp:AUTHORS >Babich A</bp:AUTHORS>
      <bp:AUTHORS >Macrez N</bp:AUTHORS>
      <bp:AUTHORS >Leopoldt D</bp:AUTHORS>
      <bp:AUTHORS >Gierschik P</bp:AUTHORS>
      <bp:AUTHORS >Illenberger D</bp:AUTHORS>
      <bp:AUTHORS >Nurnberg B</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="d45">
      <bp:ID >18317590</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Interactions between integrin alphaIIbbeta3 and the serotonin transporter regulate serotonin transport and platelet aggregation in mice and humans.</bp:TITLE>
      <bp:SOURCE >J Clin Invest</bp:SOURCE>
      <bp:YEAR >2008</bp:YEAR>
      <bp:AUTHORS >Carneiro AM</bp:AUTHORS>
      <bp:AUTHORS >Cook EH</bp:AUTHORS>
      <bp:AUTHORS >Murphy DL</bp:AUTHORS>
      <bp:AUTHORS >Blakely RD</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="abf">
      <bp:ID >11500363</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >A novel method to identify protein kinase substrates: eEF2 kinase is phosphorylated and inhibited by SAPK4/p38delta.</bp:TITLE>
      <bp:SOURCE >EMBO J</bp:SOURCE>
      <bp:YEAR >2001</bp:YEAR>
      <bp:AUTHORS >Knebel A</bp:AUTHORS>
      <bp:AUTHORS >Morrice N</bp:AUTHORS>
      <bp:AUTHORS >Cohen P</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="a37">
      <bp:ID >11053438</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Evidence against tubulin--actin homology.</bp:TITLE>
      <bp:SOURCE >FEBS Lett</bp:SOURCE>
      <bp:YEAR >1976</bp:YEAR>
      <bp:ID >10182</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Evidence against tubulin--actin homology.</bp:TITLE>
      <bp:SOURCE >FEBS Lett</bp:SOURCE>
      <bp:YEAR >1976</bp:YEAR>
      <bp:AUTHORS >Castle AG</bp:AUTHORS>
      <bp:AUTHORS >Marsh JC</bp:AUTHORS>
      <bp:AUTHORS >Crawford N</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="ad9">
      <bp:ID >18317590</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Interactions between integrin alphaIIbbeta3 and the serotonin transporter regulate serotonin transport and platelet aggregation in mice and humans.</bp:TITLE>
      <bp:SOURCE >J Clin Invest</bp:SOURCE>
      <bp:YEAR >2008</bp:YEAR>
      <bp:AUTHORS >Carneiro AM</bp:AUTHORS>
      <bp:AUTHORS >Cook EH</bp:AUTHORS>
      <bp:AUTHORS >Murphy DL</bp:AUTHORS>
      <bp:AUTHORS >Blakely RD</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="fa2">
      <bp:ID >12208764</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >[The fragmentation and reconstruction of the oligomycin-sensitive ATPase system of liver mitochondria]</bp:TITLE>
      <bp:SOURCE >Biokhimiia</bp:SOURCE>
      <bp:YEAR >1975</bp:YEAR>
      <bp:AUTHORS >Haq R</bp:AUTHORS>
      <bp:AUTHORS >Brenton JD</bp:AUTHORS>
      <bp:AUTHORS >Takahashi M</bp:AUTHORS>
      <bp:AUTHORS >Finan D</bp:AUTHORS>
      <bp:AUTHORS >Finkielsztein A</bp:AUTHORS>
      <bp:AUTHORS >Damaraju S</bp:AUTHORS>
      <bp:AUTHORS >Rottapel R</bp:AUTHORS>
      <bp:AUTHORS >Zanke B</bp:AUTHORS>
      <bp:AUTHORS >Chucklova IA</bp:AUTHORS>
      <bp:AUTHORS >Sotnikova VS</bp:AUTHORS>
      <bp:AUTHORS >Shchipakin VN</bp:AUTHORS>
      <bp:AUTHORS >Evtodienko YV</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="d4d">
      <bp:ID >14970203</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >RasGRP1 sensitizes an immature B cell line to antigen receptor-induced apoptosis.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >2004</bp:YEAR>
      <bp:AUTHORS >Guilbault B</bp:AUTHORS>
      <bp:AUTHORS >Kay RJ</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="de0">
      <bp:ID >11082445</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Regulation of c-Jun N-terminal kinase by the ORL(1) receptor through multiple G proteins.</bp:TITLE>
      <bp:SOURCE >J Pharmacol Exp Ther</bp:SOURCE>
      <bp:YEAR >2000</bp:YEAR>
      <bp:AUTHORS >Chan AS</bp:AUTHORS>
      <bp:AUTHORS >Wong YH</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c4a">
      <bp:ID >10196167</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Membrane-bound DD-carboxypeptidase and transpeptidase activities from Bacillus megaterium KM at pH 7. General properties, substrate specificity and inhibition by beta-lactam antibiotics.</bp:TITLE>
      <bp:SOURCE >Eur J Biochem</bp:SOURCE>
      <bp:YEAR >1976</bp:YEAR>
      <bp:ID >10161</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Membrane-bound DD-carboxypeptidase and transpeptidase activities from Bacillus megaterium KM at pH 7. General properties, substrate specificity and inhibition by beta-lactam antibiotics.</bp:TITLE>
      <bp:SOURCE >Eur J Biochem</bp:SOURCE>
      <bp:YEAR >1976</bp:YEAR>
      <bp:ID >10161</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Membrane-bound DD-carboxypeptidase and transpeptidase activities from Bacillus megaterium KM at pH 7. General properties, substrate specificity and inhibition by beta-lactam antibiotics.</bp:TITLE>
      <bp:SOURCE >Eur J Biochem</bp:SOURCE>
      <bp:YEAR >1976</bp:YEAR>
      <bp:AUTHORS >Marquet A</bp:AUTHORS>
      <bp:AUTHORS >Nieto M</bp:AUTHORS>
      <bp:AUTHORS >Diaz-Mauri&#241;o T</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="f3f">
      <bp:ID >14965240</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >5-HT1 receptors.</bp:TITLE>
      <bp:SOURCE >Curr Drug Targets CNS Neurol Disord</bp:SOURCE>
      <bp:YEAR >2004</bp:YEAR>
      <bp:ID >14965240</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >5-HT1 receptors.</bp:TITLE>
      <bp:SOURCE >Curr Drug Targets CNS Neurol Disord</bp:SOURCE>
      <bp:YEAR >2004</bp:YEAR>
      <bp:ID >14965240</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >5-HT1 receptors.</bp:TITLE>
      <bp:SOURCE >Curr Drug Targets CNS Neurol Disord</bp:SOURCE>
      <bp:YEAR >2004</bp:YEAR>
      <bp:AUTHORS >Lanfumey L</bp:AUTHORS>
      <bp:AUTHORS >Hamon M</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="db5">
      <bp:ID >12670941</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >p38 MAPK is involved in activin A- and hepatocyte growth factor-mediated expression of pro-endocrine gene neurogenin 3 in AR42J-B13 cells.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >2003</bp:YEAR>
      <bp:ID >12670941</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >p38 MAPK is involved in activin A- and hepatocyte growth factor-mediated expression of pro-endocrine gene neurogenin 3 in AR42J-B13 cells.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >2003</bp:YEAR>
      <bp:AUTHORS >Ogihara T</bp:AUTHORS>
      <bp:AUTHORS >Watada H</bp:AUTHORS>
      <bp:AUTHORS >Kanno R</bp:AUTHORS>
      <bp:AUTHORS >Ikeda F</bp:AUTHORS>
      <bp:AUTHORS >Nomiyama T</bp:AUTHORS>
      <bp:AUTHORS >Tanaka Y</bp:AUTHORS>
      <bp:AUTHORS >Nakao A</bp:AUTHORS>
      <bp:AUTHORS >German MS</bp:AUTHORS>
      <bp:AUTHORS >Kojima I</bp:AUTHORS>
      <bp:AUTHORS >Kawamori R</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="a28">
      <bp:ID >15572664</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE />
      <bp:SOURCE />
      <bp:YEAR />
      <bp:ID >15572664</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Activation of p90 Rsk1 is sufficient for differentiation of PC12 cells.</bp:TITLE>
      <bp:SOURCE >Mol Cell Biol</bp:SOURCE>
      <bp:YEAR >2004</bp:YEAR>
      <bp:AUTHORS >Silverman E</bp:AUTHORS>
      <bp:AUTHORS >Frodin M</bp:AUTHORS>
      <bp:AUTHORS >Gammeltoft S</bp:AUTHORS>
      <bp:AUTHORS >Maller JL</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="dfa">
      <bp:ID >15572660</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >A vascular gene trap screen defines RasGRP3 as an angiogenesis-regulated gene required for the endothelial response to phorbol esters.</bp:TITLE>
      <bp:SOURCE >Mol Cell Biol</bp:SOURCE>
      <bp:YEAR >2004</bp:YEAR>
      <bp:AUTHORS >Roberts DM</bp:AUTHORS>
      <bp:AUTHORS >Anderson AL</bp:AUTHORS>
      <bp:AUTHORS >Hidaka M</bp:AUTHORS>
      <bp:AUTHORS >Swetenburg RL</bp:AUTHORS>
      <bp:AUTHORS >Patterson C</bp:AUTHORS>
      <bp:AUTHORS >Stanford WL</bp:AUTHORS>
      <bp:AUTHORS >Bautch VL</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e2e">
      <bp:ID >15814901</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Involvement of protein kinase C and cyclic adenosine 3',5'-monophosphate-dependent kinase in steroidogenic acute regulatory protein expression and steroid biosynthesis in Leydig cells.</bp:TITLE>
      <bp:SOURCE >Biol Reprod</bp:SOURCE>
      <bp:YEAR >2005</bp:YEAR>
      <bp:AUTHORS >Jo Y</bp:AUTHORS>
      <bp:AUTHORS >King SR</bp:AUTHORS>
      <bp:AUTHORS >Khan SA</bp:AUTHORS>
      <bp:AUTHORS >Stocco DM</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="d97">
      <bp:ID >8717044</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Phosphorylation-dependent activation of the Ras-GRF/CDC25Mm exchange factor by muscarinic receptors and G-protein beta gamma subunits.</bp:TITLE>
      <bp:SOURCE >Nature</bp:SOURCE>
      <bp:YEAR >1996</bp:YEAR>
      <bp:AUTHORS >Mattingly RR</bp:AUTHORS>
      <bp:AUTHORS >Macara IG</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="d22">
      <bp:ID >12842874</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Spironolactone metabolism in man studied by gas chromatography-mass spectrometry.</bp:TITLE>
      <bp:SOURCE >Drug Metab Dispos</bp:SOURCE>
      <bp:YEAR >1975</bp:YEAR>
      <bp:ID >1221</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Spironolactone metabolism in man studied by gas chromatography-mass spectrometry.</bp:TITLE>
      <bp:SOURCE >Drug Metab Dispos</bp:SOURCE>
      <bp:YEAR >1975</bp:YEAR>
      <bp:AUTHORS >Karim A</bp:AUTHORS>
      <bp:AUTHORS >Hribar J</bp:AUTHORS>
      <bp:AUTHORS >Aksamit W</bp:AUTHORS>
      <bp:AUTHORS >Doherty M</bp:AUTHORS>
      <bp:AUTHORS >Chinn LJ</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="de6">
      <bp:ID >9235901</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >ATP synthesis catalyzed by purified DCCD-sensitive ATPase incorporated into reconstituted purple membrane vesicles.</bp:TITLE>
      <bp:SOURCE >Biochem Biophys Res Commun</bp:SOURCE>
      <bp:YEAR >1975</bp:YEAR>
      <bp:AUTHORS >Della Rocca GJ</bp:AUTHORS>
      <bp:AUTHORS >van Biesen T</bp:AUTHORS>
      <bp:AUTHORS >Daaka Y</bp:AUTHORS>
      <bp:AUTHORS >Luttrell DK</bp:AUTHORS>
      <bp:AUTHORS >Luttrell LM</bp:AUTHORS>
      <bp:AUTHORS >Lefkowitz RJ</bp:AUTHORS>
      <bp:AUTHORS >Yoshida M</bp:AUTHORS>
      <bp:AUTHORS >Sone N</bp:AUTHORS>
      <bp:AUTHORS >Hirata H</bp:AUTHORS>
      <bp:AUTHORS >Kagawa Y</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="ffa">
      <bp:ID >12690113</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Uptake and disposition of aldrin and dieldrin by isolated perfused rabbit lung.</bp:TITLE>
      <bp:SOURCE >Drug Metab Dispos</bp:SOURCE>
      <bp:YEAR >1975</bp:YEAR>
      <bp:AUTHORS >Song KS</bp:AUTHORS>
      <bp:AUTHORS >Lee WJ</bp:AUTHORS>
      <bp:AUTHORS >Chung KC</bp:AUTHORS>
      <bp:AUTHORS >Koo JS</bp:AUTHORS>
      <bp:AUTHORS >Yang EJ</bp:AUTHORS>
      <bp:AUTHORS >Choi JY</bp:AUTHORS>
      <bp:AUTHORS >Yoon JH</bp:AUTHORS>
      <bp:AUTHORS >Mehendale HM</bp:AUTHORS>
      <bp:AUTHORS >El-Bassiouni EA</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="d82">
      <bp:ID >11017917</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Inositol (1,4,5)trisphosphate metabolism and enhanced calcium mobilization in airway smooth muscle of hyperresponsive rats.</bp:TITLE>
      <bp:SOURCE >Am J Respir Cell Mol Biol</bp:SOURCE>
      <bp:YEAR >2000</bp:YEAR>
      <bp:AUTHORS >Tao FC</bp:AUTHORS>
      <bp:AUTHORS >Tolloczko B</bp:AUTHORS>
      <bp:AUTHORS >Mitchell CA</bp:AUTHORS>
      <bp:AUTHORS >Powell WS</bp:AUTHORS>
      <bp:AUTHORS >Martin JG</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="baa">
      <bp:ID >12960165</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Phorbol ester-dependent activation of peroxiredoxin I gene expression via a protein kinase C, Ras, p38 mitogen-activated protein kinase signaling pathway.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >2003</bp:YEAR>
      <bp:ID >12960165</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Phorbol ester-dependent activation of peroxiredoxin I gene expression via a protein kinase C, Ras, p38 mitogen-activated protein kinase signaling pathway.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >2003</bp:YEAR>
      <bp:ID >12960165</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Phorbol ester-dependent activation of peroxiredoxin I gene expression via a protein kinase C, Ras, p38 mitogen-activated protein kinase signaling pathway.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >2003</bp:YEAR>
      <bp:ID >12960165</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Phorbol ester-dependent activation of peroxiredoxin I gene expression via a protein kinase C, Ras, p38 mitogen-activated protein kinase signaling pathway.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >2003</bp:YEAR>
      <bp:AUTHORS >Hess A</bp:AUTHORS>
      <bp:AUTHORS >Wijayanti N</bp:AUTHORS>
      <bp:AUTHORS >Neusch&#228;fer-Rube AP</bp:AUTHORS>
      <bp:AUTHORS >Katz N</bp:AUTHORS>
      <bp:AUTHORS >Kietzmann T</bp:AUTHORS>
      <bp:AUTHORS >Immenschuh S</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="bda">
      <bp:ID >12048245</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >MEKK1 plays a critical role in activating the transcription factor C/EBP-beta-dependent gene expression in response to IFN-gamma.</bp:TITLE>
      <bp:SOURCE >Proc Natl Acad Sci U S A</bp:SOURCE>
      <bp:YEAR >2002</bp:YEAR>
      <bp:AUTHORS >Roy SK</bp:AUTHORS>
      <bp:AUTHORS >Hu J</bp:AUTHORS>
      <bp:AUTHORS >Meng Q</bp:AUTHORS>
      <bp:AUTHORS >Xia Y</bp:AUTHORS>
      <bp:AUTHORS >Shapiro PS</bp:AUTHORS>
      <bp:AUTHORS >Reddy SP</bp:AUTHORS>
      <bp:AUTHORS >Platanias LC</bp:AUTHORS>
      <bp:AUTHORS >Lindner DJ</bp:AUTHORS>
      <bp:AUTHORS >Johnson PF</bp:AUTHORS>
      <bp:AUTHORS >Pritchard C</bp:AUTHORS>
      <bp:AUTHORS >Pages G</bp:AUTHORS>
      <bp:AUTHORS >Pouyssegur J</bp:AUTHORS>
      <bp:AUTHORS >Kalvakolanu DV</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="dcb">
      <bp:ID >12145292</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Study of the heat treatment of hemoglobin by means of spin labels.</bp:TITLE>
      <bp:SOURCE >Biochem Biophys Res Commun</bp:SOURCE>
      <bp:YEAR >1975</bp:YEAR>
      <bp:ID >1036</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Study of the heat treatment of hemoglobin by means of spin labels.</bp:TITLE>
      <bp:SOURCE >Biochem Biophys Res Commun</bp:SOURCE>
      <bp:YEAR >1975</bp:YEAR>
      <bp:ID >1036</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Study of the heat treatment of hemoglobin by means of spin labels.</bp:TITLE>
      <bp:SOURCE >Biochem Biophys Res Commun</bp:SOURCE>
      <bp:YEAR >1975</bp:YEAR>
      <bp:AUTHORS >Bemski G</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="fe3">
      <bp:ID >9727040</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >A role for the p38 mitogen-activated protein kinase/Hsp 27 pathway in cholecystokinin-induced changes in the actin cytoskeleton in rat pancreatic acini.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >1998</bp:YEAR>
      <bp:AUTHORS >Sch&#228;fer C</bp:AUTHORS>
      <bp:AUTHORS >Ross SE</bp:AUTHORS>
      <bp:AUTHORS >Bragado MJ</bp:AUTHORS>
      <bp:AUTHORS >Groblewski GE</bp:AUTHORS>
      <bp:AUTHORS >Ernst SA</bp:AUTHORS>
      <bp:AUTHORS >Williams JA</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c5a">
      <bp:ID >10625698</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Utilization of ammonia for tryptophan synthesis.</bp:TITLE>
      <bp:SOURCE >Biochem Biophys Res Commun</bp:SOURCE>
      <bp:YEAR >1975</bp:YEAR>
      <bp:AUTHORS >Ryder JW</bp:AUTHORS>
      <bp:AUTHORS >Fahlman R</bp:AUTHORS>
      <bp:AUTHORS >Wallberg-Henriksson H</bp:AUTHORS>
      <bp:AUTHORS >Alessi DR</bp:AUTHORS>
      <bp:AUTHORS >Krook A</bp:AUTHORS>
      <bp:AUTHORS >Zierath JR</bp:AUTHORS>
      <bp:AUTHORS >Zalkin H</bp:AUTHORS>
      <bp:AUTHORS >Murphy T</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="cde">
      <bp:ID >11696358</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Involvement of B-Raf in Ras-induced Raf-1 activation.</bp:TITLE>
      <bp:SOURCE >FEBS Lett</bp:SOURCE>
      <bp:YEAR >2001</bp:YEAR>
      <bp:AUTHORS >Mizutani S</bp:AUTHORS>
      <bp:AUTHORS >Inouye K</bp:AUTHORS>
      <bp:AUTHORS >Koide H</bp:AUTHORS>
      <bp:AUTHORS >Kaziro Y</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="ef4">
      <bp:ID >10629034</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Sequential regulation of the small GTPase Rap1 in human platelets.</bp:TITLE>
      <bp:SOURCE >Mol Cell Biol</bp:SOURCE>
      <bp:YEAR >2000</bp:YEAR>
      <bp:AUTHORS >Franke B</bp:AUTHORS>
      <bp:AUTHORS >van Triest M</bp:AUTHORS>
      <bp:AUTHORS >de Bruijn KM</bp:AUTHORS>
      <bp:AUTHORS >van Willigen G</bp:AUTHORS>
      <bp:AUTHORS >Nieuwenhuis HK</bp:AUTHORS>
      <bp:AUTHORS >Negrier C</bp:AUTHORS>
      <bp:AUTHORS >Akkerman JW</bp:AUTHORS>
      <bp:AUTHORS >Bos JL</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="ee6">
      <bp:ID >11698415</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Green tea polyphenol stimulates a Ras, MEKK1, MEK3, and p38 cascade to increase activator protein 1 factor-dependent involucrin gene expression in normal human keratinocytes.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >2002</bp:YEAR>
      <bp:ID >11698415</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Green tea polyphenol stimulates a Ras, MEKK1, MEK3, and p38 cascade to increase activator protein 1 factor-dependent involucrin gene expression in normal human keratinocytes.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >2002</bp:YEAR>
      <bp:AUTHORS >Balasubramanian S</bp:AUTHORS>
      <bp:AUTHORS >Efimova T</bp:AUTHORS>
      <bp:AUTHORS >Eckert RL</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="bce">
      <bp:ID >14575867</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Phosphoinositide 3-kinase is involved in Xenopus and Labrus melanophore aggregation.</bp:TITLE>
      <bp:SOURCE >Cell Signal</bp:SOURCE>
      <bp:YEAR >2003</bp:YEAR>
      <bp:ID >14575867</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Phosphoinositide 3-kinase is involved in Xenopus and Labrus melanophore aggregation.</bp:TITLE>
      <bp:SOURCE >Cell Signal</bp:SOURCE>
      <bp:YEAR >2003</bp:YEAR>
      <bp:AUTHORS >Andersson TP</bp:AUTHORS>
      <bp:AUTHORS >Sk&#246;ld HN</bp:AUTHORS>
      <bp:AUTHORS >Svensson SP</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="b13">
      <bp:ID >9755064</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Effect of osmotic pressure, ionic strength and dibutyryl cyclic adenosine monophosphate on the adhesion of hen erythrocytes.</bp:TITLE>
      <bp:SOURCE >Blut</bp:SOURCE>
      <bp:YEAR >1976</bp:YEAR>
      <bp:ID >10025</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Effect of osmotic pressure, ionic strength and dibutyryl cyclic adenosine monophosphate on the adhesion of hen erythrocytes.</bp:TITLE>
      <bp:SOURCE >Blut</bp:SOURCE>
      <bp:YEAR >1976</bp:YEAR>
      <bp:AUTHORS >Imre S</bp:AUTHORS>
      <bp:AUTHORS >Szil&#225;gyi T</bp:AUTHORS>
      <bp:AUTHORS >T&#243;th S</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="b26">
      <bp:ID >10706690</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Oxidative biotransformation of 2-acetylaminofluorene in fetal and placental tissues of humans and monkeys. Correlations with aryl hydrocarbon hydroxylase activities.</bp:TITLE>
      <bp:SOURCE >Drug Metab Dispos</bp:SOURCE>
      <bp:YEAR >1975</bp:YEAR>
      <bp:AUTHORS >Caivano M</bp:AUTHORS>
      <bp:AUTHORS >Cohen P</bp:AUTHORS>
      <bp:AUTHORS >Juchau MR</bp:AUTHORS>
      <bp:AUTHORS >Namkung MJ</bp:AUTHORS>
      <bp:AUTHORS >Berry DL</bp:AUTHORS>
      <bp:AUTHORS >Zachariah PK</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="bde">
      <bp:ID >18445122</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Going with the flow: trafficking-dependent and -independent regulation of serotonin transport.</bp:TITLE>
      <bp:SOURCE >Traffic</bp:SOURCE>
      <bp:YEAR >2008</bp:YEAR>
      <bp:AUTHORS >Steiner JA</bp:AUTHORS>
      <bp:AUTHORS >Carneiro AM</bp:AUTHORS>
      <bp:AUTHORS >Blakely RD</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e13">
      <bp:ID >10644746</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Nitric oxide activation of p38 mitogen-activated protein kinase in 293T fibroblasts requires cGMP-dependent protein kinase.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >2000</bp:YEAR>
      <bp:ID >10644746</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Nitric oxide activation of p38 mitogen-activated protein kinase in 293T fibroblasts requires cGMP-dependent protein kinase.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >2000</bp:YEAR>
      <bp:ID >10644746</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Nitric oxide activation of p38 mitogen-activated protein kinase in 293T fibroblasts requires cGMP-dependent protein kinase.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >2000</bp:YEAR>
      <bp:AUTHORS >Browning DD</bp:AUTHORS>
      <bp:AUTHORS >McShane MP</bp:AUTHORS>
      <bp:AUTHORS >Marty C</bp:AUTHORS>
      <bp:AUTHORS >Ye RD</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="b83">
      <bp:ID >14566944</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Ultrastructural localization of the norepinephrine transporter in superficial and deep layers of the rat prelimbic prefrontal cortex and its spatial relationship to probable dopamine terminals.</bp:TITLE>
      <bp:SOURCE >J Comp Neurol</bp:SOURCE>
      <bp:YEAR >2003</bp:YEAR>
      <bp:AUTHORS >Miner LH</bp:AUTHORS>
      <bp:AUTHORS >Schroeter S</bp:AUTHORS>
      <bp:AUTHORS >Blakely RD</bp:AUTHORS>
      <bp:AUTHORS >Sesack SR</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e4c">
      <bp:ID >9006914</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Tumor necrosis factor alpha-induced E-selectin expression is activated by the nuclear factor-kappaB and c-JUN N-terminal kinase/p38 mitogen-activated protein kinase pathways.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >1997</bp:YEAR>
      <bp:ID >9006914</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Tumor necrosis factor alpha-induced E-selectin expression is activated by the nuclear factor-kappaB and c-JUN N-terminal kinase/p38 mitogen-activated protein kinase pathways.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >1997</bp:YEAR>
      <bp:AUTHORS >Read MA</bp:AUTHORS>
      <bp:AUTHORS >Whitley MZ</bp:AUTHORS>
      <bp:AUTHORS >Gupta S</bp:AUTHORS>
      <bp:AUTHORS >Pierce JW</bp:AUTHORS>
      <bp:AUTHORS >Best J</bp:AUTHORS>
      <bp:AUTHORS >Davis RJ</bp:AUTHORS>
      <bp:AUTHORS >Collins T</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c2b">
      <bp:ID >10463587</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Glycerol inhibition of purified and chromatin-associated mouse liver hepatoma RNA polymerase II activity.</bp:TITLE>
      <bp:SOURCE >Biochem Biophys Res Commun</bp:SOURCE>
      <bp:YEAR >1975</bp:YEAR>
      <bp:ID >1029</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Glycerol inhibition of purified and chromatin-associated mouse liver hepatoma RNA polymerase II activity.</bp:TITLE>
      <bp:SOURCE >Biochem Biophys Res Commun</bp:SOURCE>
      <bp:YEAR >1975</bp:YEAR>
      <bp:ID >1029</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Glycerol inhibition of purified and chromatin-associated mouse liver hepatoma RNA polymerase II activity.</bp:TITLE>
      <bp:SOURCE >Biochem Biophys Res Commun</bp:SOURCE>
      <bp:YEAR >1975</bp:YEAR>
      <bp:ID >1029</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Glycerol inhibition of purified and chromatin-associated mouse liver hepatoma RNA polymerase II activity.</bp:TITLE>
      <bp:SOURCE >Biochem Biophys Res Commun</bp:SOURCE>
      <bp:YEAR >1975</bp:YEAR>
      <bp:AUTHORS >Smith RJ</bp:AUTHORS>
      <bp:AUTHORS >Duerksen JD</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="ec4">
      <bp:ID >9873047</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Maturation of the adrenal medulla--IV. Effects of morphine.</bp:TITLE>
      <bp:SOURCE >Biochem Pharmacol</bp:SOURCE>
      <bp:YEAR >1975</bp:YEAR>
      <bp:AUTHORS >New L</bp:AUTHORS>
      <bp:AUTHORS >Zhao M</bp:AUTHORS>
      <bp:AUTHORS >Li Y</bp:AUTHORS>
      <bp:AUTHORS >Bassett WW</bp:AUTHORS>
      <bp:AUTHORS >Feng Y</bp:AUTHORS>
      <bp:AUTHORS >Ludwig S</bp:AUTHORS>
      <bp:AUTHORS >Padova FD</bp:AUTHORS>
      <bp:AUTHORS >Gram H</bp:AUTHORS>
      <bp:AUTHORS >Han J</bp:AUTHORS>
      <bp:AUTHORS >Anderson TR</bp:AUTHORS>
      <bp:AUTHORS >Slotkin TA</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="b4d">
      <bp:ID >12393899</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Micellar solubilization of fatty acids in aqueous media containing bile salts and phospholipids.</bp:TITLE>
      <bp:SOURCE >Br J Nutr</bp:SOURCE>
      <bp:YEAR >1976</bp:YEAR>
      <bp:AUTHORS >Hetman M</bp:AUTHORS>
      <bp:AUTHORS >Hsuan SL</bp:AUTHORS>
      <bp:AUTHORS >Habas A</bp:AUTHORS>
      <bp:AUTHORS >Higgins MJ</bp:AUTHORS>
      <bp:AUTHORS >Xia Z</bp:AUTHORS>
      <bp:AUTHORS >Smith A</bp:AUTHORS>
      <bp:AUTHORS >Lough AK</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c3b">
      <bp:ID >11839761</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Adenylate cyclase activity in chick retina.</bp:TITLE>
      <bp:SOURCE >Gen Pharmacol</bp:SOURCE>
      <bp:YEAR >1976</bp:YEAR>
      <bp:ID >10228</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Adenylate cyclase activity in chick retina.</bp:TITLE>
      <bp:SOURCE >Gen Pharmacol</bp:SOURCE>
      <bp:YEAR >1976</bp:YEAR>
      <bp:AUTHORS >Schwarcz R</bp:AUTHORS>
      <bp:AUTHORS >Coyle JT</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="aae">
      <bp:ID >12529253</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Role of phosphoinositide 3-kinase in the nonselective cation channel activation by endothelin-1/endothelinB receptor.</bp:TITLE>
      <bp:SOURCE >Am J Physiol Cell Physiol</bp:SOURCE>
      <bp:YEAR >2003</bp:YEAR>
      <bp:ID >12529253</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Role of phosphoinositide 3-kinase in the nonselective cation channel activation by endothelin-1/endothelinB receptor.</bp:TITLE>
      <bp:SOURCE >Am J Physiol Cell Physiol</bp:SOURCE>
      <bp:YEAR >2003</bp:YEAR>
      <bp:AUTHORS >Kawanabe Y</bp:AUTHORS>
      <bp:AUTHORS >Hashimoto N</bp:AUTHORS>
      <bp:AUTHORS >Masaki T</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="ea6">
      <bp:ID >11983682</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >An oxygen dependent current in Aplysia neurons: an approach to the question of cellular hypoxic adaptation.</bp:TITLE>
      <bp:SOURCE >Comp Biochem Physiol A Comp Physiol</bp:SOURCE>
      <bp:YEAR >1975</bp:YEAR>
      <bp:AUTHORS >Soroka V</bp:AUTHORS>
      <bp:AUTHORS >Kiryushko D</bp:AUTHORS>
      <bp:AUTHORS >Novitskaya V</bp:AUTHORS>
      <bp:AUTHORS >Ronn LC</bp:AUTHORS>
      <bp:AUTHORS >Poulsen FM</bp:AUTHORS>
      <bp:AUTHORS >Holm A</bp:AUTHORS>
      <bp:AUTHORS >Bock E</bp:AUTHORS>
      <bp:AUTHORS >Berezin V</bp:AUTHORS>
      <bp:AUTHORS >Steffin M</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="b0e">
      <bp:ID >12242299</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Incorporation of (1-14C)palmitoyl-CoA into phosphatidylcholine by plasma membranes of rat submaxillary glands in vitro.</bp:TITLE>
      <bp:SOURCE >Eur J Biochem</bp:SOURCE>
      <bp:YEAR >1976</bp:YEAR>
      <bp:AUTHORS >Roberts EC</bp:AUTHORS>
      <bp:AUTHORS >Shapiro PS</bp:AUTHORS>
      <bp:AUTHORS >Nahreini TS</bp:AUTHORS>
      <bp:AUTHORS >Pages G</bp:AUTHORS>
      <bp:AUTHORS >Pouyssegur J</bp:AUTHORS>
      <bp:AUTHORS >Ahn NG</bp:AUTHORS>
      <bp:AUTHORS >Nijjar MS</bp:AUTHORS>
      <bp:AUTHORS >Pritchard ET</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="fe4">
      <bp:ID >7797459</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >How MAP kinases are regulated.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >1995</bp:YEAR>
      <bp:ID >7797459</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >How MAP kinases are regulated.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >1995</bp:YEAR>
      <bp:AUTHORS >Cobb MH</bp:AUTHORS>
      <bp:AUTHORS >Goldsmith EJ</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="b23">
      <bp:ID >11123233</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Factors affecting the molecular structure and the agglutinating ability of concanavalin A and other lectins.</bp:TITLE>
      <bp:SOURCE >Eur J Biochem</bp:SOURCE>
      <bp:YEAR >1975</bp:YEAR>
      <bp:AUTHORS >Azuma N</bp:AUTHORS>
      <bp:AUTHORS >Akasaka N</bp:AUTHORS>
      <bp:AUTHORS >Kito H</bp:AUTHORS>
      <bp:AUTHORS >Ikeda M</bp:AUTHORS>
      <bp:AUTHORS >Gahtan V</bp:AUTHORS>
      <bp:AUTHORS >Sasajima T</bp:AUTHORS>
      <bp:AUTHORS >Sumpio BE</bp:AUTHORS>
      <bp:AUTHORS >Huet M</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="b9f">
      <bp:ID >17032905</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Amphetamine induces a calcium/calmodulin-dependent protein kinase II-dependent reduction in norepinephrine transporter surface expression linked to changes in syntaxin 1A/transporter complexes.</bp:TITLE>
      <bp:SOURCE >Mol Pharmacol</bp:SOURCE>
      <bp:YEAR >2007</bp:YEAR>
      <bp:AUTHORS >Dipace C</bp:AUTHORS>
      <bp:AUTHORS >Sung U</bp:AUTHORS>
      <bp:AUTHORS >Binda F</bp:AUTHORS>
      <bp:AUTHORS >Blakely RD</bp:AUTHORS>
      <bp:AUTHORS >Galli A</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c3a">
      <bp:ID >10713965</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Carbachol-induced [Ca2+]i increase, but not activation of protein kinase C, stimulates exocytosis in rat parotid acini.</bp:TITLE>
      <bp:SOURCE >J Physiol</bp:SOURCE>
      <bp:YEAR >2000</bp:YEAR>
      <bp:ID >10713965</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Carbachol-induced [Ca2+]i increase, but not activation of protein kinase C, stimulates exocytosis in rat parotid acini.</bp:TITLE>
      <bp:SOURCE >J Physiol</bp:SOURCE>
      <bp:YEAR >2000</bp:YEAR>
      <bp:AUTHORS >Yoshimura K</bp:AUTHORS>
      <bp:AUTHORS >Murakami M</bp:AUTHORS>
      <bp:AUTHORS >Segawa A</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="d9c">
      <bp:ID >14965240</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >5-HT1 receptors.</bp:TITLE>
      <bp:SOURCE >Curr Drug Targets CNS Neurol Disord</bp:SOURCE>
      <bp:YEAR >2004</bp:YEAR>
      <bp:AUTHORS >Lanfumey L</bp:AUTHORS>
      <bp:AUTHORS >Hamon M</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="d21">
      <bp:ID >10751227</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >5-HT(2A) receptors stimulate mitogen-activated protein kinase via H(2)O(2) generation in rat renal mesangial cells.</bp:TITLE>
      <bp:SOURCE >Am J Physiol Renal Physiol</bp:SOURCE>
      <bp:YEAR >2000</bp:YEAR>
      <bp:ID >10751227</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >5-HT(2A) receptors stimulate mitogen-activated protein kinase via H(2)O(2) generation in rat renal mesangial cells.</bp:TITLE>
      <bp:SOURCE >Am J Physiol Renal Physiol</bp:SOURCE>
      <bp:YEAR >2000</bp:YEAR>
      <bp:AUTHORS >Greene EL</bp:AUTHORS>
      <bp:AUTHORS >Houghton O</bp:AUTHORS>
      <bp:AUTHORS >Collinsworth G</bp:AUTHORS>
      <bp:AUTHORS >Garnovskaya MN</bp:AUTHORS>
      <bp:AUTHORS >Nagai T</bp:AUTHORS>
      <bp:AUTHORS >Sajjad T</bp:AUTHORS>
      <bp:AUTHORS >Bheemanathini V</bp:AUTHORS>
      <bp:AUTHORS >Grewal JS</bp:AUTHORS>
      <bp:AUTHORS >Paul RV</bp:AUTHORS>
      <bp:AUTHORS >Raymond JR</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="a3b">
      <bp:ID >8622647</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Ras-induced activation of Raf-1 is dependent on tyrosine phosphorylation.</bp:TITLE>
      <bp:SOURCE >Mol Cell Biol</bp:SOURCE>
      <bp:YEAR >1996</bp:YEAR>
      <bp:AUTHORS >Jelinek T</bp:AUTHORS>
      <bp:AUTHORS >Dent P</bp:AUTHORS>
      <bp:AUTHORS >Sturgill TW</bp:AUTHORS>
      <bp:AUTHORS >Weber MJ</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c18">
      <bp:ID >12746434</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Spectrophotometric end-point method for assay of serum cystyl-aminopeptidase in pregnancy.</bp:TITLE>
      <bp:SOURCE >Clin Chem</bp:SOURCE>
      <bp:YEAR >1976</bp:YEAR>
      <bp:AUTHORS >Kim JS</bp:AUTHORS>
      <bp:AUTHORS >Chang JH</bp:AUTHORS>
      <bp:AUTHORS >Yu HK</bp:AUTHORS>
      <bp:AUTHORS >Ahn JH</bp:AUTHORS>
      <bp:AUTHORS >Yum JS</bp:AUTHORS>
      <bp:AUTHORS >Lee SK</bp:AUTHORS>
      <bp:AUTHORS >Jung KH</bp:AUTHORS>
      <bp:AUTHORS >Park DH</bp:AUTHORS>
      <bp:AUTHORS >Yoon Y</bp:AUTHORS>
      <bp:AUTHORS >Byun SM</bp:AUTHORS>
      <bp:AUTHORS >Chung SI</bp:AUTHORS>
      <bp:AUTHORS >Durham BH</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="a89">
      <bp:ID >12393899</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >D-glucose-6-phosphate dehydrogenase (Entner-Doudoroff enzyme) from Pseudomonas fluorescens. Purification, properties and regulation.</bp:TITLE>
      <bp:SOURCE >Eur J Biochem</bp:SOURCE>
      <bp:YEAR >1975</bp:YEAR>
      <bp:AUTHORS >Hetman M</bp:AUTHORS>
      <bp:AUTHORS >Hsuan SL</bp:AUTHORS>
      <bp:AUTHORS >Habas A</bp:AUTHORS>
      <bp:AUTHORS >Higgins MJ</bp:AUTHORS>
      <bp:AUTHORS >Xia Z</bp:AUTHORS>
      <bp:AUTHORS >Lessmann D</bp:AUTHORS>
      <bp:AUTHORS >Schimz KL</bp:AUTHORS>
      <bp:AUTHORS >Kurz G</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="a8f">
      <bp:ID >16803896</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Serotonin-, protein kinase C-, and Hic-5-associated redistribution of the platelet serotonin transporter.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >2006</bp:YEAR>
      <bp:ID >16803896</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Serotonin-, protein kinase C-, and Hic-5-associated redistribution of the platelet serotonin transporter.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >2006</bp:YEAR>
      <bp:AUTHORS >Carneiro AM</bp:AUTHORS>
      <bp:AUTHORS >Blakely RD</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="a98">
      <bp:ID >12600988</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Membrane-bound DD-carboxypeptidase and transpeptidase activities from Bacillus megaterium KM at pH 7. General properties, substrate specificity and inhibition by beta-lactam antibiotics.</bp:TITLE>
      <bp:SOURCE >Eur J Biochem</bp:SOURCE>
      <bp:YEAR >1976</bp:YEAR>
      <bp:ID >10161</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Membrane-bound DD-carboxypeptidase and transpeptidase activities from Bacillus megaterium KM at pH 7. General properties, substrate specificity and inhibition by beta-lactam antibiotics.</bp:TITLE>
      <bp:SOURCE >Eur J Biochem</bp:SOURCE>
      <bp:YEAR >1976</bp:YEAR>
      <bp:AUTHORS >Marquet A</bp:AUTHORS>
      <bp:AUTHORS >Nieto M</bp:AUTHORS>
      <bp:AUTHORS >Diaz-Mauri&#241;o T</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="cbd">
      <bp:ID >14668344</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Alpha-thrombin-mediated phosphatidylinositol 3-kinase activation through release of Gbetagamma dimers from Galphaq and Galphai2.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >2004</bp:YEAR>
      <bp:AUTHORS >Goel R</bp:AUTHORS>
      <bp:AUTHORS >Phillips-Mason PJ</bp:AUTHORS>
      <bp:AUTHORS >Gardner A</bp:AUTHORS>
      <bp:AUTHORS >Raben DM</bp:AUTHORS>
      <bp:AUTHORS >Baldassare JJ</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="a8c">
      <bp:ID >10918063</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Phorbol ester-induced expression of airway squamous cell differentiation marker, SPRR1B, is regulated by protein kinase Cdelta /Ras/MEKK1/MKK1-dependent/AP-1 signal transduction pathway.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >2000</bp:YEAR>
      <bp:ID >10918063</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Phorbol ester-induced expression of airway squamous cell differentiation marker, SPRR1B, is regulated by protein kinase Cdelta /Ras/MEKK1/MKK1-dependent/AP-1 signal transduction pathway.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >2000</bp:YEAR>
      <bp:AUTHORS >Vuong H</bp:AUTHORS>
      <bp:AUTHORS >Patterson T</bp:AUTHORS>
      <bp:AUTHORS >Shapiro P</bp:AUTHORS>
      <bp:AUTHORS >Kalvakolanu DV</bp:AUTHORS>
      <bp:AUTHORS >Wu R</bp:AUTHORS>
      <bp:AUTHORS >Ma WY</bp:AUTHORS>
      <bp:AUTHORS >Dong Z</bp:AUTHORS>
      <bp:AUTHORS >Kleeberger SR</bp:AUTHORS>
      <bp:AUTHORS >Reddy SP</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="cbf">
      <bp:ID >15963952</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Proteomic analysis of human norepinephrine transporter complexes reveals associations with protein phosphatase 2A anchoring subunit and 14-3-3 proteins.</bp:TITLE>
      <bp:SOURCE >Biochem Biophys Res Commun</bp:SOURCE>
      <bp:YEAR >2005</bp:YEAR>
      <bp:ID >15963952</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Proteomic analysis of human norepinephrine transporter complexes reveals associations with protein phosphatase 2A anchoring subunit and 14-3-3 proteins.</bp:TITLE>
      <bp:SOURCE >Biochem Biophys Res Commun</bp:SOURCE>
      <bp:YEAR >2005</bp:YEAR>
      <bp:AUTHORS >Sung U</bp:AUTHORS>
      <bp:AUTHORS >Jennings JL</bp:AUTHORS>
      <bp:AUTHORS >Link AJ</bp:AUTHORS>
      <bp:AUTHORS >Blakely RD</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="f98">
      <bp:ID >11035106</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Protein kinase C zeta plays a central role in activation of the p42/44 mitogen-activated protein kinase by endotoxin in alveolar macrophages.</bp:TITLE>
      <bp:SOURCE >J Immunol</bp:SOURCE>
      <bp:YEAR >2000</bp:YEAR>
      <bp:AUTHORS >Monick MM</bp:AUTHORS>
      <bp:AUTHORS >Carter AB</bp:AUTHORS>
      <bp:AUTHORS >Flaherty DM</bp:AUTHORS>
      <bp:AUTHORS >Peterson MW</bp:AUTHORS>
      <bp:AUTHORS >Hunninghake GW</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="fb3">
      <bp:ID >11959661</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Enhanced IPC by activation of pertussis toxin-sensitive and -insensitive G protein-coupled purinoceptors.</bp:TITLE>
      <bp:SOURCE >Am J Physiol Heart Circ Physiol</bp:SOURCE>
      <bp:YEAR >2002</bp:YEAR>
      <bp:AUTHORS >Ninomiya H</bp:AUTHORS>
      <bp:AUTHORS >Otani H</bp:AUTHORS>
      <bp:AUTHORS >Lu K</bp:AUTHORS>
      <bp:AUTHORS >Uchiyama T</bp:AUTHORS>
      <bp:AUTHORS >Kido M</bp:AUTHORS>
      <bp:AUTHORS >Imamura H</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="a55">
      <bp:ID >12805287</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >A mutation in the human norepinephrine transporter gene (SLC6A2) associated with orthostatic intolerance disrupts surface expression of mutant and wild-type transporters.</bp:TITLE>
      <bp:SOURCE >J Neurosci</bp:SOURCE>
      <bp:YEAR >2003</bp:YEAR>
      <bp:AUTHORS >Hahn MK</bp:AUTHORS>
      <bp:AUTHORS >Robertson D</bp:AUTHORS>
      <bp:AUTHORS >Blakely RD</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="d4f">
      <bp:ID >11856330</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Anti-(Raf-1) RNA aptamers that inhibit Ras-induced Raf-1 activation.</bp:TITLE>
      <bp:SOURCE >Eur J Biochem</bp:SOURCE>
      <bp:YEAR >2002</bp:YEAR>
      <bp:AUTHORS >Kimoto M</bp:AUTHORS>
      <bp:AUTHORS >Shirouzu M</bp:AUTHORS>
      <bp:AUTHORS >Mizutani S</bp:AUTHORS>
      <bp:AUTHORS >Koide H</bp:AUTHORS>
      <bp:AUTHORS >Kaziro Y</bp:AUTHORS>
      <bp:AUTHORS >Hirao I</bp:AUTHORS>
      <bp:AUTHORS >Yokoyama S</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="b92">
      <bp:ID >10747974</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Government freezes administrators' salaries.</bp:TITLE>
      <bp:SOURCE >Dimens Health Serv</bp:SOURCE>
      <bp:YEAR >1976</bp:YEAR>
      <bp:ID >1309</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Government freezes administrators' salaries.</bp:TITLE>
      <bp:SOURCE >Dimens Health Serv</bp:SOURCE>
      <bp:YEAR >1976</bp:YEAR>
      <bp:AUTHORS >Fagan A</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="edf">
      <bp:ID >11879201</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Mechanism of the regulation of type IB phosphoinositide 3OH-kinase byG-protein betagamma subunits.</bp:TITLE>
      <bp:SOURCE >Biochem J</bp:SOURCE>
      <bp:YEAR >2002</bp:YEAR>
      <bp:AUTHORS >Krugmann S</bp:AUTHORS>
      <bp:AUTHORS >Cooper MA</bp:AUTHORS>
      <bp:AUTHORS >Williams DH</bp:AUTHORS>
      <bp:AUTHORS >Hawkins PT</bp:AUTHORS>
      <bp:AUTHORS >Stephens LR</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="bbd">
      <bp:ID >9759836</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Impact of psychosocial factors on the conduct of combined drug and psychotherapy research.</bp:TITLE>
      <bp:SOURCE >Br J Psychiatry</bp:SOURCE>
      <bp:YEAR >1975</bp:YEAR>
      <bp:AUTHORS >Craxton A</bp:AUTHORS>
      <bp:AUTHORS >Shu G</bp:AUTHORS>
      <bp:AUTHORS >Graves JD</bp:AUTHORS>
      <bp:AUTHORS >Saklatvala J</bp:AUTHORS>
      <bp:AUTHORS >Krebs EG</bp:AUTHORS>
      <bp:AUTHORS >Clark EA</bp:AUTHORS>
      <bp:AUTHORS >Stone WN</bp:AUTHORS>
      <bp:AUTHORS >Green BL</bp:AUTHORS>
      <bp:AUTHORS >Gleser GC</bp:AUTHORS>
      <bp:AUTHORS >Whitman RM</bp:AUTHORS>
      <bp:AUTHORS >Foster BB</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c12">
      <bp:ID >11701463</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Differential production of interferon and lymphotoxin by human tonsil lymphocytes.</bp:TITLE>
      <bp:SOURCE >Cell Immunol</bp:SOURCE>
      <bp:YEAR >1975</bp:YEAR>
      <bp:AUTHORS >Tokunou T</bp:AUTHORS>
      <bp:AUTHORS >Ichiki T</bp:AUTHORS>
      <bp:AUTHORS >Takeda K</bp:AUTHORS>
      <bp:AUTHORS >Funakoshi Y</bp:AUTHORS>
      <bp:AUTHORS >Iino N</bp:AUTHORS>
      <bp:AUTHORS >Takeshita A</bp:AUTHORS>
      <bp:AUTHORS >Klimpel GR</bp:AUTHORS>
      <bp:AUTHORS >Day KD</bp:AUTHORS>
      <bp:AUTHORS >Lucas DO</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="cb6">
      <bp:ID >10438924</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >The B cell antigen receptor activates the Akt (protein kinase B)/glycogen synthase kinase-3 signaling pathway via phosphatidylinositol 3-kinase.</bp:TITLE>
      <bp:SOURCE >J Immunol</bp:SOURCE>
      <bp:YEAR >1999</bp:YEAR>
      <bp:AUTHORS >Gold MR</bp:AUTHORS>
      <bp:AUTHORS >Scheid MP</bp:AUTHORS>
      <bp:AUTHORS >Santos L</bp:AUTHORS>
      <bp:AUTHORS >Dang-Lawson M</bp:AUTHORS>
      <bp:AUTHORS >Roth RA</bp:AUTHORS>
      <bp:AUTHORS >Matsuuchi L</bp:AUTHORS>
      <bp:AUTHORS >Duronio V</bp:AUTHORS>
      <bp:AUTHORS >Krebs DL</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="a0e">
      <bp:ID >11406578</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >The B-box dominates SAP-1-SRF interactions in the structure of the ternary complex.</bp:TITLE>
      <bp:SOURCE >EMBO J</bp:SOURCE>
      <bp:YEAR >2001</bp:YEAR>
      <bp:ID >11406578</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >The B-box dominates SAP-1-SRF interactions in the structure of the ternary complex.</bp:TITLE>
      <bp:SOURCE >EMBO J</bp:SOURCE>
      <bp:YEAR >2001</bp:YEAR>
      <bp:AUTHORS >Hassler M</bp:AUTHORS>
      <bp:AUTHORS >Richmond TJ</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="cef">
      <bp:ID >10958792</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Atomic models for the polypeptide backbones of myohemerythrin and hemerythrin.</bp:TITLE>
      <bp:SOURCE >Biochem Biophys Res Commun</bp:SOURCE>
      <bp:YEAR >1975</bp:YEAR>
      <bp:AUTHORS >Persons DL</bp:AUTHORS>
      <bp:AUTHORS >Yazlovitskaya EM</bp:AUTHORS>
      <bp:AUTHORS >Pelling JC</bp:AUTHORS>
      <bp:AUTHORS >Hendrickson WA</bp:AUTHORS>
      <bp:AUTHORS >Ward KB</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="bd2">
      <bp:ID >9379049</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Activation of p38mapk, MKK3, and MKK4 by TNF-alpha in mouse bone marrow-derived macrophages.</bp:TITLE>
      <bp:SOURCE >J Immunol</bp:SOURCE>
      <bp:YEAR >1997</bp:YEAR>
      <bp:AUTHORS >Winston BW</bp:AUTHORS>
      <bp:AUTHORS >Chan ED</bp:AUTHORS>
      <bp:AUTHORS >Johnson GL</bp:AUTHORS>
      <bp:AUTHORS >Riches DW</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="a30">
      <bp:ID >9808624</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >JNKK1 organizes a MAP kinase module through specific and sequential interactions with upstream and downstream components mediated by its amino-terminal extension.</bp:TITLE>
      <bp:SOURCE >Genes Dev</bp:SOURCE>
      <bp:YEAR >1998</bp:YEAR>
      <bp:AUTHORS >Xia Y</bp:AUTHORS>
      <bp:AUTHORS >Wu Z</bp:AUTHORS>
      <bp:AUTHORS >Su B</bp:AUTHORS>
      <bp:AUTHORS >Murray B</bp:AUTHORS>
      <bp:AUTHORS >Karin M</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="a47">
      <bp:ID >11971024</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >SHIP negatively regulates IgE + antigen-induced IL-6 production in mast cells by inhibiting NF-kappa B activity.</bp:TITLE>
      <bp:SOURCE >J Immunol</bp:SOURCE>
      <bp:YEAR >2002</bp:YEAR>
      <bp:AUTHORS >Kalesnikoff J</bp:AUTHORS>
      <bp:AUTHORS >Baur N</bp:AUTHORS>
      <bp:AUTHORS >Leitges M</bp:AUTHORS>
      <bp:AUTHORS >Hughes MR</bp:AUTHORS>
      <bp:AUTHORS >Damen JE</bp:AUTHORS>
      <bp:AUTHORS >Huber M</bp:AUTHORS>
      <bp:AUTHORS >Krystal G</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="ec8">
      <bp:ID >12488455</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Na+ promotes the dissociation between Galpha GDP and Gbeta gamma, activating G protein-gated K+ channels.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >2003</bp:YEAR>
      <bp:AUTHORS >Rishal I</bp:AUTHORS>
      <bp:AUTHORS >Keren-Raifman T</bp:AUTHORS>
      <bp:AUTHORS >Yakubovich D</bp:AUTHORS>
      <bp:AUTHORS >Ivanina T</bp:AUTHORS>
      <bp:AUTHORS >Dessauer CW</bp:AUTHORS>
      <bp:AUTHORS >Slepak VZ</bp:AUTHORS>
      <bp:AUTHORS >Dascal N</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="d6b">
      <bp:ID >8939929</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Mammalian mitogen-activated protein kinase pathways are regulated through formation of specific kinase-activator complexes.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >1996</bp:YEAR>
      <bp:AUTHORS >Zanke BW</bp:AUTHORS>
      <bp:AUTHORS >Rubie EA</bp:AUTHORS>
      <bp:AUTHORS >Winnett E</bp:AUTHORS>
      <bp:AUTHORS >Chan J</bp:AUTHORS>
      <bp:AUTHORS >Randall S</bp:AUTHORS>
      <bp:AUTHORS >Parsons M</bp:AUTHORS>
      <bp:AUTHORS >Boudreau K</bp:AUTHORS>
      <bp:AUTHORS >McInnis M</bp:AUTHORS>
      <bp:AUTHORS >Yan M</bp:AUTHORS>
      <bp:AUTHORS >Templeton DJ</bp:AUTHORS>
      <bp:AUTHORS >Woodgett JR</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c69">
      <bp:ID >10716930</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Molecular determinants that mediate selective activation of p38 MAP kinase isoforms.</bp:TITLE>
      <bp:SOURCE >EMBO J</bp:SOURCE>
      <bp:YEAR >2000</bp:YEAR>
      <bp:ID >10716930</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Molecular determinants that mediate selective activation of p38 MAP kinase isoforms.</bp:TITLE>
      <bp:SOURCE >EMBO J</bp:SOURCE>
      <bp:YEAR >2000</bp:YEAR>
      <bp:AUTHORS >Enslen H</bp:AUTHORS>
      <bp:AUTHORS >Brancho DM</bp:AUTHORS>
      <bp:AUTHORS >Davis RJ</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="d92">
      <bp:ID >12446733</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >The requirement of specific membrane domains for Raf-1 phosphorylation and activation.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >2003</bp:YEAR>
      <bp:AUTHORS >Carey KD</bp:AUTHORS>
      <bp:AUTHORS >Watson RT</bp:AUTHORS>
      <bp:AUTHORS >Pessin JE</bp:AUTHORS>
      <bp:AUTHORS >Stork PJ</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e47">
      <bp:ID >10477597</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Report of the first hemispheric meeting on meningococcal disease.</bp:TITLE>
      <bp:SOURCE >Bull Pan Am Health Organ</bp:SOURCE>
      <bp:YEAR >1976</bp:YEAR>
      <bp:ID >10028</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Report of the first hemispheric meeting on meningococcal disease.</bp:TITLE>
      <bp:SOURCE >Bull Pan Am Health Organ</bp:SOURCE>
      <bp:YEAR >1976</bp:YEAR>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="a51">
      <bp:ID >10744767</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Dual role of pseudosubstrate in the coordinated regulation of protein kinase C by phosphorylation and diacylglycerol.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >2000</bp:YEAR>
      <bp:AUTHORS >Dutil EM</bp:AUTHORS>
      <bp:AUTHORS >Newton AC</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="d39">
      <bp:ID >12896977</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >The role of the tail in temperature regulation of the cotton rat, Sigmodon hispidus.</bp:TITLE>
      <bp:SOURCE >Comp Biochem Physiol A Comp Physiol</bp:SOURCE>
      <bp:YEAR >1975</bp:YEAR>
      <bp:AUTHORS >Smith JL</bp:AUTHORS>
      <bp:AUTHORS >Collins I</bp:AUTHORS>
      <bp:AUTHORS >Chandramouli GV</bp:AUTHORS>
      <bp:AUTHORS >Butscher WG</bp:AUTHORS>
      <bp:AUTHORS >Zaitseva E</bp:AUTHORS>
      <bp:AUTHORS >Freebern WJ</bp:AUTHORS>
      <bp:AUTHORS >Haggerty CM</bp:AUTHORS>
      <bp:AUTHORS >Doseeva V</bp:AUTHORS>
      <bp:AUTHORS >Gardner K</bp:AUTHORS>
      <bp:AUTHORS >Kirksey ER</bp:AUTHORS>
      <bp:AUTHORS >Pagels JF</bp:AUTHORS>
      <bp:AUTHORS >Blem CR</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="b29">
      <bp:ID >12738761</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Transactivation of the epidermal growth factor receptor mediates parathyroid hormone and prostaglandin F2 alpha-stimulated mitogen-activated protein kinase activation in cultured transgenic murine osteoblasts.</bp:TITLE>
      <bp:SOURCE >Mol Endocrinol</bp:SOURCE>
      <bp:YEAR >2003</bp:YEAR>
      <bp:ID >12738761</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Transactivation of the epidermal growth factor receptor mediates parathyroid hormone and prostaglandin F2 alpha-stimulated mitogen-activated protein kinase activation in cultured transgenic murine osteoblasts.</bp:TITLE>
      <bp:SOURCE >Mol Endocrinol</bp:SOURCE>
      <bp:YEAR >2003</bp:YEAR>
      <bp:ID >12738761</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Transactivation of the epidermal growth factor receptor mediates parathyroid hormone and prostaglandin F2 alpha-stimulated mitogen-activated protein kinase activation in cultured transgenic murine osteoblasts.</bp:TITLE>
      <bp:SOURCE >Mol Endocrinol</bp:SOURCE>
      <bp:YEAR >2003</bp:YEAR>
      <bp:AUTHORS >Ahmed I</bp:AUTHORS>
      <bp:AUTHORS >Gesty-Palmer D</bp:AUTHORS>
      <bp:AUTHORS >Drezner MK</bp:AUTHORS>
      <bp:AUTHORS >Luttrell LM</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="fee">
      <bp:ID >12621039</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Critical regions for activation gating of the inositol 1,4,5-trisphosphate receptor.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >2003</bp:YEAR>
      <bp:AUTHORS >Uchida K</bp:AUTHORS>
      <bp:AUTHORS >Miyauchi H</bp:AUTHORS>
      <bp:AUTHORS >Furuichi T</bp:AUTHORS>
      <bp:AUTHORS >Michikawa T</bp:AUTHORS>
      <bp:AUTHORS >Mikoshiba K</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="f4a">
      <bp:ID >9094716</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >cAMP activates MAP kinase and Elk-1 through a B-Raf- and Rap1-dependent pathway.</bp:TITLE>
      <bp:SOURCE >Cell</bp:SOURCE>
      <bp:YEAR >1997</bp:YEAR>
      <bp:AUTHORS >Vossler MR</bp:AUTHORS>
      <bp:AUTHORS >Yao H</bp:AUTHORS>
      <bp:AUTHORS >York RD</bp:AUTHORS>
      <bp:AUTHORS >Pan MG</bp:AUTHORS>
      <bp:AUTHORS >Rim CS</bp:AUTHORS>
      <bp:AUTHORS >Stork PJ</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="b37">
      <bp:ID >11278709</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Kinetic and spectral studies of type I and type II compounds with rat hepatic microsomes in the presence of the major metabolite of diphenylhydantoin.</bp:TITLE>
      <bp:SOURCE >Drug Metab Dispos</bp:SOURCE>
      <bp:YEAR >1975</bp:YEAR>
      <bp:AUTHORS >Sung JY</bp:AUTHORS>
      <bp:AUTHORS >Shin SW</bp:AUTHORS>
      <bp:AUTHORS >Ahn YS</bp:AUTHORS>
      <bp:AUTHORS >Chung KC</bp:AUTHORS>
      <bp:AUTHORS >Stavchansky SA</bp:AUTHORS>
      <bp:AUTHORS >Kostenbauder HB</bp:AUTHORS>
      <bp:AUTHORS >Lubawy WC</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="f1a">
      <bp:ID >10642513</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Gi-mediated translocation of GLUT4 is independent of p85/p110alpha and p110gamma phosphoinositide 3-kinases but might involve the activation of Akt kinase.</bp:TITLE>
      <bp:SOURCE >Biochem J</bp:SOURCE>
      <bp:YEAR >2000</bp:YEAR>
      <bp:AUTHORS >Wang L</bp:AUTHORS>
      <bp:AUTHORS >Hayashi H</bp:AUTHORS>
      <bp:AUTHORS >Kishi K</bp:AUTHORS>
      <bp:AUTHORS >Huang L</bp:AUTHORS>
      <bp:AUTHORS >Hagi A</bp:AUTHORS>
      <bp:AUTHORS >Tamaoka K</bp:AUTHORS>
      <bp:AUTHORS >Hawkins PT</bp:AUTHORS>
      <bp:AUTHORS >Ebina Y</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="b24">
      <bp:ID >10951185</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Inhibition of human liver beta-galactosidases and beta-glucosidase by n-bromoacetyl-beta-D-galactosylamine.</bp:TITLE>
      <bp:SOURCE >Biochim Biophys Acta</bp:SOURCE>
      <bp:YEAR >1975</bp:YEAR>
      <bp:ID >1095</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Inhibition of human liver beta-galactosidases and beta-glucosidase by n-bromoacetyl-beta-D-galactosylamine.</bp:TITLE>
      <bp:SOURCE >Biochim Biophys Acta</bp:SOURCE>
      <bp:YEAR >1975</bp:YEAR>
      <bp:AUTHORS >Meisler MH</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="ca9">
      <bp:ID >12196911</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Monoamine transporter gene structure and polymorphisms in relation to psychiatric and other complex disorders.</bp:TITLE>
      <bp:SOURCE >Pharmacogenomics J</bp:SOURCE>
      <bp:YEAR >2002</bp:YEAR>
      <bp:AUTHORS >Hahn MK</bp:AUTHORS>
      <bp:AUTHORS >Blakely RD</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="dee">
      <bp:ID >11574474</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >A Drosophila MAPKKK, D-MEKK1, mediates stress responses through activation of p38 MAPK.</bp:TITLE>
      <bp:SOURCE >EMBO J</bp:SOURCE>
      <bp:YEAR >2001</bp:YEAR>
      <bp:ID >11574474</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >A Drosophila MAPKKK, D-MEKK1, mediates stress responses through activation of p38 MAPK.</bp:TITLE>
      <bp:SOURCE >EMBO J</bp:SOURCE>
      <bp:YEAR >2001</bp:YEAR>
      <bp:ID >11574474</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >A Drosophila MAPKKK, D-MEKK1, mediates stress responses through activation of p38 MAPK.</bp:TITLE>
      <bp:SOURCE >EMBO J</bp:SOURCE>
      <bp:YEAR >2001</bp:YEAR>
      <bp:AUTHORS >Inoue H</bp:AUTHORS>
      <bp:AUTHORS >Tateno M</bp:AUTHORS>
      <bp:AUTHORS >Fujimura-Kamada K</bp:AUTHORS>
      <bp:AUTHORS >Takaesu G</bp:AUTHORS>
      <bp:AUTHORS >Adachi-Yamada T</bp:AUTHORS>
      <bp:AUTHORS >Ninomiya-Tsuji J</bp:AUTHORS>
      <bp:AUTHORS >Irie K</bp:AUTHORS>
      <bp:AUTHORS >Nishida Y</bp:AUTHORS>
      <bp:AUTHORS >Matsumoto K</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e07">
      <bp:ID >8887554</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Effect of chloroquine on cultured fibroblasts: release of lysosomal hydrolases and inhibition of their uptake.</bp:TITLE>
      <bp:SOURCE >Biochem Biophys Res Commun</bp:SOURCE>
      <bp:YEAR >1975</bp:YEAR>
      <bp:AUTHORS >Tan Y</bp:AUTHORS>
      <bp:AUTHORS >Rouse J</bp:AUTHORS>
      <bp:AUTHORS >Zhang A</bp:AUTHORS>
      <bp:AUTHORS >Cariati S</bp:AUTHORS>
      <bp:AUTHORS >Cohen P</bp:AUTHORS>
      <bp:AUTHORS >Comb MJ</bp:AUTHORS>
      <bp:AUTHORS >Wiesmann UN</bp:AUTHORS>
      <bp:AUTHORS >DiDonato S</bp:AUTHORS>
      <bp:AUTHORS >Herschkowitz NN</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="b90">
      <bp:ID >11315998</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Increased expression of protein kinase Calpha, interleukin-1alpha, and RhoA guanosine 5'-triphosphatase in osteoblasts expressing the Ser252Trp fibroblast growth factor 2 receptor Apert mutation: identification by analysis of complementary DNA microarray.</bp:TITLE>
      <bp:SOURCE >J Bone Miner Res</bp:SOURCE>
      <bp:YEAR >2001</bp:YEAR>
      <bp:AUTHORS >Lomri A</bp:AUTHORS>
      <bp:AUTHORS >Lemonnier J</bp:AUTHORS>
      <bp:AUTHORS >Delannoy P</bp:AUTHORS>
      <bp:AUTHORS >Marie PJ</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="bb9">
      <bp:ID >14570902</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Phospholipase activity of phospholipase C-gamma1 is required for nerve growth factor-regulated MAP kinase signaling cascade in PC12 cells.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >2003</bp:YEAR>
      <bp:AUTHORS >Rong R</bp:AUTHORS>
      <bp:AUTHORS >Ahn JY</bp:AUTHORS>
      <bp:AUTHORS >Chen P</bp:AUTHORS>
      <bp:AUTHORS >Suh PG</bp:AUTHORS>
      <bp:AUTHORS >Ye K</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="d6d">
      <bp:ID >11408617</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Activation of residual acidic alpha-mannosidase activity in mannosidosis tissues by metal ions.</bp:TITLE>
      <bp:SOURCE >Biochem Biophys Res Commun</bp:SOURCE>
      <bp:YEAR >1975</bp:YEAR>
      <bp:ID >1037</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Activation of residual acidic alpha-mannosidase activity in mannosidosis tissues by metal ions.</bp:TITLE>
      <bp:SOURCE >Biochem Biophys Res Commun</bp:SOURCE>
      <bp:YEAR >1975</bp:YEAR>
      <bp:AUTHORS >Hultberg B</bp:AUTHORS>
      <bp:AUTHORS >Masson PK</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="a35">
      <bp:ID >16452680</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Chronic stress increases the plasmalemmal distribution of the norepinephrine transporter and the coexpression of tyrosine hydroxylase in norepinephrine axons in the prefrontal cortex.</bp:TITLE>
      <bp:SOURCE >J Neurosci</bp:SOURCE>
      <bp:YEAR >2006</bp:YEAR>
      <bp:AUTHORS >Miner LH</bp:AUTHORS>
      <bp:AUTHORS >Jedema HP</bp:AUTHORS>
      <bp:AUTHORS >Moore FW</bp:AUTHORS>
      <bp:AUTHORS >Blakely RD</bp:AUTHORS>
      <bp:AUTHORS >Grace AA</bp:AUTHORS>
      <bp:AUTHORS >Sesack SR</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="ded">
      <bp:ID >9207092</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >The effect of sulphydryl compounds and cross linking agents on the viscous and viscoelastic properties of mucus.</bp:TITLE>
      <bp:SOURCE >Biorheology</bp:SOURCE>
      <bp:YEAR >1975</bp:YEAR>
      <bp:ID >1125</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >The effect of sulphydryl compounds and cross linking agents on the viscous and viscoelastic properties of mucus.</bp:TITLE>
      <bp:SOURCE >Biorheology</bp:SOURCE>
      <bp:YEAR >1975</bp:YEAR>
      <bp:AUTHORS >Tournier C</bp:AUTHORS>
      <bp:AUTHORS >Whitmarsh AJ</bp:AUTHORS>
      <bp:AUTHORS >Cavanagh J</bp:AUTHORS>
      <bp:AUTHORS >Barrett T</bp:AUTHORS>
      <bp:AUTHORS >Davis RJ</bp:AUTHORS>
      <bp:AUTHORS >Davis SS</bp:AUTHORS>
      <bp:AUTHORS >Scobie S</bp:AUTHORS>
      <bp:AUTHORS >Inglis A</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e18">
      <bp:ID >10444401</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Correlation of 14C-griseofulvin metabolism in rat liver microsomes, isolated perfused rat livers, and in rats with bile duct cannulas.</bp:TITLE>
      <bp:SOURCE >Drug Metab Dispos</bp:SOURCE>
      <bp:YEAR >1975</bp:YEAR>
      <bp:ID >1223</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Correlation of 14C-griseofulvin metabolism in rat liver microsomes, isolated perfused rat livers, and in rats with bile duct cannulas.</bp:TITLE>
      <bp:SOURCE >Drug Metab Dispos</bp:SOURCE>
      <bp:YEAR >1975</bp:YEAR>
      <bp:AUTHORS >Chang RL</bp:AUTHORS>
      <bp:AUTHORS >Zampaglione N</bp:AUTHORS>
      <bp:AUTHORS >Lin C</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="f47">
      <bp:ID >17188889</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Calcium-dependent interactions of the human norepinephrine transporter with syntaxin 1A.</bp:TITLE>
      <bp:SOURCE >Mol Cell Neurosci</bp:SOURCE>
      <bp:YEAR >2007</bp:YEAR>
      <bp:AUTHORS >Sung U</bp:AUTHORS>
      <bp:AUTHORS >Blakely RD</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="a90">
      <bp:ID >11416000</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Bufuralol, a new beta-adrenoceptor blocking agent.</bp:TITLE>
      <bp:SOURCE >Experientia</bp:SOURCE>
      <bp:YEAR >1975</bp:YEAR>
      <bp:ID >1287</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Bufuralol, a new beta-adrenoceptor blocking agent.</bp:TITLE>
      <bp:SOURCE >Experientia</bp:SOURCE>
      <bp:YEAR >1975</bp:YEAR>
      <bp:AUTHORS >Fothergill GA</bp:AUTHORS>
      <bp:AUTHORS >Francis RJ</bp:AUTHORS>
      <bp:AUTHORS >Hamilton TC</bp:AUTHORS>
      <bp:AUTHORS >Osbond JM</bp:AUTHORS>
      <bp:AUTHORS >Parkes MW</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="d9d">
      <bp:ID >10636870</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Why urinalysis?</bp:TITLE>
      <bp:SOURCE >Cent Afr J Med</bp:SOURCE>
      <bp:YEAR >1975</bp:YEAR>
      <bp:ID >1150</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Why urinalysis?</bp:TITLE>
      <bp:SOURCE >Cent Afr J Med</bp:SOURCE>
      <bp:YEAR >1975</bp:YEAR>
      <bp:AUTHORS >Harkness J</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="b2e">
      <bp:ID >12032150</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >On the isolation of a prolactin inhibiting factor (hormone).</bp:TITLE>
      <bp:SOURCE >Biochem Biophys Res Commun</bp:SOURCE>
      <bp:YEAR >1975</bp:YEAR>
      <bp:ID >1015</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >On the isolation of a prolactin inhibiting factor (hormone).</bp:TITLE>
      <bp:SOURCE >Biochem Biophys Res Commun</bp:SOURCE>
      <bp:YEAR >1975</bp:YEAR>
      <bp:AUTHORS >Greibrokk T</bp:AUTHORS>
      <bp:AUTHORS >Hansen J</bp:AUTHORS>
      <bp:AUTHORS >Knudsen R</bp:AUTHORS>
      <bp:AUTHORS >Lam YK</bp:AUTHORS>
      <bp:AUTHORS >Folkers K</bp:AUTHORS>
      <bp:AUTHORS >Bowers CY</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="a59">
      <bp:ID >7592979</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Trypsin-catalyzed activation of aspartase.</bp:TITLE>
      <bp:SOURCE >Biochem Biophys Res Commun</bp:SOURCE>
      <bp:YEAR >1975</bp:YEAR>
      <bp:AUTHORS >Engel K</bp:AUTHORS>
      <bp:AUTHORS >Schultz H</bp:AUTHORS>
      <bp:AUTHORS >Martin F</bp:AUTHORS>
      <bp:AUTHORS >Kotlyarov A</bp:AUTHORS>
      <bp:AUTHORS >Plath K</bp:AUTHORS>
      <bp:AUTHORS >Hahn M</bp:AUTHORS>
      <bp:AUTHORS >Heinemann U</bp:AUTHORS>
      <bp:AUTHORS >Gaestel M</bp:AUTHORS>
      <bp:AUTHORS >Mizuta K</bp:AUTHORS>
      <bp:AUTHORS >Tokushige M</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="a6d">
      <bp:ID >8621725</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Signal transduction pathways regulated by mitogen-activated/extracellular response kinase kinase kinase induce cell death.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >1996</bp:YEAR>
      <bp:AUTHORS >Johnson NL</bp:AUTHORS>
      <bp:AUTHORS >Gardner AM</bp:AUTHORS>
      <bp:AUTHORS >Diener KM</bp:AUTHORS>
      <bp:AUTHORS >Lange-Carter CA</bp:AUTHORS>
      <bp:AUTHORS >Gleavy J</bp:AUTHORS>
      <bp:AUTHORS >Jarpe MB</bp:AUTHORS>
      <bp:AUTHORS >Minden A</bp:AUTHORS>
      <bp:AUTHORS >Karin M</bp:AUTHORS>
      <bp:AUTHORS >Zon LI</bp:AUTHORS>
      <bp:AUTHORS >Johnson GL</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c59">
      <bp:ID >11238126</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >[Kinetics and mechanism of action of horseradish peroxidase in the reaction of dioxyfumaric acid oxidation with atmospheric oxygen]</bp:TITLE>
      <bp:SOURCE >Biokhimiia</bp:SOURCE>
      <bp:YEAR >1975</bp:YEAR>
      <bp:ID >11238126</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Cell-cycle-dependent activation of mitogen-activated protein kinase kinase (MEK-1/2) in myeloid leukemia cell lines and induction of growth inhibition and apoptosis by inhibitors of RAS signaling.</bp:TITLE>
      <bp:SOURCE >Blood</bp:SOURCE>
      <bp:YEAR >2001</bp:YEAR>
      <bp:AUTHORS >Morgan MA</bp:AUTHORS>
      <bp:AUTHORS >Dolp O</bp:AUTHORS>
      <bp:AUTHORS >Reuter CW</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="bad">
      <bp:ID >8617731</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Post-translational modification of H-Ras is required for activation of, but not for association with, B-Raf.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >1996</bp:YEAR>
      <bp:AUTHORS >Okada T</bp:AUTHORS>
      <bp:AUTHORS >Masuda T</bp:AUTHORS>
      <bp:AUTHORS >Shinkai M</bp:AUTHORS>
      <bp:AUTHORS >Kariya K</bp:AUTHORS>
      <bp:AUTHORS >Kataoka T</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="ac9">
      <bp:ID >12746452</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >cFLIP-L inhibits p38 MAPK activation: an additional anti-apoptotic mechanism in bile acid-mediated apoptosis.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >2003</bp:YEAR>
      <bp:ID >12746452</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >cFLIP-L inhibits p38 MAPK activation: an additional anti-apoptotic mechanism in bile acid-mediated apoptosis.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >2003</bp:YEAR>
      <bp:ID >12746452</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >cFLIP-L inhibits p38 MAPK activation: an additional anti-apoptotic mechanism in bile acid-mediated apoptosis.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >2003</bp:YEAR>
      <bp:AUTHORS >Grambihler A</bp:AUTHORS>
      <bp:AUTHORS >Higuchi H</bp:AUTHORS>
      <bp:AUTHORS >Bronk SF</bp:AUTHORS>
      <bp:AUTHORS >Gores GJ</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e62">
      <bp:ID >9675184</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Isoform-specific function of single inositol 1,4,5-trisphosphate receptor channels.</bp:TITLE>
      <bp:SOURCE >Biophys J</bp:SOURCE>
      <bp:YEAR >1998</bp:YEAR>
      <bp:AUTHORS >Ramos-Franco J</bp:AUTHORS>
      <bp:AUTHORS >Fill M</bp:AUTHORS>
      <bp:AUTHORS >Mignery GA</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="bb3">
      <bp:ID >11352924</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Interaction of gamma 1-syntrophin with diacylglycerol kinase-zeta. Regulation of nuclear localization by PDZ interactions.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >2001</bp:YEAR>
      <bp:AUTHORS >Hogan A</bp:AUTHORS>
      <bp:AUTHORS >Shepherd L</bp:AUTHORS>
      <bp:AUTHORS >Chabot J</bp:AUTHORS>
      <bp:AUTHORS >Quenneville S</bp:AUTHORS>
      <bp:AUTHORS >Prescott SM</bp:AUTHORS>
      <bp:AUTHORS >Topham MK</bp:AUTHORS>
      <bp:AUTHORS >Gee SH</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="eca">
      <bp:ID >10593906</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Both p38alpha(MAPK) and JNK/SAPK pathways are important for induction of nitric-oxide synthase by interleukin-1beta in rat glomerular mesangial cells.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >1999</bp:YEAR>
      <bp:AUTHORS >Guan Z</bp:AUTHORS>
      <bp:AUTHORS >Buckman SY</bp:AUTHORS>
      <bp:AUTHORS >Springer LD</bp:AUTHORS>
      <bp:AUTHORS >Morrison AR</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e9b">
      <bp:ID >17941718</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Hypoinsulinemia regulates amphetamine-induced reverse transport of dopamine.</bp:TITLE>
      <bp:SOURCE >PLoS Biol</bp:SOURCE>
      <bp:YEAR >2007</bp:YEAR>
      <bp:AUTHORS >Williams JM</bp:AUTHORS>
      <bp:AUTHORS >Owens WA</bp:AUTHORS>
      <bp:AUTHORS >Turner GH</bp:AUTHORS>
      <bp:AUTHORS >Saunders C</bp:AUTHORS>
      <bp:AUTHORS >Dipace C</bp:AUTHORS>
      <bp:AUTHORS >Blakely RD</bp:AUTHORS>
      <bp:AUTHORS >France CP</bp:AUTHORS>
      <bp:AUTHORS >Gore JC</bp:AUTHORS>
      <bp:AUTHORS >Daws LC</bp:AUTHORS>
      <bp:AUTHORS >Avison MJ</bp:AUTHORS>
      <bp:AUTHORS >Galli A</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="bae">
      <bp:ID >9065414</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >C-terminal mutation of G protein beta subunit affects differentially extracellular signal-regulated kinase and c-Jun N-terminal kinase pathways in human embryonal kidney 293 cells.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >1997</bp:YEAR>
      <bp:ID >9065414</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >C-terminal mutation of G protein beta subunit affects differentially extracellular signal-regulated kinase and c-Jun N-terminal kinase pathways in human embryonal kidney 293 cells.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >1997</bp:YEAR>
      <bp:AUTHORS >Yamauchi J</bp:AUTHORS>
      <bp:AUTHORS >Kaziro Y</bp:AUTHORS>
      <bp:AUTHORS >Itoh H</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c14">
      <bp:ID >15153095</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Oxidative neuronal injury. The dark side of ERK1/2.</bp:TITLE>
      <bp:SOURCE >Eur J Biochem</bp:SOURCE>
      <bp:YEAR >2004</bp:YEAR>
      <bp:AUTHORS >Chu CT</bp:AUTHORS>
      <bp:AUTHORS >Levinthal DJ</bp:AUTHORS>
      <bp:AUTHORS >Kulich SM</bp:AUTHORS>
      <bp:AUTHORS >Chalovich EM</bp:AUTHORS>
      <bp:AUTHORS >DeFranco DB</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="a62">
      <bp:ID >14676298</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Requirement for Ras guanine nucleotide releasing protein 3 in coupling phospholipase C-gamma2 to Ras in B cell receptor signaling.</bp:TITLE>
      <bp:SOURCE >J Exp Med</bp:SOURCE>
      <bp:YEAR >2003</bp:YEAR>
      <bp:AUTHORS >Oh-hora M</bp:AUTHORS>
      <bp:AUTHORS >Johmura S</bp:AUTHORS>
      <bp:AUTHORS >Hashimoto A</bp:AUTHORS>
      <bp:AUTHORS >Hikida M</bp:AUTHORS>
      <bp:AUTHORS >Kurosaki T</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="b53">
      <bp:ID >12970364</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Agonist-specific transactivation of phosphoinositide 3-kinase signaling pathway mediated by the dopamine D2 receptor.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >2003</bp:YEAR>
      <bp:AUTHORS >Nair VD</bp:AUTHORS>
      <bp:AUTHORS >Sealfon SC</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="ebc">
      <bp:ID >9139689</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >LYSYL oxidase dependent synthesis of a collagen cross-link containing histidine.</bp:TITLE>
      <bp:SOURCE >Biochem Biophys Res Commun</bp:SOURCE>
      <bp:YEAR >1975</bp:YEAR>
      <bp:ID >1033</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >LYSYL oxidase dependent synthesis of a collagen cross-link containing histidine.</bp:TITLE>
      <bp:SOURCE >Biochem Biophys Res Commun</bp:SOURCE>
      <bp:YEAR >1975</bp:YEAR>
      <bp:AUTHORS >Siegel RC</bp:AUTHORS>
      <bp:AUTHORS >Lian JB</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="f91">
      <bp:ID >12496361</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Isolation and purification of cytokinin binding protein from tobacco leaves by affinity column chromatography.</bp:TITLE>
      <bp:SOURCE >Biochem Biophys Res Commun</bp:SOURCE>
      <bp:YEAR >1975</bp:YEAR>
      <bp:AUTHORS >Enarsson M</bp:AUTHORS>
      <bp:AUTHORS >Erlandsson A</bp:AUTHORS>
      <bp:AUTHORS >Larsson H</bp:AUTHORS>
      <bp:AUTHORS >Forsberg-Nilsson K</bp:AUTHORS>
      <bp:AUTHORS >Takegami T</bp:AUTHORS>
      <bp:AUTHORS >Yoshida K</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="da9">
      <bp:ID >12169624</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >High resolution crystal structure of the human PDK1 catalytic domain defines the regulatory phosphopeptide docking site.</bp:TITLE>
      <bp:SOURCE >EMBO J</bp:SOURCE>
      <bp:YEAR >2002</bp:YEAR>
      <bp:AUTHORS >Biondi RM</bp:AUTHORS>
      <bp:AUTHORS >Komander D</bp:AUTHORS>
      <bp:AUTHORS >Thomas CC</bp:AUTHORS>
      <bp:AUTHORS >Lizcano JM</bp:AUTHORS>
      <bp:AUTHORS >Deak M</bp:AUTHORS>
      <bp:AUTHORS >Alessi DR</bp:AUTHORS>
      <bp:AUTHORS >van Aalten DM</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="be5">
      <bp:ID >10488088</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Change in the kinetics of sulphacetamide tissue distribution in Walker tumor-bearing rats.</bp:TITLE>
      <bp:SOURCE >Drug Metab Dispos</bp:SOURCE>
      <bp:YEAR >1975</bp:YEAR>
      <bp:AUTHORS >Pugazhenthi S</bp:AUTHORS>
      <bp:AUTHORS >Miller E</bp:AUTHORS>
      <bp:AUTHORS >Sable C</bp:AUTHORS>
      <bp:AUTHORS >Young P</bp:AUTHORS>
      <bp:AUTHORS >Heidenreich KA</bp:AUTHORS>
      <bp:AUTHORS >Boxer LM</bp:AUTHORS>
      <bp:AUTHORS >Reusch JE</bp:AUTHORS>
      <bp:AUTHORS >Nadeau D</bp:AUTHORS>
      <bp:AUTHORS >Marchand C</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="f54">
      <bp:ID >14499342</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Maturation of the adrenal medulla--IV. Effects of morphine.</bp:TITLE>
      <bp:SOURCE >Biochem Pharmacol</bp:SOURCE>
      <bp:YEAR >1975</bp:YEAR>
      <bp:AUTHORS >Coxon PY</bp:AUTHORS>
      <bp:AUTHORS >Rane MJ</bp:AUTHORS>
      <bp:AUTHORS >Uriarte S</bp:AUTHORS>
      <bp:AUTHORS >Powell DW</bp:AUTHORS>
      <bp:AUTHORS >Singh S</bp:AUTHORS>
      <bp:AUTHORS >Butt W</bp:AUTHORS>
      <bp:AUTHORS >Chen Q</bp:AUTHORS>
      <bp:AUTHORS >McLeish KR</bp:AUTHORS>
      <bp:AUTHORS >Anderson TR</bp:AUTHORS>
      <bp:AUTHORS >Slotkin TA</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e57">
      <bp:ID >7836388</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >The interaction between protein kinase C and lipid cofactors studied by simultaneous observation of lipid and protein fluorescence.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >1995</bp:YEAR>
      <bp:ID >7836388</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >The interaction between protein kinase C and lipid cofactors studied by simultaneous observation of lipid and protein fluorescence.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >1995</bp:YEAR>
      <bp:AUTHORS >Pap EH</bp:AUTHORS>
      <bp:AUTHORS >van den Berg PA</bp:AUTHORS>
      <bp:AUTHORS >Borst JW</bp:AUTHORS>
      <bp:AUTHORS >Visser AJ</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="a88">
      <bp:ID >10942386</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >The cJun N-terminal kinase (JNK) signaling pathway mediates induction of urokinase-type plasminogen activator (uPA) by the alkylating agent MNNG.</bp:TITLE>
      <bp:SOURCE >Blood</bp:SOURCE>
      <bp:YEAR >2000</bp:YEAR>
      <bp:ID >10942386</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >The cJun N-terminal kinase (JNK) signaling pathway mediates induction of urokinase-type plasminogen activator (uPA) by the alkylating agent MNNG.</bp:TITLE>
      <bp:SOURCE >Blood</bp:SOURCE>
      <bp:YEAR >2000</bp:YEAR>
      <bp:AUTHORS >Parra M</bp:AUTHORS>
      <bp:AUTHORS >Llu&#237;s F</bp:AUTHORS>
      <bp:AUTHORS >Miralles F</bp:AUTHORS>
      <bp:AUTHORS >Caelles C</bp:AUTHORS>
      <bp:AUTHORS >Mu&#241;oz-C&#225;noves P</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="a32">
      <bp:ID >7622446</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >The regulation of AP-1 activity by mitogen-activated protein kinases.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >1995</bp:YEAR>
      <bp:AUTHORS >Karin M</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="ff3">
      <bp:ID >10825383</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Reconstitution of the human 5-HT(1D) receptor-G-protein coupling: evidence for constitutive activity and multiple receptor conformations.</bp:TITLE>
      <bp:SOURCE >Mol Pharmacol</bp:SOURCE>
      <bp:YEAR >2000</bp:YEAR>
      <bp:AUTHORS >Brys R</bp:AUTHORS>
      <bp:AUTHORS >Josson K</bp:AUTHORS>
      <bp:AUTHORS >Castelli MP</bp:AUTHORS>
      <bp:AUTHORS >Jurzak M</bp:AUTHORS>
      <bp:AUTHORS >Lijnen P</bp:AUTHORS>
      <bp:AUTHORS >Gommeren W</bp:AUTHORS>
      <bp:AUTHORS >Leysen JE</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="b38">
      <bp:ID >12181435</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Antibody capture assay reveals bell-shaped concentration-response isotherms for h5-HT(1A) receptor-mediated Galpha(i3) activation: conformational selection by high-efficacy agonists, and relationship to trafficking of receptor signaling.</bp:TITLE>
      <bp:SOURCE >Mol Pharmacol</bp:SOURCE>
      <bp:YEAR >2002</bp:YEAR>
      <bp:AUTHORS >Newman-Tancredi A</bp:AUTHORS>
      <bp:AUTHORS >Cussac D</bp:AUTHORS>
      <bp:AUTHORS >Marini L</bp:AUTHORS>
      <bp:AUTHORS >Millan MJ</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="a49">
      <bp:ID >10625698</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Study of the heat treatment of hemoglobin by means of spin labels.</bp:TITLE>
      <bp:SOURCE >Biochem Biophys Res Commun</bp:SOURCE>
      <bp:YEAR >1975</bp:YEAR>
      <bp:AUTHORS >Ryder JW</bp:AUTHORS>
      <bp:AUTHORS >Fahlman R</bp:AUTHORS>
      <bp:AUTHORS >Wallberg-Henriksson H</bp:AUTHORS>
      <bp:AUTHORS >Alessi DR</bp:AUTHORS>
      <bp:AUTHORS >Krook A</bp:AUTHORS>
      <bp:AUTHORS >Zierath JR</bp:AUTHORS>
      <bp:AUTHORS >Bemski G</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="cdc">
      <bp:ID >14702343</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Rap1-mediated lymphocyte function-associated antigen-1 activation by the T cell antigen receptor is dependent on phospholipase C-gamma1.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >2004</bp:YEAR>
      <bp:AUTHORS >Katagiri K</bp:AUTHORS>
      <bp:AUTHORS >Shimonaka M</bp:AUTHORS>
      <bp:AUTHORS >Kinashi T</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="f25">
      <bp:ID >9725212</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Protein kinase C regulates Fas (CD95/APO-1) expression.</bp:TITLE>
      <bp:SOURCE >J Immunol</bp:SOURCE>
      <bp:YEAR >1998</bp:YEAR>
      <bp:ID >9725212</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Protein kinase C regulates Fas (CD95/APO-1) expression.</bp:TITLE>
      <bp:SOURCE >J Immunol</bp:SOURCE>
      <bp:YEAR >1998</bp:YEAR>
      <bp:AUTHORS >Wang R</bp:AUTHORS>
      <bp:AUTHORS >Zhang L</bp:AUTHORS>
      <bp:AUTHORS >Yin D</bp:AUTHORS>
      <bp:AUTHORS >Mufson RA</bp:AUTHORS>
      <bp:AUTHORS >Shi Y</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="b9d">
      <bp:ID >12810757</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Properties of a free and a solubilized form of bound alpha,alpha-trehalase purified from honey bee thorax.</bp:TITLE>
      <bp:SOURCE >Can J Biochem</bp:SOURCE>
      <bp:YEAR >1975</bp:YEAR>
      <bp:AUTHORS >Ichiki T</bp:AUTHORS>
      <bp:AUTHORS >Tokunou T</bp:AUTHORS>
      <bp:AUTHORS >Fukuyama K</bp:AUTHORS>
      <bp:AUTHORS >Iino N</bp:AUTHORS>
      <bp:AUTHORS >Masuda S</bp:AUTHORS>
      <bp:AUTHORS >Takeshita A</bp:AUTHORS>
      <bp:AUTHORS >Talbot BG</bp:AUTHORS>
      <bp:AUTHORS >Muir JG</bp:AUTHORS>
      <bp:AUTHORS >Huber RE</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="d2c">
      <bp:ID >11732999</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >CTGF/Hcs24 induces chondrocyte differentiation through a p38 mitogen-activated protein kinase (p38MAPK), and proliferation through a p44/42 MAPK/extracellular-signal regulated kinase (ERK).</bp:TITLE>
      <bp:SOURCE >Eur J Biochem</bp:SOURCE>
      <bp:YEAR >2001</bp:YEAR>
      <bp:ID >11732999</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >CTGF/Hcs24 induces chondrocyte differentiation through a p38 mitogen-activated protein kinase (p38MAPK), and proliferation through a p44/42 MAPK/extracellular-signal regulated kinase (ERK).</bp:TITLE>
      <bp:SOURCE >Eur J Biochem</bp:SOURCE>
      <bp:YEAR >2001</bp:YEAR>
      <bp:AUTHORS >Yosimichi G</bp:AUTHORS>
      <bp:AUTHORS >Nakanishi T</bp:AUTHORS>
      <bp:AUTHORS >Nishida T</bp:AUTHORS>
      <bp:AUTHORS >Hattori T</bp:AUTHORS>
      <bp:AUTHORS >Takano-Yamamoto T</bp:AUTHORS>
      <bp:AUTHORS >Takigawa M</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="f9d">
      <bp:ID >11006268</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Quantitative fractionation of alkaline phosphatase isoenzymes according to their thermostability.</bp:TITLE>
      <bp:SOURCE >Clin Chem</bp:SOURCE>
      <bp:YEAR >1976</bp:YEAR>
      <bp:AUTHORS >Pomerance M</bp:AUTHORS>
      <bp:AUTHORS >Abdullah HB</bp:AUTHORS>
      <bp:AUTHORS >Kamerji S</bp:AUTHORS>
      <bp:AUTHORS >Correze C</bp:AUTHORS>
      <bp:AUTHORS >Blondeau JP</bp:AUTHORS>
      <bp:AUTHORS >PetitClerc C</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c57">
      <bp:ID >12801936</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Protein kinase A blocks Raf-1 activity by stimulating 14-3-3 binding and blocking Raf-1 interaction with Ras.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >2003</bp:YEAR>
      <bp:ID >12801936</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Protein kinase A blocks Raf-1 activity by stimulating 14-3-3 binding and blocking Raf-1 interaction with Ras.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >2003</bp:YEAR>
      <bp:ID >12801936</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Protein kinase A blocks Raf-1 activity by stimulating 14-3-3 binding and blocking Raf-1 interaction with Ras.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >2003</bp:YEAR>
      <bp:ID >12801936</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Protein kinase A blocks Raf-1 activity by stimulating 14-3-3 binding and blocking Raf-1 interaction with Ras.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >2003</bp:YEAR>
      <bp:ID >12801936</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Protein kinase A blocks Raf-1 activity by stimulating 14-3-3 binding and blocking Raf-1 interaction with Ras.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >2003</bp:YEAR>
      <bp:AUTHORS >Dumaz N</bp:AUTHORS>
      <bp:AUTHORS >Marais R</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c6f">
      <bp:ID >11297525</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >The distribution and elimination of radioactivity in the rat after administration of 14C-4-acetamidophenyl-2-acetoxybenzoate (benorylate).</bp:TITLE>
      <bp:SOURCE >Arzneimittelforschung</bp:SOURCE>
      <bp:YEAR >1975</bp:YEAR>
      <bp:ID >1051</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >The distribution and elimination of radioactivity in the rat after administration of 14C-4-acetamidophenyl-2-acetoxybenzoate (benorylate).</bp:TITLE>
      <bp:SOURCE >Arzneimittelforschung</bp:SOURCE>
      <bp:YEAR >1975</bp:YEAR>
      <bp:ID >1051</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >The distribution and elimination of radioactivity in the rat after administration of 14C-4-acetamidophenyl-2-acetoxybenzoate (benorylate).</bp:TITLE>
      <bp:SOURCE >Arzneimittelforschung</bp:SOURCE>
      <bp:YEAR >1975</bp:YEAR>
      <bp:AUTHORS >Liss E</bp:AUTHORS>
      <bp:AUTHORS >Robertson A</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="f3e">
      <bp:ID >10891480</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Investigations on the kinetic mechanism of octopine dehydrogenase. 1. Steady-state kinetics.</bp:TITLE>
      <bp:SOURCE >Eur J Biochem</bp:SOURCE>
      <bp:YEAR >1975</bp:YEAR>
      <bp:AUTHORS >Corbit KC</bp:AUTHORS>
      <bp:AUTHORS >Soh JW</bp:AUTHORS>
      <bp:AUTHORS >Yoshida K</bp:AUTHORS>
      <bp:AUTHORS >Eves EM</bp:AUTHORS>
      <bp:AUTHORS >Weinstein IB</bp:AUTHORS>
      <bp:AUTHORS >Rosner MR</bp:AUTHORS>
      <bp:AUTHORS >Doublet MO</bp:AUTHORS>
      <bp:AUTHORS >Olomucki A</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="d84">
      <bp:ID >11245462</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Inhibition of extracellular signal-regulated kinase (ERK) mediates cell cycle phase independent apoptosis in vinblastine-treated ML-1 cells.</bp:TITLE>
      <bp:SOURCE >Cancer Res</bp:SOURCE>
      <bp:YEAR >2001</bp:YEAR>
      <bp:AUTHORS >Stadheim TA</bp:AUTHORS>
      <bp:AUTHORS >Xiao H</bp:AUTHORS>
      <bp:AUTHORS >Eastman A</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c5d">
      <bp:ID >8621389</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Molecular cloning of mitogen-activated protein/ERK kinase kinases (MEKK) 2 and 3. Regulation of sequential phosphorylation pathways involving mitogen-activated protein kinase and c-Jun kinase.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >1996</bp:YEAR>
      <bp:ID >8621389</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Molecular cloning of mitogen-activated protein/ERK kinase kinases (MEKK) 2 and 3. Regulation of sequential phosphorylation pathways involving mitogen-activated protein kinase and c-Jun kinase.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >1996</bp:YEAR>
      <bp:ID >8621389</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Molecular cloning of mitogen-activated protein/ERK kinase kinases (MEKK) 2 and 3. Regulation of sequential phosphorylation pathways involving mitogen-activated protein kinase and c-Jun kinase.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >1996</bp:YEAR>
      <bp:AUTHORS >Blank JL</bp:AUTHORS>
      <bp:AUTHORS >Gerwins P</bp:AUTHORS>
      <bp:AUTHORS >Elliott EM</bp:AUTHORS>
      <bp:AUTHORS >Sather S</bp:AUTHORS>
      <bp:AUTHORS >Johnson GL</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="ed0">
      <bp:ID >11124982</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >The light response of ON bipolar neurons requires G[alpha]o.</bp:TITLE>
      <bp:SOURCE >J Neurosci</bp:SOURCE>
      <bp:YEAR >2000</bp:YEAR>
      <bp:AUTHORS >Dhingra A</bp:AUTHORS>
      <bp:AUTHORS >Lyubarsky A</bp:AUTHORS>
      <bp:AUTHORS >Jiang M</bp:AUTHORS>
      <bp:AUTHORS >Pugh EN Jr</bp:AUTHORS>
      <bp:AUTHORS >Birnbaumer L</bp:AUTHORS>
      <bp:AUTHORS >Sterling P</bp:AUTHORS>
      <bp:AUTHORS >Vardi N</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c96">
      <bp:ID >11503142</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Guanine nucleotide exchange factors CalDAG-GEFI and CalDAG-GEFII are colocalized in striatal projection neurons.</bp:TITLE>
      <bp:SOURCE >J Comp Neurol</bp:SOURCE>
      <bp:YEAR >2001</bp:YEAR>
      <bp:AUTHORS >Toki S</bp:AUTHORS>
      <bp:AUTHORS >Kawasaki H</bp:AUTHORS>
      <bp:AUTHORS >Tashiro N</bp:AUTHORS>
      <bp:AUTHORS >Housman DE</bp:AUTHORS>
      <bp:AUTHORS >Graybiel AM</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e94">
      <bp:ID >11441089</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Correlation of 14C-griseofulvin metabolism in rat liver microsomes, isolated perfused rat livers, and in rats with bile duct cannulas.</bp:TITLE>
      <bp:SOURCE >Drug Metab Dispos</bp:SOURCE>
      <bp:YEAR >1975</bp:YEAR>
      <bp:ID >1223</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Correlation of 14C-griseofulvin metabolism in rat liver microsomes, isolated perfused rat livers, and in rats with bile duct cannulas.</bp:TITLE>
      <bp:SOURCE >Drug Metab Dispos</bp:SOURCE>
      <bp:YEAR >1975</bp:YEAR>
      <bp:AUTHORS >Chang RL</bp:AUTHORS>
      <bp:AUTHORS >Zampaglione N</bp:AUTHORS>
      <bp:AUTHORS >Lin C</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="ea0">
      <bp:ID >9361191</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Inducible expression of a mutant form of MEK1 in Swiss 3T3 cells.</bp:TITLE>
      <bp:SOURCE >J Cell Biochem</bp:SOURCE>
      <bp:YEAR >1997</bp:YEAR>
      <bp:AUTHORS >Syu LJ</bp:AUTHORS>
      <bp:AUTHORS >Guan KL</bp:AUTHORS>
      <bp:AUTHORS >Saltiel AR</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="b25">
      <bp:ID >12796499</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Two waves of platelet secretion induced by thromboxane A2 receptor and a critical role for phosphoinositide 3-kinases.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >2003</bp:YEAR>
      <bp:AUTHORS >Li Z</bp:AUTHORS>
      <bp:AUTHORS >Zhang G</bp:AUTHORS>
      <bp:AUTHORS >Le Breton GC</bp:AUTHORS>
      <bp:AUTHORS >Gao X</bp:AUTHORS>
      <bp:AUTHORS >Malik AB</bp:AUTHORS>
      <bp:AUTHORS >Du X</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e2b">
      <bp:ID >8668348</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Identification of signalling proteins interacting with B-Raf in the yeast two-hybrid system.</bp:TITLE>
      <bp:SOURCE >Oncogene</bp:SOURCE>
      <bp:YEAR >1996</bp:YEAR>
      <bp:AUTHORS >Papin C</bp:AUTHORS>
      <bp:AUTHORS >Denouel A</bp:AUTHORS>
      <bp:AUTHORS >Calothy G</bp:AUTHORS>
      <bp:AUTHORS >Eychene A</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c17">
      <bp:ID >1447167</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >A mouse CDC25-like product enhances the formation of the active GTP complex of human ras p21 and Saccharomyces cerevisiae RAS2 proteins.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >1992</bp:YEAR>
      <bp:AUTHORS >Jacquet E</bp:AUTHORS>
      <bp:AUTHORS >Vanoni M</bp:AUTHORS>
      <bp:AUTHORS >Ferrari C</bp:AUTHORS>
      <bp:AUTHORS >Alberghina L</bp:AUTHORS>
      <bp:AUTHORS >Martegani E</bp:AUTHORS>
      <bp:AUTHORS >Parmeggiani A</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="f08">
      <bp:ID >7744823</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Direct interaction between Ras and the kinase domain of mitogen-activated protein kinase kinase kinase (MEKK1).</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >1995</bp:YEAR>
      <bp:AUTHORS >Russell M</bp:AUTHORS>
      <bp:AUTHORS >Lange-Carter CA</bp:AUTHORS>
      <bp:AUTHORS >Johnson GL</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="ea3">
      <bp:ID >15492006</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >G alpha 13 signals via p115RhoGEF cascades regulating JNK1 and primitive endoderm formation.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >2004</bp:YEAR>
      <bp:AUTHORS >Lee YN</bp:AUTHORS>
      <bp:AUTHORS >Malbon CC</bp:AUTHORS>
      <bp:AUTHORS >Wang HY</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="b63">
      <bp:ID >8700529</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >The brain specific Ras exchange factor CDC25 Mm: modulation of its activity through Gi-protein-mediated signals.</bp:TITLE>
      <bp:SOURCE >Oncogene</bp:SOURCE>
      <bp:YEAR >1996</bp:YEAR>
      <bp:AUTHORS >Zippel R</bp:AUTHORS>
      <bp:AUTHORS >Orecchia S</bp:AUTHORS>
      <bp:AUTHORS >Sturani E</bp:AUTHORS>
      <bp:AUTHORS >Martegani E</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="fbe">
      <bp:ID >12628924</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >A Specific effect of external ATP on the permeability of transformed 3T3 cells.</bp:TITLE>
      <bp:SOURCE >Biochem Biophys Res Commun</bp:SOURCE>
      <bp:YEAR >1975</bp:YEAR>
      <bp:AUTHORS >Vermeulen L</bp:AUTHORS>
      <bp:AUTHORS >De Wilde G</bp:AUTHORS>
      <bp:AUTHORS >Van Damme P</bp:AUTHORS>
      <bp:AUTHORS >Vanden Berghe W</bp:AUTHORS>
      <bp:AUTHORS >Haegeman G</bp:AUTHORS>
      <bp:AUTHORS >Rozengurt E</bp:AUTHORS>
      <bp:AUTHORS >Heppel LA</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="b9e">
      <bp:ID >9528766</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Adrenoreceptors of the guinea-pig urinary bladder.</bp:TITLE>
      <bp:SOURCE >Br J Pharmacol</bp:SOURCE>
      <bp:YEAR >1976</bp:YEAR>
      <bp:ID >10034</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Adrenoreceptors of the guinea-pig urinary bladder.</bp:TITLE>
      <bp:SOURCE >Br J Pharmacol</bp:SOURCE>
      <bp:YEAR >1976</bp:YEAR>
      <bp:AUTHORS >Dave KC</bp:AUTHORS>
      <bp:AUTHORS >Dhattiwala AS</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="f57">
      <bp:ID >10330161</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Protein kinase Cdelta mediates neurogenic but not mitogenic activation of mitogen-activated protein kinase in neuronal cells.</bp:TITLE>
      <bp:SOURCE >Mol Cell Biol</bp:SOURCE>
      <bp:YEAR >1999</bp:YEAR>
      <bp:AUTHORS >Corbit KC</bp:AUTHORS>
      <bp:AUTHORS >Foster DA</bp:AUTHORS>
      <bp:AUTHORS >Rosner MR</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c0d">
      <bp:ID >11859076</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Evidence of tandem duplication of genes in a merodiploid region of Pneumococcal mutants resistant to sulfonamide.</bp:TITLE>
      <bp:SOURCE >Genetics</bp:SOURCE>
      <bp:YEAR >1975</bp:YEAR>
      <bp:AUTHORS >Charvet C</bp:AUTHORS>
      <bp:AUTHORS >Auberger P</bp:AUTHORS>
      <bp:AUTHORS >Tartare-Deckert S</bp:AUTHORS>
      <bp:AUTHORS >Bernard A</bp:AUTHORS>
      <bp:AUTHORS >Deckert M</bp:AUTHORS>
      <bp:AUTHORS >Kashmiri SV</bp:AUTHORS>
      <bp:AUTHORS >Hotchkiss RD</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="a33">
      <bp:ID >8940180</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Mek1 phosphorylation site mutants activate Raf-1 in NIH 3T3 cells.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >1996</bp:YEAR>
      <bp:ID >8940180</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Mek1 phosphorylation site mutants activate Raf-1 in NIH 3T3 cells.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >1996</bp:YEAR>
      <bp:AUTHORS >Alessandrini A</bp:AUTHORS>
      <bp:AUTHORS >Greulich H</bp:AUTHORS>
      <bp:AUTHORS >Huang W</bp:AUTHORS>
      <bp:AUTHORS >Erikson RL</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="ea8">
      <bp:ID >11812784</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Beef liver L-Glutamate dehydrogenase mechanism: presteady state study of the catalytic reduction of 2.oxoglutarate by NADPH.</bp:TITLE>
      <bp:SOURCE >Biochem Biophys Res Commun</bp:SOURCE>
      <bp:YEAR >1975</bp:YEAR>
      <bp:ID >1038</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Beef liver L-Glutamate dehydrogenase mechanism: presteady state study of the catalytic reduction of 2.oxoglutarate by NADPH.</bp:TITLE>
      <bp:SOURCE >Biochem Biophys Res Commun</bp:SOURCE>
      <bp:YEAR >1975</bp:YEAR>
      <bp:AUTHORS >Jallon JM</bp:AUTHORS>
      <bp:AUTHORS >Risler Y</bp:AUTHORS>
      <bp:AUTHORS >Iwatsubo M</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="ab1">
      <bp:ID >8626650</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Involvement of the switch 2 domain of Ras in its interaction with guanine nucleotide exchange factors.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >1996</bp:YEAR>
      <bp:AUTHORS >Quilliam LA</bp:AUTHORS>
      <bp:AUTHORS >Hisaka MM</bp:AUTHORS>
      <bp:AUTHORS >Zhong S</bp:AUTHORS>
      <bp:AUTHORS >Lowry A</bp:AUTHORS>
      <bp:AUTHORS >Mosteller RD</bp:AUTHORS>
      <bp:AUTHORS >Han J</bp:AUTHORS>
      <bp:AUTHORS >Drugan JK</bp:AUTHORS>
      <bp:AUTHORS >Broek D</bp:AUTHORS>
      <bp:AUTHORS >Campbell SL</bp:AUTHORS>
      <bp:AUTHORS >Der CJ</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="ccf">
      <bp:ID >15879121</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >A new tyrosine phosphorylation site in PLC gamma 1: the role of tyrosine 775 in immune receptor signaling.</bp:TITLE>
      <bp:SOURCE >J Immunol</bp:SOURCE>
      <bp:YEAR >2005</bp:YEAR>
      <bp:AUTHORS >Serrano CJ</bp:AUTHORS>
      <bp:AUTHORS >Graham L</bp:AUTHORS>
      <bp:AUTHORS >DeBell K</bp:AUTHORS>
      <bp:AUTHORS >Rawat R</bp:AUTHORS>
      <bp:AUTHORS >Veri MC</bp:AUTHORS>
      <bp:AUTHORS >Bonvini E</bp:AUTHORS>
      <bp:AUTHORS >Rellahan BL</bp:AUTHORS>
      <bp:AUTHORS >Reischl IG</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c90">
      <bp:ID >11907026</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Identification of "big" human placental lactogen in placenta and serum.</bp:TITLE>
      <bp:SOURCE >Endocrinology</bp:SOURCE>
      <bp:YEAR >1975</bp:YEAR>
      <bp:AUTHORS >Funakoshi Y</bp:AUTHORS>
      <bp:AUTHORS >Ichiki T</bp:AUTHORS>
      <bp:AUTHORS >Takeda K</bp:AUTHORS>
      <bp:AUTHORS >Tokuno T</bp:AUTHORS>
      <bp:AUTHORS >Iino N</bp:AUTHORS>
      <bp:AUTHORS >Takeshita A</bp:AUTHORS>
      <bp:AUTHORS >Schneider AB</bp:AUTHORS>
      <bp:AUTHORS >Kowalski K</bp:AUTHORS>
      <bp:AUTHORS >Sherwood LM</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="bf1">
      <bp:ID >12782630</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Exchange factors of the RasGRP family mediate Ras activation in the Golgi.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >2003</bp:YEAR>
      <bp:ID >12782630</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Exchange factors of the RasGRP family mediate Ras activation in the Golgi.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >2003</bp:YEAR>
      <bp:AUTHORS >Caloca MJ</bp:AUTHORS>
      <bp:AUTHORS >Zugaza JL</bp:AUTHORS>
      <bp:AUTHORS >Bustelo XR</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c58">
      <bp:ID >12361670</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE />
      <bp:SOURCE />
      <bp:YEAR />
      <bp:ID >12361670</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Developing novel treatments for mood disorders: accelerating discovery.</bp:TITLE>
      <bp:SOURCE >Biol Psychiatry</bp:SOURCE>
      <bp:YEAR >2002</bp:YEAR>
      <bp:ID >12361670</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Developing novel treatments for mood disorders: accelerating discovery.</bp:TITLE>
      <bp:SOURCE >Biol Psychiatry</bp:SOURCE>
      <bp:YEAR >2002</bp:YEAR>
      <bp:AUTHORS >Tamminga CA</bp:AUTHORS>
      <bp:AUTHORS >Nemeroff CB</bp:AUTHORS>
      <bp:AUTHORS >Blakely RD</bp:AUTHORS>
      <bp:AUTHORS >Brady L</bp:AUTHORS>
      <bp:AUTHORS >Carter CS</bp:AUTHORS>
      <bp:AUTHORS >Davis KL</bp:AUTHORS>
      <bp:AUTHORS >Dingledine R</bp:AUTHORS>
      <bp:AUTHORS >Gorman JM</bp:AUTHORS>
      <bp:AUTHORS >Grigoriadis DE</bp:AUTHORS>
      <bp:AUTHORS >Henderson DC</bp:AUTHORS>
      <bp:AUTHORS >B Innis RB</bp:AUTHORS>
      <bp:AUTHORS >Killen J</bp:AUTHORS>
      <bp:AUTHORS >Laughren TP</bp:AUTHORS>
      <bp:AUTHORS >McDonald WM</bp:AUTHORS>
      <bp:AUTHORS >M Murphy GM Jr</bp:AUTHORS>
      <bp:AUTHORS >Paul SM</bp:AUTHORS>
      <bp:AUTHORS >Rudorfer MV</bp:AUTHORS>
      <bp:AUTHORS >Sausville E</bp:AUTHORS>
      <bp:AUTHORS >Schatzberg AF</bp:AUTHORS>
      <bp:AUTHORS >Scolnick EM</bp:AUTHORS>
      <bp:AUTHORS >Suppes T</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="fc1">
      <bp:ID >18614672</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Anomalous dopamine release associated with a human dopamine transporter coding variant.</bp:TITLE>
      <bp:SOURCE >J Neurosci</bp:SOURCE>
      <bp:YEAR >2008</bp:YEAR>
      <bp:AUTHORS >Mazei-Robison MS</bp:AUTHORS>
      <bp:AUTHORS >Bowton E</bp:AUTHORS>
      <bp:AUTHORS >Holy M</bp:AUTHORS>
      <bp:AUTHORS >Schmudermaier M</bp:AUTHORS>
      <bp:AUTHORS >Freissmuth M</bp:AUTHORS>
      <bp:AUTHORS >Sitte HH</bp:AUTHORS>
      <bp:AUTHORS >Galli A</bp:AUTHORS>
      <bp:AUTHORS >Blakely RD</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c84">
      <bp:ID >17067279</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >The functional impact of SLC6 transporter genetic variation.</bp:TITLE>
      <bp:SOURCE >Annu Rev Pharmacol Toxicol</bp:SOURCE>
      <bp:YEAR >2007</bp:YEAR>
      <bp:AUTHORS >Hahn MK</bp:AUTHORS>
      <bp:AUTHORS >Blakely RD</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="d9a">
      <bp:ID >9065412</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Identification of two essential phosphorylated threonine residues in the catalytic domain of Mekk1. Indirect activation by Pak3 and protein kinase C.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >1997</bp:YEAR>
      <bp:ID >9065412</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Identification of two essential phosphorylated threonine residues in the catalytic domain of Mekk1. Indirect activation by Pak3 and protein kinase C.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >1997</bp:YEAR>
      <bp:AUTHORS >Siow YL</bp:AUTHORS>
      <bp:AUTHORS >Kalmar GB</bp:AUTHORS>
      <bp:AUTHORS >Sanghera JS</bp:AUTHORS>
      <bp:AUTHORS >Tai G</bp:AUTHORS>
      <bp:AUTHORS >Oh SS</bp:AUTHORS>
      <bp:AUTHORS >Pelech SL</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="fc5">
      <bp:ID >10783132</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Induction of cell cornification and enhanced squamous-cell marker SPRR1 gene expression by phorbol ester are regulated by different signaling pathways in human conducting airway epithelial cells.</bp:TITLE>
      <bp:SOURCE >Am J Respir Cell Mol Biol</bp:SOURCE>
      <bp:YEAR >2000</bp:YEAR>
      <bp:ID >10783132</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Induction of cell cornification and enhanced squamous-cell marker SPRR1 gene expression by phorbol ester are regulated by different signaling pathways in human conducting airway epithelial cells.</bp:TITLE>
      <bp:SOURCE >Am J Respir Cell Mol Biol</bp:SOURCE>
      <bp:YEAR >2000</bp:YEAR>
      <bp:AUTHORS >Deng J</bp:AUTHORS>
      <bp:AUTHORS >Chen Y</bp:AUTHORS>
      <bp:AUTHORS >Wu R</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e6d">
      <bp:ID >10022874</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >The accreditation approach to infection control.</bp:TITLE>
      <bp:SOURCE >Dimens Health Serv</bp:SOURCE>
      <bp:YEAR >1975</bp:YEAR>
      <bp:AUTHORS >Waskiewicz AJ</bp:AUTHORS>
      <bp:AUTHORS >Johnson JC</bp:AUTHORS>
      <bp:AUTHORS >Penn B</bp:AUTHORS>
      <bp:AUTHORS >Mahalingam M</bp:AUTHORS>
      <bp:AUTHORS >Kimball SR</bp:AUTHORS>
      <bp:AUTHORS >Cooper JA</bp:AUTHORS>
      <bp:AUTHORS >Murray J</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="b11">
      <bp:ID >11490018</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Comparative biotransformation of triflubazam in rats, dogs, and monkeys.</bp:TITLE>
      <bp:SOURCE >Drug Metab Dispos</bp:SOURCE>
      <bp:YEAR >1975</bp:YEAR>
      <bp:AUTHORS >Ishizuka T</bp:AUTHORS>
      <bp:AUTHORS >Okajima F</bp:AUTHORS>
      <bp:AUTHORS >Ishiwara M</bp:AUTHORS>
      <bp:AUTHORS >Iizuka K</bp:AUTHORS>
      <bp:AUTHORS >Ichimonji I</bp:AUTHORS>
      <bp:AUTHORS >Kawata T</bp:AUTHORS>
      <bp:AUTHORS >Tsukagoshi H</bp:AUTHORS>
      <bp:AUTHORS >Dobashi K</bp:AUTHORS>
      <bp:AUTHORS >Nakazawa T</bp:AUTHORS>
      <bp:AUTHORS >Mori M</bp:AUTHORS>
      <bp:AUTHORS >Alton KB</bp:AUTHORS>
      <bp:AUTHORS >Patrick JE</bp:AUTHORS>
      <bp:AUTHORS >Shaw C</bp:AUTHORS>
      <bp:AUTHORS >McGuire JL</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="f5d">
      <bp:ID >15491994</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >SMRT and N-CoR corepressors are regulated by distinct kinase signaling pathways.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >2004</bp:YEAR>
      <bp:AUTHORS >Jonas BA</bp:AUTHORS>
      <bp:AUTHORS >Privalsky ML</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="dbd">
      <bp:ID >15322221</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >[Sialyltransferase in human malignant melanoma]</bp:TITLE>
      <bp:SOURCE >Clin Chim Acta</bp:SOURCE>
      <bp:YEAR >1976</bp:YEAR>
      <bp:ID >10104</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >[Sialyltransferase in human malignant melanoma].</bp:TITLE>
      <bp:SOURCE >Clin Chim Acta</bp:SOURCE>
      <bp:YEAR >1976</bp:YEAR>
      <bp:AUTHORS >Simonnet H</bp:AUTHORS>
      <bp:AUTHORS >Martel MB</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="ce6">
      <bp:ID >10747974</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Reduced glutathione--a comparative study of erythrocytes from various species of marsupials in Australia.</bp:TITLE>
      <bp:SOURCE >Comp Biochem Physiol A Comp Physiol</bp:SOURCE>
      <bp:YEAR >1975</bp:YEAR>
      <bp:AUTHORS >Meyer-ter-Vehn T</bp:AUTHORS>
      <bp:AUTHORS >Covacci A</bp:AUTHORS>
      <bp:AUTHORS >Kist M</bp:AUTHORS>
      <bp:AUTHORS >Pahl HL</bp:AUTHORS>
      <bp:AUTHORS >Agar NS</bp:AUTHORS>
      <bp:AUTHORS >Stephens T</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="b55">
      <bp:ID >12896977</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Statistical insight through H.I.S.</bp:TITLE>
      <bp:SOURCE >Dimens Health Serv</bp:SOURCE>
      <bp:YEAR >1976</bp:YEAR>
      <bp:AUTHORS >Smith JL</bp:AUTHORS>
      <bp:AUTHORS >Collins I</bp:AUTHORS>
      <bp:AUTHORS >Chandramouli GV</bp:AUTHORS>
      <bp:AUTHORS >Butscher WG</bp:AUTHORS>
      <bp:AUTHORS >Zaitseva E</bp:AUTHORS>
      <bp:AUTHORS >Freebern WJ</bp:AUTHORS>
      <bp:AUTHORS >Haggerty CM</bp:AUTHORS>
      <bp:AUTHORS >Doseeva V</bp:AUTHORS>
      <bp:AUTHORS >Gardner K</bp:AUTHORS>
      <bp:AUTHORS >Reid G</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="fc3">
      <bp:ID >14963045</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Helicobacter pylori CagA induces Ras-independent morphogenetic response through SHP-2 recruitment and activation.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >2004</bp:YEAR>
      <bp:AUTHORS >Higashi H</bp:AUTHORS>
      <bp:AUTHORS >Nakaya A</bp:AUTHORS>
      <bp:AUTHORS >Tsutsumi R</bp:AUTHORS>
      <bp:AUTHORS >Yokoyama K</bp:AUTHORS>
      <bp:AUTHORS >Fujii Y</bp:AUTHORS>
      <bp:AUTHORS >Ishikawa S</bp:AUTHORS>
      <bp:AUTHORS >Higuchi M</bp:AUTHORS>
      <bp:AUTHORS >Takahashi A</bp:AUTHORS>
      <bp:AUTHORS >Kurashima Y</bp:AUTHORS>
      <bp:AUTHORS >Teishikata Y</bp:AUTHORS>
      <bp:AUTHORS >Tanaka S</bp:AUTHORS>
      <bp:AUTHORS >Azuma T</bp:AUTHORS>
      <bp:AUTHORS >Hatakeyama M</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="b1e">
      <bp:ID >9639556</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Differential activation of stress-activated protein kinase kinases SKK4/MKK7 and SKK1/MKK4 by the mixed-lineage kinase-2 and mitogen-activated protein kinase kinase (MKK) kinase-1.</bp:TITLE>
      <bp:SOURCE >Biochem J</bp:SOURCE>
      <bp:YEAR >1998</bp:YEAR>
      <bp:ID >9639556</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Differential activation of stress-activated protein kinase kinases SKK4/MKK7 and SKK1/MKK4 by the mixed-lineage kinase-2 and mitogen-activated protein kinase kinase (MKK) kinase-1.</bp:TITLE>
      <bp:SOURCE >Biochem J</bp:SOURCE>
      <bp:YEAR >1998</bp:YEAR>
      <bp:AUTHORS >Cuenda A</bp:AUTHORS>
      <bp:AUTHORS >Dorow DS</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="d69">
      <bp:ID >16055563</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Human serotonin transporter variants display altered sensitivity to protein kinase G and p38 mitogen-activated protein kinase.</bp:TITLE>
      <bp:SOURCE >Proc Natl Acad Sci U S A</bp:SOURCE>
      <bp:YEAR >2005</bp:YEAR>
      <bp:AUTHORS >Prasad HC</bp:AUTHORS>
      <bp:AUTHORS >Zhu CB</bp:AUTHORS>
      <bp:AUTHORS >McCauley JL</bp:AUTHORS>
      <bp:AUTHORS >Samuvel DJ</bp:AUTHORS>
      <bp:AUTHORS >Ramamoorthy S</bp:AUTHORS>
      <bp:AUTHORS >Shelton RC</bp:AUTHORS>
      <bp:AUTHORS >Hewlett WA</bp:AUTHORS>
      <bp:AUTHORS >Sutcliffe JS</bp:AUTHORS>
      <bp:AUTHORS >Blakely RD</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="fdd">
      <bp:ID >8798679</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Trypsin-catalyzed activation of aspartase.</bp:TITLE>
      <bp:SOURCE >Biochem Biophys Res Commun</bp:SOURCE>
      <bp:YEAR >1975</bp:YEAR>
      <bp:AUTHORS >Kyriakis JM</bp:AUTHORS>
      <bp:AUTHORS >Avruch J</bp:AUTHORS>
      <bp:AUTHORS >Mizuta K</bp:AUTHORS>
      <bp:AUTHORS >Tokushige M</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="eee">
      <bp:ID >11520792</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Inhibition of the adenylylation of glutamine synthetase by methionine sulfone during nitrogenase derepression.</bp:TITLE>
      <bp:SOURCE >Biochem Biophys Res Commun</bp:SOURCE>
      <bp:YEAR >1975</bp:YEAR>
      <bp:ID >1024</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Inhibition of the adenylylation of glutamine synthetase by methionine sulfone during nitrogenase derepression.</bp:TITLE>
      <bp:SOURCE >Biochem Biophys Res Commun</bp:SOURCE>
      <bp:YEAR >1975</bp:YEAR>
      <bp:AUTHORS >Bishop PE</bp:AUTHORS>
      <bp:AUTHORS >McParland RH</bp:AUTHORS>
      <bp:AUTHORS >Evans HJ</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c74">
      <bp:ID >10704466</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Evidence for histidine as another functional group of delta-aminolevulinic acid dehydratase from beef liver.</bp:TITLE>
      <bp:SOURCE >Biochem Biophys Res Commun</bp:SOURCE>
      <bp:YEAR >1975</bp:YEAR>
      <bp:AUTHORS >Allen M</bp:AUTHORS>
      <bp:AUTHORS >Svensson L</bp:AUTHORS>
      <bp:AUTHORS >Roach M</bp:AUTHORS>
      <bp:AUTHORS >Hambor J</bp:AUTHORS>
      <bp:AUTHORS >McNeish J</bp:AUTHORS>
      <bp:AUTHORS >Gabel CA</bp:AUTHORS>
      <bp:AUTHORS >Tsukamoto I</bp:AUTHORS>
      <bp:AUTHORS >Yoshinaga T</bp:AUTHORS>
      <bp:AUTHORS >Sano S</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="ee1">
      <bp:ID >8622669</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >MKK3- and MKK6-regulated gene expression is mediated by the p38 mitogen-activated protein kinase signal transduction pathway.</bp:TITLE>
      <bp:SOURCE >Mol Cell Biol</bp:SOURCE>
      <bp:YEAR >1996</bp:YEAR>
      <bp:ID >8622669</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >MKK3- and MKK6-regulated gene expression is mediated by the p38 mitogen-activated protein kinase signal transduction pathway.</bp:TITLE>
      <bp:SOURCE >Mol Cell Biol</bp:SOURCE>
      <bp:YEAR >1996</bp:YEAR>
      <bp:AUTHORS >Raingeaud J</bp:AUTHORS>
      <bp:AUTHORS >Whitmarsh AJ</bp:AUTHORS>
      <bp:AUTHORS >Barrett T</bp:AUTHORS>
      <bp:AUTHORS >D&#233;rijard B</bp:AUTHORS>
      <bp:AUTHORS >Davis RJ</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="f51">
      <bp:ID >11907026</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Problems with practolol.</bp:TITLE>
      <bp:SOURCE >Drugs</bp:SOURCE>
      <bp:YEAR >1975</bp:YEAR>
      <bp:AUTHORS >Funakoshi Y</bp:AUTHORS>
      <bp:AUTHORS >Ichiki T</bp:AUTHORS>
      <bp:AUTHORS >Takeda K</bp:AUTHORS>
      <bp:AUTHORS >Tokuno T</bp:AUTHORS>
      <bp:AUTHORS >Iino N</bp:AUTHORS>
      <bp:AUTHORS >Takeshita A</bp:AUTHORS>
      <bp:AUTHORS >Wall-Manning HJ</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="f27">
      <bp:ID >11454682</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >The dependence of tryptamine excretion on urinary pH.</bp:TITLE>
      <bp:SOURCE >Clin Chim Acta</bp:SOURCE>
      <bp:YEAR >1975</bp:YEAR>
      <bp:ID >1161</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >The dependence of tryptamine excretion on urinary pH.</bp:TITLE>
      <bp:SOURCE >Clin Chim Acta</bp:SOURCE>
      <bp:YEAR >1975</bp:YEAR>
      <bp:ID >1161</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >The dependence of tryptamine excretion on urinary pH.</bp:TITLE>
      <bp:SOURCE >Clin Chim Acta</bp:SOURCE>
      <bp:YEAR >1975</bp:YEAR>
      <bp:ID >1161</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >The dependence of tryptamine excretion on urinary pH.</bp:TITLE>
      <bp:SOURCE >Clin Chim Acta</bp:SOURCE>
      <bp:YEAR >1975</bp:YEAR>
      <bp:AUTHORS >Price J</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="fdf">
      <bp:ID >11245588</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Fluorimetric determination of cephalexin.</bp:TITLE>
      <bp:SOURCE >J Pharm Pharmacol</bp:SOURCE>
      <bp:YEAR >1976</bp:YEAR>
      <bp:ID >10383</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Fluorimetric determination of cephalexin.</bp:TITLE>
      <bp:SOURCE >J Pharm Pharmacol</bp:SOURCE>
      <bp:YEAR >1976</bp:YEAR>
      <bp:AUTHORS >Barbhaiya RH</bp:AUTHORS>
      <bp:AUTHORS >Turner P</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="cad">
      <bp:ID >12495932</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Problems of the pathogenesis, clinics, and therapy of panarteritis of the aorta and its branches.</bp:TITLE>
      <bp:SOURCE >Cor Vasa</bp:SOURCE>
      <bp:YEAR >1975</bp:YEAR>
      <bp:ID >1207</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Problems of the pathogenesis, clinics, and therapy of panarteritis of the aorta and its branches.</bp:TITLE>
      <bp:SOURCE >Cor Vasa</bp:SOURCE>
      <bp:YEAR >1975</bp:YEAR>
      <bp:AUTHORS >Ratner NA</bp:AUTHORS>
      <bp:AUTHORS >Vikhert AM</bp:AUTHORS>
      <bp:AUTHORS >Abugova SP</bp:AUTHORS>
      <bp:AUTHORS >Arabidze GG</bp:AUTHORS>
      <bp:AUTHORS >Matveeva LS</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="a70">
      <bp:ID >11500364</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Regulation of elongation factor 2 kinase by p90(RSK1) and p70 S6 kinase.</bp:TITLE>
      <bp:SOURCE >EMBO J</bp:SOURCE>
      <bp:YEAR >2001</bp:YEAR>
      <bp:AUTHORS >Wang X</bp:AUTHORS>
      <bp:AUTHORS >Li W</bp:AUTHORS>
      <bp:AUTHORS >Williams M</bp:AUTHORS>
      <bp:AUTHORS >Terada N</bp:AUTHORS>
      <bp:AUTHORS >Alessi DR</bp:AUTHORS>
      <bp:AUTHORS >Proud CG</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="fd9">
      <bp:ID >11496823</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Delineation of the intimate details of the backbone conformation of pyridine nucleotide coenzymes in aqueous solution.</bp:TITLE>
      <bp:SOURCE >Biochem Biophys Res Commun</bp:SOURCE>
      <bp:YEAR >1975</bp:YEAR>
      <bp:AUTHORS >Hirasawa N</bp:AUTHORS>
      <bp:AUTHORS >Ohuchi K</bp:AUTHORS>
      <bp:AUTHORS >Bose KS</bp:AUTHORS>
      <bp:AUTHORS >Sarma RH</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="d51">
      <bp:ID >18674600</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Cholinergic neurons of mouse intrinsic cardiac ganglia contain noradrenergic enzymes, norepinephrine transporters, and the neurotrophin receptors tropomyosin-related kinase A and p75.</bp:TITLE>
      <bp:SOURCE >Neuroscience</bp:SOURCE>
      <bp:YEAR >2008</bp:YEAR>
      <bp:AUTHORS >Hoard JL</bp:AUTHORS>
      <bp:AUTHORS >Hoover DB</bp:AUTHORS>
      <bp:AUTHORS >Mabe AM</bp:AUTHORS>
      <bp:AUTHORS >Blakely RD</bp:AUTHORS>
      <bp:AUTHORS >Feng N</bp:AUTHORS>
      <bp:AUTHORS >Paolocci N</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="abd">
      <bp:ID >15201137</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Immunolocalization of type 2 inositol 1,4,5-trisphosphate receptors in cardiac myocytes from newborn mice.</bp:TITLE>
      <bp:SOURCE >Am J Physiol Cell Physiol</bp:SOURCE>
      <bp:YEAR >2004</bp:YEAR>
      <bp:ID >15201137</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Immunolocalization of type 2 inositol 1,4,5-trisphosphate receptors in cardiac myocytes from newborn mice.</bp:TITLE>
      <bp:SOURCE >Am J Physiol Cell Physiol</bp:SOURCE>
      <bp:YEAR >2004</bp:YEAR>
      <bp:AUTHORS >Garc&#237;a KD</bp:AUTHORS>
      <bp:AUTHORS >Shah T</bp:AUTHORS>
      <bp:AUTHORS >Garc&#237;a J</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="eab">
      <bp:ID >11395491</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Identification of the minimal tyrosine residues required for linker for activation of T cell function.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >2001</bp:YEAR>
      <bp:ID >11395491</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Identification of the minimal tyrosine residues required for linker for activation of T cell function.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >2001</bp:YEAR>
      <bp:AUTHORS >Lin J</bp:AUTHORS>
      <bp:AUTHORS >Weiss A</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="d26">
      <bp:ID >9852158</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Calcium and protein kinase C regulate the actin cytoskeleton in the synaptic terminal of retinal bipolar cells.</bp:TITLE>
      <bp:SOURCE >J Cell Biol</bp:SOURCE>
      <bp:YEAR >1998</bp:YEAR>
      <bp:ID >9852158</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Calcium and protein kinase C regulate the actin cytoskeleton in the synaptic terminal of retinal bipolar cells.</bp:TITLE>
      <bp:SOURCE >J Cell Biol</bp:SOURCE>
      <bp:YEAR >1998</bp:YEAR>
      <bp:AUTHORS >Job C</bp:AUTHORS>
      <bp:AUTHORS >Lagnado L</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="d27">
      <bp:ID >11120810</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Evidence for protein kinase C-dependent and -independent activation of mitogen-activated protein kinase in T cells: potential role of additional diacylglycerol binding proteins.</bp:TITLE>
      <bp:SOURCE >J Immunol</bp:SOURCE>
      <bp:YEAR >2000</bp:YEAR>
      <bp:AUTHORS >Puente LG</bp:AUTHORS>
      <bp:AUTHORS >Stone JC</bp:AUTHORS>
      <bp:AUTHORS >Ostergaard HL</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="ffb">
      <bp:ID >7896797</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Sequestration of a G-protein beta gamma subunit or ADP-ribosylation of Rho can inhibit thrombin-induced activation of platelet phosphoinositide 3-kinases.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >1995</bp:YEAR>
      <bp:AUTHORS >Zhang J</bp:AUTHORS>
      <bp:AUTHORS >Benovic JL</bp:AUTHORS>
      <bp:AUTHORS >Sugai M</bp:AUTHORS>
      <bp:AUTHORS >Wetzker R</bp:AUTHORS>
      <bp:AUTHORS >Gout I</bp:AUTHORS>
      <bp:AUTHORS >Rittenhouse SE</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="f80">
      <bp:ID >10753939</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >A model for the origin of stable protocells in a primitive alkaline ocean.</bp:TITLE>
      <bp:SOURCE >Biosystems</bp:SOURCE>
      <bp:YEAR >1975</bp:YEAR>
      <bp:AUTHORS >Paine E</bp:AUTHORS>
      <bp:AUTHORS >Palmantier R</bp:AUTHORS>
      <bp:AUTHORS >Akiyama SK</bp:AUTHORS>
      <bp:AUTHORS >Olden K</bp:AUTHORS>
      <bp:AUTHORS >Roberts JD</bp:AUTHORS>
      <bp:AUTHORS >Snyder WD</bp:AUTHORS>
      <bp:AUTHORS >Fox SW</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="bcd">
      <bp:ID >12070163</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Regulation of T cell receptor-induced activation of the Ras-ERK pathway by diacylglycerol kinase zeta.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >2002</bp:YEAR>
      <bp:AUTHORS >Zhong XP</bp:AUTHORS>
      <bp:AUTHORS >Hainey EA</bp:AUTHORS>
      <bp:AUTHORS >Olenchock BA</bp:AUTHORS>
      <bp:AUTHORS >Zhao H</bp:AUTHORS>
      <bp:AUTHORS >Topham MK</bp:AUTHORS>
      <bp:AUTHORS >Koretzky GA</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="deb">
      <bp:ID >10196191</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Discriminatory residues in Ras and Rap for guanine nucleotide exchange factor recognition.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >1999</bp:YEAR>
      <bp:AUTHORS >van den Berghe N</bp:AUTHORS>
      <bp:AUTHORS >Cool RH</bp:AUTHORS>
      <bp:AUTHORS >Wittinghofer A</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="cd5">
      <bp:ID >12351703</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Dopamine-D2S receptor inhibition of calcium influx, adenylyl cyclase, and mitogen-activated protein kinase in pituitary cells: distinct Galpha and Gbetagamma requirements.</bp:TITLE>
      <bp:SOURCE >Mol Endocrinol</bp:SOURCE>
      <bp:YEAR >2002</bp:YEAR>
      <bp:AUTHORS >Banihashemi B</bp:AUTHORS>
      <bp:AUTHORS >Albert PR</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e1e">
      <bp:ID >17492052</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Mice lacking the signaling molecule CalDAG-GEFI represent a model for leukocyte adhesion deficiency type III.</bp:TITLE>
      <bp:SOURCE >J Clin Invest</bp:SOURCE>
      <bp:YEAR >2007</bp:YEAR>
      <bp:AUTHORS >Bergmeier W</bp:AUTHORS>
      <bp:AUTHORS >Goerge T</bp:AUTHORS>
      <bp:AUTHORS >Wang HW</bp:AUTHORS>
      <bp:AUTHORS >Crittenden JR</bp:AUTHORS>
      <bp:AUTHORS >Baldwin AC</bp:AUTHORS>
      <bp:AUTHORS >Cifuni SM</bp:AUTHORS>
      <bp:AUTHORS >Housman DE</bp:AUTHORS>
      <bp:AUTHORS >Graybiel AM</bp:AUTHORS>
      <bp:AUTHORS >Wagner DD</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c2d">
      <bp:ID >10835426</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >CalDAG-GEFIII activation of Ras, R-ras, and Rap1.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >2000</bp:YEAR>
      <bp:AUTHORS >Yamashita S</bp:AUTHORS>
      <bp:AUTHORS >Mochizuki N</bp:AUTHORS>
      <bp:AUTHORS >Ohba Y</bp:AUTHORS>
      <bp:AUTHORS >Tobiume M</bp:AUTHORS>
      <bp:AUTHORS >Okada Y</bp:AUTHORS>
      <bp:AUTHORS >Sawa H</bp:AUTHORS>
      <bp:AUTHORS >Nagashima K</bp:AUTHORS>
      <bp:AUTHORS >Matsuda M</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c05">
      <bp:ID >9679149</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Restraint may force quicker cost-sharing.</bp:TITLE>
      <bp:SOURCE >Dimens Health Serv</bp:SOURCE>
      <bp:YEAR >1976</bp:YEAR>
      <bp:AUTHORS >Clerk A</bp:AUTHORS>
      <bp:AUTHORS >Michael A</bp:AUTHORS>
      <bp:AUTHORS >Sugden PH</bp:AUTHORS>
      <bp:AUTHORS >Brosseau BL</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="a48">
      <bp:ID >10711350</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Effect of chloroquine on cultured fibroblasts: release of lysosomal hydrolases and inhibition of their uptake.</bp:TITLE>
      <bp:SOURCE >Biochem Biophys Res Commun</bp:SOURCE>
      <bp:YEAR >1975</bp:YEAR>
      <bp:AUTHORS >Shiraishi M</bp:AUTHORS>
      <bp:AUTHORS >Hirasawa N</bp:AUTHORS>
      <bp:AUTHORS >Kobayashi Y</bp:AUTHORS>
      <bp:AUTHORS >Oikawa S</bp:AUTHORS>
      <bp:AUTHORS >Murakami A</bp:AUTHORS>
      <bp:AUTHORS >Ohuchi K</bp:AUTHORS>
      <bp:AUTHORS >Wiesmann UN</bp:AUTHORS>
      <bp:AUTHORS >DiDonato S</bp:AUTHORS>
      <bp:AUTHORS >Herschkowitz NN</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="eaa">
      <bp:ID >15078882</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Contribution of protease-activated receptors 1 and 4 and glycoprotein Ib-IX-V in the G(i)-independent activation of platelet Rap1B by thrombin.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >2004</bp:YEAR>
      <bp:AUTHORS >Lova P</bp:AUTHORS>
      <bp:AUTHORS >Campus F</bp:AUTHORS>
      <bp:AUTHORS >Lombardi R</bp:AUTHORS>
      <bp:AUTHORS >Cattaneo M</bp:AUTHORS>
      <bp:AUTHORS >Sinigaglia F</bp:AUTHORS>
      <bp:AUTHORS >Balduini C</bp:AUTHORS>
      <bp:AUTHORS >Torti M</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="eeb">
      <bp:ID >15826941</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >WAVE3-mediated cell migration and lamellipodia formation are regulated downstream of phosphatidylinositol 3-kinase.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >2005</bp:YEAR>
      <bp:AUTHORS >Sossey-Alaoui K</bp:AUTHORS>
      <bp:AUTHORS >Li X</bp:AUTHORS>
      <bp:AUTHORS >Ranalli TA</bp:AUTHORS>
      <bp:AUTHORS >Cowell JK</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="a63">
      <bp:ID >11463795</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Ontogeny of homeothermy in Microtus pennsylvanicus and Octodon degus.</bp:TITLE>
      <bp:SOURCE >Comp Biochem Physiol A Comp Physiol</bp:SOURCE>
      <bp:YEAR >1975</bp:YEAR>
      <bp:AUTHORS >Bandyopadhyay G</bp:AUTHORS>
      <bp:AUTHORS >Sajan MP</bp:AUTHORS>
      <bp:AUTHORS >Kanoh Y</bp:AUTHORS>
      <bp:AUTHORS >Standaert ML</bp:AUTHORS>
      <bp:AUTHORS >Quon MJ</bp:AUTHORS>
      <bp:AUTHORS >Reed BC</bp:AUTHORS>
      <bp:AUTHORS >Dikic I</bp:AUTHORS>
      <bp:AUTHORS >Farese RV</bp:AUTHORS>
      <bp:AUTHORS >Rosen RC</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="b42">
      <bp:ID >7923353</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >A novel kinase cascade triggered by stress and heat shock that stimulates MAPKAP kinase-2 and phosphorylation of the small heat shock proteins.</bp:TITLE>
      <bp:SOURCE >Cell</bp:SOURCE>
      <bp:YEAR >1994</bp:YEAR>
      <bp:AUTHORS >Rouse J</bp:AUTHORS>
      <bp:AUTHORS >Cohen P</bp:AUTHORS>
      <bp:AUTHORS >Trigon S</bp:AUTHORS>
      <bp:AUTHORS >Morange M</bp:AUTHORS>
      <bp:AUTHORS >Alonso-Llamazares A</bp:AUTHORS>
      <bp:AUTHORS >Zamanillo D</bp:AUTHORS>
      <bp:AUTHORS >Hunt T</bp:AUTHORS>
      <bp:AUTHORS >Nebreda AR</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="b80">
      <bp:ID >11463794</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Changes in plasma glucose and liver glycogen following the administration of gluconeogenic precursors to the starving fowl.</bp:TITLE>
      <bp:SOURCE >Comp Biochem Physiol A Comp Physiol</bp:SOURCE>
      <bp:YEAR >1975</bp:YEAR>
      <bp:ID >1190</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Changes in plasma glucose and liver glycogen following the administration of gluconeogenic precursors to the starving fowl.</bp:TITLE>
      <bp:SOURCE >Comp Biochem Physiol A Comp Physiol</bp:SOURCE>
      <bp:YEAR >1975</bp:YEAR>
      <bp:ID >1190</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Changes in plasma glucose and liver glycogen following the administration of gluconeogenic precursors to the starving fowl.</bp:TITLE>
      <bp:SOURCE >Comp Biochem Physiol A Comp Physiol</bp:SOURCE>
      <bp:YEAR >1975</bp:YEAR>
      <bp:AUTHORS >Davison TF</bp:AUTHORS>
      <bp:AUTHORS >Langslow DR</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e81">
      <bp:ID >11058585</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Characterization of p190RhoGEF, a RhoA-specific guanine nucleotide exchange factor that interacts with microtubules.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >2001</bp:YEAR>
      <bp:AUTHORS >van Horck FP</bp:AUTHORS>
      <bp:AUTHORS >Ahmadian MR</bp:AUTHORS>
      <bp:AUTHORS >Haeusler LC</bp:AUTHORS>
      <bp:AUTHORS >Moolenaar WH</bp:AUTHORS>
      <bp:AUTHORS >Kranenburg O</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#">
      <bp:TERM xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >serotonin signaling pathway</bp:TERM>
      <bp:ID xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >PW:0000854</bp:ID>
      <bp:Ontology xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >Pathway Ontology</bp:Ontology>
    </bp:openControlledVocabulary>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="cfc">
      <bp:ID >10226075</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Partial characterization of a novel mitogen-activated protein kinase/extracellular signal-regulated kinase activator in airway smooth-muscle cells.</bp:TITLE>
      <bp:SOURCE >Am J Respir Cell Mol Biol</bp:SOURCE>
      <bp:YEAR >1999</bp:YEAR>
      <bp:AUTHORS >Kartha S</bp:AUTHORS>
      <bp:AUTHORS >Naureckas ET</bp:AUTHORS>
      <bp:AUTHORS >Li J</bp:AUTHORS>
      <bp:AUTHORS >Hershenson MB</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="a17">
      <bp:ID >8756648</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >The N-terminal pleckstrin, coiled-coil, and IQ domains of the exchange factor Ras-GRF act cooperatively to facilitate activation by calcium.</bp:TITLE>
      <bp:SOURCE >Mol Cell Biol</bp:SOURCE>
      <bp:YEAR >1996</bp:YEAR>
      <bp:AUTHORS >Buchsbaum R</bp:AUTHORS>
      <bp:AUTHORS >Telliez JB</bp:AUTHORS>
      <bp:AUTHORS >Goonesekera S</bp:AUTHORS>
      <bp:AUTHORS >Feig LA</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e74">
      <bp:ID >11701463</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Effect of a single administration of testosterone on the immune response and lymphoid tissues in mice.</bp:TITLE>
      <bp:SOURCE >Cell Immunol</bp:SOURCE>
      <bp:YEAR >1975</bp:YEAR>
      <bp:AUTHORS >Tokunou T</bp:AUTHORS>
      <bp:AUTHORS >Ichiki T</bp:AUTHORS>
      <bp:AUTHORS >Takeda K</bp:AUTHORS>
      <bp:AUTHORS >Funakoshi Y</bp:AUTHORS>
      <bp:AUTHORS >Iino N</bp:AUTHORS>
      <bp:AUTHORS >Takeshita A</bp:AUTHORS>
      <bp:AUTHORS >Fujii H</bp:AUTHORS>
      <bp:AUTHORS >Nawa Y</bp:AUTHORS>
      <bp:AUTHORS >Tsuchiya H</bp:AUTHORS>
      <bp:AUTHORS >Matsuno K</bp:AUTHORS>
      <bp:AUTHORS >Fukumoto T</bp:AUTHORS>
      <bp:AUTHORS >Fukuda S</bp:AUTHORS>
      <bp:AUTHORS >Kotani M</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="cdd">
      <bp:ID >10827000</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Geographical and electrical features of large neurons in Limulus abdominal ganglia.</bp:TITLE>
      <bp:SOURCE >Comp Biochem Physiol A Comp Physiol</bp:SOURCE>
      <bp:YEAR >1975</bp:YEAR>
      <bp:ID >1180</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Geographical and electrical features of large neurons in Limulus abdominal ganglia.</bp:TITLE>
      <bp:SOURCE >Comp Biochem Physiol A Comp Physiol</bp:SOURCE>
      <bp:YEAR >1975</bp:YEAR>
      <bp:AUTHORS >Levy RA</bp:AUTHORS>
      <bp:AUTHORS >Nystrom RA</bp:AUTHORS>
      <bp:AUTHORS >Nadelhaft I</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="cf8">
      <bp:ID >12839832</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Aldosterone potentiates 1,25-dihydroxyvitamin D3 action in renal thick ascending limb via a nongenomic, ERK-dependent pathway.</bp:TITLE>
      <bp:SOURCE >Am J Physiol Cell Physiol</bp:SOURCE>
      <bp:YEAR >2003</bp:YEAR>
      <bp:AUTHORS >Good DW</bp:AUTHORS>
      <bp:AUTHORS >George T</bp:AUTHORS>
      <bp:AUTHORS >Watts BA 3rd</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e06">
      <bp:ID >9162092</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Characterization of the mitogen-activated protein kinase kinase 4 (MKK4)/c-Jun NH2-terminal kinase 1 and MKK3/p38 pathways regulated by MEK kinases 2 and 3. MEK kinase 3 activates MKK3 but does not cause activation of p38 kinase in vivo.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >1997</bp:YEAR>
      <bp:ID >9162092</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Characterization of the mitogen-activated protein kinase kinase 4 (MKK4)/c-Jun NH2-terminal kinase 1 and MKK3/p38 pathways regulated by MEK kinases 2 and 3. MEK kinase 3 activates MKK3 but does not cause activation of p38 kinase in vivo.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >1997</bp:YEAR>
      <bp:ID >9162092</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Characterization of the mitogen-activated protein kinase kinase 4 (MKK4)/c-Jun NH2-terminal kinase 1 and MKK3/p38 pathways regulated by MEK kinases 2 and 3. MEK kinase 3 activates MKK3 but does not cause activation of p38 kinase in vivo.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >1997</bp:YEAR>
      <bp:AUTHORS >Deacon K</bp:AUTHORS>
      <bp:AUTHORS >Blank JL</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="d95">
      <bp:ID >10325235</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Activated protein kinase C isoforms target to cardiomyocyte caveolae : stimulation of local protein phosphorylation.</bp:TITLE>
      <bp:SOURCE >Circ Res</bp:SOURCE>
      <bp:YEAR >1999</bp:YEAR>
      <bp:ID >10325235</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Activated protein kinase C isoforms target to cardiomyocyte caveolae : stimulation of local protein phosphorylation.</bp:TITLE>
      <bp:SOURCE >Circ Res</bp:SOURCE>
      <bp:YEAR >1999</bp:YEAR>
      <bp:AUTHORS >Rybin VO</bp:AUTHORS>
      <bp:AUTHORS >Xu X</bp:AUTHORS>
      <bp:AUTHORS >Steinberg SF</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="a66">
      <bp:ID >11108712</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Carbonic anhydrase levels in the tissues of flounders adapted to sea water and fresh water.</bp:TITLE>
      <bp:SOURCE >Comp Biochem Physiol A Comp Physiol</bp:SOURCE>
      <bp:YEAR >1975</bp:YEAR>
      <bp:AUTHORS >Swarthout JT</bp:AUTHORS>
      <bp:AUTHORS >Doggett TA</bp:AUTHORS>
      <bp:AUTHORS >Lemker JL</bp:AUTHORS>
      <bp:AUTHORS >Partridge NC</bp:AUTHORS>
      <bp:AUTHORS >Mashiter KE</bp:AUTHORS>
      <bp:AUTHORS >Morgan MR</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="d08">
      <bp:ID >17190838</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >An essential role for RasGRP1 in mast cell function and IgE-mediated allergic response.</bp:TITLE>
      <bp:SOURCE >J Exp Med</bp:SOURCE>
      <bp:YEAR >2007</bp:YEAR>
      <bp:AUTHORS >Liu Y</bp:AUTHORS>
      <bp:AUTHORS >Zhu M</bp:AUTHORS>
      <bp:AUTHORS >Nishida K</bp:AUTHORS>
      <bp:AUTHORS >Hirano T</bp:AUTHORS>
      <bp:AUTHORS >Zhang W</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="b2f">
      <bp:ID >11306453</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Mitogen-activated protein kinase kinase 4 metastasis suppressor gene expression is inversely related to histological pattern in advancing human prostatic cancers.</bp:TITLE>
      <bp:SOURCE >Cancer Res</bp:SOURCE>
      <bp:YEAR >2001</bp:YEAR>
      <bp:ID >11306453</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Mitogen-activated protein kinase kinase 4 metastasis suppressor gene expression is inversely related to histological pattern in advancing human prostatic cancers.</bp:TITLE>
      <bp:SOURCE >Cancer Res</bp:SOURCE>
      <bp:YEAR >2001</bp:YEAR>
      <bp:ID >11306453</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Mitogen-activated protein kinase kinase 4 metastasis suppressor gene expression is inversely related to histological pattern in advancing human prostatic cancers.</bp:TITLE>
      <bp:SOURCE >Cancer Res</bp:SOURCE>
      <bp:YEAR >2001</bp:YEAR>
      <bp:AUTHORS >Kim HL</bp:AUTHORS>
      <bp:AUTHORS >Vander Griend DJ</bp:AUTHORS>
      <bp:AUTHORS >Yang X</bp:AUTHORS>
      <bp:AUTHORS >Benson DA</bp:AUTHORS>
      <bp:AUTHORS >Dubauskas Z</bp:AUTHORS>
      <bp:AUTHORS >Yoshida BA</bp:AUTHORS>
      <bp:AUTHORS >Chekmareva MA</bp:AUTHORS>
      <bp:AUTHORS >Ichikawa Y</bp:AUTHORS>
      <bp:AUTHORS >Sokoloff MH</bp:AUTHORS>
      <bp:AUTHORS >Zhan P</bp:AUTHORS>
      <bp:AUTHORS >Karrison T</bp:AUTHORS>
      <bp:AUTHORS >Lin A</bp:AUTHORS>
      <bp:AUTHORS >Stadler WM</bp:AUTHORS>
      <bp:AUTHORS >Ichikawa T</bp:AUTHORS>
      <bp:AUTHORS >Rubin MA</bp:AUTHORS>
      <bp:AUTHORS >Rinker-Schaeffer CW</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="cd7">
      <bp:ID >9218480</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Phosphorylation at conserved carboxyl-terminal hydrophobic motif regulates the catalytic and regulatory domains of protein kinase C.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >1997</bp:YEAR>
      <bp:ID >9218480</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Phosphorylation at conserved carboxyl-terminal hydrophobic motif regulates the catalytic and regulatory domains of protein kinase C.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >1997</bp:YEAR>
      <bp:AUTHORS >Edwards AS</bp:AUTHORS>
      <bp:AUTHORS >Newton AC</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="ff5">
      <bp:ID >9130707</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Convergence of MAP kinase pathways on the ternary complex factor Sap-1a.</bp:TITLE>
      <bp:SOURCE >EMBO J</bp:SOURCE>
      <bp:YEAR >1997</bp:YEAR>
      <bp:AUTHORS >Janknecht R</bp:AUTHORS>
      <bp:AUTHORS >Hunter T</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="b84">
      <bp:ID >11574420</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Hexosamine-induced fibronectin protein synthesis in mesangial cells is associated with increases in cAMP responsive element binding (CREB) phosphorylation and nuclear CREB: the involvement of protein kinases A and C.</bp:TITLE>
      <bp:SOURCE >Diabetes</bp:SOURCE>
      <bp:YEAR >2001</bp:YEAR>
      <bp:AUTHORS >Singh LP</bp:AUTHORS>
      <bp:AUTHORS >Andy J</bp:AUTHORS>
      <bp:AUTHORS >Anyamale V</bp:AUTHORS>
      <bp:AUTHORS >Greene K</bp:AUTHORS>
      <bp:AUTHORS >Alexander M</bp:AUTHORS>
      <bp:AUTHORS >Crook ED</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="eac">
      <bp:ID >10781029</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Micellar solubilization of fatty acids in aqueous media containing bile salts and phospholipids.</bp:TITLE>
      <bp:SOURCE >Br J Nutr</bp:SOURCE>
      <bp:YEAR >1976</bp:YEAR>
      <bp:AUTHORS >Neufeld B</bp:AUTHORS>
      <bp:AUTHORS >Grosse-Wilde A</bp:AUTHORS>
      <bp:AUTHORS >Hoffmeyer A</bp:AUTHORS>
      <bp:AUTHORS >Jordan BW</bp:AUTHORS>
      <bp:AUTHORS >Chen P</bp:AUTHORS>
      <bp:AUTHORS >Dinev D</bp:AUTHORS>
      <bp:AUTHORS >Ludwig S</bp:AUTHORS>
      <bp:AUTHORS >Rapp UR</bp:AUTHORS>
      <bp:AUTHORS >Smith A</bp:AUTHORS>
      <bp:AUTHORS >Lough AK</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="aed">
      <bp:ID >12623839</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Comparative studies of parasympatholytic drugs on stomach (double blind test) and analysis of relation between gastric form and tonus.</bp:TITLE>
      <bp:SOURCE >Arzneimittelforschung</bp:SOURCE>
      <bp:YEAR >1975</bp:YEAR>
      <bp:AUTHORS >Platanias LC</bp:AUTHORS>
      <bp:AUTHORS >Tohei N</bp:AUTHORS>
      <bp:AUTHORS >Hosono T</bp:AUTHORS>
      <bp:AUTHORS >Yoshinaga T</bp:AUTHORS>
      <bp:AUTHORS >Himeno S</bp:AUTHORS>
      <bp:AUTHORS >Saito R</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="f83">
      <bp:ID >8969228</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Activation of MEKK by formyl-methionyl-leucyl-phenylalanine in human neutrophils. Mapping pathways for mitogen-activated protein kinase activation.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >1996</bp:YEAR>
      <bp:ID >8969228</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Activation of MEKK by formyl-methionyl-leucyl-phenylalanine in human neutrophils. Mapping pathways for mitogen-activated protein kinase activation.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >1996</bp:YEAR>
      <bp:ID >8969228</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Activation of MEKK by formyl-methionyl-leucyl-phenylalanine in human neutrophils. Mapping pathways for mitogen-activated protein kinase activation.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >1996</bp:YEAR>
      <bp:AUTHORS >Avdi NJ</bp:AUTHORS>
      <bp:AUTHORS >Winston BW</bp:AUTHORS>
      <bp:AUTHORS >Russel M</bp:AUTHORS>
      <bp:AUTHORS >Young SK</bp:AUTHORS>
      <bp:AUTHORS >Johnson GL</bp:AUTHORS>
      <bp:AUTHORS >Worthen GS</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e67">
      <bp:ID >10666409</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >The crustacean cuticle--III. Composition of the individual layers in Cancer pagurus cuticle.</bp:TITLE>
      <bp:SOURCE >Comp Biochem Physiol A Comp Physiol</bp:SOURCE>
      <bp:YEAR >1975</bp:YEAR>
      <bp:AUTHORS >Nakano A</bp:AUTHORS>
      <bp:AUTHORS >Baines CP</bp:AUTHORS>
      <bp:AUTHORS >Kim SO</bp:AUTHORS>
      <bp:AUTHORS >Pelech SL</bp:AUTHORS>
      <bp:AUTHORS >Downey JM</bp:AUTHORS>
      <bp:AUTHORS >Cohen MV</bp:AUTHORS>
      <bp:AUTHORS >Critz SD</bp:AUTHORS>
      <bp:AUTHORS >Welinder BS</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="a52">
      <bp:ID >11560921</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >alpha-Synuclein affects the MAPK pathway and accelerates cell death.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >2001</bp:YEAR>
      <bp:AUTHORS >Iwata A</bp:AUTHORS>
      <bp:AUTHORS >Maruyama M</bp:AUTHORS>
      <bp:AUTHORS >Kanazawa I</bp:AUTHORS>
      <bp:AUTHORS >Nukina N</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="a8a">
      <bp:ID >9391009</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Repression of the calcitonin gene-related peptide promoter by 5-HT1 receptor activation.</bp:TITLE>
      <bp:SOURCE >J Neurosci</bp:SOURCE>
      <bp:YEAR >1997</bp:YEAR>
      <bp:AUTHORS >Durham PL</bp:AUTHORS>
      <bp:AUTHORS >Sharma RV</bp:AUTHORS>
      <bp:AUTHORS >Russo AF</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e8e">
      <bp:ID >10777559</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Crk activation of JNK via C3G and R-Ras.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >2000</bp:YEAR>
      <bp:AUTHORS >Mochizuki N</bp:AUTHORS>
      <bp:AUTHORS >Ohba Y</bp:AUTHORS>
      <bp:AUTHORS >Kobayashi S</bp:AUTHORS>
      <bp:AUTHORS >Otsuka N</bp:AUTHORS>
      <bp:AUTHORS >Graybiel AM</bp:AUTHORS>
      <bp:AUTHORS >Tanaka S</bp:AUTHORS>
      <bp:AUTHORS >Matsuda M</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="cbe">
      <bp:ID >11571230</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >The inhibition of the motility of human spermatozoa by various pharmacologic agents.</bp:TITLE>
      <bp:SOURCE >Biol Reprod</bp:SOURCE>
      <bp:YEAR >1975</bp:YEAR>
      <bp:ID >1117</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >The inhibition of the motility of human spermatozoa by various pharmacologic agents.</bp:TITLE>
      <bp:SOURCE >Biol Reprod</bp:SOURCE>
      <bp:YEAR >1975</bp:YEAR>
      <bp:AUTHORS >Peterson RN</bp:AUTHORS>
      <bp:AUTHORS >Freund M</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="ab4">
      <bp:ID >12649327</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Antisense protein tyrosine phosphatase 1B reverses activation of p38 mitogen-activated protein kinase in liver of ob/ob mice.</bp:TITLE>
      <bp:SOURCE >Mol Endocrinol</bp:SOURCE>
      <bp:YEAR >2003</bp:YEAR>
      <bp:AUTHORS >Gum RJ</bp:AUTHORS>
      <bp:AUTHORS >Gaede LL</bp:AUTHORS>
      <bp:AUTHORS >Heindel MA</bp:AUTHORS>
      <bp:AUTHORS >Waring JF</bp:AUTHORS>
      <bp:AUTHORS >Trevillyan JM</bp:AUTHORS>
      <bp:AUTHORS >Zinker BA</bp:AUTHORS>
      <bp:AUTHORS >Stark ME</bp:AUTHORS>
      <bp:AUTHORS >Wilcox D</bp:AUTHORS>
      <bp:AUTHORS >Jirousek MR</bp:AUTHORS>
      <bp:AUTHORS >Rondinone CM</bp:AUTHORS>
      <bp:AUTHORS >Ulrich RG</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="dca">
      <bp:ID >11732999</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >CTGF/Hcs24 induces chondrocyte differentiation through a p38 mitogen-activated protein kinase (p38MAPK), and proliferation through a p44/42 MAPK/extracellular-signal regulated kinase (ERK).</bp:TITLE>
      <bp:SOURCE >Eur J Biochem</bp:SOURCE>
      <bp:YEAR >2001</bp:YEAR>
      <bp:AUTHORS >Yosimichi G</bp:AUTHORS>
      <bp:AUTHORS >Nakanishi T</bp:AUTHORS>
      <bp:AUTHORS >Nishida T</bp:AUTHORS>
      <bp:AUTHORS >Hattori T</bp:AUTHORS>
      <bp:AUTHORS >Takano-Yamamoto T</bp:AUTHORS>
      <bp:AUTHORS >Takigawa M</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e84">
      <bp:ID >11350959</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Mitogen- and stress-activated protein kinase 1 mediates activation of Akt by ultraviolet B irradiation.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >2001</bp:YEAR>
      <bp:AUTHORS >Nomura M</bp:AUTHORS>
      <bp:AUTHORS >Kaji A</bp:AUTHORS>
      <bp:AUTHORS >Ma WY</bp:AUTHORS>
      <bp:AUTHORS >Zhong S</bp:AUTHORS>
      <bp:AUTHORS >Liu G</bp:AUTHORS>
      <bp:AUTHORS >Bowden GT</bp:AUTHORS>
      <bp:AUTHORS >Miyamoto KI</bp:AUTHORS>
      <bp:AUTHORS >Dong Z</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e0c">
      <bp:ID >14688255</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >The use of radioactive microspheres to compare the effects of hydralazine, guanethidine and SK&amp;F 24260 on the redistribution of cardiac output in anaesthetized rabbits.</bp:TITLE>
      <bp:SOURCE >Br J Pharmacol</bp:SOURCE>
      <bp:YEAR >1975</bp:YEAR>
      <bp:AUTHORS >Chrestensen CA</bp:AUTHORS>
      <bp:AUTHORS >Schroeder MJ</bp:AUTHORS>
      <bp:AUTHORS >Shabanowitz J</bp:AUTHORS>
      <bp:AUTHORS >Hunt DF</bp:AUTHORS>
      <bp:AUTHORS >Pelo JW</bp:AUTHORS>
      <bp:AUTHORS >Worthington MT</bp:AUTHORS>
      <bp:AUTHORS >Sturgill TW</bp:AUTHORS>
      <bp:AUTHORS >Johnson BM</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="f8d">
      <bp:ID >11916537</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Multiplicity of mechanisms of serotonin receptor signal transduction.</bp:TITLE>
      <bp:SOURCE >Pharmacol Ther</bp:SOURCE>
      <bp:YEAR >2001</bp:YEAR>
      <bp:ID >11916537</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Multiplicity of mechanisms of serotonin receptor signal transduction.</bp:TITLE>
      <bp:SOURCE >Pharmacol Ther</bp:SOURCE>
      <bp:YEAR >2001</bp:YEAR>
      <bp:AUTHORS >Raymond JR</bp:AUTHORS>
      <bp:AUTHORS >Mukhin YV</bp:AUTHORS>
      <bp:AUTHORS >Gelasco A</bp:AUTHORS>
      <bp:AUTHORS >Turner J</bp:AUTHORS>
      <bp:AUTHORS >Collinsworth G</bp:AUTHORS>
      <bp:AUTHORS >Gettys TW</bp:AUTHORS>
      <bp:AUTHORS >Grewal JS</bp:AUTHORS>
      <bp:AUTHORS >Garnovskaya MN</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="d34">
      <bp:ID >9759836</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Glycerol inhibition of purified and chromatin-associated mouse liver hepatoma RNA polymerase II activity.</bp:TITLE>
      <bp:SOURCE >Biochem Biophys Res Commun</bp:SOURCE>
      <bp:YEAR >1975</bp:YEAR>
      <bp:AUTHORS >Craxton A</bp:AUTHORS>
      <bp:AUTHORS >Shu G</bp:AUTHORS>
      <bp:AUTHORS >Graves JD</bp:AUTHORS>
      <bp:AUTHORS >Saklatvala J</bp:AUTHORS>
      <bp:AUTHORS >Krebs EG</bp:AUTHORS>
      <bp:AUTHORS >Clark EA</bp:AUTHORS>
      <bp:AUTHORS >Smith RJ</bp:AUTHORS>
      <bp:AUTHORS >Duerksen JD</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="dcd">
      <bp:ID >11328854</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Letter: Ocular reactions to beta-blocking drugs.</bp:TITLE>
      <bp:SOURCE >Br Med J</bp:SOURCE>
      <bp:YEAR >1975</bp:YEAR>
      <bp:AUTHORS >Maizels ET</bp:AUTHORS>
      <bp:AUTHORS >Mukherjee A</bp:AUTHORS>
      <bp:AUTHORS >Sithanandam G</bp:AUTHORS>
      <bp:AUTHORS >Peters CA</bp:AUTHORS>
      <bp:AUTHORS >Cottom J</bp:AUTHORS>
      <bp:AUTHORS >Mayo KE</bp:AUTHORS>
      <bp:AUTHORS >Hunzicker-Dunn M</bp:AUTHORS>
      <bp:AUTHORS >Wright P</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="bf5">
      <bp:ID >12181454</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Effects of phosphoinositide 3-kinase on the endothelin-1-induced activation of voltage-independent Ca(2+) channels and mitogenesis in Chinese hamster ovary cells stably expressing endothelin(a) receptor.</bp:TITLE>
      <bp:SOURCE >Mol Pharmacol</bp:SOURCE>
      <bp:YEAR >2002</bp:YEAR>
      <bp:AUTHORS >Kawanabe Y</bp:AUTHORS>
      <bp:AUTHORS >Hashimoto N</bp:AUTHORS>
      <bp:AUTHORS >Masaki T</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="a42">
      <bp:ID >12584202</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Differential production of interferon and lymphotoxin by human tonsil lymphocytes.</bp:TITLE>
      <bp:SOURCE >Cell Immunol</bp:SOURCE>
      <bp:YEAR >1975</bp:YEAR>
      <bp:AUTHORS >Bakovic M</bp:AUTHORS>
      <bp:AUTHORS >Waite K</bp:AUTHORS>
      <bp:AUTHORS >Vance DE</bp:AUTHORS>
      <bp:AUTHORS >Klimpel GR</bp:AUTHORS>
      <bp:AUTHORS >Day KD</bp:AUTHORS>
      <bp:AUTHORS >Lucas DO</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c82">
      <bp:ID >11591753</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >betac cytokine receptor-induced stimulation of cAMP response element binding protein phosphorylation requires protein kinase C in myeloid cells: a novel cytokine signal transduction cascade.</bp:TITLE>
      <bp:SOURCE >J Immunol</bp:SOURCE>
      <bp:YEAR >2001</bp:YEAR>
      <bp:AUTHORS >Gubina E</bp:AUTHORS>
      <bp:AUTHORS >Luo X</bp:AUTHORS>
      <bp:AUTHORS >Kwon E</bp:AUTHORS>
      <bp:AUTHORS >Sakamoto K</bp:AUTHORS>
      <bp:AUTHORS >Shi YF</bp:AUTHORS>
      <bp:AUTHORS >Mufson RA</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c29">
      <bp:ID >10096607</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Differential cellular expression of isoforms of inositol 1,4,5-triphosphate receptors in neurons and glia in brain.</bp:TITLE>
      <bp:SOURCE >J Comp Neurol</bp:SOURCE>
      <bp:YEAR >1999</bp:YEAR>
      <bp:AUTHORS >Sharp AH</bp:AUTHORS>
      <bp:AUTHORS >Nucifora FC Jr</bp:AUTHORS>
      <bp:AUTHORS >Blondel O</bp:AUTHORS>
      <bp:AUTHORS >Sheppard CA</bp:AUTHORS>
      <bp:AUTHORS >Zhang C</bp:AUTHORS>
      <bp:AUTHORS >Snyder SH</bp:AUTHORS>
      <bp:AUTHORS >Russell JT</bp:AUTHORS>
      <bp:AUTHORS >Ryugo DK</bp:AUTHORS>
      <bp:AUTHORS >Ross CA</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="b65">
      <bp:ID >19179283</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Functional coding variation in recombinant inbred mouse lines reveals multiple serotonin transporter-associated phenotypes.</bp:TITLE>
      <bp:SOURCE >Proc Natl Acad Sci U S A</bp:SOURCE>
      <bp:YEAR >2009</bp:YEAR>
      <bp:AUTHORS >Carneiro AM</bp:AUTHORS>
      <bp:AUTHORS >Airey DC</bp:AUTHORS>
      <bp:AUTHORS >Thompson B</bp:AUTHORS>
      <bp:AUTHORS >Zhu CB</bp:AUTHORS>
      <bp:AUTHORS >Lu L</bp:AUTHORS>
      <bp:AUTHORS >Chesler EJ</bp:AUTHORS>
      <bp:AUTHORS >Erikson KM</bp:AUTHORS>
      <bp:AUTHORS >Blakely RD</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="a75">
      <bp:ID >8668348</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Identification of signalling proteins interacting with B-Raf in the yeast two-hybrid system.</bp:TITLE>
      <bp:SOURCE >Oncogene</bp:SOURCE>
      <bp:YEAR >1996</bp:YEAR>
      <bp:ID >8668348</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Identification of signalling proteins interacting with B-Raf in the yeast two-hybrid system.</bp:TITLE>
      <bp:SOURCE >Oncogene</bp:SOURCE>
      <bp:YEAR >1996</bp:YEAR>
      <bp:AUTHORS >Papin C</bp:AUTHORS>
      <bp:AUTHORS >Denouel A</bp:AUTHORS>
      <bp:AUTHORS >Calothy G</bp:AUTHORS>
      <bp:AUTHORS >Eychene A</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="a69">
      <bp:ID >17005849</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Na+, Cl-, and pH dependence of the human choline transporter (hCHT) in Xenopus oocytes: the proton inactivation hypothesis of hCHT in synaptic vesicles.</bp:TITLE>
      <bp:SOURCE >J Neurosci</bp:SOURCE>
      <bp:YEAR >2006</bp:YEAR>
      <bp:AUTHORS >Iwamoto H</bp:AUTHORS>
      <bp:AUTHORS >Blakely RD</bp:AUTHORS>
      <bp:AUTHORS >De Felice LJ</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="a0f">
      <bp:ID >14645660</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Altered striatal function and muscarinic cholinergic receptors in acetylcholinesterase knockout mice.</bp:TITLE>
      <bp:SOURCE >Mol Pharmacol</bp:SOURCE>
      <bp:YEAR >2003</bp:YEAR>
      <bp:AUTHORS >Volpicelli-Daley LA</bp:AUTHORS>
      <bp:AUTHORS >Hrabovska A</bp:AUTHORS>
      <bp:AUTHORS >Duysen EG</bp:AUTHORS>
      <bp:AUTHORS >Ferguson SM</bp:AUTHORS>
      <bp:AUTHORS >Blakely RD</bp:AUTHORS>
      <bp:AUTHORS >Lockridge O</bp:AUTHORS>
      <bp:AUTHORS >Levey AI</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="bf3">
      <bp:ID >11306453</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Mitogen-activated protein kinase kinase 4 metastasis suppressor gene expression is inversely related to histological pattern in advancing human prostatic cancers.</bp:TITLE>
      <bp:SOURCE >Cancer Res</bp:SOURCE>
      <bp:YEAR >2001</bp:YEAR>
      <bp:ID >11306453</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Mitogen-activated protein kinase kinase 4 metastasis suppressor gene expression is inversely related to histological pattern in advancing human prostatic cancers.</bp:TITLE>
      <bp:SOURCE >Cancer Res</bp:SOURCE>
      <bp:YEAR >2001</bp:YEAR>
      <bp:ID >11306453</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Mitogen-activated protein kinase kinase 4 metastasis suppressor gene expression is inversely related to histological pattern in advancing human prostatic cancers.</bp:TITLE>
      <bp:SOURCE >Cancer Res</bp:SOURCE>
      <bp:YEAR >2001</bp:YEAR>
      <bp:AUTHORS >Kim HL</bp:AUTHORS>
      <bp:AUTHORS >Vander Griend DJ</bp:AUTHORS>
      <bp:AUTHORS >Yang X</bp:AUTHORS>
      <bp:AUTHORS >Benson DA</bp:AUTHORS>
      <bp:AUTHORS >Dubauskas Z</bp:AUTHORS>
      <bp:AUTHORS >Yoshida BA</bp:AUTHORS>
      <bp:AUTHORS >Chekmareva MA</bp:AUTHORS>
      <bp:AUTHORS >Ichikawa Y</bp:AUTHORS>
      <bp:AUTHORS >Sokoloff MH</bp:AUTHORS>
      <bp:AUTHORS >Zhan P</bp:AUTHORS>
      <bp:AUTHORS >Karrison T</bp:AUTHORS>
      <bp:AUTHORS >Lin A</bp:AUTHORS>
      <bp:AUTHORS >Stadler WM</bp:AUTHORS>
      <bp:AUTHORS >Ichikawa T</bp:AUTHORS>
      <bp:AUTHORS >Rubin MA</bp:AUTHORS>
      <bp:AUTHORS >Rinker-Schaeffer CW</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="bd0">
      <bp:ID >8687465</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Difference in the mechanism of interaction of Raf-1 and B-Raf with H-Ras.</bp:TITLE>
      <bp:SOURCE >Biochem Biophys Res Commun</bp:SOURCE>
      <bp:YEAR >1996</bp:YEAR>
      <bp:AUTHORS >Shinkai M</bp:AUTHORS>
      <bp:AUTHORS >Masuda T</bp:AUTHORS>
      <bp:AUTHORS >Kariya K</bp:AUTHORS>
      <bp:AUTHORS >Tamada M</bp:AUTHORS>
      <bp:AUTHORS >Shirouzu M</bp:AUTHORS>
      <bp:AUTHORS >Yokoyama S</bp:AUTHORS>
      <bp:AUTHORS >Kataoka T</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e2c">
      <bp:ID >10931853</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Piperacetazine in the treatment of mixed neurotics.</bp:TITLE>
      <bp:SOURCE >Curr Ther Res Clin Exp</bp:SOURCE>
      <bp:YEAR >1976</bp:YEAR>
      <bp:ID >1209</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Piperacetazine in the treatment of mixed neurotics.</bp:TITLE>
      <bp:SOURCE >Curr Ther Res Clin Exp</bp:SOURCE>
      <bp:YEAR >1976</bp:YEAR>
      <bp:AUTHORS >Lapierre YD</bp:AUTHORS>
      <bp:AUTHORS >Lee M</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="ee7">
      <bp:ID >12496377</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Cutting edge: induced expression of a RhoA-specific guanine nucleotide exchange factor, p190RhoGEF, following CD40 stimulation and WEHI 231 B cell activation.</bp:TITLE>
      <bp:SOURCE >J Immunol</bp:SOURCE>
      <bp:YEAR >2003</bp:YEAR>
      <bp:AUTHORS >Lee JR</bp:AUTHORS>
      <bp:AUTHORS >Ha YJ</bp:AUTHORS>
      <bp:AUTHORS >Kim HJ</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="d77">
      <bp:ID >16452991</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >The proinflammatory cytokines interleukin-1beta and tumor necrosis factor-alpha activate serotonin transporters.</bp:TITLE>
      <bp:SOURCE >Neuropsychopharmacology</bp:SOURCE>
      <bp:YEAR >2006</bp:YEAR>
      <bp:AUTHORS >Zhu CB</bp:AUTHORS>
      <bp:AUTHORS >Blakely RD</bp:AUTHORS>
      <bp:AUTHORS >Hewlett WA</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e95">
      <bp:ID >406657</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >[3 cases of osteogenesis imperfecta of the Vrolik type]</bp:TITLE>
      <bp:SOURCE >Rev Pediatr Obstet Ginecol Pediatr</bp:SOURCE>
      <bp:YEAR >1977</bp:YEAR>
      <bp:ID >406657</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >[3 cases of osteogenesis imperfecta of the Vrolik type].</bp:TITLE>
      <bp:SOURCE >Rev Pediatr Obstet Ginecol Pediatr</bp:SOURCE>
      <bp:YEAR >1977</bp:YEAR>
      <bp:AUTHORS >Alexandru E</bp:AUTHORS>
      <bp:AUTHORS >Vasilescu E</bp:AUTHORS>
      <bp:AUTHORS >Ritli R</bp:AUTHORS>
      <bp:AUTHORS >Popa I</bp:AUTHORS>
      <bp:AUTHORS >Corneanu A</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="bd4">
      <bp:ID >3141589</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Serotonin 5-HT1D receptors in human prefrontal cortex and caudate: interaction with a GTP binding protein.</bp:TITLE>
      <bp:SOURCE >J Neurochem</bp:SOURCE>
      <bp:YEAR >1988</bp:YEAR>
      <bp:ID >3141589</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Serotonin 5-HT1D receptors in human prefrontal cortex and caudate: interaction with a GTP binding protein.</bp:TITLE>
      <bp:SOURCE >J Neurochem</bp:SOURCE>
      <bp:YEAR >1988</bp:YEAR>
      <bp:AUTHORS >Herrick-Davis K</bp:AUTHORS>
      <bp:AUTHORS >Titeler M</bp:AUTHORS>
      <bp:AUTHORS >Leonhardt S</bp:AUTHORS>
      <bp:AUTHORS >Struble R</bp:AUTHORS>
      <bp:AUTHORS >Price D</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c4f">
      <bp:ID >11732999</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >A heparan sulfate-degrading endoglycosidase from rat liver tissue.</bp:TITLE>
      <bp:SOURCE >Biochem Biophys Res Commun</bp:SOURCE>
      <bp:YEAR >1975</bp:YEAR>
      <bp:ID >1035</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >A heparan sulfate-degrading endoglycosidase from rat liver tissue.</bp:TITLE>
      <bp:SOURCE >Biochem Biophys Res Commun</bp:SOURCE>
      <bp:YEAR >1975</bp:YEAR>
      <bp:ID >1035</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >A heparan sulfate-degrading endoglycosidase from rat liver tissue.</bp:TITLE>
      <bp:SOURCE >Biochem Biophys Res Commun</bp:SOURCE>
      <bp:YEAR >1975</bp:YEAR>
      <bp:AUTHORS >H&#246;&#246;k M</bp:AUTHORS>
      <bp:AUTHORS >Wasteson A</bp:AUTHORS>
      <bp:AUTHORS >Oldberg A</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c36">
      <bp:ID >14532295</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >RasGRP1 represents a novel non-protein kinase C phorbol ester signaling pathway in mouse epidermal keratinocytes.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >2003</bp:YEAR>
      <bp:ID >14532295</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >RasGRP1 represents a novel non-protein kinase C phorbol ester signaling pathway in mouse epidermal keratinocytes.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >2003</bp:YEAR>
      <bp:ID >14532295</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >RasGRP1 represents a novel non-protein kinase C phorbol ester signaling pathway in mouse epidermal keratinocytes.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >2003</bp:YEAR>
      <bp:AUTHORS >Rambaratsingh RA</bp:AUTHORS>
      <bp:AUTHORS >Stone JC</bp:AUTHORS>
      <bp:AUTHORS >Blumberg PM</bp:AUTHORS>
      <bp:AUTHORS >Lorenzo PS</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="f89">
      <bp:ID >10487749</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >The p38 MAP kinase pathway signals for cytokine-induced mRNA stabilization via MAP kinase-activated protein kinase 2 and an AU-rich region-targeted mechanism.</bp:TITLE>
      <bp:SOURCE >EMBO J</bp:SOURCE>
      <bp:YEAR >1999</bp:YEAR>
      <bp:AUTHORS >Winzen R</bp:AUTHORS>
      <bp:AUTHORS >Kracht M</bp:AUTHORS>
      <bp:AUTHORS >Ritter B</bp:AUTHORS>
      <bp:AUTHORS >Wilhelm A</bp:AUTHORS>
      <bp:AUTHORS >Chen CY</bp:AUTHORS>
      <bp:AUTHORS >Shyu AB</bp:AUTHORS>
      <bp:AUTHORS >M&#252;ller M</bp:AUTHORS>
      <bp:AUTHORS >Gaestel M</bp:AUTHORS>
      <bp:AUTHORS >Resch K</bp:AUTHORS>
      <bp:AUTHORS >Holtmann H</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e9e">
      <bp:ID >11090049</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Hepatic nucleases. Extrahepatic origin and association of neutral liver ribonuclease with lysosomes.</bp:TITLE>
      <bp:SOURCE >Eur J Biochem</bp:SOURCE>
      <bp:YEAR >1975</bp:YEAR>
      <bp:ID >1273</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Hepatic nucleases. Extrahepatic origin and association of neutral liver ribonuclease with lysosomes.</bp:TITLE>
      <bp:SOURCE >Eur J Biochem</bp:SOURCE>
      <bp:YEAR >1975</bp:YEAR>
      <bp:ID >1273</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Hepatic nucleases. Extrahepatic origin and association of neutral liver ribonuclease with lysosomes.</bp:TITLE>
      <bp:SOURCE >Eur J Biochem</bp:SOURCE>
      <bp:YEAR >1975</bp:YEAR>
      <bp:AUTHORS >Bartholeyns J</bp:AUTHORS>
      <bp:AUTHORS >Peeters-Joris C</bp:AUTHORS>
      <bp:AUTHORS >Baudhuin P</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="fa7">
      <bp:ID >9831561</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Regulation of nerve growth mediated by inositol 1,4,5-trisphosphate receptors in growth cones.</bp:TITLE>
      <bp:SOURCE >Science</bp:SOURCE>
      <bp:YEAR >1998</bp:YEAR>
      <bp:AUTHORS >Takei K</bp:AUTHORS>
      <bp:AUTHORS >Shin RM</bp:AUTHORS>
      <bp:AUTHORS >Inoue T</bp:AUTHORS>
      <bp:AUTHORS >Kato K</bp:AUTHORS>
      <bp:AUTHORS >Mikoshiba K</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="ed7">
      <bp:ID >12414794</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Antiarrhythmic, haemodynamic and metabolic effects of 3alpha-amino-5alpha-androstan-2beta-ol-17-one hydrochloride in greyhounds following acute coronary artery ligation.</bp:TITLE>
      <bp:SOURCE >Br J Pharmacol</bp:SOURCE>
      <bp:YEAR >1975</bp:YEAR>
      <bp:AUTHORS >Gupta P</bp:AUTHORS>
      <bp:AUTHORS >Prywes R</bp:AUTHORS>
      <bp:AUTHORS >Marshall RJ</bp:AUTHORS>
      <bp:AUTHORS >Parratt JR</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c11">
      <bp:ID >12588875</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >MAPK signaling up-regulates the activity of hypoxia-inducible factors by its effects on p300.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >2003</bp:YEAR>
      <bp:AUTHORS >Sang N</bp:AUTHORS>
      <bp:AUTHORS >Stiehl DP</bp:AUTHORS>
      <bp:AUTHORS >Bohensky J</bp:AUTHORS>
      <bp:AUTHORS >Leshchinsky I</bp:AUTHORS>
      <bp:AUTHORS >Srinivas V</bp:AUTHORS>
      <bp:AUTHORS >Caro J</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="ccb">
      <bp:ID >15963952</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Proteomic analysis of human norepinephrine transporter complexes reveals associations with protein phosphatase 2A anchoring subunit and 14-3-3 proteins.</bp:TITLE>
      <bp:SOURCE >Biochem Biophys Res Commun</bp:SOURCE>
      <bp:YEAR >2005</bp:YEAR>
      <bp:ID >15963952</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Proteomic analysis of human norepinephrine transporter complexes reveals associations with protein phosphatase 2A anchoring subunit and 14-3-3 proteins.</bp:TITLE>
      <bp:SOURCE >Biochem Biophys Res Commun</bp:SOURCE>
      <bp:YEAR >2005</bp:YEAR>
      <bp:ID >15963952</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Proteomic analysis of human norepinephrine transporter complexes reveals associations with protein phosphatase 2A anchoring subunit and 14-3-3 proteins.</bp:TITLE>
      <bp:SOURCE >Biochem Biophys Res Commun</bp:SOURCE>
      <bp:YEAR >2005</bp:YEAR>
      <bp:AUTHORS >Sung U</bp:AUTHORS>
      <bp:AUTHORS >Jennings JL</bp:AUTHORS>
      <bp:AUTHORS >Link AJ</bp:AUTHORS>
      <bp:AUTHORS >Blakely RD</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="a0b">
      <bp:ID >14697674</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Cell surface trafficking of the antidepressant-sensitive norepinephrine transporter revealed with an ectodomain antibody.</bp:TITLE>
      <bp:SOURCE >Mol Cell Neurosci</bp:SOURCE>
      <bp:YEAR >2003</bp:YEAR>
      <bp:AUTHORS >Savchenko V</bp:AUTHORS>
      <bp:AUTHORS >Sung U</bp:AUTHORS>
      <bp:AUTHORS >Blakely RD</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c5e">
      <bp:ID >8846784</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Studies of oxygen binding energy to hemoglobin molecule.</bp:TITLE>
      <bp:SOURCE >Biochem Biophys Res Commun</bp:SOURCE>
      <bp:YEAR >1975</bp:YEAR>
      <bp:AUTHORS >Ben-Levy R</bp:AUTHORS>
      <bp:AUTHORS >Leighton IA</bp:AUTHORS>
      <bp:AUTHORS >Doza YN</bp:AUTHORS>
      <bp:AUTHORS >Attwood P</bp:AUTHORS>
      <bp:AUTHORS >Morrice N</bp:AUTHORS>
      <bp:AUTHORS >Marshall CJ</bp:AUTHORS>
      <bp:AUTHORS >Cohen P</bp:AUTHORS>
      <bp:AUTHORS >Chow YW</bp:AUTHORS>
      <bp:AUTHORS >Pietranico R</bp:AUTHORS>
      <bp:AUTHORS >Mukerji A</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="ddd">
      <bp:ID >10993748</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >SAPKs regulation of ischemic preconditioning.</bp:TITLE>
      <bp:SOURCE >Am J Physiol Heart Circ Physiol</bp:SOURCE>
      <bp:YEAR >2000</bp:YEAR>
      <bp:AUTHORS >Sato M</bp:AUTHORS>
      <bp:AUTHORS >Cordis GA</bp:AUTHORS>
      <bp:AUTHORS >Maulik N</bp:AUTHORS>
      <bp:AUTHORS >Das DK</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e6c">
      <bp:ID >12730329</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Lysophosphatidic acid signals through mitogen-activated protein kinase-extracellular signal regulated kinase in ovarian theca cells expressing the LPA1/edg2-receptor: involvement of a nonclassical pathway?</bp:TITLE>
      <bp:SOURCE >Mol Endocrinol</bp:SOURCE>
      <bp:YEAR >2003</bp:YEAR>
      <bp:AUTHORS >Budnik LT</bp:AUTHORS>
      <bp:AUTHORS >Brunswig-Spickenheier B</bp:AUTHORS>
      <bp:AUTHORS >Mukhopadhyay AK</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="a84">
      <bp:ID >131101359</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Physiology of an ATP receptor in labellar sensilla of the tsetse fly Glossina morsitans morsitans Westw. (Diptera: Glossinidae).</bp:TITLE>
      <bp:SOURCE >J Exp Biol</bp:SOURCE>
      <bp:YEAR >1976</bp:YEAR>
      <bp:ID >11268</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Physiology of an ATP receptor in labellar sensilla of the tsetse fly Glossina morsitans morsitans Westw. (Diptera: Glossinidae).</bp:TITLE>
      <bp:SOURCE >J Exp Biol</bp:SOURCE>
      <bp:YEAR >1976</bp:YEAR>
      <bp:ID >11268</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Physiology of an ATP receptor in labellar sensilla of the tsetse fly Glossina morsitans morsitans Westw. (Diptera: Glossinidae).</bp:TITLE>
      <bp:SOURCE >J Exp Biol</bp:SOURCE>
      <bp:YEAR >1976</bp:YEAR>
      <bp:AUTHORS >Mitchell BK</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="a67">
      <bp:ID >12529254</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Changes in plasma glucose and liver glycogen following the administration of gluconeogenic precursors to the starving fowl.</bp:TITLE>
      <bp:SOURCE >Comp Biochem Physiol A Comp Physiol</bp:SOURCE>
      <bp:YEAR >1975</bp:YEAR>
      <bp:AUTHORS >Gendron FP</bp:AUTHORS>
      <bp:AUTHORS >Neary JT</bp:AUTHORS>
      <bp:AUTHORS >Theiss PM</bp:AUTHORS>
      <bp:AUTHORS >Sun GY</bp:AUTHORS>
      <bp:AUTHORS >Gonzalez FA</bp:AUTHORS>
      <bp:AUTHORS >Weisman GA</bp:AUTHORS>
      <bp:AUTHORS >Davison TF</bp:AUTHORS>
      <bp:AUTHORS >Langslow DR</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="dab">
      <bp:ID >15774771</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Evidence for biphasic effects of protein kinase C on serotonin transporter function, endocytosis, and phosphorylation.</bp:TITLE>
      <bp:SOURCE >Mol Pharmacol</bp:SOURCE>
      <bp:YEAR >2005</bp:YEAR>
      <bp:AUTHORS >Jayanthi LD</bp:AUTHORS>
      <bp:AUTHORS >Samuvel DJ</bp:AUTHORS>
      <bp:AUTHORS >Blakely RD</bp:AUTHORS>
      <bp:AUTHORS >Ramamoorthy S</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e1f">
      <bp:ID >11038347</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Nitrosation of phenacetin. Formation of N-nitroso-2-nitro-4-ethoxyacetanilide as an unstable product of the nitrosation in dilute aqueous-acidic solution.</bp:TITLE>
      <bp:SOURCE >Arzneimittelforschung</bp:SOURCE>
      <bp:YEAR >1975</bp:YEAR>
      <bp:AUTHORS >MacKeigan JP</bp:AUTHORS>
      <bp:AUTHORS >Collins TS</bp:AUTHORS>
      <bp:AUTHORS >Ting JP</bp:AUTHORS>
      <bp:AUTHORS >Eisenbrand G</bp:AUTHORS>
      <bp:AUTHORS >Preussmann R</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e64">
      <bp:ID >10854065</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >A novel rap1/B-Raf/14-3-3 theta protein complex is formed in vivo during the morphogenetic differentiation of postmeiotic male germ cells.</bp:TITLE>
      <bp:SOURCE >Exp Cell Res</bp:SOURCE>
      <bp:YEAR >2000</bp:YEAR>
      <bp:AUTHORS >Berruti G</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="cc3">
      <bp:ID >14499342</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Formate assay in body fluids: application in methanol poisoning.</bp:TITLE>
      <bp:SOURCE >Biochem Med</bp:SOURCE>
      <bp:YEAR >1975</bp:YEAR>
      <bp:AUTHORS >Coxon PY</bp:AUTHORS>
      <bp:AUTHORS >Rane MJ</bp:AUTHORS>
      <bp:AUTHORS >Uriarte S</bp:AUTHORS>
      <bp:AUTHORS >Powell DW</bp:AUTHORS>
      <bp:AUTHORS >Singh S</bp:AUTHORS>
      <bp:AUTHORS >Butt W</bp:AUTHORS>
      <bp:AUTHORS >Chen Q</bp:AUTHORS>
      <bp:AUTHORS >McLeish KR</bp:AUTHORS>
      <bp:AUTHORS >Makar AB</bp:AUTHORS>
      <bp:AUTHORS >McMartin KE</bp:AUTHORS>
      <bp:AUTHORS >Palese M</bp:AUTHORS>
      <bp:AUTHORS >Tephly TR</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="fef">
      <bp:ID >8429046</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >The regulatory domain of protein kinase C beta 1 contains phosphatidylserine- and phorbol ester-dependent calcium binding activity.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >1993</bp:YEAR>
      <bp:ID >8429046</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >The regulatory domain of protein kinase C beta 1 contains phosphatidylserine- and phorbol ester-dependent calcium binding activity.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >1993</bp:YEAR>
      <bp:AUTHORS >Luo JH</bp:AUTHORS>
      <bp:AUTHORS >Kahn S</bp:AUTHORS>
      <bp:AUTHORS >O'Driscoll K</bp:AUTHORS>
      <bp:AUTHORS >Weinstein IB</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="b69">
      <bp:ID >14749369</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Activation of H-Ras in the endoplasmic reticulum by the RasGRF family guanine nucleotide exchange factors.</bp:TITLE>
      <bp:SOURCE >Mol Cell Biol</bp:SOURCE>
      <bp:YEAR >2004</bp:YEAR>
      <bp:ID >14749369</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Activation of H-Ras in the endoplasmic reticulum by the RasGRF family guanine nucleotide exchange factors.</bp:TITLE>
      <bp:SOURCE >Mol Cell Biol</bp:SOURCE>
      <bp:YEAR >2004</bp:YEAR>
      <bp:AUTHORS >Arozarena I</bp:AUTHORS>
      <bp:AUTHORS >Matallanas D</bp:AUTHORS>
      <bp:AUTHORS >Berciano MT</bp:AUTHORS>
      <bp:AUTHORS >Sanz-Moreno V</bp:AUTHORS>
      <bp:AUTHORS >Calvo F</bp:AUTHORS>
      <bp:AUTHORS >Mu&#241;oz MT</bp:AUTHORS>
      <bp:AUTHORS >Egea G</bp:AUTHORS>
      <bp:AUTHORS >Lafarga M</bp:AUTHORS>
      <bp:AUTHORS >Crespo P</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="cd8">
      <bp:ID >9789079</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >A Rap guanine nucleotide exchange factor enriched highly in the basal ganglia.</bp:TITLE>
      <bp:SOURCE >Proc Natl Acad Sci U S A</bp:SOURCE>
      <bp:YEAR >1998</bp:YEAR>
      <bp:AUTHORS >Kawasaki H</bp:AUTHORS>
      <bp:AUTHORS >Springett GM</bp:AUTHORS>
      <bp:AUTHORS >Toki S</bp:AUTHORS>
      <bp:AUTHORS >Canales JJ</bp:AUTHORS>
      <bp:AUTHORS >Harlan P</bp:AUTHORS>
      <bp:AUTHORS >Blumenstiel JP</bp:AUTHORS>
      <bp:AUTHORS >Chen EJ</bp:AUTHORS>
      <bp:AUTHORS >Bany IA</bp:AUTHORS>
      <bp:AUTHORS >Mochizuki N</bp:AUTHORS>
      <bp:AUTHORS >Ashbacher A</bp:AUTHORS>
      <bp:AUTHORS >Matsuda M</bp:AUTHORS>
      <bp:AUTHORS >Housman DE</bp:AUTHORS>
      <bp:AUTHORS >Graybiel AM</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="fa5">
      <bp:ID >7559496</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >The mouse B-raf gene encodes multiple protein isoforms with tissue-specific expression.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >1995</bp:YEAR>
      <bp:AUTHORS >Barnier JV</bp:AUTHORS>
      <bp:AUTHORS >Papin C</bp:AUTHORS>
      <bp:AUTHORS >Eychene A</bp:AUTHORS>
      <bp:AUTHORS >Lecoq O</bp:AUTHORS>
      <bp:AUTHORS >Calothy G</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="b07">
      <bp:ID >12595573</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Phosphoinositide 3-kinase activity is required for biphasic stimulation of cyclic adenosine 3',5'-monophosphate by relaxin.</bp:TITLE>
      <bp:SOURCE >Mol Endocrinol</bp:SOURCE>
      <bp:YEAR >2003</bp:YEAR>
      <bp:AUTHORS >Nguyen BT</bp:AUTHORS>
      <bp:AUTHORS >Yang L</bp:AUTHORS>
      <bp:AUTHORS >Sanborn BM</bp:AUTHORS>
      <bp:AUTHORS >Dessauer CW</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="d5d">
      <bp:ID >11400324</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >[The involvement of phosphoinositide 3-kinase (PI3-Kinase) and phospholipase C gamma (PLC gamma) pathway in the morphine-induced supraspinal antinociception in the mouse]</bp:TITLE>
      <bp:SOURCE >Nihon Shinkei Seishin Yakurigaku Zasshi</bp:SOURCE>
      <bp:YEAR >2001</bp:YEAR>
      <bp:ID >11400324</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >[The involvement of phosphoinositide 3-kinase (PI3-Kinase) and phospholipase C gamma (PLC gamma) pathway in the morphine-induced supraspinal antinociception in the mouse]</bp:TITLE>
      <bp:SOURCE >Nihon Shinkei Seishin Yakurigaku Zasshi</bp:SOURCE>
      <bp:YEAR >2001</bp:YEAR>
      <bp:AUTHORS >Narita M</bp:AUTHORS>
      <bp:AUTHORS >Ohnishi O</bp:AUTHORS>
      <bp:AUTHORS >Nemoto M</bp:AUTHORS>
      <bp:AUTHORS >Aoki T</bp:AUTHORS>
      <bp:AUTHORS >Suzuki T</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="f81">
      <bp:ID >8910314</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Phase changes induced by cyclopropane of phosphatidylserine bilayers in the presence and absence of calcium.</bp:TITLE>
      <bp:SOURCE >Biochem Biophys Res Commun</bp:SOURCE>
      <bp:YEAR >1975</bp:YEAR>
      <bp:ID >1030</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Phase changes induced by cyclopropane of phosphatidylserine bilayers in the presence and absence of calcium.</bp:TITLE>
      <bp:SOURCE >Biochem Biophys Res Commun</bp:SOURCE>
      <bp:YEAR >1975</bp:YEAR>
      <bp:AUTHORS >Simon SA</bp:AUTHORS>
      <bp:AUTHORS >MacDonald RC</bp:AUTHORS>
      <bp:AUTHORS >Bennett PB</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="fb7">
      <bp:ID >11846562</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Crystal structure of a ternary SAP-1/SRF/c-fos SRE DNA complex.</bp:TITLE>
      <bp:SOURCE >J Mol Biol</bp:SOURCE>
      <bp:YEAR >2001</bp:YEAR>
      <bp:ID >11846562</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Crystal structure of a ternary SAP-1/SRF/c-fos SRE DNA complex.</bp:TITLE>
      <bp:SOURCE >J Mol Biol</bp:SOURCE>
      <bp:YEAR >2001</bp:YEAR>
      <bp:AUTHORS >Mo Y</bp:AUTHORS>
      <bp:AUTHORS >Ho W</bp:AUTHORS>
      <bp:AUTHORS >Johnston K</bp:AUTHORS>
      <bp:AUTHORS >Marmorstein R</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="da5">
      <bp:ID >9162092</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Characterization of the mitogen-activated protein kinase kinase 4 (MKK4)/c-Jun NH2-terminal kinase 1 and MKK3/p38 pathways regulated by MEK kinases 2 and 3. MEK kinase 3 activates MKK3 but does not cause activation of p38 kinase in vivo.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >1997</bp:YEAR>
      <bp:AUTHORS >Deacon K</bp:AUTHORS>
      <bp:AUTHORS >Blank JL</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c8a">
      <bp:ID >9607940</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Single-channel properties of inositol (1,4,5)-trisphosphate receptor heterologously expressed in HEK-293 cells.</bp:TITLE>
      <bp:SOURCE >J Gen Physiol</bp:SOURCE>
      <bp:YEAR >1998</bp:YEAR>
      <bp:AUTHORS >Kaznacheyeva E</bp:AUTHORS>
      <bp:AUTHORS >Lupu VD</bp:AUTHORS>
      <bp:AUTHORS >Bezprozvanny I</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="ebb">
      <bp:ID >8633244</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Regulation of the inositol 1,4,5-trisphosphate receptor by tyrosine phosphorylation.</bp:TITLE>
      <bp:SOURCE >Science</bp:SOURCE>
      <bp:YEAR >1996</bp:YEAR>
      <bp:AUTHORS >Jayaraman T</bp:AUTHORS>
      <bp:AUTHORS >Ondrias K</bp:AUTHORS>
      <bp:AUTHORS >Ondriasov&#225; E</bp:AUTHORS>
      <bp:AUTHORS >Marks AR</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="cca">
      <bp:ID >12242299</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Distinct cell cycle timing requirements for extracellular signal-regulated kinase and phosphoinositide 3-kinase signaling pathways in somatic cell mitosis.</bp:TITLE>
      <bp:SOURCE >Mol Cell Biol</bp:SOURCE>
      <bp:YEAR >2002</bp:YEAR>
      <bp:ID >12242299</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Distinct cell cycle timing requirements for extracellular signal-regulated kinase and phosphoinositide 3-kinase signaling pathways in somatic cell mitosis.</bp:TITLE>
      <bp:SOURCE >Mol Cell Biol</bp:SOURCE>
      <bp:YEAR >2002</bp:YEAR>
      <bp:AUTHORS >Roberts EC</bp:AUTHORS>
      <bp:AUTHORS >Shapiro PS</bp:AUTHORS>
      <bp:AUTHORS >Nahreini TS</bp:AUTHORS>
      <bp:AUTHORS >Pages G</bp:AUTHORS>
      <bp:AUTHORS >Pouyssegur J</bp:AUTHORS>
      <bp:AUTHORS >Ahn NG</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="f52">
      <bp:ID >15103690</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Ultrastructural interactions between terminals expressing the norepinephrine transporter and dopamine neurons in the rat and monkey ventral tegmental area.</bp:TITLE>
      <bp:SOURCE >Synapse</bp:SOURCE>
      <bp:YEAR >2004</bp:YEAR>
      <bp:AUTHORS >Liprando LA</bp:AUTHORS>
      <bp:AUTHORS >Miner LH</bp:AUTHORS>
      <bp:AUTHORS >Blakely RD</bp:AUTHORS>
      <bp:AUTHORS >Lewis DA</bp:AUTHORS>
      <bp:AUTHORS >Sesack SR</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="fbb">
      <bp:ID >9688849</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Effects of divalent cations on single-channel conduction properties of Xenopus IP3 receptor.</bp:TITLE>
      <bp:SOURCE >Am J Physiol</bp:SOURCE>
      <bp:YEAR >1998</bp:YEAR>
      <bp:AUTHORS >Mak DO</bp:AUTHORS>
      <bp:AUTHORS >Foskett JK</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="fe8">
      <bp:ID >9346921</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Activation of p38 mitogen-activated protein kinase by signaling through G protein-coupled receptors. Involvement of Gbetagamma and Galphaq/11 subunits.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >1997</bp:YEAR>
      <bp:AUTHORS >Yamauchi J</bp:AUTHORS>
      <bp:AUTHORS >Nagao M</bp:AUTHORS>
      <bp:AUTHORS >Kaziro Y</bp:AUTHORS>
      <bp:AUTHORS >Itoh H</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="ab9">
      <bp:ID >10969079</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >MEKK1 binds raf-1 and the ERK2 cascade components.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >2000</bp:YEAR>
      <bp:AUTHORS >Karandikar M</bp:AUTHORS>
      <bp:AUTHORS >Xu S</bp:AUTHORS>
      <bp:AUTHORS >Cobb MH</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e01">
      <bp:ID >11956220</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Activation of human monoamine oxidase B gene expression by a protein kinase C MAPK signal transduction pathway involves c-Jun and Egr-1.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >2002</bp:YEAR>
      <bp:ID >11956220</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Activation of human monoamine oxidase B gene expression by a protein kinase C MAPK signal transduction pathway involves c-Jun and Egr-1.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >2002</bp:YEAR>
      <bp:AUTHORS >Wong WK</bp:AUTHORS>
      <bp:AUTHORS >Ou XM</bp:AUTHORS>
      <bp:AUTHORS >Chen K</bp:AUTHORS>
      <bp:AUTHORS >Shih JC</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="bfc">
      <bp:ID >11376011</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >The carboxyl terminus of protein kinase c provides a switch to regulate its interaction with the phosphoinositide-dependent kinase, PDK-1.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >2001</bp:YEAR>
      <bp:AUTHORS >Gao T</bp:AUTHORS>
      <bp:AUTHORS >Toker A</bp:AUTHORS>
      <bp:AUTHORS >Newton AC</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="d1d">
      <bp:ID >9642252</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Physiological disposition and metabolism of 5-(2',4'-difluorophenyl)salicyclic acid, a new salicylate.</bp:TITLE>
      <bp:SOURCE >Drug Metab Dispos</bp:SOURCE>
      <bp:YEAR >1975</bp:YEAR>
      <bp:ID >1220</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Physiological disposition and metabolism of 5-(2',4'-difluorophenyl)salicyclic acid, a new salicylate.</bp:TITLE>
      <bp:SOURCE >Drug Metab Dispos</bp:SOURCE>
      <bp:YEAR >1975</bp:YEAR>
      <bp:AUTHORS >Tocco DJ</bp:AUTHORS>
      <bp:AUTHORS >Breault GO</bp:AUTHORS>
      <bp:AUTHORS >Zacchei AG</bp:AUTHORS>
      <bp:AUTHORS >Steelman SL</bp:AUTHORS>
      <bp:AUTHORS >Perrier CV</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c19">
      <bp:ID >15213298</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >PKCdelta associates with and is involved in the phosphorylation of RasGRP3 in response to phorbol esters.</bp:TITLE>
      <bp:SOURCE >Mol Pharmacol</bp:SOURCE>
      <bp:YEAR >2004</bp:YEAR>
      <bp:AUTHORS >Brodie C</bp:AUTHORS>
      <bp:AUTHORS >Steinhart R</bp:AUTHORS>
      <bp:AUTHORS >Kazimirsky G</bp:AUTHORS>
      <bp:AUTHORS >Rubinfeld H</bp:AUTHORS>
      <bp:AUTHORS >Hyman T</bp:AUTHORS>
      <bp:AUTHORS >Ayres JN</bp:AUTHORS>
      <bp:AUTHORS >Hur GM</bp:AUTHORS>
      <bp:AUTHORS >Toth A</bp:AUTHORS>
      <bp:AUTHORS >Yang D</bp:AUTHORS>
      <bp:AUTHORS >Garfield SH</bp:AUTHORS>
      <bp:AUTHORS >Stone JC</bp:AUTHORS>
      <bp:AUTHORS >Blumberg PM</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="f96">
      <bp:ID >14984580</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >The T1796A mutation of the BRAF gene is absent in Spitz nevi.</bp:TITLE>
      <bp:SOURCE >J Cutan Pathol</bp:SOURCE>
      <bp:YEAR >2004</bp:YEAR>
      <bp:AUTHORS >Palmedo G</bp:AUTHORS>
      <bp:AUTHORS >Hantschke M</bp:AUTHORS>
      <bp:AUTHORS >R&#252;tten A</bp:AUTHORS>
      <bp:AUTHORS >Mentzel T</bp:AUTHORS>
      <bp:AUTHORS >H&#252;gel H</bp:AUTHORS>
      <bp:AUTHORS >Flaig MJ</bp:AUTHORS>
      <bp:AUTHORS >Yazdi AS</bp:AUTHORS>
      <bp:AUTHORS >Sander CA</bp:AUTHORS>
      <bp:AUTHORS >Kutzner H</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="a92">
      <bp:ID >12972622</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Protein kinase Calpha (PKCalpha) acts upstream of PKCtheta to activate IkappaB kinase and NF-kappaB in T lymphocytes.</bp:TITLE>
      <bp:SOURCE >Mol Cell Biol</bp:SOURCE>
      <bp:YEAR >2003</bp:YEAR>
      <bp:AUTHORS >Trushin SA</bp:AUTHORS>
      <bp:AUTHORS >Pennington KN</bp:AUTHORS>
      <bp:AUTHORS >Carmona EM</bp:AUTHORS>
      <bp:AUTHORS >Asin S</bp:AUTHORS>
      <bp:AUTHORS >Savoy DN</bp:AUTHORS>
      <bp:AUTHORS >Billadeau DD</bp:AUTHORS>
      <bp:AUTHORS >Paya CV</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e7b">
      <bp:ID >8765993</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Mechanisms responsible for quantal Ca2+ release from inositol trisphosphate-sensitive calcium stores.</bp:TITLE>
      <bp:SOURCE >Pflugers Arch</bp:SOURCE>
      <bp:YEAR >1996</bp:YEAR>
      <bp:AUTHORS >Parys JB</bp:AUTHORS>
      <bp:AUTHORS >Missiaen L</bp:AUTHORS>
      <bp:AUTHORS >Smedt HD</bp:AUTHORS>
      <bp:AUTHORS >Sienaert I</bp:AUTHORS>
      <bp:AUTHORS >Casteels R</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="f8c">
      <bp:ID >10825383</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Reconstitution of the human 5-HT(1D) receptor-G-protein coupling: evidence for constitutive activity and multiple receptor conformations.</bp:TITLE>
      <bp:SOURCE >Mol Pharmacol</bp:SOURCE>
      <bp:YEAR >2000</bp:YEAR>
      <bp:AUTHORS >Brys R</bp:AUTHORS>
      <bp:AUTHORS >Josson K</bp:AUTHORS>
      <bp:AUTHORS >Castelli MP</bp:AUTHORS>
      <bp:AUTHORS >Jurzak M</bp:AUTHORS>
      <bp:AUTHORS >Lijnen P</bp:AUTHORS>
      <bp:AUTHORS >Gommeren W</bp:AUTHORS>
      <bp:AUTHORS >Leysen JE</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="ba7">
      <bp:ID >11032810</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Activation of B-Raf kinase requires phosphorylation of the conserved residues Thr598 and Ser601.</bp:TITLE>
      <bp:SOURCE >EMBO J</bp:SOURCE>
      <bp:YEAR >2000</bp:YEAR>
      <bp:AUTHORS >Zhang BH</bp:AUTHORS>
      <bp:AUTHORS >Guan KL</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c6a">
      <bp:ID >9687510</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Mitogen- and stress-activated protein kinase-1 (MSK1) is directly activated by MAPK and SAPK2/p38, and may mediate activation of CREB.</bp:TITLE>
      <bp:SOURCE >EMBO J</bp:SOURCE>
      <bp:YEAR >1998</bp:YEAR>
      <bp:AUTHORS >Deak M</bp:AUTHORS>
      <bp:AUTHORS >Clifton AD</bp:AUTHORS>
      <bp:AUTHORS >Lucocq LM</bp:AUTHORS>
      <bp:AUTHORS >Alessi DR</bp:AUTHORS>
    </bp:PublicationXref>
  </Biopax>
</Pathway>